: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension, January 2023
Free Subscription

Abstracts
Retrieve all available abstracts of the following 1902 articles:
HTML format

Single Articles

ZHOU M, Li B, Chen Y, Wang A, et al
Chest X-ray features facilitate screening for pulmonary hypertension caused by fibrosing mediastinitis.
Ther Adv Chronic Dis. 2022;13:20406223221143245.
Abstract

BELLOTTI A, Arora S, Gustafson C, Funk I, et al
Predictors of Post-induction Hypotension for Patients With Pulmonary Hypertension.
Cureus. 2022;14:e31887.
Abstract

NATHAN SD, Fernandes P, Psotka M, Vitulo P, et al
Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension.
Pulm Circ. 2022;12:e12178.
Abstract

WANG S, Guo ZY, Sun XX, Yuan P, et al
Differences in disease severity and prognosis of exercise-induced right-to-left shunt between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients.
Front Cardiovasc Med. 2022;9:976730.
Abstract

SONSOZ MR, Atamaner O, Inan D, Kilicgedik A, et al
A rare cause of pulmonary hypertension: Idiopathic fibrosing mediastinitis obstructing right pulmonary artery and pulmonary veins.
Echocardiography. 2022 Dec 28. doi: 10.1111/echo.15514.
Abstract

UYAR M
Impact of Pulmonary Hypertension on Renal Functions in Obstructive Sleep Apnea Syndrome.
South Med J. 2023;116:26-32.
Abstract

WANG Y, Zhao S, Lu M
State-of-the-Art Cardiac Magnetic Resonance in Pulmonary Hypertension: An Update on Diagnosis, Risk Stratification and Treatment.
Trends Cardiovasc Med. 2022 Dec 24:S1050-1738(22)00146.
Abstract

MAQHFIRAH NURUL FITRI A, Elim D, Alif Sya'ban Mahfud M, Aisha Fitri Sultan N, et al
Polymeric hydrogel forming microneedle-mediated transdermal delivery of sildenafil citrate from direct-compressed tablet reservoir for potential improvement of pulmonary hypertension therapy.
Int J Pharm. 2022 Dec 23:122549. doi: 10.1016/j.ijpharm.2022.122549.
Abstract

MALKMUS K, Brosien M, Knoepp F, Schaffelhofer L, et al
Deletion of classical transient receptor potential 1, 3 and 6 alters pulmonary vasoconstriction in chronic hypoxia-induced pulmonary hypertension in mice.
Front Physiol. 2022;13:1080875.
Abstract

INGRAM D, Alamri AK, Penn BA, Mayeux JD, et al
Characteristics of Patients With Pulmonary Arterial Hypertension in a Pulmonary Hypertension Association-Accredited Comprehensive Care Center: A Contrast in Features When Compared With US National Registry Data.
Cureus. 2022;14:e31764.
Abstract

PEREZ PENATE G, Ochoa Parra N, Domingo Morera JA, Martinez Menaca A, et al
Evaluation of a digital health system (PAHcare) for routine care of patients with pulmonary arterial hypertension: The CBS-PAH study protocol.
Front Public Health. 2022;10:954487.
Abstract

JUJO SANADA T, Manz XD, Symersky P, Pan X, et al
Riociguat inhibits ultra-large VWF string formation on pulmonary artery endothelial cells from chronic thromboembolic pulmonary hypertension patients.
Pulm Circ. 2022;12:e12146.
Abstract

BARATTO C, Caravita S, Soranna D, Dewachter C, et al
An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease.
Pulm Circ. 2022;12:e12145.
Abstract

ZHANG V, Ganz T, Nemeth E, Umar S, et al
Bmpr2 mutant mice are an inadequate model for studying iron deficiency in pulmonary hypertension.
Pulm Circ. 2022;12:e12151.
Abstract

HASAN H, Hysko K, Jack T, Dingemann J, et al
Case report: Rescue treatment with add-on selexipag in a preterm infant with suprasystemic pulmonary hypertension, pulmonary capillary hemangiomatosis, and isolated pulmonary vein stenosis.
Front Cardiovasc Med. 2022;9:984698.
Abstract

ZUGUROV IK, Osadchii AM, Simakova MA, Moiseeva OM, et al
Surgical treatment of chronic thromboembolic pulmonary hypertension in combination with a left anterior descending artery myocardial bridge: A case report.
Front Cardiovasc Med. 2022;9:1061665.
Abstract

WINTER P, Carusi A
Professional expectations and patient expectations concerning the development of Artificial Intelligence (AI) for the early diagnosis of Pulmonary Hypertension (PH).
J Responsib Technol. 2022;12:None.
Abstract

LIAO J, Xie SS, Deng Y, Wu DD, et al
PRDX6-mediated pulmonary artery endothelial cell ferroptosis contributes to monocrotaline-induced pulmonary hypertension.
Microvasc Res. 2022 Dec 22:104471. doi: 10.1016/j.mvr.2022.104471.
Abstract

KONG J, Hardwick A, Jiang SF, Sun K, et al
CTEPH: A Kaiser Permanente Northern California Experience.
Thromb Res. 2023;221:130-136.
Abstract

SINGH S, Aggarwal V, Pandey UK, Sreenidhi HC, et al
Study of left ventricular systolic dysfunction, left ventricular diastolic dysfunction and pulmonary hypertension in CKD 3b-5ND patients-A single centre cross-sectional study.
Nefrologia (Engl Ed). 2022 Dec 21:S2013-2514(22)00183.
Abstract

CHEN J, Zhang M, Liu Y, Zhao S, et al
Histone lactylation driven by mROS-mediated glycolytic shift promotes hypoxic pulmonary hypertension.
J Mol Cell Biol. 2022 Dec 23:mjac073. doi: 10.1093.
Abstract

GONG Q, Hu Z, Jin Q, Yan Y, et al
Identification of JPX-RABEP1 Pair as an Immune-Related Biomarker and Therapeutic Target in Pulmonary Arterial Hypertension by Bioinformatics and Experimental Analyses.
Int J Mol Sci. 2022;23:15559.
Abstract

KHOURY S, Beauvais A, Colas J, Saint-Martin Willer A, et al
Lipidomic Profile Analysis of Lung Tissues Revealed Lipointoxication in Pulmonary Veno-Occlusive Disease.
Biomolecules. 2022;12:1878.
Abstract

SALUJA P, Gautam N, Amisha F, Salah HM, et al
Influence of Iron Deficiency on Clinical and Haemodynamic Parameters in Pulmonary Arterial Hypertension Cohorts.
Heart Lung Circ. 2022;31:1594-1603.
Abstract

ASAMI M, Kanai E, Yamauchi Y, Saito Y, et al
Positive Intrapleural Pressure with Carbon Dioxide May Limit Intraoperative Pulmonary Arterial Bleeding: Verification by Animal Model.
Ann Thorac Cardiovasc Surg. 2022;28:403-410.
Abstract

LALITHA R, Surak A, Bitar E, Hyderi A, et al
Fluid and electrolyte management in preterm infants with patent ductus arteriosus.
J Neonatal Perinatal Med. 2022;15:689-697.
Abstract

LUI JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, et al
Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension.
Cardiovasc Drugs Ther. 2023 Jan 6. doi: 10.1007/s10557-022-07420.
Abstract

HASSANPOUR H, Farhadi N, Bahadoran S, Akbari MR, et al
Cardiac telomere attrition following changes in the expression of shelterin genes in pulmonary hypertensive chickens.
Br Poult Sci. 2023 Jan 6. doi: 10.1080/00071668.2022.2163877.
Abstract

BUSSE AJ, Freilinger S, Eicken A, Ewert P, et al
Healthcare status of adults with pulmonary hypertension due to congenital heart disease.
Cardiovasc Diagn Ther. 2022;12:840-852.
Abstract

FREIBERGER A, Busse A, Ewert P, Huntgeburth M, et al
Quality of life in adults with congenital heart disease with and without pulmonary hypertension: a comparative study.
Cardiovasc Diagn Ther. 2022;12:758-766.
Abstract

WIETESKA-MILEK M, Kusmierczyk-Droszcz B, Ryczek R, Szmit S, et al
Outcomes of COVID-19 in patients vaccinated and unvaccinated against SARS-CoV-2 and suffering from pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Pol Arch Intern Med. 2023 Jan 5:16406. doi: 10.20452/pamw.16406.
Abstract

THIENEMANN F, Katoto PDMC, Azibani F, Kodogo V, et al
Long-Term Follow-up of Human Immunodeficiency Virus-Associated Pulmonary Hypertension: Clinical Features and Survival Outcomes of the Pan Africa Pulmonary Hypertension Cohort (PAPUCO).
Open Forum Infect Dis. 2022;9:ofac604.
Abstract

EROUME A EGOM E, Shiwani HA, Nouthe B
From acute SARS-CoV-2 infection to pulmonary hypertension.
Front Physiol. 2022;13:1023758.
Abstract

SONNY S, Yuan H, Chen S, Duncan MR, et al
GSDMD deficiency ameliorates hyperoxia-induced BPD and ROP in neonatal mice.
Sci Rep. 2023;13:143.
Abstract

XIONG CM, Zhai ZG, Liu ZH, Wang C, et al
[How do we respond to the newly-revised haemodynamic definitions of pulmonary hypertension].
Zhonghua Yi Xue Za Zhi. 2023;103:73-77.
Abstract

DUBS L, Ulrich S, Lichtblau M, Opitz I, et al
[Pulmonary Endarterectomy and Treatment for Chronic Thromboembolic Pulmonary Hypertension].
Praxis (Bern 1994). 2023;112:28-35.
Abstract

RADCHENKO GD, Botsiuk YA, Sirenko YM
Ventricular Function and Cardio-Ankle Vascular Index in Patients With Pulmonary Artery Hypertension.
Vasc Health Risk Manag. 2022;18:889-904.
Abstract

KARIMI GALOUGAHI K, Zhang Y, Kienzle V, Liu CC, et al
beta3 adrenergic agonism: A novel pathway which improves right ventricular-pulmonary arterial hemodynamics in pulmonary arterial hypertension.
Physiol Rep. 2023;11:e15549.
Abstract

HUANG X, Akgun EE, Mehmood K, Zhang H, et al
Mechanism of Hypoxia-Mediated Smooth Muscle Cell Proliferation Leading to Vascular Remodeling.
Biomed Res Int. 2022;2022:3959845.
Abstract

HOPPER RK, van der Have O, Hollander SA, Dipchand AI, et al
International practice heterogeneity in pre-transplant management of pulmonary hypertension related to pediatric left heart disease.
Pediatr Transplant. 2023 Jan 2:e14461. doi: 10.1111/petr.14461.
Abstract

LIN F, Chen Y, Mo W, Zhou H, et al
A bibliometric analysis of autophagy in lung diseases from 2012 to 2021.
Front Immunol. 2022;13:1092575.
Abstract

SCHULZ A, Wu DM, Ishigami S, Buratto E, et al
Outcomes of total anomalous pulmonary venous drainage repair in neonates and the impact of pulmonary hypertension on survival.
JTCVS Open. 2022;12:335-343.
Abstract

SUBRAMANIAN AP, Bharath AP, Barthur A, Jayranganath M, et al
Congenital portosystemic shunt with multiple splenic artery aneurysms: Reversing pulmonary hypertension and preventing aneurysm rupture.
Ann Pediatr Cardiol. 2022;15:300-303.
Abstract

WANG J, Ni C, Yang M, Zhang X, et al
Apply pressure-strain loop to quantify myocardial work in pulmonary hypertension: A prospective cohort study.
Front Cardiovasc Med. 2022;9:1022987.
Abstract

AJAYI BA, Iheonye HO, Akor AA, Ododo BI, et al
Nonspecific Interstitial Pneumonia in a 28-Year-Old Nigerian Female: Challenges in Diagnosis and Management in Resource-Constrained Setting.
West Afr J Med. 2022;39:1316-1318.
Abstract

YAMAMOTO K, Lemay SE, Yokokawa T, Breuils-Bonnet S, et al
DNA-Protein Kinase Catalytic Subunit as a Potential Target for Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2023;68:116-119.
Abstract

KIDA T, Matsuzaki K, Yokota I, Kawase N, et al
Latent trajectory modelling of pulmonary artery pressure in systemic sclerosis: a retrospective cohort study.
RMD Open. 2022;8:e002673.
Abstract

BURGER CD, Wu B, Classi P, Morland K, et al
Inhaled treprostinil vs iloprost: Comparison of adherence, persistence, and health care resource utilization in patients with pulmonary arterial hypertension.
J Manag Care Spec Pharm. 2023;29:101-108.
Abstract

NISHIURA N, Kitai T, Okada T, Sano M, et al
Long-Term Clinical Outcomes in Patients With Severe Tricuspid Regurgitation.
J Am Heart Assoc. 2023;12:e025751.
Abstract

BAJWA EK, Cislak D, Palcza J, Feng HP, et al
Effects of an inhaled soluble guanylate cyclase (sGC) stimulator MK-5475 in pulmonary arterial hypertension (PAH).
Respir Med. 2023;206:107065.
Abstract

ALSINA-RESTOY X, Torres-Castro R, Torralba-Garcia Y, Burgos F, et al
Does arterial oxygenation during exercise add prognostic value in pulmonary arterial hypertension?
Respir Med. 2023;206:107070.
Abstract

PUJITHA V, Pandey NN, Arvind B, Kumar S, et al
Idiopathic focal fibrosing mediastinitis with unilateral pulmonary arterial and venous involvement.
J Card Surg. 2022;37:5466-5467.
Abstract

WANG X, Liu X, Liu Z, Zheng X, et al
Preoperative pulmonary vascular resistance and neutrophil-to-lymphocyte ratio predict the demand of extracorporeal membrane oxygenation after pulmonary endarterectomy.
J Card Surg. 2022;37:4861-4867.
Abstract

SAID SM, Braunlin EA, Berry J, Loomis A, et al
Successful rapid staged hybrid approach for obstructed total anomalous pulmonary venous connection.
J Card Surg. 2022;37:5501-5504.
Abstract

BOUSSEAU S, Lahm T
Hungry for Chloride: Reprogramming Endothelial Cell Metabolism in Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2023;68:11-12.
Abstract

ALZAYDI MM, Abdul-Salam VB, Whitwell HJ, Russomanno G, et al
Intracellular Chloride Channels Regulate Endothelial Metabolic Reprogramming in Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2023;68:103-115.
Abstract

AGGARWAL V, Stapleton GE, Eilers LF, Gowda S, et al
Pulmonary Vein Atresia: Feasibility of Initial Recanalization Attempts with Subsequent Follow-up.
Curr Probl Cardiol. 2023;48:101463.
Abstract

KIM MS, Kim H, Seo Y, Yum SK, et al
Non-reassuring fetal status and anesthetic impact on cesarean section-delivered very-low-birthweight infants.
Pediatr Int. 2022;64:e15308.
Abstract

VENTETUOLO CE, Moutchia J, Baird GL, Appleby DH, et al
Baseline Sex Differences in Pulmonary Arterial Hypertension Randomized Clinical Trials.
Ann Am Thorac Soc. 2023;20:58-66.
Abstract

JEONG EM, Pereira M, So EY, Wu KQ, et al
Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension.
Cardiovasc Res. 2022;118:3211-3224.
Abstract

RAMLY F, Mahamooth MIJ, Abidin HAZ, Hassan J, et al
Reversible Pulmonary Hypertension in Hyperthyroid Mother: A case report and review of prior cases.
Int J Gynaecol Obstet. 2023 Jan 13. doi: 10.1002/ijgo.14669.
Abstract

FU L, Wang R, Zhao J, Ni Y, et al
'Two-step' percutaneous procedure for repairing the atrial septal defect with severe pulmonary hypertension: a case report.
J Surg Case Rep. 2023;2023:rjac612.
Abstract

KARVASARSKI E, Bentley RF, Buchan TA, Valle FH, et al
Alterations of pulmonary vascular afterload in exercise-induced pre- and post-capillary pulmonary hypertension.
Physiol Rep. 2023;11:e15559.
Abstract

WU Z, Zhu L, Nie X, Wei L, et al
USP15 promotes pulmonary vascular remodeling in pulmonary hypertension in a YAP1/TAZ-dependent manner.
Exp Mol Med. 2023 Jan 12. doi: 10.1038/s12276-022-00920.
Abstract

LU W, Huang J, Shen Q, Sun F, et al
Identification of diagnostic biomarkers for idiopathic pulmonary hypertension with metabolic syndrome by bioinformatics and machine learning.
Sci Rep. 2023;13:615.
Abstract

KRZYZEWSKA A, Baranowska-Kuczko M, Kasacka I, Kozlowska H, et al
Cannabidiol inhibits lung proliferation in monocrotaline-induced pulmonary hypertension in rats.
Biomed Pharmacother. 2023;159:114234.
Abstract

LAMIA B, Dallongeville J, Bensimon L, Hakme A, et al
Riociguat real-world use in patients with chronic thromboembolic pulmonary hypertension: A retrospective, observational cohort study in France.
Respir Med Res. 2022;83:100987.
Abstract

HONG S, Kang X, Lio KU, LE Y, et al
Multidisciplinary approach for the management of term pregnancy complicated by Eisenmenger syndrome.
J Zhejiang Univ Sci B. 2023;24:89-93.
Abstract

LI D, Wang J, Fang Y, Hu Y, et al
Impaired cell-cell communication and axon guidance because of pulmonary hypoperfusion during postnatal alveolar development.
Respir Res. 2023;24:12.
Abstract

PALA C, Blake SM
One Size Does Not Fit All: Congenital Diaphragmatic Hernia Management in Neonates.
Neonatal Netw. 2023;42:45-51.
Abstract

MYRONENKO O, Foris V, Crnkovic S, Olschewski A, et al
Endotyping COPD: hypoxia-inducible factor-2 as a molecular "switch" between the vascular and airway phenotypes?
Eur Respir Rev. 2023;32:220173.
Abstract

DE BELEN E, McConnell JW, Elwing JM, Paculdo D, et al
Gaps in the Care of Pulmonary Hypertension: A Cross-Sectional Patient Simulation Study Among Practicing Cardiologists and Pulmonologists.
J Am Heart Assoc. 2023 Jan 11:e026413. doi: 10.1161/JAHA.122.026413.
Abstract

CHOUVARINE P, Hysko K, Chan SY, Oliveira P, et al
Second International Pulmonary Hypertension/Heart Failure Symposium-Structural heart disease, right ventricular dysfunction, and stem cell therapy: The European Pediatric Pulmonary Vascular Disease Network.
Pulm Circ. 2023;13:e12175.
Abstract

GRIVA P, Stamatakis E, Varvarousi G, Loukeri A, et al
The Use of Vigileo(R) Monitor in a Parturient With Severe Mitral Valve Stenosis and Severe Pulmonary Hypertension Undergoing Cesarean Section Under General Anesthesia: A Case Report and Literature Review.
Cureus. 2022;14:e32284.
Abstract

WANG YX, Reyes-Garcia J, Di Mise A, Zheng YM, et al
Role of ryanodine receptor 2 and FK506-binding protein 12.6 dissociation in pulmonary hypertension.
J Gen Physiol. 2023;155:e202213100.
Abstract

LIAN TY, Zhou YP, Zhu YJ, Guo F, et al
Reply: Homocysteine and Thrombophilia in Pulmonary Hypertension.
JACC Asia. 2022;2:651.
Abstract

ANDERSON JJ, Lau EM
Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia.
JACC Asia. 2022;2:538-546.
Abstract

SPENCE JD
Homocysteine and Thrombophilia in Pulmonary Hypertension.
JACC Asia. 2022;2:650-651.
Abstract

HARTOPO AB, Anggrahini DW, Satwiko MG, Damarkusuma A, et al
Usefulness of Combining NT-proBNP Level and Right Atrial Diameter for Simple and Early Noninvasive Detection of Pulmonary Hypertension Among Adult Patients with Atrial Septal Defect.
Acta Med Indones. 2022;54:556-566.
Abstract

LV C, Huang Y, Liao G, Wu L, et al
Pregnancy outcomes in women with pulmonary hypertension: a retrospective study in China.
BMC Pregnancy Childbirth. 2023;23:16.
Abstract

LUIS CALLEJAS RUBIO J, Escobar EM, Martinez EN, de la Fuente PM, et al
Impact of the revised hemodynamic definition of pulmonary hypertension.
Rev Esp Cardiol (Engl Ed). 2023 Jan 6:S1885-5857(23)00014.
Abstract

BALAKRISHNAN B, Owens B, Hayes R, Wen S, et al
A Systematic Review of Echocardiographic Parameters for the Screening of Pulmonary Hypertension: What Are the Odds?
Cureus. 2022;14:e32185.
Abstract

LIN C, Mi J, Zhang Y, Duan S, et al
A nomogram prediction model for early death in patients with persistent pulmonary hypertension of the newborn.
Front Cardiovasc Med. 2022;9:1077339.
Abstract

FRANTZ RP, Leopold JA, Hassoun PM, Hemnes AR, et al
Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study.
Pulm Circ. 2023;13:e12181.
Abstract

ZHOU Z, Gu Y, Zheng H, Yan C, et al
Interventional Occlusion of Large Patent Ductus Arteriosus in Adults with Severe Pulmonary Hypertension.
J Clin Med. 2023;12:354.
Abstract

MARCHETTA S, Verbelen T, Claessen G, Quarck R, et al
A Comprehensive Assessment of Right Ventricular Function in Chronic Thromboembolic Pulmonary Hypertension.
J Clin Med. 2022;12:47.
Abstract

SWINAREW AS, Gabor J, Kusz B, Skoczynski S, et al
Exhaled Air Metabolome Analysis for Pulmonary Arterial Hypertension Fingerprints Identification-The Preliminary Study.
Int J Environ Res Public Health. 2022;20:503.
Abstract

CERNE JW, Pathrose A, Sarnari R, Veer M, et al
Left Ventricular Fibrosis Assessment by Native T1, ECV, and LGE in Pulmonary Hypertension Patients.
Diagnostics (Basel). 2022;13:71.
Abstract

CHEN Y, Zhou D, Xiong M, Xi X, et al
Correction to: Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension: an observational study and nomogram construction.
Respir Res. 2023;24:4.
Abstract

ESCALADA-PELLITERO S, Garcia-Salido A, Clemente-Garulo D, Azorin-Cuadrillero D, et al
Fatal Pulmonary Veno-Occlusive Disease and Systemic Juvenile Idiopathic Arthritis: Case Report and Literature Review.
Reumatol Clin (Engl Ed). 2023;19:53-56.
Abstract

LIU C, Shi Y
Comment on "Fluid restriction in management of patent ductus arteriosus in Italy: a nationwide survey".
Eur J Pediatr. 2023;182:469-470.
Abstract

FARMAKIS IT, Keller K, Barco S, Konstantinides SV, et al
From acute pulmonary embolism to post-pulmonary embolism sequelae.
Vasa. 2023;52:29-37.
Abstract

WOLTER NL, Jaffe IZ
Emerging vascular cell-specific roles for mineralocorticoid receptor: implications for understanding sex differences in cardiovascular disease.
Am J Physiol Cell Physiol. 2023;324:C193-C204.
Abstract

FRANCESCATO G, Capolupo I, Cerbo RM, Doni D, et al
Fluid restriction in management of patent ductus arteriosus in Italy: a nationwide survey.
Eur J Pediatr. 2023;182:393-401.
Abstract

DE GROOT-VAN DER MOOREN MD, Scheerman BC, Rammeloo LAJ, van Wieringen H, et al
Neonatal mortality and morbidity in Down syndrome in the time of prenatal aneuploidy testing: a retrospective cohort study.
Eur J Pediatr. 2022 Nov 9. pii: 10.1007/s00431-022-04686.
Abstract

SCHOETTLER ML, Saldana BD, Berkenkamp L, Chonat S, et al
Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic Microangiopathy.
Transplant Cell Ther. 2023;29:45.
Abstract

WILLCOX A, Lee NT, Nandurkar HH, Sashindranath M, et al
CD39 in the development and progression of pulmonary arterial hypertension.
Purinergic Signal. 2022;18:409-419.
Abstract

RENET S, Chaumais MC, Gallant-Dewavrin M, Jouet E, et al
Knowledge exchange between patient and pharmacist: A mixed methods study to explore the role of pharmacists in patient education and counseling in asthma and pulmonary arterial hypertension.
Ann Pharm Fr. 2023;81:53-63.
Abstract

HE YF, Liu Y, Yu JH, Cheng H, et al
Pharmacokinetics, mass balance, and metabolism of [(14)C]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertension.
Acta Pharmacol Sin. 2023;44:221-233.
Abstract

TAHARA N, Sugiyama Y, Tahara A, Bekki M, et al
Reverse remodeling of small pulmonary arteries and right ventricle in pulmonary arterial hypertension.
J Nucl Cardiol. 2022;29:3615-3618.
Abstract

KRISTROM K, Karlstam E, Nielsen T, Lagerqvist A, et al
A Case of Congenital Pulmonary Vein Stenosis with Secondary Post-Capillary Pulmonary Hypertension and Left Sided Congestive Heart Failure in a Cat.
Vet Sci. 2022;10:23.
Abstract

LUI JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, et al
Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosisâ€‘Related Pulmonary Hypertension.
Cardiovasc Drugs Ther. 2023 Jan 20. doi: 10.1007/s10557-023-07431.
Abstract

KLETZER J, Hecht S, Ramsauer S, Scharinger B, et al
A Story of PA/BSA and Biomarkers to Diagnose Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis-The Rise of IGF-BP2 and GDF-15.
J Cardiovasc Dev Dis. 2023;10:22.
Abstract

SAINATHAN S, Ryan J, Said S, Mullinari L, et al
Outcomes of heart-lung transplantation in Eisenmenger syndrome compared to primary pulmonary hypertension.
Asian Cardiovasc Thorac Ann. 2023 Jan 19:2184923231151551.
Abstract

PARVIZI R, Bilehjani E, Mahmoudian B, Koohi A, et al
Single-Center Experience of Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: The Results from the Tabriz University Medical Sciences (TUMS) CTEPH Program.
Thorac Cardiovasc Surg. 2023 Jan 19. doi: 10.1055/s-0042-1760204.
Abstract

SATYAMURTHY A, Poojary G, Dibben G, Padmakumar R, et al
Exercise Training in Pulmonary Hypertension: AN UPDATED SYSTEMATIC REVIEW WITH META-ANALYSIS.
J Cardiopulm Rehabil Prev. 2023 Jan 12. doi: 10.1097/HCR.0000000000000765.
Abstract

DEGERING J, Egenlauf B, Harutyunova S, Benjamin N, et al
Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri((R))): a prospective, 6-months, open label, observational, non-interventional study.
Respir Res. 2023;24:18.
Abstract

KURNIK M, Bozic H, Vindisar A, Kolar P, et al
Pulmonary hypertension at admission predicts ICU mortality in elderly critically ill with severe COVID-19 pneumonia: retrospective cohort study.
Cardiovasc Ultrasound. 2023;21:1.
Abstract

ZENG X, Liu Q, Rathinasabapathy A, Zha L, et al
Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report.
BMC Pulm Med. 2023;23:26.
Abstract

MASARONE D, Kittleson M, Pollesello P, Tedford RJ, et al
Use of Levosimendan in Patients with Pulmonary Hypertension: What is the Current Evidence?
Drugs. 2023 Jan 18. doi: 10.1007/s40265-022-01833.
Abstract

ROSENKRANZ S
[2022 ESC/ERS guidelines on the diagnostics and treatment of pulmonary hypertension : A focussed review].
Herz. 2023 Jan 17. doi: 10.1007/s00059-022-05155.
Abstract

VALERA RJ, Fonnegra CB, Cogollo VJ, Sarmiento-Cobos M, et al
Impact of Rapid Weight Loss after Bariatric Surgery in Systemic Inflammatory Response and Pulmonary Hemodynamics in Severely Obese Subjects with Pulmonary Hypertension.
J Am Coll Surg. 2023;236:365-372.
Abstract

RAMOS JG, Wieslander B, Fyrdahl A, Reiter G, et al
Pulmonary Hypertension by Catheterization Is More Accurately Detected by Cardiovascular Magnetic Resonance 4D-Flow Than Echocardiography.
JACC Cardiovasc Imaging. 2022 Oct 28:S1936-878X(22)00550.
Abstract

WANG YC, Lin PL, Huang CH
Perioperative Echocardiographic Prediction of Pulmonary Hypertension by Pulmonary Artery Acceleration Time During Cardiac Surgery with Cardiopulmonary Bypass.
J Am Soc Echocardiogr. 2023 Jan 13:S0894-7317(23)00013.
Abstract

TANTAWY A, El-Sherif N, Makkeyah S, Eldeen NS, et al
Sleep disordered breathing and its relation to stroke and pulmonary hypertension in children with sickle cell disease: a single-center cross-sectional study.
Ann Hematol. 2023 Jan 16. doi: 10.1007/s00277-023-05099.
Abstract

ALAMRI AK, Shelburne NJ, Mayeux JD, Brittain E, et al
Pulmonary Hypertension Association's 2022 International Conference Scientific Sessions Overview.
Pulm Circ. 2023;13:e12182.
Abstract

ZHU R, Cheng GY, Denas G, Pengo V, et al
Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension.
Eur J Intern Med. 2023 Jan 13:S0953-6205(23)00017.
Abstract

OLUWOLE I, Tan JBC, DeSouza S, Hutchinson M, et al
The association between bronchopulmonary dysplasia grade and risks of adverse neurodevelopmental outcomes among preterm infants born at less than 30 weeks of gestation.
J Matern Fetal Neonatal Med. 2023;36:2167074.
Abstract

D'ARMINI AM, Pin M, Celentano A, Te Masiglat LJ, et al
Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension: Relationship between treated branches and outcome.
Int J Cardiol. 2023 Jan 12:S0167-5273(23)00056.
Abstract

MORA CUESTA VM, Martinez Menaca A, Iturbe Fernandez D, Tello Mena S, et al
Impact of the New Classification of Pulmonary Hypertension in Patients With Advanced Respiratory Disease.
Arch Bronconeumol. 2023 Jan 6:S0300-2896(23)00004.
Abstract

GUTIERREZ-ARIAS R, Hinojosa-Riadi J, Sandoval-Canio A, Santana-Garrido H, et al
Effectiveness of Respiratory Muscle Training in Adults With Pulmonary Hypertension. A Systematic Review and Meta-Analysis.
Heart Lung Circ. 2023 Jan 12:S1443-9506(22)01226.
Abstract

CHU C, Liu S, Ding J, Xu P, et al
Swietenine Alleviates Vascular Remodeling by Enhancing Mitophagy of Pulmonary Arterial Smooth Muscle Cells in Experimental Pulmonary Hypertension.
Can J Cardiol. 2023 Jan 11:S0828-282X(23)00005.
Abstract

TORUN A, Erdem A, Oguz M, Cinar T, et al
Successful treatment of pulmonary hypertension with macitentan in a patient with Hermansky-Pudlak syndrome.
Kardiol Pol. 2023 Jan 14. doi: 10.33963/KP.a2023.0012.
Abstract

LIAO H, Zhang N, Pan L, Du J, et al
Predictors for pulmonary artery involvement in Takayasu arteritis and its cluster analysis.
Arthritis Res Ther. 2023;25:9.
Abstract

LI B, Liu X, Wang B, Liu X, et al
QRS-T angle as a predictor of pulmonary arterial hypertension: A review.
Medicine (Baltimore). 2023;102:e32320.
Abstract

ALMUSALLY RM
Early recognition of pulmonary complications of sickle cell disease.
Saudi Med J. 2023;44:10-18.
Abstract

ZENG Z, Zhou X, Zhu Y, Huang X, et al
Kruppel-like Factor 7 inhibits proliferation and migration of pulmonary smooth muscle cells via p21 activation.
Eur J Pharmacol. 2022;940:175473.
Abstract

DING L, Qi H, Wang Y, Zhang Z, et al
Recent advances in ginsenosides against respiratory diseases: Therapeutic targets and potential mechanisms.
Biomed Pharmacother. 2023;158:114096.
Abstract

XING C, Wang X, Pan X, Yu J, et al
Outcomes of atrial septostomy and effect on long-term survival in patients with idiopathic pulmonary arterial hypertension: A single-center cohort.
Int J Cardiol. 2023;373:118-123.
Abstract

QADUS S, Naser AY, Ofori-Asenso R, Ademi Z, et al
Adherence and Discontinuation of Disease-Specific Therapies for Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
Am J Cardiovasc Drugs. 2023;23:19-33.
Abstract

KREMER N, Rako Z, Glocker F, Tello K, et al
Monitoring of Right Ventricular Failure With Daily Pressure Volume Loops Obtained via an Application and 3-Dimensional Echocardiography.
Circ Heart Fail. 2022 Nov 14:e010097. doi: 10.1161/CIRCHEARTFAILURE.122.010097.
Abstract

MAHDI N, Nadeem I, Ur Rasool M, Ul Munamm SA, et al
Pulmonary hypertension due to pulmonary embolism secondary to COVID-19: A district general hospital experience from the UK.
J R Coll Physicians Edinb. 2023 Jan 27:14782715231152677.
Abstract

ZHENG Y, Ma H, Yan Y, Ye P, et al
Deficiency of filamin A in smooth muscle cells protects against hypoxiaâ€‘mediated pulmonary hypertension in mice.
Int J Mol Med. 2023;51:22.
Abstract

DONAHOE LL, Patel S, Tole S, Zorzi AP, et al
Osteosarcoma emboli presenting as chronic thromboembolic pulmonary hypertension in a child.
Pediatr Hematol Oncol. 2023;40:65-69.
Abstract

MOMOSE R, Inami T, Takeuchi K, Kikuchi H, et al
Combination Therapy With Pulmonary Vasodilatation and JAK2 Inhibition for Pulmonary Hypertension With Polycythemia Vera.
CJC Open. 2022;5:90-92.
Abstract

Erratum: Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension: Erratum.
Transplant Direct. 2023;9:e1444.
Abstract

KEEN C, Smith I, Hashmi-Greenwood M, Sage K, et al
Pulmonary Hypertension and Measurement of Exercise Capacity Remotely: Evaluation of the 1-min Sit-to-Stand Test (PERSPIRE) - a cohort study.
ERJ Open Res. 2023;9:00295-2022.
Abstract

LOUW E, Baines N, Maarman G, Osman M, et al
The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patients.
Pulm Circ. 2023;13:e12184.
Abstract

YANG F, Wang D, Zhang X, Fan H, et al
Novel variants of seryl-tRNA synthetase resulting in HUPRA syndrome featured in pulmonary hypertension.
Front Cardiovasc Med. 2023;9:1058569.
Abstract

NELSON EJ, Cook E, Nelson S, Brown R, et al
Quantifying side effects and caregiver burdens of pediatric pulmonary hypertension therapies.
BMC Pediatr. 2023;23:43.
Abstract

LESLIE E, Gibson AL, Gonzalez Bosc LV, Mermier C, et al
Can Maternal Exercise Prevent High-Altitude Pulmonary Hypertension in Children?
High Alt Med Biol. 2023 Jan 25. doi: 10.1089/ham.2022.0098.
Abstract

CHIANSIRIKRAIVUTI N, Sapankaew T, Pirompanich P
Clinical characteristics of pulmonary hypertension patients who underwent right heart catheterization in Thailand: 5-year retrospective single-centre study.
Lung India. 2023;40:42-47.
Abstract

DIDDEN EM, Lee E, Wyckmans J, Quinn D, et al
Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data.
Pulm Circ. 2023;13:e12188.
Abstract

LIU X, Li X, Duan J, Zhang R, et al
The percentage of circulating fibrocytes is associated with increased morbidity of pulmonary hypertension in patients on hemodialysis.
Semin Dial. 2023 Jan 24. doi: 10.1111/sdi.13139.
Abstract

WANG L, Zhang W, Li C, Chen X, et al
Identification of biomarkers related to copper metabolism in patients with pulmonary arterial hypertension.
BMC Pulm Med. 2023;23:31.
Abstract

DANEVA Z, Chen YL, Ta HQ, Manchikalapudi V, et al
Endothelial IK and SK channel activation decreases pulmonary arterial pressure and vascular remodeling in pulmonary hypertension.
Pulm Circ. 2023;13:e12186.
Abstract

HOSNA AU, Miller D, Makhoul K, Noff N, et al
A Case of Chronic Pulmonary Embolism Resulting in Pulmonary Hypertension and Decompensated Right Heart Failure.
Cureus. 2022;14:e32771.
Abstract

SONG J, Su H, Cao Y
TurboHawk plaque rotation system for chronic thromboembolic pulmonary hypertension.
Eur Heart J Case Rep. 2023;7:ytad009.
Abstract

BHAGWANI AR, Ali M, Piper B, Liu M, et al
A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3.
iScience. 2023;26:105935.
Abstract

MACDONALD A, Salehi M, Alabed S, Maiter A, et al
Semi-automatic thresholding of RV trabeculation improves repeatability and diagnostic value in suspected pulmonary hypertension.
Front Cardiovasc Med. 2023;9:1037385.
Abstract

KIMURA M, Kohno T, Shinya Y, Hiraide T, et al
De-escalation of oxygen-therapy and medication in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty.
Can J Cardiol. 2023 Jan 19:S0828-282X(23)00051.
Abstract

BECH-HANSSEN O, Smith JG, Astengo M, Bollano E, et al
Pulmonary Hypertension Phenotype Can Be Identified in Heart Failure with Reduced Ejection Fraction Using Echocardiographic Assessment of Pulmonary Artery Pressure with Supportive Use of Pressure Reflection Variables.
J Am Soc Echocardiogr. 2023 Jan 18:S0894-7317(23)00021.
Abstract

GRZESK G, Witczynska A, Weglarz M, Wolowiec L, et al
Soluble Guanylyl Cyclase Activators-Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension.
Molecules. 2023;28:861.
Abstract

ALQARNI AA
Increased Thromboxane A(2) Levels in Pulmonary Artery Smooth Muscle Cells Isolated from Patients with Chronic Obstructive Pulmonary Disease.
Medicina (Kaunas). 2023;59:165.
Abstract

KRIVICKIENE A, Verikas D, Kreckauskiene R, Padervinskiene L, et al
Different Causes of Functional Tricuspid Valve Regurgitation Are Linked to Differences in Tricuspid Valve and Right-Sided Heart Geometry and Function: 3D Echocardiography Study.
Medicina (Kaunas). 2022;59:57.
Abstract

KHATTAB E, Velidakis N, Gkougkoudi E, Kadoglou NPE, et al
Exercise-Induced Pulmonary Hypertension: A Valid Entity or Another Factor of Confusion?
Life (Basel). 2023;13:128.
Abstract

KOIKE T, Iwata H, Chikata Y, Doi S, et al
Favorable Prognosis in Patients with Recovered Pulmonary Hypertension after TAVI: An Analysis of the LAPLACE-TAVI Registry.
J Clin Med. 2023;12:729.
Abstract

GENECAND L, Simian G, Desponds R, Wacker J, et al
The Influence of Methods for Cardiac Output Determination on the Diagnosis of Precapillary Pulmonary Hypertension: A Mathematical Model.
J Clin Med. 2023;12:410.
Abstract

ZHENG J, Liu H, Yu M, Lin B, et al
BMPR2 Variants Underlie Nonsyndromic Oligodontia.
Int J Mol Sci. 2023;24:1648.
Abstract

ANHEYER D, Bugaj TJ, Ludtke R, Appelbaum S, et al
No Placebo Effect beyond Regression to the Mean on the Six Minute Walk Test in Pulmonary Arterial Hypertension Trials.
Int J Mol Sci. 2023;24:1069.
Abstract

ALI MK, Tian X, Zhao L, Schimmel K, et al
PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension.
Cells. 2023;12:316.
Abstract

DEVALLANCE ER, Dustin CM, de Jesus DS, Ghouleh IA, et al
Specificity Protein 1-Mediated Promotion of CXCL12 Advances Endothelial Cell Metabolism and Proliferation in Pulmonary Hypertension.
Antioxidants (Basel). 2022;12:71.
Abstract

NEWMAN-LINDSAY S, Lakshminrusimha S, Sankaran D
Diazoxide for Neonatal Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension.
Children (Basel). 2022;10:5.
Abstract

ABUD KCO, Machado CM, Vilas Boas LS, Maeda NY, et al
Respiratory viruses and postoperative hemodynamics in patients with unrestrictive congenital cardiac communications: a prospective cohort study.
Eur J Med Res. 2023;28:38.
Abstract

SALAMA AA, Padang R, Thaden JJ, Kane CJ, et al
Value of a Right Ventricular-Specific Longitudinal Systolic Strain Software Package in Risk Prediction in Patients with Known or Suspected Pulmonary Hypertension.
J Am Soc Echocardiogr. 2023 Jan 17:S0894-7317(23)00018.
Abstract

KOLB M, Lechartier B, Aubert JD, Daccord C, et al
[Pneumology: what's new in 2022].
Rev Med Suisse. 2023;19.
Abstract

HODA M, Lemler M, Cory M
Vein of Galen Aneurysmal Malformation with Anomalous Right Superior Vena Cava to the Left Atrium Leading to Atypical Clinical and Echocardiographic Findings.
Pediatr Cardiol. 2023;44:254-259.
Abstract

DAI C, Kong B, Shuai W, Xiao Z, et al
Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease.
ESC Heart Fail. 2023;10:578-593.
Abstract

CHILCOTE D, Mercer-Rosa L, Wang Y, Kawut SM, et al
Alveolar dead space fraction is not associated with early RV systolic dysfunction in pediatric ARDS.
Pediatr Pulmonol. 2023;58:559-565.
Abstract

MARRA AM, D'Assante R, Salzano A, Iacoviello M, et al
Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry.
ESC Heart Fail. 2023;10:159-166.
Abstract

CHENG R, Conrad M
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Patients With Chronic Obstructive Pulmonary Disease: A Note of Caution.
J Am Heart Assoc. 2023 Feb 3:e028898. doi: 10.1161/JAHA.122.028898.
Abstract

ALLEN BJ, Frye H, Ramanathan R, Caggiano LR, et al
Biomechanical and Mechanobiological Drivers of the Transition From PostCapillary Pulmonary Hypertension to Combined Pre-/PostCapillary Pulmonary Hypertension.
J Am Heart Assoc. 2023 Feb 3:e028121. doi: 10.1161/JAHA.122.028121.
Abstract

FUJII H, Taniguchi Y, Yoneda S, Miwa K, et al
Efficacy and Safety of Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension and Comorbid Chronic Obstructive Pulmonary Disease.
J Am Heart Assoc. 2023 Feb 3:e026466. doi: 10.1161/JAHA.122.026466.
Abstract

ABDULKAREEM AO, Tiwari P, Lone ZR, Iqbal H, et al
Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension.
Eur J Pharmacol. 2023 Jan 30:175558. doi: 10.1016/j.ejphar.2023.175558.
Abstract

ISSA R, Minhas AMK, Issa R, Ariss RW, et al
Urban-Rural disparities in pulmonary hypertension-related mortality between 2004 and 2019: a call to improve access to specialty care centers for rural residents in the United States.
Curr Probl Cardiol. 2023 Jan 30:101623. doi: 10.1016/j.cpcardiol.2023.101623.
Abstract

SYKES AV, Sonners C, Schmickl CN, Raphelson J, et al
The Impact of Underlying Obstructive Sleep Apnea Treatment on Exercise Capacity in Patients With Pulmonary Hypertension Undergoing a Cardiac Rehabilitation Program.
J Cardiopulm Rehabil Prev. 2022 Dec 14. doi: 10.1097/HCR.0000000000000745.
Abstract

KRAJEWSKI P
Dr. Salih Uzun et al. Letter to the Editor: Comment on 'Optical coherence tomography angiography findings in patients with chronic thromboembolic pulmonary hypertension.
Retina. 2022 Dec 26. doi: 10.1097/IAE.0000000000003717.
Abstract

UZUN S, Uzun F, Ercal O
Optical coherence tomography angiography findings in patients with chronic thromboembolic pulmonary hypertension.
Retina. 2022 Dec 26. doi: 10.1097/IAE.0000000000003716.
Abstract

DIXON JT, DiFilippo FP, Renapurkar RD, Huang SS, et al
Novel Depiction of Collateral Flow in Chronic Thromboembolic Pulmonary Hypertension Using 4D Dynamic 82Rb PET/CT.
Clin Nucl Med. 2023 Jan 20. doi: 10.1097/RLU.0000000000004567.
Abstract

XANTHOULI P, Gordjani O, Benjamin N, Trudzinski FC, et al
Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension.
Sci Rep. 2023;13:1839.
Abstract

ROSENKRANZ S, Delcroix M, Giannakoulas G, Hoeper MM, et al
The 'Ten Commandments' of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Eur Heart J. 2023 Feb 1:ehad018. doi: 10.1093.
Abstract

SHOROFSKY MJ, Morgan GJ, Mejia E, Rodriguez SA, et al
Management of Complex Pulmonary Vein Stenosis at Altitude Combining Comprehensive Percutaneous Interventional Treatment with Sirolimus, Pulmonary Hypertension Medications and Intraluminal Imaging with Optical Coherence Tomography.
Pediatr Cardiol. 2023 Feb 1. doi: 10.1007/s00246-023-03102.
Abstract

ALOTAIBI M, Fernandes T, Tang AB, Magalang GA, et al
Sex-related Differences in Eicosanoid Levels in Chronic Thromboembolic Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2023;68:228-231.
Abstract

MA Q, Yang Q, Xu J, Sellers HG, et al
Purine synthesis suppression reduces the development and progression of pulmonary hypertension in rodent models.
Eur Heart J. 2023 Jan 31:ehad044. doi: 10.1093.
Abstract

ZHAN TL, Chen YW, Wu JJ, Li F, et al
[A case of severe pulmonary hypertension in children treated by transcatheter Potts shunt].
Zhonghua Er Ke Za Zhi. 2023;61:169-171.
Abstract

ABBASI MA, Albulushi A, Dhar K, Lowes B, et al
The Effect of Exercise on Endothelin 1 Level in Patients With Pulmonary Hypertension.
Curr Probl Cardiol. 2023 Jan 28:101627. doi: 10.1016/j.cpcardiol.2023.101627.
Abstract

KIM HH, Lee HS, Kim HS, Youn YN, et al
Clinical Outcomes of Endoscope-Assisted Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension.
Yonsei Med J. 2023;64:104-110.
Abstract

DAIGO K, Katsumata Y, Esaki K, Iwasawa Y, et al
Predictors of Improvement in Exercise Tolerance After Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
J Am Heart Assoc. 2023 Jan 31:e027395. doi: 10.1161/JAHA.122.027395.
Abstract

LI C, Xia J, Yiminniyaze R, Dong L, et al
Hub Genes and Immune Cell Infiltration in Hypoxia-Induced Pulmonary Hypertension: Bioinformatics Analysis and In Vivo Validation.
Comb Chem High Throughput Screen. 2023.
Abstract

HOU C, Xie L, Wang T, Zheng J, et al
Comparative transcription profiling of mRNA and lncRNA in pulmonary arterial hypertension after C75 treatment.
BMC Pulm Med. 2023;23:46.
Abstract

ANEGAWA E, Seguchi O, Mochizuki H, Kuroda K, et al
Pulmonary Vascular Reverse Remodeling After Left Ventricular Assist Device Implantation in Patients With Pulmonary Hypertension.
ASAIO J. 2023;69:151-158.
Abstract

GU S, Goel K, Forbes LM, Kheyfets VO, et al
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension.
Compr Physiol. 2023;13:4295-4319.
Abstract

GONZALES J, Fraidenburg DR
Caught in a vicious cycle: Cell-free hemoglobin and the pathogenesis of pulmonary hypertension.
Pulm Circ. 2023;13:e12194.
Abstract

CAO Y, Zhang Y, Song J
Multi-Imaging Modality Facilitates Screening of Pulmonary Hypertension at High Altitude.
JACC Asia. 2022;2:816-818.
Abstract

EJIRI K, Ogawa A, Shimokawahara H, Matsubara H, et al
Treatment of Vascular Injury During Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension.
JACC Asia. 2022;2:831-842.
Abstract

ZENG Y, Yu Q, Maimaitiaili N, Li B, et al
Clinical and Predictive Value of Computed Tomography Angiography in High-Altitude Pulmonary Hypertension.
JACC Asia. 2022;2:803-815.
Abstract

VOGEL NT, Annis J, Prisco SZ, Kazmirczak F, et al
Ferroptosis Promotes Pulmonary Hypertension.
bioRxiv. 2023 Jan 20:2023.01.19.524721. doi: 10.1101/2023.01.19.524721.
Abstract

LEVI M
Identifying patients at risk for chronic thromboembolic pulmonary hypertension.
Eur J Intern Med. 2023 Jan 25:S0953-6205(23)00025.
Abstract

KAWADE A, Yamamura A, Kondo R, Suzuki Y, et al
Corosolic acid ameliorates vascular remodeling in pulmonary arterial hypertension via the downregulation of STAT3 signaling.
J Pharmacol Sci. 2023;151:119-127.
Abstract

ARAS MA, Abreau S, Mills H, Radhakrishnan L, et al
Electrocardiogram Detection of Pulmonary Hypertension Using Deep Learning.
J Card Fail. 2023 Jan 24:S1071-9164(23)00012.
Abstract

MAEDER MT
The beta3-adrenoreceptor agonist mirabegron for the treatment of combined pre- and post-capillary pulmonary hypertension: new pathway or dead end?
Eur J Heart Fail. 2023 Jan 24. doi: 10.1002/ejhf.2780.
Abstract

JIANG Y, Huang J, Xia Y, Sun Z, et al
Hypoxia activates GPR146 which participates in pulmonary vascular remodeling by promoting pyroptosis of pulmonary artery endothelial cells.
Eur J Pharmacol. 2023;941:175502.
Abstract

MARUYAMA H, Sakai S, Dewachter L, Dewachter C, et al
Prostacyclin receptor agonists induce DUSP1 to inhibit pulmonary artery smooth muscle cell proliferation.
Life Sci. 2023;315:121372.
Abstract

JONES XM, Fox R, Motawakel J, Trivedi RK, et al
Reversal of right ventricular pressure loading improves function independent of fibrosis.
J Physiol. 2023;601:397-399.
Abstract

WADA MK, Fukuhara Y, Hayakawa I, Kaname T, et al
KARS-related diseases with macrothrombocytes and pulmonary arterial hypertension.
Pediatr Int. 2023;65:e15428.
Abstract

CARVALHO T
Merck bets on sotatercept in pulmonary arterial hypertension.
Nat Med. 2023;29:2-3.
Abstract

LUNA-LOPEZ R, de Pablo Gafas A, Escribano Subias P, Lopez Gude MJ, et al
Double lung transplantation in pulmonary arterial hypertension associated with congenital heart disease.
Rev Esp Cardiol (Engl Ed). 2023;76:132-134.
Abstract

AKIL A, Ziegeler S, Rehers S, Lavae-Mokhtari M, et al
Lung Volume Reduction Surgery Reduces Pulmonary Arterial Hypertension Associated With Severe Lung Emphysema and Hypercapnia.
ASAIO J. 2023;69:218-224.
Abstract

YOUSSEF DE, Averin K, Richards S, Sheppard C, et al
A North American, single-center experience implanting fenestrated atrial devices and atrial flow regulators into a heterogeneous group of pediatric pulmonary hypertension patients.
Front Pediatr. 2023;11:1073336.
Abstract

ELNADY MA, Elkorashy R, Nabil A, Ibrahim EK, et al
Predictors of pulmonary hypertension in patients with hypersensitivity pneumonitis.
BMC Pulm Med. 2023;23:61.
Abstract

ZHANG Z, Wang X, Wang S, Jia Z, et al
Network Pharmacology and Molecular Docking Analysis of Shufeiya Recipe in the Treatment of Pulmonary Hypertension.
Biomed Res Int. 2022;2022:7864976.
Abstract

SIMONNEAU G, Fadel E, Vonk Noordegraaf A, Toshner M, et al
Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021.
Eur Respir Rev. 2023;32:220132.
Abstract

HERTEL M, Preissner S, Gohlke BO, Kuebler WM, et al
Real-world evidence for beneficial effects of dipyrone in 4,278 patients with pulmonary hypertension - Analysis of the risk of ventilation, hospitalization, and agranulocytosis.
Eur J Pharmacol. 2023 Feb 6:175567. doi: 10.1016/j.ejphar.2023.175567.
Abstract

HAWKINS RB, Strobel RJ, Mehaffey JH, Quader MA, et al
Pulmonary Hypertension and Operative Risk in Mitral Valve and Coronary Surgery.
J Surg Res. 2023;286:49-56.
Abstract

DINTAKURTI SH, Kamath S, Mahon C, Singh S, et al
Pulmonary hypertension: the hallmark of acute COVID-19 microvascular angiopathy?
ERJ Open Res. 2023;9:00389-2022.
Abstract

KAREDATH J, Dar H, Ganipineni VDP, Gorle SA, et al
Effect of Phosphodiesterase-5 (PDE-5) Inhibitors on Clinical Outcomes in Patients With Pulmonary Hypertension: A Meta-Analysis of Randomized Control Trials.
Cureus. 2023;15:e33363.
Abstract

UHL S, Grieshaber P, Arnold R, Loukanov T, et al
Impact of hybrid procedure on pulmonary arterial dimensions and right ventricular load after biventricular repair.
J Cardiothorac Surg. 2023;18:65.
Abstract

YOUSAF M, iIlahi M, Bibi A, Elhassan H, et al
Chronic anemia complicated by cardiac failure, pulmonary hypertension, and pericardial effusion: a case report.
J Med Case Rep. 2023;17:44.
Abstract

MENDIOLA EA, da Silva Goncalves Bos D, Leichter DM, Vang A, et al
Right Ventricular Architectural Remodeling and Functional Adaptation in Pulmonary Hypertension.
Circ Heart Fail. 2023 Feb 7:e009768. doi: 10.1161/CIRCHEARTFAILURE.122.009768.
Abstract

COLALILLO A, Hoffmann-Vold AM, Pellicano C, Romaniello A, et al
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort.
Autoimmun Rev. 2023;22:103290.
Abstract

ANGRIMAN F, Franchin L, Piroli F, Imazio M, et al
Machine learning to identifying patients with pulmonary hypertension: Hope or hype?
Int J Cardiol. 2023 Feb 4:S0167-5273(23)00118.
Abstract

ROSAS PC, Neves LAA, Senese PB, Gralinski MR, et al
Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension.
J Vis Exp. 2023;.
Abstract

MOORE AC, Sieck KN, Lojovich SJ, Mueller RP, et al
Alagille Syndrome and Repeat Oxygenator Failure during Cardiopulmonary Bypass: A Word of Caution.
J Extra Corpor Technol. 2022;54:338-342.
Abstract

WANG S, Sun D, Liu C, Guo Y, et al
Weighted gene co-expression network analysis reveals the hub genes associated with pulmonary hypertension.
Exp Biol Med (Maywood). 2023 Feb 5:15353702221147557.
Abstract

XIONG J, Liu T, Zheng J, Du L, et al
Acute severe pulmonary hypertension during weaning from cardiopulmonary bypass for aortic valve replacement surgery: A case report.
Perfusion. 2023 Feb 3:2676591231155741. doi: 10.1177/02676591231155741.
Abstract

YONEDA K, Takahashi S, Nakayama K, Iwahashi M, et al
Combination of echocardiography and pulmonary function tests could predict no complication of pulmonary hypertension during 5 years in patients with systemic sclerosis.
Int J Rheum Dis. 2023 Feb 3. doi: 10.1111/1756-185X.14576.
Abstract

KOL A, Kepez A, Akaslan D, Kanar B, et al
Effects of balloon pulmonary angioplasty procedure on electrocardiographic parameters in patients with chronic thromboembolic pulmonary hypertension.
J Electrocardiol. 2023;77:72-77.
Abstract

LI W, Chen W, Peng H, Xiao Z, et al
Shikonin improves pulmonary vascular remodeling in monocrotalineâ€‘induced pulmonary arterial hypertension via regulation of PKM2.
Mol Med Rep. 2023;27:60.
Abstract

VANDENBROEK MM, Skebo SI, Ormiston ML
Targeting BMPR-II in pulmonary arterial hypertension: a case of Hercules versus the Hydra?
Expert Opin Ther Targets. 2022;26:1027-1030.
Abstract

LIU Q, Wu D, He B, Ding X, et al
Attenuating endothelial leakiness with self-assembled DNA nanostructures for pulmonary arterial hypertension.
Nanoscale Horiz. 2023;8:270-278.
Abstract

LIU Y, Li Y, Zhang J, Zhao Y, et al
Pregnancy outcomes of women with Eisenmenger syndrome: A single-center study.
Int J Cardiol. 2023;374:35-41.
Abstract

ATSUKAWA M, Tsubota A, Kondo C, Koyano KS, et al
Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study.
Hepatol Int. 2023;17:139-149.
Abstract

BROWN CE, Steiner JM, Modes M, Lynch Y, et al
Palliative Care Perspectives of Patients with Pulmonary Arterial Hypertension.
Ann Am Thorac Soc. 2023;20:331-334.
Abstract

LICHTSINN K, Sehgal I, Wilson A
Asystole in 2 Pediatric Patients During Dexmedetomidine Infusion.
J Pharm Pract. 2023;36:176-179.
Abstract

MALOIR Q, Petitjean H, Parzibut G, Weber T, et al
[Advances in pulmonary hypertension diagnosis and risk stratification].
Rev Med Liege. 2023;78:99-106.
Abstract

TEIXEIRA-FONSECA JL, de Lima Conceicao MR, Leal-Silva P, Roman-Campos D, et al
Ranolazine exerts atrial antiarrhythmic effects in a rat model of monocrotaline- induced pulmonary hypertension.
Basic Clin Pharmacol Toxicol. 2023 Feb 17. doi: 10.1111/bcpt.13845.
Abstract

NAKWAN N, Kunhapan P, Chaiyasung T, Satproedprai N, et al
Genome-wide association study identifies WWC2 as a possible locus associated with persistent pulmonary hypertension of the newborn in the Thai population.
Transl Pediatr. 2023;12:1-12.
Abstract

MAMAZHAKYPOV A, Lother A
Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research.
Front Cardiovasc Med. 2023;10:1118516.
Abstract

YONEYAMA S, Ozaki K, Kubota N, Okubo T, et al
Efficacy of angioscopy to evaluate guidewire position in mesh formation in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
Cardiovasc Interv Ther. 2023 Feb 15. doi: 10.1007/s12928-023-00916.
Abstract

MOONEN A, Ng MKC, Playford D, Strange G, et al
Atrial functional mitral regurgitation: prevalence, characteristics and outcomes from the National Echo Database of Australia.
Open Heart. 2023;10:e002180.
Abstract

SATO T, Fukui S, Shirota Y, Hasegawa K, et al
Recovery From Advanced Right Heart Failure Due to Takayasu Arteritis Complicated by Severe Pulmonary Hypertension With Balloon Pulmonary Angioplastyã€€- Usefulness of Multimodality Imaging.
Circ J. 2023 Feb 15. doi: 10.1253/circj.CJ-22-0706.
Abstract

WIDMANN L, Keranov S, Jafari L, Liebetrau C, et al
Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension.
Clin Res Cardiol. 2023 Feb 15. doi: 10.1007/s00392-023-02162.
Abstract

KERANOV S, Widmann L, Jafari L, Liebetrau C, et al
GDF-15 and soluble ST2 as biomarkers of right ventricular dysfunction in pulmonary hypertension.
Biomark Med. 2023 Feb 15. doi: 10.2217/bmm-2022-0395.
Abstract

BRAAMS NJ, Kianzad A, Meijboom LJ, Westenberg J, et al
Right Ventricular Function During Exercise After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension.
J Am Heart Assoc. 2023 Feb 15:e027638. doi: 10.1161/JAHA.122.027638.
Abstract

BERNARDO RJ, de Jesus Perez V
The social and economic disadvantage in pulmonary hypertension: A work (still) in progress.
Pulm Circ. 2023;13:e12196.
Abstract

RAVNESTAD H, Andersen R, Birkeland S, Svalebjorg M, et al
Pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: Comparison of changes in hemodynamics and functional capacity.
Pulm Circ. 2023;13:e12199.
Abstract

MYLVAGANAM R, Lawrence R, Goldberg I, Rahaghi F, et al
Differences in referral to a chronic thromboembolic pulmonary hypertension center following acute pulmonary embolism: a locoregional experience.
J Thromb Thrombolysis. 2023 Feb 12. doi: 10.1007/s11239-023-02781.
Abstract

YUAN L, Tang Y, Yin L, Lin X, et al
The Role of Transmembrane protein 16A (TMEM16A) in Pulmonary hypertension.
Cardiovasc Pathol. 2023 Feb 11:107525. doi: 10.1016/j.carpath.2023.107525.
Abstract

PIPER B, Bogamuwa S, Hossain T, Farkas D, et al
RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension.
bioRxiv. 2023 Feb 6:2023.02.03.526842. doi: 10.1101/2023.02.03.526842.
Abstract

YOUSSEF DE, Handler SS, Richards SM, Sheppard CA, et al
Multicenter review of a tadalafil suspension formulation for infants and children with pulmonary hypertension: A North American experience.
Front Pediatr. 2023;11:1055131.
Abstract

CIANCIULLI TF, Prieto O, Stewart-Harris A, Rodriguez AS, et al
Subcostal right ventricular free wall strain in patients with pulmonary hypertension.
Medicina (B Aires). 2023;83:19-28.
Abstract

LI Y, Deng X, Zhou H, Zheng X, et al
Bile acid predicts congenital portosystemic venous shunt in patients with pulmonary arterial hypertension.
Eur J Med Res. 2023;28:74.
Abstract

WU JH, Wang YJ, Liau JY, Lee NC, et al
Rapid genetic diagnosis of neonatal persistent pulmonary hypertension with a novel FOXF1 mutation.
Pediatr Neonatol. 2023 Jan 25:S1875-9572(23)00018.
Abstract

ALHARBI AH, Alrajhi NA, Alfaris AK, Hawari MR, et al
Metastatic pancreatic cancer presenting with pulmonary arterial hypertension.
Saudi Med J. 2023;44:218-222.
Abstract

TORRES-ROJAS MB, Cueto-Robledo G, Roldan-Valadez E, Navarro-Vergara DI, et al
Association between the degree of severity of pulmonary hypertension with the presence of pulmonary artery aneurysm: a brief updated review for clinicians.
Curr Probl Cardiol. 2023 Feb 9:101645. doi: 10.1016/j.cpcardiol.2023.101645.
Abstract

MANEIRO MELON NM, Velazquez Martin M, Huertas Nieto S, Albarran Gonzalez-Trevilla A, et al
Effectiveness and Safety of Balloon Pulmonary Angioplasty for the Treatment of Patients with Persistent Pulmonary Hypertension after Pulmonary Endarterectomy.
J Clin Med. 2023;12:905.
Abstract

PENG Y, Dai J, Zhao YY
Egln1(Tie2Cre) Mice Exhibit Similar Therapeutic Responses to Sildenafil, Ambrisentan, and Treprostinil as Pulmonary Arterial Hypertension (PAH) Patients, Supporting Egln1(Tie2Cre) Mice as a Useful PAH Model.
Int J Mol Sci. 2023;24:2391.
Abstract

GOTEN C, Usui S, Takashima SI, Inoue O, et al
Important Role of Endogenous Nerve Growth Factor Receptor in the Pathogenesis of Hypoxia-Induced Pulmonary Hypertension in Mice.
Int J Mol Sci. 2023;24:1868.
Abstract

CHEN W, Luo J, Chen J, Chen Y, et al
Effect of multidisciplinary team (MDT) centred on pregnant women with pulmonary hypertension on treatment and outcomes of pregnancy.
BMC Pulm Med. 2023;23:62.
Abstract

TAKAFUJI H, Amano H, Obunai K
Cyanosis in atrial septal defect with prominent crista terminalis.
Cardiol Young. 2023;33:306-308.
Abstract

ZHANG HD, Yan Y, He YY, Liu QQ, et al
Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease.
Int J Cardiol. 2023;375:29-35.
Abstract

MULLALY R, McCallion N, El-Khuffash A
Inhaled nitric oxide in preterm neonates with preterm prelabour rupture of membranes, a systematic review.
Acta Paediatr. 2022 Nov 15. doi: 10.1111/apa.16596.
Abstract

JIANG C, Jiang W
Lasso algorithm and support vector machine strategy to screen pulmonary arterial hypertension gene diagnostic markers.
Scott Med J. 2023;68:21-31.
Abstract

LICHTSINN K, Waltz PK, Azzuqa A, Church J, et al
Impact of a standardized management guideline for infants with CDH: A single-center experience.
J Pediatr Surg. 2022 Aug 1. pii: S0022-3468(22)00499.
Abstract

BOYERS S, Nayyar R, Melov SJ, Tanous D, et al
A case series describing the multidisciplinary management of pulmonary arterial hypertension in pregnancy: Time for optimism.
Aust N Z J Obstet Gynaecol. 2022 Jun 14. doi: 10.1111/ajo.13557.
Abstract

TAKATSUKI S, Nakayama T, Shimizu Y, Kawai R, et al
Clinical efficacy and safety of selexipag in children and young adults with idiopathic and heritable pulmonary arterial hypertension.
Cardiol Young. 2023;33:196-200.
Abstract

HAUMANN RG, Buys D, Hofland E, Romijn HW, et al
A modified perfusion protocol for pulmonary endarterectomy in a patient with a hematologic malignancy treated with a tyrosine kinase inhibitor.
Perfusion. 2023;38:418-421.
Abstract

KARPOV AA, Vachrushev NS, Shilenko LA, Smirnov SS, et al
Sympathetic Denervation and Pharmacological Stimulation of Parasympathetic Nervous System Prevent Pulmonary Vascular Bed Remodeling in Rat Model of Chronic Thromboembolic Pulmonary Hypertension.
J Cardiovasc Dev Dis. 2023;10:40.
Abstract

SHIMAHARA Y, Suzuki S, Fujiyoshi T, Honda S, et al
Combination therapy of preceding balloon pulmonary angioplasty and pulmonary endarterectomy for high-surgical-risk patients with chronic thromboembolic pulmonary hypertension.
Interdiscip Cardiovasc Thorac Surg. 2023.
Abstract

YI D, Liu B, Ding H, Li S, et al
E2F1 Mediates SOX17 Deficiency-Induced Pulmonary Hypertension.
bioRxiv. 2023 Feb 16:2023.02.15.528740. doi: 10.1101/2023.02.15.528740.
Abstract

Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respi
Eur Heart J. 2023 Feb 23:ehad005. doi: 10.1093.
Abstract

JORAIRAHMADI S, Javaherforooshzadeh F, Babazadeh M, Gholizadeh B, et al
Comparison of Nebulized Versus Intravenous Milrinone on Reducing Pulmonary Arterial Pressure in Patients with Pulmonary Hypertension Candidate for Open-cardiac Surgery: A Double-Blind Randomized Clinical Trial.
Anesth Pain Med. 2022;12:e122994.
Abstract

GARRICK SP, Berger PJ, Nold MF, Nold-Petry CA, et al
Murine Double Hit Model for Neonatal Cardiopulmonary Diseases: Bronchopulmonary Dysplasia (BPD) and Pulmonary Hypertension Associated with BPD.
Bio Protoc. 2022;12:e4669.
Abstract

YE W, Chen X, Li X, Guo X, et al
Oxygenation index and NT-proBNP as predictors of pulmonary hypertension and ventilation/perfusion mismatch in acute pulmonary embolism.
Front Cardiovasc Med. 2023;10:1090805.
Abstract

ZHANG X, Zhai Z, Geng X, Zhu Y, et al
Doppler Echocardiography Combined with NTproBNP/BNP in the Diagnosis of Pulmonary Artery Hypertension Associated with Congenital Heart Disease.
Comput Math Methods Med. 2023;2023:1896026.
Abstract

BOGAARD HJ, Goncharova EA, de Jesus Perez VA
Editorial: Pulmonary hypertension in the modern era: Science and clinical practice, Volume II.
Front Med (Lausanne). 2023;10:1136157.
Abstract

JOSEPH P, Savarimuthu S, Zhao J, Yan X, et al
Noninvasive determinants of pulmonary hypertension in interstitial lung disease.
Pulm Circ. 2023;13:e12197.
Abstract

CULLIVAN S, Gaine S, Sitbon O
New trends in pulmonary hypertension.
Eur Respir Rev. 2023;32:220211.
Abstract

NAWAYTOU H, Hills NK, Clyman RI
Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension.
Pediatr Res. 2023 Feb 17. doi: 10.1038/s41390-023-02522.
Abstract

HU L, Yu Y, Shen Y, Huang H, et al
Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages.
Redox Biol. 2023;61:102638.
Abstract

ZHANG L, Liu X, Wei Q, Zou L, et al
Arginine attenuates chronic mountain sickness in rats via microRNA-144-5p.
Mamm Genome. 2023;34:76-89.
Abstract

SIMON MA, Cormack JM, Sharifi Kia D
Knowing All the Angles (on Right Ventricular Myocardial Remodeling).
Circ Heart Fail. 2023;16:e010290.
Abstract

UNLU S, Voigt JU
Right ventriculo-arterial coupling assessed by right ventricular strain is a superior predictor of clinical outcome in patients with pulmonary arterial hypertension.
Eur Heart J Cardiovasc Imaging. 2023;24:e53.
Abstract

RICHTER MJ, Rako ZA, Tello K
Ratio between right ventricular strain and systolic pulmonary artery pressure as a surrogate for right ventricular to pulmonary arterial coupling: validation against the gold standard.
Eur Heart J Cardiovasc Imaging. 2023;24:e50-e52.
Abstract

WILLMANN S, Keller AK, Meyer M, van der Mey D, et al
Population pharmacokinetics of riociguat in a pediatric population (aged >/= 6 years) with pulmonary arterial hypertension.
Pediatr Pulmonol. 2023;58:908-917.
Abstract

DING W, Gu Y, Wu H, Wang H, et al
Mediastinal shift angle (MSA) measurement with MRI: a simple and effective tool for prenatal risk stratification in fetuses with congenital diaphragmatic hernia.
Eur Radiol. 2023;33:1668-1676.
Abstract

ARISS RW, Alhazmi L, Nazir S, Khouri SJ, et al
Brain-type natriuretic peptide levels and invasive hemodynamic parameters in dialysis dependent patients.
Am J Med Sci. 2023;365:258-262.
Abstract

BAI C, Chang Q, Wu H, Meng F, et al
Effect of fetal lung maturation on the treatment of patent ductus arteriosus in premature infants.
Minerva Pediatr (Torino). 2022 Sep 23. pii: S2724-5276.22.06985.
Abstract

ALI MS, Sethi J, Ghori UK, De Cardenas J, et al
Safety of Transbronchial Biopsies in Patients with Pulmonary Hypertension: Systematic Review and Meta-Analysis.
Ann Am Thorac Soc. 2023 Mar 3. doi: 10.1513/AnnalsATS.202211.
Abstract

UPADHYA P, Garg S, A J, Ponraj ND, et al
An unexpected and unusual cause of pulmonary hypertension in a patient with hypersensitivity pneumonitis: partial anomalous pulmonary venous connection causing pulmonary artery hypertension.
Monaldi Arch Chest Dis. 2023 Mar 3. doi: 10.4081/monaldi.2023.2497.
Abstract

CHAN S, Brugha R, Quyam S, Moledina S, et al
Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia: a guide for paediatric respiratory specialists.
Breathe (Sheff). 2022;18:220209.
Abstract

ZEDER K, Olschewski H, Kovacs G
Updated definition of exercise pulmonary hypertension.
Breathe (Sheff). 2022;18:220232.
Abstract

KROMPA A, Marino P
Diagnosis and management of pulmonary hypertension related to chronic respiratory disease.
Breathe (Sheff). 2022;18:220205.
Abstract

GREENOUGH A
Management of infants with congenital diaphragmatic hernia and pulmonary hypertension-one size does not fit all.
Pediatr Res. 2023 Mar 2. doi: 10.1038/s41390-023-02551.
Abstract

KUMAR VHS
Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?
JAMA Ophthalmol. 2023 Mar 2. doi: 10.1001/jamaophthalmol.2023.0018.
Abstract

RAGHUVEER TS, Zackula RE, Okut H
Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?
JAMA Ophthalmol. 2023 Mar 2. doi: 10.1001/jamaophthalmol.2023.0012.
Abstract

NITKIN CR, Richardson T, Lewis T
Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?-Reply.
JAMA Ophthalmol. 2023 Mar 2. doi: 10.1001/jamaophthalmol.2023.0009.
Abstract

CHIANG PH, Lin CC
Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?
JAMA Ophthalmol. 2023 Mar 2. doi: 10.1001/jamaophthalmol.2023.0015.
Abstract

ALZGHOUL H, Jin P, Vahdatpour C, Alzghoul BN, et al
Fatal venous air embolism in the setting of hemodialysis and pulmonary hypertension: A point of care ultrasound diagnosis.
Respir Med Case Rep. 2023;42:101819.
Abstract

DESAI A, Desai DM, Jamil A, Csendes D, et al
Outcomes of Preprocedural Pulmonary Hypertension on All-Cause and Cardiac Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review.
Cureus. 2023;15:e34300.
Abstract

PIAO C, Wang WJ, Deng Y, Wang K, et al
Clinical outcomes of pulmonary hypertension in pregnancy among women with congenital heart disease in China.
J Matern Fetal Neonatal Med. 2023;36:2183349.
Abstract

CORTUK M, Yildizeli B, Kurar E, Kayis SA, et al
Fibrinogen-Aalpha THR312ALA Polymorphism is Associated to Chronic Thromboembolic Pulmonary Hypertension in Turkey.
Anatol J Cardiol. 2023;27:153-159.
Abstract

FRUMP AL, Yakubov B, Walts A, Fisher A, et al
Estrogen Receptor-alpha Exerts Endothelium-Protective Effects and Attenuates Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2023;68:341-344.
Abstract

COLUNGA AL, Colebank MJ, Olufsen MS
Parameter inference in a computational model of haemodynamics in pulmonary hypertension.
J R Soc Interface. 2023;20:20220735.
Abstract

SPAZIANI G, Monti S, Misuraca L, Airo E, et al
[Pulmonary hypertension clinical pathway: ANMCO Tuscany Board model].
G Ital Cardiol (Rome). 2023;24:178-187.
Abstract

MANES A, Dardi F, Galie N, Palazzini M, et al
[European guidelines on pulmonary hypertension: what's new?].
G Ital Cardiol (Rome). 2023;24:161-165.
Abstract

SOLIMAN KM, Rao V, Daoud A
Pulmonary hypertension in a hemodialysis porcine model: possible unforeseen causes.
Ren Fail. 2022;44:945.
Abstract

KAMESHIMA S, Nakamura Y, Uehara K, Kodama T, et al
Effects of a Soluble Guanylate Cyclase Stimulator Riociguat on Contractility of Isolated Pulmonary Artery and Hemodynamics of U46619-Induced Pulmonary Hypertension in Dogs.
Vet Sci. 2023;10:159.
Abstract

ZHANG H, D'Alessandro A, Li M, Reisz JA, et al
Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension.
Vascul Pharmacol. 2023 Feb 25:107157. doi: 10.1016/j.vph.2023.107157.
Abstract

NKOKE C, Jingi AM, Noubiap JJ, Dzudie A, et al
Pulmonary hypertension among patients hospitalized with acute heart failure in Buea, South West Region of Cameroon.
Pan Afr Med J. 2022;42:216.
Abstract

LEONG K, Howard L, Giudice FL, Davies R, et al
Utility of cardiac magnetic resonance feature tracking strain assessment in chronic thromboembolic pulmonary hypertension for prediction of REVEAL 2.0 high risk status.
Pulm Circ. 2023;13:e12116.
Abstract

SABRI MS, Riaz F, Tara N, Anwar M, et al
A Rare Case of Severe Isolated Right Heart Failure with Secundum Type Atrial Septal Defect and Mitral Regurgitation Without Pulmonary Hypertension.
Cureus. 2023;15:e34112.
Abstract

KAMENSKAYA OV, Klinkova AS, Loginova IY, Porotnikova SS, et al
[Impairment of cognitive functions in patients with chronic thromboembolic pulmonary hypertension before and after surgical treatment].
Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123:126-131.
Abstract

SHAFIQ M, Lone ZR, Abdulkareem AO, Kaur G, et al
Inhibition of poly (ADP-ribose) Polymerase-1 (PARP-1) improves endothelial function in pulmonary hypertension.
Pulm Pharmacol Ther. 2023 Feb 24:102200. doi: 10.1016/j.pupt.2023.102200.
Abstract

SUN Y, Liu S, Chen C, Yang S, et al
The mechanism of programmed death and endoplasmic reticulum stress in pulmonary hypertension.
Cell Death Discov. 2023;9:78.
Abstract

JHA AK, Jha N, Malik V
Perioperative Decision-Making in Pulmonary Hypertension.
Heart Lung Circ. 2023 Feb 23:S1443-9506(23)00069.
Abstract

LUO L, Yin H, Gou D
Gut Microbiota and Metabolome Changes in Three Pulmonary Hypertension Rat Models.
Microorganisms. 2023;11:472.
Abstract

IZUMIDA T, Imamura T, Tanaka S, Joho S, et al
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report.
Medicina (Kaunas). 2023;59:401.
Abstract

JIA Z, Wang S, Yan H, Cao Y, et al
Pulmonary Vascular Remodeling in Pulmonary Hypertension.
J Pers Med. 2023;13:366.
Abstract

ZHANG N, Zhao X, Li J, Huang L, et al
Machine Learning Based on Computed Tomography Pulmonary Angiography in Evaluating Pulmonary Artery Pressure in Patients with Pulmonary Hypertension.
J Clin Med. 2023;12:1297.
Abstract

MOCCALDI B, De Michieli L, Binda M, Famoso G, et al
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
Int J Mol Sci. 2023;24:4178.
Abstract

MARTIN DE MIGUEL I, Cruz-Utrilla A, Oliver E, Escribano-Subias P, et al
Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension.
Int J Mol Sci. 2023;24:4147.
Abstract

OTANI N, Watanabe R, Tomoe T, Toyoda S, et al
Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension.
Int J Mol Sci. 2023;24:3979.
Abstract

SUH AJ, Suzuki DI, Gychka SG, Brelidze TI, et al
gp120 Envelope Glycoproteins of HIV-1 Group M Subtype A and Subtype B Differentially Affect Gene Expression in Human Vascular Endothelial Cells.
Int J Mol Sci. 2023;24:3536.
Abstract

RYANTO GRT, Musthafa A, Hara T, Emoto N, et al
Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension.
Int J Mol Sci. 2023;24:3332.
Abstract

DESAI K, Di Lorenzo M, Zuckerman WA, Emeruwa E, et al
Safety and Efficacy of Sildenafil for Group 2 Pulmonary Hypertension in Left Heart Failure.
Children (Basel). 2023;10:270.
Abstract

SI-MOHAMED SA, Zumbihl L, Turquier S, Boccalini S, et al
Lung Dual-Energy CT Perfusion Blood Volume as a Marker of Severity in Chronic Thromboembolic Pulmonary Hypertension.
Diagnostics (Basel). 2023;13:769.
Abstract

LEUILLIER M, Platel V, Tu L, Feugray G, et al
Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats.
Cells. 2023;12:665.
Abstract

RYANTO GRT, Suraya R, Nagano T
Mitochondrial Dysfunction in Pulmonary Hypertension.
Antioxidants (Basel). 2023;12:372.
Abstract

NARENDRULA A, Minhas AMK, Issa R, Ariss RW, et al
Age stratified trends in pulmonary hypertension-related mortality in the United States, 2004-2019.
Am J Med Sci. 2023 Feb 22:S0002-9629(23)01057.
Abstract

ASO K, Kasahara H
Anti-EJ antibody-positive antisynthetase syndrome developed pulmonary arterial hypertension 7 years after the onset of disease: the necessity of periodic evaluation.
Clin Exp Rheumatol. 2023;41:400-401.
Abstract

NIE X, Wu Z, Shang J, Zhu L, et al
Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3beta signaling pathway and alleviates pulmonary arterial hypertension in rats.
Eur J Pharmacol. 2023 Jan 24:175546. doi: 10.1016/j.ejphar.2023.175546.
Abstract

WERTHEIM BM, Wang RS, Guillermier C, Hutter CV, et al
Proline and glucose metabolic reprogramming supports vascular endothelial and medial biomass in pulmonary arterial hypertension.
JCI Insight. 2023;8:e163932.
Abstract

SHAH S, Vishwakarma VK, Arava SK, Mridha AR, et al
Differential effect of basal vitamin D status in monocrotaline induced pulmonary arterial hypertension in normal and vitamin D deficient rats: Possible involvement of eNOS/TGF-beta/alpha-SMA signaling pathways.
J Nutr Biochem. 2023;113:109246.
Abstract

NAGANO N, Katayama D, Imaizumi T, Hijikata M, et al
Fluctuations in unbound bilirubin levels during acetaminophen therapy for patent ductus arteriosus.
Pediatr Int. 2023;65:e15434.
Abstract

DUNCAN E, Small A, Sulica R, Halpern D, et al
Undiagnosed ventricular septal defect with resultant Eisenmenger syndrome presenting with diplopia.
Am J Emerg Med. 2023;65:218.
Abstract

DENG X, Bao Z, Yang X, Mei Y, et al
Molecular mechanisms of cell death in bronchopulmonary dysplasia.
Apoptosis. 2023;28.
Abstract

WANDTKE JC, Kaproth-Joslin K
Pulmonary Embolism Can Be Diagnosed with Dynamic Chest Radiography without Using Intravenous Contrast Material.
Radiology. 2022 Nov 8:222507. doi: 10.1148/radiol.222507.
Abstract

LIANG H, Fritz AV, Martin AK
Perioperative Circulatory Support and Management for Lung Transplantation: A Case-Based Review.
Semin Cardiothorac Vasc Anesth. 2023;27:68-74.
Abstract

DURDU H, Demir R, Zeren M, Basturk P, et al
Evaluation of primary and accessory respiratory muscles and their influence on exercise capacity and dyspnea in pulmonary arterial hypertension.
Heart Lung. 2023;57:173-179.
Abstract

BENINCASA G, Maron BA, Affinito O, D'Alto M, et al
Association Between Circulating CD4(+) T Cell Methylation Signatures of Network-Oriented SOCS3 Gene and Hemodynamics in Patients Suffering Pulmonary Arterial Hypertension.
J Cardiovasc Transl Res. 2023;16:17-30.
Abstract

SEYMOUR E, Mallory G, Morales-Demori R
Surgical and Cardiac Catheterization Outcomes of Scimitar Syndrome Patients: A Three Decade Single-Center Experience.
Pediatr Cardiol. 2023;44:579-586.
Abstract

HUNGERFORD SL, Kearney K, Song N, Bart N, et al
Prognostic role of pulmonary impedance estimation to predict right ventricular dysfunction in pulmonary hypertension.
ESC Heart Fail. 2023 Mar 10. doi: 10.1002/ehf2.14180.
Abstract

SWISHER JW, Weaver E
The Evolving Management and Treatment Options for Patients with Pulmonary Hypertension: Current Evidence and Challenges.
Vasc Health Risk Manag. 2023;19:103-126.
Abstract

XANTHOULI P, Gordjani O, Benjamin N, Harutyunova S, et al
Hypochromic red cells as a prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension.
Arthritis Res Ther. 2023;25:38.
Abstract

LEMAY SE, Grobs Y, Boucherat O
Right Ventricular Dysfunction in Pulmonary Hypertension: Is Resistin a Promising Target?
J Am Heart Assoc. 2023 Mar 9:e8285. doi: 10.1161/JAHA.123.029503.
Abstract

MYLLYLAHTI L, Ropponen J, Lax M, Lassila R, et al
Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension.
Clin Appl Thromb Hemost. 2023;29:10760296231158369.
Abstract

SHI Y, Liu J, Zhang R, Zhang M, et al
Targeting Endothelial ENO1 (Enolase) -PI3K-Akt-mTOR Axis Alleviates Hypoxic Pulmonary Hypertension.
Hypertension. 2023 Mar 8. doi: 10.1161/HYPERTENSIONAHA.122.19857.
Abstract

CROSSMAN LM, Rajaram P, Hart CM, Pernetz MA, et al
Evaluation of right ventricular strain in two separate cohorts with precapillary pulmonary hypertension.
Pulm Circ. 2023;13:e12204.
Abstract

MAMALAKIS M, Dwivedi K, Sharkey M, Alabed S, et al
A transparent artificial intelligence framework to assess lung disease in pulmonary hypertension.
Sci Rep. 2023;13:3812.
Abstract

ISHII S, Minatsuki S, Hatano M, Saito A, et al
The ratio of TAPSE to PASP predicts prognosis in lung transplant candidates with pulmonary arterial hypertension.
Sci Rep. 2023;13:3758.
Abstract

DUGGAL M, Moore SS, Simoneau J, Girard G, et al
Pulmonary Hypertension and Necrotizing Enterocolitis in Neonates Treated with Diazoxide.
Am J Perinatol. 2023 Mar 7. doi: 10.1055/s-0043-1764385.
Abstract

LANGLAIS EL, Avram R
Overcoming Diagnostic Delays in Pulmonary Hypertension with Deep Learning ECG Analysis.
J Card Fail. 2023 Mar 4:S1071-9164(23)00063.
Abstract

JAYAKUMAR N, Keir A
EBNEO commentary: Oral versus intravenous sildenafil for pulmonary hypertension in neonates.
Acta Paediatr. 2023 Mar 6. doi: 10.1111/apa.16725.
Abstract

HWANG JK, Shin SH, Kim EK, Kim SH, et al
Association of newer definitions of bronchopulmonary dysplasia with pulmonary hypertension and long-term outcomes.
Front Pediatr. 2023;11:1108925.
Abstract

PHILIP N, Pi H, Gadkari M, Yun X, et al
Transpulmonary amino acid metabolism in the sugen hypoxia model of pulmonary hypertension.
Pulm Circ. 2023;13:e12205.
Abstract

ZHANG M, Zeng Q, Zhou S, Zhu G, et al
Mendelian randomization study on causal association of IL-6 signaling with pulmonary arterial hypertension.
Clin Exp Hypertens. 2023;45:2183963.
Abstract

CRUZ-UTRILLA A, Garcia-Martin EP, Dominguez Perez L, Ruiz Curiel A, et al
ECMO in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as a bridge-to-therapy.
Kardiol Pol. 2023 Mar 5. doi: 10.33963/KP.a2023.0055.
Abstract

ZHANG C, Zhang T, Xing Y, Lu W, et al
Airway Delivery of Streptococcus Salivarius is Sufficient to Induce Experimental Pulmonary Hypertension in Rat.
Br J Pharmacol. 2023 Mar 4. doi: 10.1111/bph.16064.
Abstract

WU DD, Deng Y, Liao J, Xie SS, et al
STING mediates SU5416/hypoxia-induced pulmonary arterial hypertension in rats by regulating macrophage NLRP3 inflammasome activation.
Immunobiology. 2023;228:152345.
Abstract

LIU Y, Tang BL, Lu ML, Wang HX, et al
Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathway.
J Cell Mol Med. 2023;27:622-633.
Abstract

KANG T, Liu L, Tan F, Zhang D, et al
Inhibition of YTHDF1 prevents hypoxia-induced pulmonary artery smooth muscle cell proliferation by regulating Foxm1 translation in an m6A-dependent manner.
Exp Cell Res. 2023;424:113505.
Abstract

EKHLASI M, Sheikhi S, Majd ZK, Peiravian F, et al
Cost-Effectiveness Analysis of Macitentan in Comparison With Bosentan in the Treatment of Pulmonary Arterial Hypertension in Iran.
Value Health Reg Issues. 2023;34:78-85.
Abstract

BAHUDHANAPATI H, Kass DJ
Integrating the Integrated Stress Response.
Am J Respir Cell Mol Biol. 2023;68:243-244.
Abstract

CHANDRASEKARA S, Lau EM, Anderson J, Collins N, et al
Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing.
Heart Lung Circ. 2023;32:156-165.
Abstract

LI B, Gillmeyer KR, Molloy-Paolillo B, Vimalananda VG, et al
Scoping Review of Pulmonary Telemedicine Consults: Current Knowledge and Research Gaps.
Ann Am Thorac Soc. 2023;20:456-465.
Abstract

SANTOS-RIBEIRO D, Lecocq M, de Beukelaer M, Verleden S, et al
Disruption of GCN2 Pathway Aggravates Vascular and Parenchymal Remodeling during Pulmonary Fibrosis.
Am J Respir Cell Mol Biol. 2023;68:326-338.
Abstract

HORN-OUDSHOORN EJJ, Vermeulen MJ, Knol R, Te Pas AB, et al
The Oxygen Saturation Index as Early Predictor of Outcomes in Congenital Diaphragmatic Hernia.
Neonatology. 2022 Nov 28:1-8. doi: 10.1159/000527407.
Abstract

MATUTE GUERRERO A, Abanses Moreno P, Villasmil Chaparro I
Pulmonary thrombotic microangiopathy caused by neoplastic urothelial carcinoma cells.
Med Clin (Barc). 2023;160:226-227.
Abstract

KINGREY JF, Zhou CY, Dalal B, Elwing JM, et al
Expert provider survey of longitudinal assessment in patients with pulmonary arterial hypertension.
Heart Lung. 2023;58:34-38.
Abstract

CRUZ-UTRILLA A, Escribano Subias MP, Tenorio Castano JA, Del Cerro Marin MJ, et al
Digenic Inheritance in a Case of Pulmonary Arterial Hypertension Associated with Two Incidental Septal Defects and Multiple Thoracic Collaterals.
Arch Bronconeumol. 2023;59:169-170.
Abstract

KUTLUG AGACKIRAN S, Sunbul M, Dogan Z, Kocakaya D, et al
Pulmonary arterial wall thickness increased in Behcet's disease patients with major organ involvement: Is it a sign of severity?
Rheumatology (Oxford). 2023;62:1238-1242.
Abstract

UPTON PD, Dunmore BJ, Li W, Morrell NW, et al
An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension.
Dev Dyn. 2023;252:327-342.
Abstract

XU Y, Hu T, Ding H, Yuan Y, et al
miR-485-5p alleviates obstructive sleep apnea syndrome with hypertension by inhibiting PI3K/AKT signaling pathway via downregulating HIF3A expression.
Sleep Breath. 2023;27:109-119.
Abstract

LEE KI, Manuntag LJ, Kifayat A, Manuntag SE, et al
Cardiovascular Manifestations of Systemic Sclerosis: An Overview of Pathophysiology, Screening Modalities, and Treatment Options.
Cardiol Rev. 2023;31:22-27.
Abstract

TINNING FB, Petersen OBB, Steensberg JN, Buchvald FF, et al
[Diagnosis and treatment of a multisystemic disorder in children called congenital portosystemic shunts].
Ugeskr Laeger. 2021;183:V01210041.
Abstract

ESCRIBANO SUBIAS P, Aurtenetxe Perez A, Perez Olivares C, Gomez Climent L, et al
Recent advances in the management of pulmonary arterial hypertension: lessons from the upfront combination of ambrisentan and tadalafil.
Expert Rev Respir Med. 2021;15:493-504.
Abstract

URABE C, Takaya Y, Nakayama R, Nakamura K, et al
Shear Wave Dispersion Slope of the Liver Can Predict Adverse Outcomes in Patients with Pulmonary Hypertension.
Int Heart J. 2023 Mar 15. doi: 10.1536.
Abstract

LIN Q, Kumar S, Kariyawasam U, Yang X, et al
Human Resistin Induces Cardiac Dysfunction in Pulmonary Hypertension.
J Am Heart Assoc. 2023 Mar 16:e027621. doi: 10.1161/JAHA.122.027621.
Abstract

KAVGACI A, Kula S, Incedere F, Terlemez S, et al
Subcutaneous use of treprostinil in pediatric pulmonary hypertension patients: A report of three cases.
Turk Gogus Kalp Damar Cerrahisi Derg. 2023;31:145-148.
Abstract

YOUSSEF D, Richards S, Lague S, Sheppard C, et al
A Canadian, retrospective, multicenter experience with selexipag for a heterogeneous group of pediatric pulmonary hypertension patients.
Front Pediatr. 2023;11:1055158.
Abstract

DENG RW, Fan YL, Wu BX
[Advances in diagnosis and treatment of pulmonary hypertension based on the 2022 ESC Guidelines].
Zhonghua Xin Xue Guan Bing Za Zhi. 2023;51:314-319.
Abstract

DITTRICH AM, Mienert J, Pott J, Engels L, et al
Clinical phenotyping of plasma thrombospondin-2 reveals relationship to right ventricular structure and function in pulmonary hypertension.
ERJ Open Res. 2023;9:00528-2022.
Abstract

WANG N, Hua J, Fu Y, An J, et al
Updated perspective of EPAS1 and the role in pulmonary hypertension.
Front Cell Dev Biol. 2023;11:1125723.
Abstract

TAMURA H, Hosokawa S, Takahashi T, Kishi K, et al
Balloon Pulmonary Angioplasty for Recurrent Lesions Six Years Following Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension.
Cureus. 2023;15:e34846.
Abstract

EL-KERSH K, Jalil BA
Pulmonary Hypertension Inhaled Therapies: An Updated Review.
Am J Med Sci. 2023 Mar 13:S0002-9629(23)01061.
Abstract

GOPALAN D, Riley JYJ, Leong K, Guo HH, et al
Pulmonary Vein Sign on Computed Tomography Pulmonary Angiography in Proximal and Distal Chronic Thromboembolic Pulmonary Hypertension With Hemodynamic Correlation.
J Thorac Imaging. 2023 Mar 15. doi: 10.1097/RTI.0000000000000706.
Abstract

ZOU X, Liu T, Huang Z, Zhou W, et al
SOX17 is a Critical Factor in Maintaining Endothelial Function in Pulmonary Hypertension by an Exosome-Mediated Autocrine Manner.
Adv Sci (Weinh). 2023 Mar 15:e2206139. doi: 10.1002/advs.202206139.
Abstract

ULUTAS Z, Ermis H, Ermis N, Berber I, et al
Bone Marrow Transplantation as a Rare Cause of Pulmonary Arterial Hypertension.
Turk Kardiyol Dern Ars. 2023;51:151-154.
Abstract

HU C, Liu M, Yu H, Wang J, et al
[Risk factors of early death after lung transplantation in patients with idiopathic pulmonary fibrosis complicated with pulmonary arterial hypertension].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023;35:124-129.
Abstract

MAO J, Ma L
Research progress on the mechanism of phenotypic transformation of pulmonary artery smooth muscle cells induced by hypoxia.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023;51:750-757.
Abstract

SAITO Y, Obokata M, Harada T, Kagami K, et al
Disproportionate exercise-induced pulmonary hypertension in relation to cardiac output in heart failure with preserved ejection fraction: a non-invasive echocardiographic study.
Eur J Heart Fail. 2023 Mar 13. doi: 10.1002/ejhf.2821.
Abstract

SU L, Li X, Mao X, Xu T, et al
Circ-Ntrk2 acts as a miR-296-5p sponge to activate the TGF-beta1/p38 MAPK pathway and promote pulmonary hypertension and vascular remodelling.
Respir Res. 2023;24:78.
Abstract

KIM KA, Jung MH
Pulmonary Tumor Thrombotic Microangiopathy: An Under-Recognized Potentially Fatal Cause of Pulmonary Hypertension.
Korean Circ J. 2023;53:185-188.
Abstract

ABDELAZEEM H, Tu L, Thuillet R, Ottaviani M, et al
AMPK activation by metformin protects against pulmonary hypertension in rats and relaxes isolated human pulmonary artery.
Eur J Pharmacol. 2023 Mar 11:175579. doi: 10.1016/j.ejphar.2023.175579.
Abstract

LEY L, Holtgen R, Bogossian H, Ghofrani HA, et al
Electrocardiogram in patients with pulmonary hypertension.
J Electrocardiol. 2023;79:24-29.
Abstract

CHIU YW, Wu YW
Pulmonary Hypertension, an Evolutional Disease with Multidisciplinary Team Management.
Acta Cardiol Sin. 2023;39:209-212.
Abstract

LIU YY, Wu SH, Tsai CT, Sun FJ, et al
Pulse Wave Analysis Predicts Invasive Hemodynamics in Pre-Capillary Pulmonary Hypertension.
Acta Cardiol Sin. 2023;39:319-330.
Abstract

YANG L, Tian J, Wang J, Zeng J, et al
The protective role of EP300 in monocrotaline-induced pulmonary hypertension.
Front Cardiovasc Med. 2023;10:1037217.
Abstract

JOSHI SR, Atabay EK, Liu J, Ding Y, et al
Sotatercept analog improves cardiopulmonary remodeling and pulmonary hypertension in experimental left heart failure.
Front Cardiovasc Med. 2023;10:1064290.
Abstract

FANG SC, Huang CY, Huang SM, Shao YJ, et al
Associations and relative risks of pulmonary hypertension and lung diseases in individuals with methamphetamine use disorder.
Pulmonology. 2023 Mar 10:S2531-0437(23)00008.
Abstract

HUANG YS, Chen ZW, Lee WJ, Wu CK, et al
Treatment Response Evaluation by Computed Tomography Pulmonary Vasculature Analysis in Patients With Chronic Thromboembolic Pulmonary Hypertension.
Korean J Radiol. 2023 Mar 7. doi: 10.3348/kjr.2022.0675.
Abstract

YASENJIANG M, Cheng H, Guo Z, Yu X, et al
Correlation between pulmonary vascular performance and hemodynamics in patients with pulmonary arterial hypertension.
Clin Exp Hypertens. 2023;45:2185253.
Abstract

SALEH K, Khan N, Dougherty K, Bodi G, et al
The First Pulmonary Hypertension Registry in the United Arab Emirates (UAEPH): Clinical Characteristics, Hemodynamic Parameters with Focus on Treatment and Outcomes for Patients with Group 1-PH.
J Clin Med. 2023;12:1996.
Abstract

AVRIEL A, Bar Lavie Shay A, Hershko Klement A, Taylor J, et al
Point-of-Care Ultrasonography in a Pulmonary Hypertension Clinic: A Randomized Pilot Study.
J Clin Med. 2023;12:1752.
Abstract

SEN P, Shashikadze B, Flenkenthaler F, Van de Kamp E, et al
Proteomics- and Metabolomics-Based Analysis of Metabolic Changes in a Swine Model of Pulmonary Hypertension.
Int J Mol Sci. 2023;24:4870.
Abstract

PARK JF, Liang J, Umar S
Electrical Remodeling in Right Ventricular Failure Due to Pulmonary Hypertension: Unraveling Novel Therapeutic Targets.
Int J Mol Sci. 2023;24:4633.
Abstract

BARANSKA-PAWELCZAK K, Wojciechowska C, Jachec W
Pregnancy in Patients with Pulmonary Arterial Hypertension in Light of New ESC Guidelines on Pulmonary Hypertension.
Int J Environ Res Public Health. 2023;20:4625.
Abstract

LI Q, Hujiaaihemaiti M, Wang J, Uddin MN, et al
Identifying key transcription factors and miRNAs coregulatory networks associated with immune infiltrations and drug interactions in idiopathic pulmonary arterial hypertension.
Math Biosci Eng. 2023;20:4153-4177.
Abstract

ARSLAN A, Yanartas M, Tas S, Bozbuga N, et al
The Effect of Perioperative Fluid Management and Operative Modifications on Mortality and Morbidity in Patients Undergoing Pulmonary Endarterectomy.
Braz J Cardiovasc Surg. 2023;38:22-28.
Abstract

GUPTA R, Kim JS, Baughman RP
An expert overview of pulmonary fibrosis in sarcoidosis.
Expert Rev Respir Med. 2023;17:119-130.
Abstract

BARROS LSA, Castillo JM, Lacerda HR
Abnormal right ventricular echocardiographic findings in recovered patients associated with severe acute respiratory syndrome in COVID-19.
Echocardiography. 2023;40:227-234.
Abstract

ZHANG J, Li Y, Chen Y, Yu X, et al
Circ-calm4 regulates hypoxia-induced pulmonary artery smooth muscle autophagy by binding Purb.
J Mol Cell Cardiol. 2023;176:41-54.
Abstract

MILNE KM, James MD, Smyth RM, Vincent SG, et al
Neurophysiological mechanisms of exertional dyspnea in post-pulmonary embolism syndrome.
J Appl Physiol (1985). 2023;134:667-677.
Abstract

KARACA Y, Hidayet S, Bayramoglu A, Yildirim E, et al
Evaluation of pulmonary artery stiffness and right ventricle functions in polycythemia vera patients by transthoracic echocardiography.
Echocardiography. 2023;40:196-203.
Abstract

MICHALSKI M, Haas N, Pozza RD, Michel S, et al
Tricuspid Annular Plane Systolic Excursion (TAPSE) correlates with mean pulmonary artery pressure especially 10 years after pediatric heart transplantation.
Clin Transplant. 2022 May 16:e14710. doi: 10.1111/ctr.14710.
Abstract

KARASU BB, Aydincak HT
Right ventricular-pulmonary arterial uncoupling in mild-to-moderate asthma.
J Asthma. 2022 May 3:1-13. doi: 10.1080/02770903.2022.2073548.
Abstract

YANG Z, Li P, Yuan Q, Wang X, et al
Inhibition of miR-4640-5p alleviates pulmonary hypertension in chronic obstructive pulmonary disease patients by regulating nitric oxide synthase 1.
Respir Res. 2023;24:92.
Abstract

FOGEL LA, Grady RM, He M, Kitcharoensakkul M, et al
Steroid-Responsive Pulmonary Hypertension in a Pediatric Patient with Chronic Granulomatous Disease and Histoplasmosis.
J Clin Immunol. 2023 Mar 24. doi: 10.1007/s10875-023-01473.
Abstract

LIN Y, Pang L, Huang S, Shen J, et al
A nomogram for predicting 3-year mortality in patients with pulmonary hypertension due to left heart failure: A retrospective analysis of a prospective registry study.
Cardiology. 2023 Mar 23. doi: 10.1159/000530206.
Abstract

TAMURA H, Hosokawa S, Yuba K, Kishi K, et al
Rescue balloon pulmonary angioplasty for worsening chronic thromboembolic pulmonary hypertension with essential thrombocythaemia and the JAK2-V617F mutation: a case report.
Eur Heart J Case Rep. 2023;7:ytad106.
Abstract

SINGH M, Berkey F, Fragin J, Grine K, et al
Pulmonary hypertension: An update of Dx and Tx guidelines.
J Fam Pract. 2023;72:72-83.
Abstract

MORRIS NR, Kermeen FD, Jones AW, Lee JY, et al
Exercise-based rehabilitation programmes for pulmonary hypertension.
Cochrane Database Syst Rev. 2023;3:CD011285.
Abstract

DUZGUN Z, Kayikcioglu LM, Aktan C, Bara B, et al
Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension.
Turk J Med Sci. 2023;53:130-141.
Abstract

JANI V, Aslam MI, Fenwick AJ, Ma W, et al
Right Ventricular Sarcomere Contractile Depression and the Role of Thick Filament Activation in Human Heart Failure with Pulmonary Hypertension.
bioRxiv. 2023 Mar 12:2023.03.09.531988. doi: 10.1101/2023.03.09.531988.
Abstract

HU CJ, Laux A, Gandjeva A, Wang L, et al
The Effect of HIF Inhibition on the Phenotype of Fibroblasts in Human and Bovine Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2023 Mar 21. doi: 10.1165/rcmb.2022-0114.
Abstract

XING Y, Qi J, Cheng X, Song X, et al
Circ-myh8 Promotes Pulmonary Hypertension by Recruiting KAT7 to Govern Hypoxia-Inducible Factor-1alpha Expression.
J Am Heart Assoc. 2023 Mar 21:e028299. doi: 10.1161/JAHA.122.028299.
Abstract

ZHANG X, Yang Z, Su S, Nan X, et al
Kaempferol ameliorates pulmonary vascular remodeling in chronic hypoxia-induced pulmonary hypertension rats via regulating Akt-GSK3beta-cyclin axis.
Toxicol Appl Pharmacol. 2023;466:116478.
Abstract

BEKEDAM FT, Goumans MJ, Bogaard HJ, de Man FS, et al
Molecular mechanisms and targets of right ventricular fibrosis in pulmonary hypertension.
Pharmacol Ther. 2023 Mar 18:108389. doi: 10.1016/j.pharmthera.2023.108389.
Abstract

BARRET T, Degano B, Bouvaist H, Pison C, et al
Routine Rehabilitation as a Treatment Component for Patients With Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertensions.
J Cardiopulm Rehabil Prev. 2023 Mar 21. doi: 10.1097/HCR.0000000000000755.
Abstract

ZUIN M, Bilato C, Rigatelli G, Quadretti L, et al
Trends in age-specific and sex-specific pulmonary hypertension mortality in Italy between 2005 and 2017.
J Cardiovasc Med (Hagerstown). 2023 Mar 20. doi: 10.2459/JCM.0000000000001457.
Abstract

HUSSAIN T, Chai L, Wang Y, Zhang Q, et al
Activation of PPAR-gamma prevents TERT-mediated pulmonary vascular remodeling in MCT-induced pulmonary hypertension.
Heliyon. 2023;9:e14173.
Abstract

FUKASAWA Y, Yamamoto H, Ito M, Saito A, et al
Case report: High-dose epoprostenol therapy in pediatric patients with pulmonary hypertension and developmental lung disease.
Front Pediatr. 2023;11:1116434.
Abstract

XIAO M, Lai D, Yu Y, Wu Q, et al
Pathogenesis of pulmonary hypertension caused by left heart disease.
Front Cardiovasc Med. 2023;10:1079142.
Abstract

ASLLANAJ B, Benge E, Bae J, McWhorter Y, et al
Fluid management in septic patients with pulmonary hypertension, review of the literature.
Front Cardiovasc Med. 2023;10:1096871.
Abstract

RAWLINGS GH, Novakova B, Armstrong I, Thompson AR, et al
Can self-compassion help us better understand the impact of pulmonary hypertension on those with the condition and their carers? A cross-sectional analysis.
Pulm Circ. 2023;13:e12208.
Abstract

BOXHAMMER E, Kletzer J, Kellermair J, Scharinger B, et al
CT measured pulmonary artery to ascending aorta ratio stratified by echocardiographically obtained systolic pulmonary artery pressure values for noninvasive detection of pulmonary hypertension in patients with severe aortic valve stenosis.
Clin Res Cardiol. 2023 Mar 20. doi: 10.1007/s00392-023-02182.
Abstract

CARLOZZI LN, Lee J, Barros LM, Buber Y, et al
Establishing a balloon pulmonary angioplasty program for chronic thromboembolic pulmonary hypertension: A United States single-center experience.
Respir Med. 2023 Mar 17:107215. doi: 10.1016/j.rmed.2023.107215.
Abstract

EL-KHUFFASH A, Mullaly R, McNamara PJ
Patent ductus arteriosus, bronchopulmonary dysplasia and pulmonary hypertension-a complex conundrum with many phenotypes?
Pediatr Res. 2023 Mar 18. doi: 10.1038/s41390-023-02578.
Abstract

HEGAZY Y, Aryan M, Panchani N, Reif M, et al
The correlation in echocardiogram to right heart catheterization in identifying pulmonary hypertension as a barrier to liver transplantation.
Am J Med Sci. 2023 Mar 16:S0002-9629(23)01070.
Abstract

LAMMERS AE, Marek J, Diller GP, Haworth SG, et al
Prognostic Value of Transthoracic Echocardiography in Children With Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2023;12:e023118.
Abstract

FORTMEIER V, Lachmann M, Unterhuber M, Stolz L, et al
Epiphenomenon or Prognostically Relevant Interventional Target? A Novel Proportionality Framework for Severe Tricuspid Regurgitation.
J Am Heart Assoc. 2023;12:e028737.
Abstract

DONG J, Jiang XM, Xie DJ, Luo J, et al
Establishment of a canine model of pulmonary arterial hypertension induced by dehydromonocrotaline and ultrasonographic study of right ventricular remodeling.
Clin Exp Hypertens. 2023;45:2190503.
Abstract

SCHUSTER M, Muller J, Schwarz EI, Saxer S, et al
Oxygen Therapy in Pulmonary Vascular Disease: A Systematic Review, Meta-Analysis, and Comment.
Heart Fail Clin. 2023;19.
Abstract

CHANG KY, Giorgio K, Schmitz K, Walker RF, et al
Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2023;12:e027559.
Abstract

HELD M, Pfeuffer-Jovic E, Wilkens H, Guder G, et al
Frequency and characterization of CTEPH and CTEPD according to the mPAP threshold > 20 mm Hg: Retrospective analysis from data of a prospective PE aftercare program.
Respir Med. 2023;210:107177.
Abstract

XUN M, Zhang J, Wu M, Chen Y, et al
Long non-coding RNAs: The growth controller of vascular smooth muscle cells in cardiovascular diseases.
Int J Biochem Cell Biol. 2023;157:106392.
Abstract

MARTENS P, Bhattacharya S, Longinow J, Ives L, et al
Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis.
Circ Heart Fail. 2023 Jan 25:e010078. doi: 10.1161/CIRCHEARTFAILURE.122.010078.
Abstract

GAO J, Yin H, Dong Y, Wang X, et al
A Novel Role of Uricosuric Agent Benzbromarone in BK Channel Activation and Reduction of Airway Smooth Muscle Contraction.
Mol Pharmacol. 2023;103:241-254.
Abstract

MONTALBARON MB, Tian L, Yu VX, Awad MI, et al
Multi-institutional search for patient factors associated with adverse events following tracheotomy.
Am J Otolaryngol. 2023;44:103773.
Abstract

BENINCASA G, Napoli C, Loscalzo J, Maron BA, et al
Pursuing Functional Biomarkers in Complex Disease: Focus on Pulmonary Arterial Hypertension.
Am Heart J. 2022 Dec 21:S0002-8703(22)00330-1. doi: 10.1016/j.ahj.2022.
Abstract

UCROS S, Aparicio C, Castro-Rodriguez JA, Ivy D, et al
High altitude pulmonary edema in children: A systematic review.
Pediatr Pulmonol. 2023;58:1059-1067.
Abstract

BROWN CE, Steiner JM, Leary PJ, Curtis JR, et al
A World of Maximalist Medicine: Physician Perspectives on Palliative Care and End-of-life for Patients With Pulmonary Arterial Hypertension.
J Pain Symptom Manage. 2023;65:e329-e335.
Abstract

BORBA GC, Andrade FP, de Souza Ferreira T, Pinotti AFF, et al
Estimation of pulmonary artery systolic pressure in hemodialysis patients and its association with cardiorespiratory fitness and pulmonary function.
Int Urol Nephrol. 2023;55:961-968.
Abstract

FRANKLIN SD, Fierro J, Hysinger EB, Phinizy PA, et al
Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage Samples of Children with Bronchopulmonary Dysplasia.
J Pediatr. 2023;253:79-85.
Abstract

LEVIN JC, Annesi CA, Williams DN, Abman SH, et al
Discharge Practices for Infants with Bronchopulmonary Dysplasia: A Survey of National Experts.
J Pediatr. 2022 Sep 17. pii: S0022-3476(22)00822.
Abstract

KNIGHT DS, Karia N, Cole AR, Maclean RH, et al
Distinct cardiovascular phenotypes are associated with prognosis in systemic sclerosis: a cardiovascular magnetic resonance study.
Eur Heart J Cardiovasc Imaging. 2023;24:463-471.
Abstract

FAYYAZ AU, Sabbah MS, Dasari S, Griffiths LG, et al
Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertension.
Cardiovasc Res. 2023;119:268-282.
Abstract

SHEN M, Zheng C, Chen L, Li M, et al
LCZ696 (sacubitril/valsartan) inhibits pulmonary hypertension induced right ventricular remodeling by targeting pyruvate dehydrogenase kinase 4.
Biomed Pharmacother. 2023;162:114569.
Abstract

AKASLAN D, Aslanger E, Atas H, Kocakaya D, et al
Are Guideline-recommended Risk Classification Schemes in Pulmonary Hypertension Adequately Robust to Guide the Real-world Setting?
Balkan Med J. 2023 Mar 31. doi: 10.4274/balkanmedj.galenos.2023.2023.
Abstract

LUHADIA K, Yashi K, Virk J, Parikh T, et al
Type 1 Pulmonary Hypertension and Silicosis in a Bluestone Cutter: A Case Report on Raising Awareness.
Cureus. 2023;15:e35425.
Abstract

HUMBERT M, Kovacs G, Hoeper MM, Badagliacca R, et al
[2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].
G Ital Cardiol (Rome). 2023;24:1e-116e.
Abstract

YUCHI Y, Suzuki R, Yasumura Y, Saito T, et al
Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension.
J Vet Intern Med. 2023 Mar 30. doi: 10.1111/jvim.16686.
Abstract

JIN N, Yu M, Du X, Wu Z, et al
Identification of potential serum biomarkers for congenital heart disease children with pulmonary arterial hypertension by metabonomics.
BMC Cardiovasc Disord. 2023;23:167.
Abstract

TAO XC, Wang JZ, Gu SC, Liu M, et al
[Rescue balloon pulmonary angioplasty for a patient with acute exacerbation of chronic thromboembolic pulmonary hypertension supported by extracorporeal membrane oxygenation: a case report].
Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:408-412.
Abstract

ALALAIWE A, Alsenaidy MA, Almalki ZS, Fayed MH, et al
Development and Optimization of Sildenafil Orodispersible Mini-Tablets (ODMTs) for Treatment of Pediatric Pulmonary Hypertension Using Response Surface Methodology.
Pharmaceutics. 2023;15:923.
Abstract

GONZALES J, Fraidenburg DR
Pharmacology and Emerging Therapies for Group 3 Pulmonary Hypertension Due to Chronic Lung Disease.
Pharmaceuticals (Basel). 2023;16:418.
Abstract

CERNE JW, Shehata C, Ragin A, Pathrose A, et al
Potential Prognostic Value of Native T1 in Pulmonary Hypertension Patients.
Life (Basel). 2023;13:775.
Abstract

SHAH AJ, Beckmann T, Vorla M, Kalra DK, et al
New Drugs and Therapies in Pulmonary Arterial Hypertension.
Int J Mol Sci. 2023;24:5850.
Abstract

PARPERIS K, Velidakis N, Khattab E, Gkougkoudi E, et al
Systemic Lupus Erythematosus and Pulmonary Hypertension.
Int J Mol Sci. 2023;24:5085.
Abstract

BZDEGA K, Kutkowska-Kazmierczak A, Deutsch GH, Plaskota I, et al
Prenatal Detection of a FOXF1 Deletion in a Fetus with ACDMPV and Hydronephrosis.
Genes (Basel). 2023;14:563.
Abstract

SAKARIN S, Rungsipipat A, Surachetpong SD
Perivascular inflammatory cells and their association with pulmonary arterial remodelling in dogs with pulmonary hypertension due to myxomatous mitral valve disease.
Vet Res Commun. 2023 Mar 28. doi: 10.1007/s11259-023-10106.
Abstract

ZENG Z, Wang X, Cui L, Wang H, et al
Natural Products for the Treatment of Pulmonary Hypertension: Mechanism, Progress, and Future Opportunities.
Curr Issues Mol Biol. 2023;45:2351-2371.
Abstract

MANFRINI V, Badagliacca R, Messaggio E, Poscia R, et al
Exploratory study on the endogenous ouabain in idiopathic pulmonary arterial hypertension patients.
Ann Ist Super Sanita. 2023;59:76-79.
Abstract

WANG K, Verma A, Fish KE, Hu JR, et al
A Case of Fulminant Right Heart Failure Owing to Tumoral Pulmonary Hypertension.
JACC Case Rep. 2023;10:101715.
Abstract

WANG Y, Ning WW, Jin YF, Zhu QQ, et al
Anlotinib dramatically improved pulmonary hypertension and hypoxia caused by Pulmonary Tumor Thrombotic Microangiopathy (PTTM) associated with gastric carcinoma: a case report.
Thromb J. 2023;21:33.
Abstract

FAIRCLOTH JM, Bhatt ND, Chartan CA, Coleman RD, et al
Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration.
Front Pediatr. 2023;11:1050508.
Abstract

HICKEY T, Jayakumar S, Perrino AC Jr
Severe Pulmonary Hypertension Meets Intraperitoneal Surgery: No Place to Inflate?
Cureus. 2023;15:e35318.
Abstract

EINECKE D
[Not Available].
MMW Fortschr Med. 2023;165:19.
Abstract

POPE JE, Denton CP, Johnson SR, Fernandez-Codina A, et al
State-of-the-art evidence in the treatment of systemic sclerosis.
Nat Rev Rheumatol. 2023;19:212-226.
Abstract

LIU W, Hua Y, Zheng D, Lv W, et al
Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults.
Circ J. 2023;87:527-535.
Abstract

PAVLOVA OS, Gulyaev MV, Gervits LL, Hurshkainen AA, et al
capital TE, Cyrillic(1) mapping of rat lungs in (19) F MRI using octafluorocyclobutane.
Magn Reson Med. 2023;89:2318-2331.
Abstract

ZHANG H, Zhang D, Wang X, Liu Y, et al
Prognostic implication of a novel right ventricular injury score in septic patients.
ESC Heart Fail. 2023;10:1205-1213.
Abstract

HU Y, Zong Y, Jin L, Zou J, et al
Reduced Apela/APJ system expression in patients with pulmonary artery hypertension secondary to chronic obstructive pulmonary disease.
Heart Lung. 2023;59:8-15.
Abstract

GALDINO GAM, Rehder-Santos P, Linares SN, Beltrame T, et al
Cerebral oxygenation during cardiopulmonary exercise testing in cardiorespiratory diseases: A systematic review.
Heart Lung. 2023;59:23-32.
Abstract

JONAS K, Zulawinska B, Borys A, Wolkow P, et al
A new mutation in the EIF2AK4 gene in familial pulmonary veno-occlusive disease.
Pol Arch Intern Med. 2023;133:16413.
Abstract

DANDOY CE, Tsong WH, Sarikonda K, McGarvey N, et al
Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy.
Transplant Cell Ther. 2023;29:282.
Abstract

SAITO Y, Omae Y, Mizobuchi S, Fujito H, et al
Prognostic significance of pulmonary arterial wedge pressure estimated by deep learning in acute heart failure.
ESC Heart Fail. 2023;10:1103-1113.
Abstract

NAESSEN T, Einarsson G, Henrohn D, Wikstrom G, et al
Peripheral Vascular Ageing in Pulmonary Arterial Hypertension as Assessed by Common Carotid Artery Intima Thickness and Intima/Media Thickness Ratio: An Investigation Using Non-Invasive High-Resolution Ultrasound.
Heart Lung Circ. 2023;32:338-347.
Abstract

TAKAYASU H
Upregulated TSP1 and CD47 expression in the lung in nitrofen-induced congenital diaphragmatic hernia.
Pediatr Int. 2023;65:e15447.
Abstract

SAID SM, Hoggard E, Narasimhan S
Surgical Experience With Crossed and Anomalous Origin of the Pulmonary Arteries From the Pulmonary Trunk: A Single Center Report of 24 Cases.
World J Pediatr Congenit Heart Surg. 2023;14:185-193.
Abstract

RAKO ZA, Kremer N, Yogeswaran A, Richter MJ, et al
Adaptive versus maladaptive right ventricular remodelling.
ESC Heart Fail. 2023;10:762-775.
Abstract

PICCARI L, Allwood B, Antoniou K, Chung JH, et al
Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hype
Pulm Circ. 2023;13:e12213.
Abstract

CREA F
Focus issue on vascular biology and medicine spanning from management of stroke to new therapeutic targets in aortic dissection and pulmonary hypertension.
Eur Heart J. 2023;44:1193-1196.
Abstract

KHURANA J, Orbach DB, Gauvreau K, Collins SA, et al
Pulmonary Hypertension in Infants and Children with Vein of Galen Malformation and Association with Clinical Outcomes.
J Pediatr. 2023 Apr 4:113404. doi: 10.1016/j.jpeds.2023.113404.
Abstract

GONG C, Guo X, Wan K, Chen C, et al
Corrected MRI Pulmonary Transit Time for Identification of Combined Precapillary and Postcapillary Pulmonary Hypertension in Patients With Left Heart Disease.
J Magn Reson Imaging. 2023;57:1518-1528.
Abstract

ILONZE OJ
Outcomes of pregnancy with pulmonary hypertension: low risk or a false dawn?
Cardiovasc J Afr. 2023;34:1.
Abstract

CHANG HP, Lien R, Chu SM, Lin JJ, et al
Outcomes of and factors associated with the development of bronchopulmonary dysplasia with pulmonary hypertension in very low birth weight infants: A retrospective study in a medical center.
Front Pediatr. 2023;11:1055439.
Abstract

GUO W, Zhang M, Li H, Wang Y, et al
A comparative study on the diagnostic efficacy of different diagnostic criteria for exercise pulmonary hypertension.
Int J Cardiol. 2023 Apr 3:S0167-5273(23)00479.
Abstract

KUMAR R, Lee MH, Kassa B, Fonseca Balladares DC, et al
Repetitive Schistosoma Exposure Causes Perivascular Lung Fibrosis and Persistent Pulmonary Hypertension.
Clin Sci (Lond). 2023 Apr 4:CS20220642. doi: 10.1042/CS20220642.
Abstract

ELESAWY SA, El-Serogy HA, Sorour EA, Zoair AM, et al
Plasma mid-regional proadrenomedullin level in children with pulmonary hypertension associated with CHD.
Cardiol Young. 2023 Apr 4:1-7. doi: 10.1017/S1047951123000471.
Abstract

ZHANQIANG L, Huoqiang H, Dianxiang L
Epigenetics mechanism and therapeutic potential of approved epi-drugs in pulmonary hypertension disease.
Curr Top Med Chem. 2023 Apr 3. doi: 10.2174/1568026623666230403090650.
Abstract

AZAR J, Ayyad M, Jaber Y, Ayasa LA, et al
Scurvy-induced pulmonary arterial hypertension.
BMJ Case Rep. 2023;16:e254730.
Abstract

YANG L, Wan N, Gong F, Wang X, et al
Transcription factors and potential therapeutic targets for pulmonary hypertension.
Front Cell Dev Biol. 2023;11:1132060.
Abstract

SERMET R, Piliero N, Guillien A, Madoun S, et al
Pulmonary arterial compliance and exercise capacity after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
ERJ Open Res. 2023;9:00590-2022.
Abstract

GAYEN S, Mamary AJ
Predictors of hospitalization for respiratory failure among patients with sarcoidosis-associated pulmonary hypertension.
Pulm Circ. 2023;13:e12212.
Abstract

OBIKANE H, Shimodai-Yamada S, Koizumi N, Ogino H, et al
Histopathological Evaluation of Pulmonary Thromboendarterectomy Specimens of Chronic Thromboembolic Pulmonary Hypertension.
J Atheroscler Thromb. 2023 Apr 1. doi: 10.5551/jat.63973.
Abstract

KUBOTA K, Imai Y, Okuyama T, Ishiyama Y, et al
Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis.
Int Heart J. 2023;64:316-320.
Abstract

WARNER ED, Brailovsky Y, Oliveros E, Bhardwaj A, et al
High Output Heart Failure, Pulmonary Hypertension and Right Ventricular Failure in Patients with Arteriovenous Fistulas: A call to action.
J Card Fail. 2023 Mar 31:S1071-9164(23)00108.
Abstract

SINGH P, Deshpande S, Nagpal R, Garegrat R, et al
Management of neonatal pulmonary hypertension-a survey of neonatal intensive care units in India.
BMC Pediatr. 2023;23:149.
Abstract

WU XH, He YY, Chen ZR, He ZY, et al
Single-cell analysis of peripheral blood from high-altitude pulmonary hypertension patients identifies a distinct monocyte phenotype.
Nat Commun. 2023;14:1820.
Abstract

DENIZ MF, Sinan MYA, Y Ld Z A, K N EBZR, et al
Percutaneous Treatment of Left Main Coronary Artery Compression in a Pulmonary Artery Hypertension Patient Associated with Atrial Septal Defect.
Turk Kardiyol Dern Ars. 2023;51:221-225.
Abstract

NATHANSEN AB, Moller AM
[Not Available].
Ugeskr Laeger. 2023;185:V06220421.
Abstract

YANG H, Pan J, Wang W, Guo T, et al
Application of Artificial Intelligence-Based Auxiliary Diagnosis in Congenital Heart Disease Screening.
Anatol J Cardiol. 2023;27:205-216.
Abstract

GRYNBLAT J, Malekzadeh-Milani SG, Meot M, Perros F, et al
Monitoring of Hemodynamics With Right Heart Catheterization in Children With Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2023;12:e029085.
Abstract

HAFEEZ N, Kirillova A, Yue Y, Rao RJ, et al
Single Nucleotide Polymorphism rs9277336 Controls the Nuclear Alpha Actinin 4-Human Leukocyte Antigen-DPA1 Axis and Pulmonary Endothelial Pathophenotypes in Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2023;12:e027894.
Abstract

YANG HT, Wang G, Zhu PC, Xiao ZY, et al
Silencing EIF3A ameliorates pulmonary arterial hypertension through HDAC1 and PTEN/PI3K/AKT pathway in vitro and in vivo.
Exp Cell Res. 2023;426:113555.
Abstract

KIZHAKKE PULIYAKOTE AS, Prisk GK, Elliott AR, Kim NH, et al
The spatial-temporal dynamics of pulmonary blood flow are altered in pulmonary arterial hypertension.
J Appl Physiol (1985). 2023;134:969-979.
Abstract

VAIDY A, Vaidya A
Pulmonary arterial hypertension in pregnancy.
Curr Opin Cardiol. 2023;38:250-256.
Abstract

TANRIVERDI LH
Novel aspects of the renin-angiotensin system for pulmonary arterial hypertension.
Hypertens Res. 2023;46:1049-1050.
Abstract

REZA AA, Kohram F, Reza HA, Kalin TR, et al
FOXF1 Regulates Alveolar Epithelial Morphogenesis through Transcriptional Activation of Mesenchymal WNT5A.
Am J Respir Cell Mol Biol. 2023;68:430-443.
Abstract

HONG J, Wong B, Huynh C, Tang B, et al
Tm4sf1-marked Endothelial Subpopulation Is Dysregulated in Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2023;68:381-394.
Abstract

CACCIAPAGLIA F, Airo P, Fornaro M, Trerotoli P, et al
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients.
Rheumatology (Oxford). 2023;62:1552-1558.
Abstract

GARCIA MVF, Souza R, Caruso P
Predictors of invasive mechanical ventilation use in patients with acute decompensated pulmonary hypertension admitted to the intensive care unit.
ERJ Open Res. 2023;9:00598-2022.
Abstract

HE M, Tao K, Xiang M, Sun J, et al
Hpgd affects the progression of hypoxic pulmonary hypertension by regulating vascular remodeling.
BMC Pulm Med. 2023;23:116.
Abstract

MA C, Xu Q, Huang S, Song J, et al
The HIF-1alpha/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy.
FASEB J. 2023;37:e22906.
Abstract

ISHIDA K, Kohno H, Matsuura K, Sugiura T, et al
Impact of residual pulmonary hypertension on long-term outcomes after pulmonary endarterectomy in the modern era.
Pulm Circ. 2023;13:e12215.
Abstract

BOUSSEAU S, Sobrano Fais R, Gu S, Frump A, et al
Pathophysiology and new advances in pulmonary hypertension.
BMJ Med. 2023;2:e000137.
Abstract

PUGNALONI F, Capolupo I, Patel N, Giliberti P, et al
Role of microRNAs in Congenital Diaphragmatic Hernia-Associated Pulmonary Hypertension.
Int J Mol Sci. 2023;24:6656.
Abstract

MORIYAMA H, Endo J
Pathophysiological Involvement of Mast Cells and the Lipid Mediators in Pulmonary Vascular Remodeling.
Int J Mol Sci. 2023;24:6619.
Abstract

CAMARA RP, Coelho FDN, Cruz-Martins N, Marques-Alves P, et al
Incidence of Bloodstream Infection in Patients with Pulmonary Hypertension under Intravenous Epoprostenol or Iloprost-A Multicentre, Retrospective Study.
Int J Mol Sci. 2023;24:6434.
Abstract

HE Z, Chang T, Chen Y, Wang H, et al
PARM1 Drives Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension via AKT/FOXO3A Axis.
Int J Mol Sci. 2023;24:6385.
Abstract

HOSOKAWA K, Abe K, Funakoshi K, Tamura Y, et al
Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study.
J Thromb Haemost. 2023 Apr 10:S1538-7836(23)00270.
Abstract

HUNGERFORD S, Kearney K, Song N, Kotlyar E, et al
Characteristic changes to pulsatile and steady-state load according to pulmonary hypertension classification.
Physiol Rep. 2023;11:e15662.
Abstract

YURIDITSKY E, Horowitz JM, Lau JF
Chronic thromboembolic pulmonary hypertension and the post-pulmonary embolism (PE) syndrome.
Vasc Med. 2023 Apr 10:1358863X231165105. doi: 10.1177/1358863X231165105.
Abstract

SHINDO A, Ueda K, Minatsuki S, Nakayama Y, et al
Novel AGL variants in a patient with glycogen storage disease type IIIb and pulmonary hypertension caused by pulmonary veno-occlusive disease: A case report.
Front Genet. 2023;14:1148067.
Abstract

GONZALEZ-RIVAS D, Koziej PH, Sediqi S, Ruprecht B, et al
Uniportal hybrid robotic-assisted right upper sleeve lobectomy in an 83-year-old patient with severe pulmonary hypertension.
Ann Cardiothorac Surg. 2023;12:136-138.
Abstract

SIAGIAN SN, Prakoso R, Mendel B, Hazami Z, et al
Transesophageal echocardiography-guided percutaneous closure of multiple muscular ventricular septal defects with pulmonary hypertension using single device: A case report.
Front Cardiovasc Med. 2023;10:1093563.
Abstract

ZHOU C, Tao J, Li S
Case report: Unruptured sinus of Valsalva aneurysms causing postural angina pectoris and false "pulmonary hypertension".
Front Cardiovasc Med. 2023;10:1120633.
Abstract

SANCHEZ-BECERRA JC, Guillen-Torres R, Becerra-Becerra R, Marquez-Gonzalez H, et al
Targeted neonatal echocardiography and lung ultrasound in preterm infants with chronic lung disease with and without pulmonary hypertension, screened using a standardized algorithm.
Front Pediatr. 2023;11:1104940.
Abstract

YU D, Zhang T, Zhou G, Wu Z, et al
Co-profiling reveals distinct patterns of genomic chromatin accessibility and gene expression in pulmonary hypertension caused by chronic hypoxia.
Respir Res. 2023;24:104.
Abstract

MARTINHO M, Cale R, Ferreira F, Alegria S, et al
Chronic thromboembolic pulmonary hypertension - the challenging approach of a young patient with distal disease.
Pulmonology. 2023 Apr 6:S2531-0437(23)00053-3. doi: 10.1016/j.pulmoe.2023.
Abstract

WU PW, Yeh SJ, Lee PC, Pan KT, et al
Hemodynamic and Echocardiographic Characteristics and the Presence of Pulmonary Hypertension in Patent Ductus Arteriosus Patients who Underwent Transcatheter Closure.
Pediatr Cardiol. 2023 Apr 8. doi: 10.1007/s00246-023-03157.
Abstract

KORMAN BD, Lachant DJ, Castelino FV
Pulmonary Hypertension: How to Best Treat the Different Scleroderma Phenotypes?
Rheum Dis Clin North Am. 2023;49:345-357.
Abstract

VARJU C, Pauling JD, Saketkoo LA
Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis.
Rheum Dis Clin North Am. 2023;49:211-248.
Abstract

MARON BA
Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer.
J Am Heart Assoc. 2023 Apr 7:e029024. doi: 10.1161/JAHA.122.029024.
Abstract

MATSUO M, Doi T, Katsuki M, Yoshimura Y, et al
Association between intraoperative pulmonary artery pressure and cardiovascular complications after off-pump coronary artery bypass surgery: a single-center observational study.
BMC Anesthesiol. 2023;23:114.
Abstract

ZOLTY R
Advances in the discovery of drugs that treat pulmonary arterial hypertension.
Expert Opin Drug Discov. 2023;18:445-466.
Abstract

LIN KC, Yeh JN, Shao PL, Chiang JY, et al
Jagged/Notch proteins promote endothelial-mesenchymal transition-mediated pulmonary arterial hypertension via upregulation of the expression of GATAs.
J Cell Mol Med. 2023;27:1110-1130.
Abstract

YAMAGUCHI Y, Hosokawa S, Haraguchi G, Kajikawa Y, et al
The Anti-Inflammatory Effects and Clinical Potential of Dexmedetomidine in Pulmonary Arterial Hypertension.
J Pharmacol Exp Ther. 2023;385:88-94.
Abstract

VISWANATHAN G, Rajagopal S
De novo purine synthesis: a new target in pulmonary arterial hypertension?
Eur Heart J. 2023 Feb 20:ehad078. doi: 10.1093.
Abstract

OKOUR M, Thapar MM, Farrell C, Lukas MA, et al
Pediatric Population Pharmacokinetic Modeling and Exposure-Response Analysis of Ambrisentan in Pulmonary Arterial Hypertension and Comparison With Adult Data.
J Clin Pharmacol. 2023;63:593-603.
Abstract

ELMI-SARABI M, Couture E, Jarry S, Saade E, et al
Inhaled Epoprostenol and Milrinone Effect on Right Ventricular Pressure Waveform Monitoring.
Can J Cardiol. 2023;39:474-482.
Abstract

CROWELL PR, Frederick MR, Fombin RA, Varghese NP, et al
Prevalence of malnutrition in pediatric pulmonary hypertension cohort and role for registered dietitian involvement.
Front Pediatr. 2023;11:995470.
Abstract

TSUBATA H, Nakanishi N, Itatani K, Takigami M, et al
Pulmonary artery blood flow dynamics in chronic thromboembolic pulmonary hypertension.
Sci Rep. 2023;13:6490.
Abstract

WEISS A, Yogeswaran A, Mamazhakypov A, Schermuly RT, et al
Right ventricular failure in pulmonary hypertension: recent insights from experimental models.
Herz. 2023 Apr 20. doi: 10.1007/s00059-023-05180.
Abstract

ZHENG W, Li T, Wei J, Yan Y, et al
Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression.
Korean J Physiol Pharmacol. 2023;27:209-220.
Abstract

JIN S, Zhao S, Wan X, Zhang M, et al
A Positive Microbubble Study in Ventricular Septal Defect Patient Without Pulmonary Hypertension.
JACC Case Rep. 2023;11:101782.
Abstract

CRNKOVIC S, Kwapiszewska G
Guilt by Association - Stepwise Entanglement of the Role of HIF in Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2023 Apr 19. doi: 10.1165/rcmb.2023-0103.
Abstract

SHI Y, Liu J, Zhang R, Zhang M, et al
Targeting Endothelial ENO1 (Alpha-Enolase) -PI3K-Akt-mTOR Axis Alleviates Hypoxic Pulmonary Hypertension.
Hypertension. 2023;80:1035-1047.
Abstract

GUO X, Li MX, Bayer C, Yang YQ, et al
[Effect of platelet-derived growth factor-BB on pulmonary vascular remodeling in neonatal rats with hypoxic pulmonary hypertension and its mechanism].
Zhongguo Dang Dai Er Ke Za Zhi. 2023;25:407-414.
Abstract

WANG L, Wang F, Tuo Y, Wan H, et al
Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes.
BMC Pulm Med. 2023;23:127.
Abstract

PALEVICIUTE E, Celutkiene J, Simbelyte T, Gumbiene L, et al
Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trial.
Trials. 2023;24:281.
Abstract

YUAN R, Liu M, Cheng Y, Yan F, et al
Biomimetic Nanoparticle-Mediated Target Delivery of Hypoxia-Responsive Plasmid of Angiotensin-Converting Enzyme 2 to Reverse Hypoxic Pulmonary Hypertension.
ACS Nano. 2023 Apr 18. doi: 10.1021/acsnano.2c12190.
Abstract

ZHOU W, Du Z, Tao Y, Zhang GX, et al
Effect of preoperative pulmonary artery pressure on the prognosis of end-stage heart failure patients after heart transplantation.
J Cardiothorac Surg. 2023;18:154.
Abstract

HUANG W, Liu H, Pan Y, Wang X, et al
A modified primary culture method of rat pulmonary vein smooth muscle cells.
J Cardiothorac Surg. 2023;18:146.
Abstract

CARBONE RG, Monselise A, Barisione E, Fontana V, et al
Pulmonary hypertension in systemic sclerosis with usual interstitial pneumonia.
Intern Emerg Med. 2023 Apr 17. doi: 10.1007/s11739-023-03267.
Abstract

KAKALETSIS S, Malinowski M, Mathur M, Sugerman GP, et al
Untangling the mechanisms of pulmonary hypertension-induced right ventricular stiffening in a large animal model.
bioRxiv. 2023 Apr 6:2023.04.03.535491. doi: 10.1101/2023.04.03.535491.
Abstract

HINTON M, Thliveris JA, Hatch GM, Dakshinamurti S, et al
Nitric oxide augments signaling for contraction in hypoxic pulmonary arterial smooth muscle-Implications for hypoxic pulmonary hypertension.
Front Physiol. 2023;14:1144574.
Abstract

GUO Y, He Z, Chen Z, Chen F, et al
Inhibition of Th17 cells by donepezil ameliorates experimental lung fibrosis and pulmonary hypertension.
Theranostics. 2023;13:1826-1842.
Abstract

YANG Y, Chen H, Dong Q, Liao K, et al
Severity of functional tricuspid regurgitation is associated with mortality in patients with pulmonary hypertension in long-term follow-up.
Pulm Circ. 2023;13:e12222.
Abstract

MADDIPATI V, Sankhyan P, Goswami DP, Mahajan A, et al
Pulmonary hypertension in patients with multiple myeloma: A comprehensive review.
Pulm Circ. 2023;13:e12210.
Abstract

YUNG D, Jackson EO, Blumenfeld A, Redding G, et al
A multidisciplinary approach to severe bronchopulmonary dysplasia is associated with resolution of pulmonary hypertension.
Front Pediatr. 2023;11:1077422.
Abstract

MORALES-CANO D, Izquierdo-Garcia JL, Barreira B, Esquivel-Ruiz S, et al
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model.
Front Pharmacol. 2023;14:1021535.
Abstract

YOSHITOMI Y, Suwa Y, Tsuchiya H, Goto M, et al
Pulmonary Hypertension Associated with Anti-synthetase Syndrome: A Case Report and Literature Review.
Intern Med. 2023 Apr 14. doi: 10.2169/internalmedicine.9809.
Abstract

DENG M, Liu A, Xu W, Yang H, et al
Right and left ventricular blood pool T2 ratio on cardiac magnetic resonance imaging correlates with hemodynamics in patients with pulmonary hypertension.
Insights Imaging. 2023;14:66.
Abstract

DE BIE FR, Avitabile CM, Flohr S, Land S, et al
Treprostinil in neonates with congenital diaphragmatic hernia-related pulmonary hypertension.
J Pediatr. 2023 Apr 12:113420. doi: 10.1016/j.jpeds.2023.113420.
Abstract

POPOVICH YM, Rosul MV, Sich PR, Laver OP, et al
THROMBOLYSIS IN PULMONARY EMBOLISM TREATMENT.
Wiad Lek. 2023;76:604-609.
Abstract

SHI J, Shao M, Zhou X, Lu Y, et al
Postcardiac injury syndrome caused by radiofrequency catheter ablation of persistent atrial fibrillation: severe pulmonary arterial hypertension with severe tricuspid regurgitation: a rare case report and literature review.
BMC Cardiovasc Disord. 2023;23:192.
Abstract

PLATT C, Longthorpe C, Sit J, Marks SD, et al
Pulmonary hypertension in juvenile-onset systemic lupus erythematosus: a case series.
Clin Exp Rheumatol. 2023 Apr 13. doi: 10.55563.
Abstract

BUENDIA JA, Patino DG, Lindarte EF
Ambrisentan for in pediatric pulmonary arterial hypertension: A cost-utility analysis.
Pediatr Pulmonol. 2023;58:1562-1568.
Abstract

HUANG Z, Dong F, Wang M, Hu F, et al
Comparison of long-term survival after endovascular treatment versus medical therapy in patients with Takayasu's arteritis and pulmonary artery stenosis.
Clin Exp Rheumatol. 2023;41:887-892.
Abstract

LI X, Zhang X, Hou X, Bing X, et al
Obstructive sleep apnea-increased DEC1 regulates systemic inflammation and oxidative stress that promotes development of pulmonary arterial hypertension.
Apoptosis. 2023;28.
Abstract

TORTUM F, Tekin E, Gur A, Kerget B, et al
Use of the PaO(2)/FiO(2) Ratio in Pulmonary Embolism: Evaluation of its Correlation with Pulmonary Arterial Computed Tomography Obstruction Index.
Acad Radiol. 2023;30:893-899.
Abstract

OU Y, Zong D, Ouyang R
Role of epigenetic abnormalities and intervention in obstructive sleep apnea target organs.
Chin Med J (Engl). 2023;136:631-644.
Abstract

FIKE CD, Aschner JL
Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future.
Pharmaceuticals (Basel). 2023;16:503.
Abstract

TORNLING G, Batta R, Salvail D, Raud J, et al
Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats.
Int J Mol Sci. 2023;24:7478.
Abstract

RICHTER MJ, Tello K
[Pulmonary hypertension associated with lung disease].
Herz. 2023 Apr 27. doi: 10.1007/s00059-023-05173.
Abstract

YUCHI Y, Suzuki R, Satomi S, Saito T, et al
Cardiovascular Effect of Epoprostenol and Intravenous Cardiac Drugs for Acute Heart Failure on Canine Pulmonary Hypertension.
Vet Sci. 2023;10:302.
Abstract

PROHASKA CC, Zhang X, Schwantes-An TL, Stearman RS, et al
RASA3 is a candidate gene in sickle cell disease-associated pulmonary hypertension and pulmonary arterial hypertension.
Pulm Circ. 2023;13:e12227.
Abstract

SCHROEDER L, Holcher S, Leyens J, Geipel A, et al
Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension.
Eur J Pediatr. 2023 Apr 27. doi: 10.1007/s00431-023-04971.
Abstract

JAIN N, Sheikh MA, Bajaj D, Townsend W, et al
Periprocedural Complications With Balloon Pulmonary Angioplasty: Analysis of Global Studies.
JACC Cardiovasc Interv. 2023;16:976-983.
Abstract

SONNWEBER T, Tymoszuk P, Steringer-Mascherbauer R, Sigmund E, et al
The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension-a long-term retrospective multicenter trial.
BMC Pulm Med. 2023;23:143.
Abstract

PERROS F, Jutant EM, Savale L, Dorfmuller P, et al
[Physiopathology and treatment of pulmonary arterial hypertension].
Med Sci (Paris). 2023;39:359-369.
Abstract

QIU F, Jiang B, Lin Y, Li H, et al
Dual PEDF and HGF Overexpression: A New Therapy for Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2023 Apr 24. doi: 10.1165/rcmb.2022-0459.
Abstract

CABELLO-GANEM A, Serrano-Roman J, Espejel-Guzman A, Ramirez-Perea F, et al
Pulmonary hypertension secondary to Takayasu arteritis and atrial septal defect.
Clin Rheumatol. 2023 Apr 24. doi: 10.1007/s10067-023-06607.
Abstract

RAZEE A, Banerjee S, Hong J, Magaki S, et al
Thoracic Spinal Cord Neuroinflammation as a Novel Therapeutic Target in Pulmonary Hypertension.
Hypertension. 2023 Apr 24. doi: 10.1161/HYPERTENSIONAHA.122.20782.
Abstract

PALAZZINI M, Dardi F, Magnani I, Guarino D, et al
Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease.
Eur Heart J Suppl. 2023;25.
Abstract

THOMAS C, Chandel A, King CS, Aryal S, et al
Prevalence of pulmonary hypertension in patients with COVID-19 related lung disease listed for lung transplantation: A UNOS registry analysis.
Pulm Circ. 2023;13:e12228.
Abstract

THORE P, Staentzel J, Valentin S, Guillaumot A, et al
Hemodynamic characteristics in patients with pulmonary hypertension and chronic obstructive pulmonary disease: A retrospective monocentric cohort study.
Respir Med Res. 2023;83:101008.
Abstract

TOYAMA T, Kudryashova TV, Ichihara A, Lenna S, et al
GATA6 coordinates cross-talk between BMP10 and oxidative stress axis in pulmonary arterial hypertension.
Sci Rep. 2023;13:6593.
Abstract

GUAN Y, Jin Y, Lu Y, Ao D, et al
Correlation of ABO blood groups with treatment response and efficacy in infants with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide.
BMC Pregnancy Childbirth. 2023;23:276.
Abstract

SUN M, Gao LJ, Zhang Y, Jing GJ, et al
Effect of tracheal intubation on postoperative complications in patients with pulmonary hypertension combined with non-cardiothoracic, non-obstetric surgery.
Medicine (Baltimore). 2023;102:e33635.
Abstract

AKTAA S, Gale CP, Brida M, Giannakoulas G, et al
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail. 2023 Mar 16. doi: 10.1002/ejhf.2830.
Abstract

RAHAGHI FF, Trivieri MG, Sahay S
The role of riociguat in combination therapies for pulmonary arterial hypertension.
Respir Med. 2023;211:107196.
Abstract

LU Q, Sun X, Yegambaram M, Ornatowski W, et al
Nitration-mediated activation of the small GTPase RhoA stimulates cellular glycolysis through enhanced mitochondrial fission.
J Biol Chem. 2023;299:103067.
Abstract

DEL POZO R, Blanco I, Lopez-Meseguer M, Escribano-Subias P, et al
Effectiveness and persistence with selexipag in pulmonary arterial hypertension in the real-life setting.
Eur J Intern Med. 2023;111:140-142.
Abstract

LIU CW, Le HHT, Denaro Iii P, Dai Z, et al
E-cigarettes induce dysregulation of autophagy leading to endothelial dysfunction in pulmonary arterial hypertension.
Stem Cells. 2023 Jan 14:sxad004. doi: 10.1093.
Abstract

GIESINGER RE, Stanford AH, Thomas B, Abman SH, et al
Safety and Feasibility of Riociguat Therapy for the Treatment of Chronic Pulmonary Arterial Hypertension in Infancy.
J Pediatr. 2022 Nov 30:S0022-3476(22)01079-4. doi: 10.1016/j.jpeds.2022.
Abstract

UNLU S, Bezy S, Cvijic M, Duchenne J, et al
Right ventricular strain related to pulmonary artery pressure predicts clinical outcome in patients with pulmonary arterial hypertension.
Eur Heart J Cardiovasc Imaging. 2023;24:635-642.
Abstract

GU Y, Han K, Zhang Z, Zhao Z, et al
(68)Ga-FAPI PET/CT for molecular assessment of fibroblast activation in right heart in pulmonary arterial hypertension: a single-center, pilot study.
J Nucl Cardiol. 2022 Mar 23. pii: 10.1007/s12350-022-02952.
Abstract

HUANG H, Lin D, Hu L, Wang J, et al
QKI Promotes Hypoxia-induced Smooth Muscle Reprogramming in Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2023 May 5. doi: 10.1165/rcmb.2022-0349.
Abstract

MCSWEENEY J, Colglazier E, Becerra J, Leary B, et al
Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients.
Pulm Circ. 2023;13:e12224.
Abstract

HONG C, Chen R, Hu L, Liu H, et al
Aetiological distribution of pulmonary hypertension and the value of transthoracic echocardiography screening in the respiratory department: A retrospective analysis from China.
Clin Respir J. 2023 May 4. doi: 10.1111/crj.13623.
Abstract

BRUERA S, Sreedhar A, Agarwal SK, Muthukumar V, et al
Immunosuppression for the treatment of pulmonary hypertension in patients with systemic lupus erythematosus: A systematic review.
Int J Rheum Dis. 2023 May 4. doi: 10.1111/1756-185X.14706.
Abstract

BANDORSKI D, Heibel S, Holtgen R, Bogossian H, et al
Incidence and prognostic significance of malignant arrhythmias during (repetitive) Holter electrocardiograms in patients with pulmonary hypertension.
Front Cardiovasc Med. 2023;10:1084051.
Abstract

CHOOBDAR FA, Shahhosseini P, Vahedi Z, Khosravi N, et al
Comparison of the efficacy of inhaled versus infused milrinone in the management of persistent pulmonary hypertension of the newborn in resource-limited settings: A randomized clinical trial.
Pediatr Pulmonol. 2023 May 3. doi: 10.1002/ppul.26451.
Abstract

PILOTO B, Fernandes CJCDS, Jardim C, Castro M, et al
Loss of response to calcium channel blockers after long-term follow-up treatment in patients with idiopathic pulmonary arterial hypertension.
J Bras Pneumol. 2023;49:e20220337.
Abstract

ZHAI Z, Boon GJAM, Staring M, van Dam LF, et al
Automated quantification of the pulmonary vasculature in pulmonary embolism and chronic thromboembolic pulmonary hypertension.
Pulm Circ. 2023;13:e12223.
Abstract

KALLONEN J, Corbascio M, Radegran G, Bredin F, et al
Quality of life and functional status after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: A Swedish single-center study.
Pulm Circ. 2023;13:e12219.
Abstract

YANG X, Yang Y, Liu K, Zhang C, et al
Traditional Chinese medicine monomers: Targeting pulmonary artery smooth muscle cells proliferation to treat pulmonary hypertension.
Heliyon. 2023;9:e14916.
Abstract

NABATI M, Parsaee H
Combined use of double Doppler Tei index and lung ultrasound for predicting pulmonary hypertension and corpulmonale in neonates with respiratory distress.
J Clin Ultrasound. 2023;51:636-638.
Abstract

GAUR J, Singh RK, Kulkarni C, Dube S, et al
Assessment of Pulmonary Hypertension in Chronic Kidney Disease Patients using Doppler Echocardiography.
Heart Views. 2023;24:24-28.
Abstract

SIDDAIAH R, Oji-Mmuo C, Aluquin VPR, Kawasawa YI, et al
Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension-A pilot study.
Pulm Circ. 2023;13:e12232.
Abstract

CHING S, Yue CS
A rare cause of pulmonary hypertension in an elderly woman.
J Geriatr Cardiol. 2023;20:314-316.
Abstract

LOGANTHA SJRJ, Yamanushi TT, Absi M, Temple IP, et al
Remodelling and dysfunction of the sinus node in pulmonary arterial hypertension.
Philos Trans R Soc Lond B Biol Sci. 2023;378:20220178.
Abstract

ARIMA F
[Warm autoimmune hemolytic anemia complicated with pulmonary hypertension exhibiting pulmonary mosaic attenuation pattern].
Rinsho Ketsueki. 2023;64:290-292.
Abstract

SALAZAR AM, Al-Asad KS, Prasad RM, Panama G, et al
Pulmonary Artery Denervation As A New Therapeutic Option for Pulmonary Hypertension: A Systematic Review and Meta-Analysis.
Curr Probl Cardiol. 2023 Apr 28:101776. doi: 10.1016/j.cpcardiol.2023.101776.
Abstract

HENDRIKS PM, Staal DP, Pastoor H, Kolpa CIA, et al
Sexual function is impaired in women and men with pulmonary hypertension.
Clin Res Cardiol. 2023 Apr 30. doi: 10.1007/s00392-023-02214.
Abstract

ZEITOUNI M, Morlon Q, Silvain J, Procopi N, et al
Implication of the new definition of pulmonary hypertension in patients evaluated for heart transplantation.
Int J Cardiol. 2023 Apr 27:S0167-5273(23)00602.
Abstract

LV C, Wu L, Liao G, Huang Y, et al
Maternal and fetal/neonatal outcomes of pregnancies complicated by pulmonary hypertension: a retrospective study of 154 patients.
Clinics (Sao Paulo). 2023;78:100194.
Abstract

KAPOOR R, Fatima J, Shukla V
An Unusual Case of Hyperthyroidism.
J Assoc Physicians India. 2023;71:1.
Abstract

HARTOPO AB, Anggrahini DW, Dinarti LK, Schafer AK, et al
Prognostic Value for Mortality of Plasma Bioactive Adrenomedullin in Patients with Pulmonary Arterial Hypertension: A Sub Analysis of the Biomarker Study in the COHARD-PH Registry.
Medicina (Kaunas). 2023;59:748.
Abstract

WANG D, Gomes MT, Mo Y, Prohaska CC, et al
Human Endogenous Retrovirus, SARS-CoV-2, and HIV Promote PAH via Inflammation and Growth Stimulation.
Int J Mol Sci. 2023;24:7472.
Abstract

MONNET X, Lai C
Which haemodynamic monitoring should we chose for critically ill patients with acute circulatory failure?
Curr Opin Crit Care. 2023;29:275-280.
Abstract

ZHANG Z, Zheng W, Chen M, Xie Q, et al
A new risk score for the assessment of outcomes for Chinese patients with peripartum cardiomyopathy.
Heart Lung. 2023;60:81-86.
Abstract

GONG JN, Mao JJ, Kuang TG, Yang SQ, et al
Analysis of clinical features between active and inactive patients of Takayasu's arteritis with pulmonary arteries involvement.
Int J Cardiol. 2023;381:88-93.
Abstract

DENG X, Jiang N, Huang C, Zhou S, et al
Mortality and prognostic factors in connective tissue disease-associated pulmonary arterial hypertension patients complicated with right heart failure.
Int J Rheum Dis. 2023;26:862-869.
Abstract

VEITH C, Knoepp F
Histone Methyl Transferase G9a/GLP-A Novel Avenue in Pulmonary Arterial Hypertension Treatment?
Am J Respir Cell Mol Biol. 2023;68:475-477.
Abstract

KOSTYUNINA DS, Rowan SC, Pakhomov NV, Dillon E, et al
Shear Stress Markedly Alters the Proteomic Response to Hypoxia in Human Pulmonary Endothelial Cells.
Am J Respir Cell Mol Biol. 2023;68:551-565.
Abstract

AWADA C, Bourgeois A, Lemay SE, Grobs Y, et al
G9a/GLP Targeting Ameliorates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2023;68:537-550.
Abstract

LEE HW, Adachi T, Pak B, Park S, et al
BMPR1A promotes ID2-ZEB1 interaction to suppress excessive endothelial to mesenchymal transition.
Cardiovasc Res. 2023;119:813-825.
Abstract

MARTINEZ-SOLANO J, Ortiz-Bautista C, Gutierrez-Ibanes E, Garcia-Cosio MD, et al
Optical coherence tomography assessment of pulmonary vascular remodeling in advanced heart failure. The OCTOPUS-CHF study.
Rev Esp Cardiol (Engl Ed). 2023;76:312-321.
Abstract

FOURNIER E, Selegny M, Amsallem M, Haddad F, et al
Multiparametric evaluation of right ventricular function in pulmonary arterial hypertension associated with congenital heart disease.
Rev Esp Cardiol (Engl Ed). 2023;76:333-343.
Abstract

MIRZA M K, Abqari S, Haseen A, Yadav M, et al
Transcatheter closure of ventricular septal defects: preliminary results in children weighing 10 kg or less.
Cardiol Young. 2023;33:539-545.
Abstract

PALAZZUOLI A, Savarese G
An update on diabetes spectrum in heart failure: current evidence and potential therapeutic applications.
Heart Fail Rev. 2023;28:573-575.
Abstract

ZAMBELAS JM, Karmouty-Quintana H
Snakes and Ladders: A Potential Therapy of HGF and PEDF in Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2023 May 11. doi: 10.1165/rcmb.2023-0118.
Abstract

DORONIN DV, Fomichev AV, Agaeva KA, Zhul'kov MO, et al
[Changes in Pulmonary Hemodynamics Resulted From Long-Term Mechanical Heart Support].
Kardiologiia. 2023;63:16-21.
Abstract

QUARCK R, Willems L, Tielemans B, Stoian L, et al
Impairment of Angiogenesis-Driven Clot Resolution Is a Key Event in the Progression to Chronic Thromboembolic Pulmonary Hypertension: Validation in a Novel Rabbit Model.
Arterioscler Thromb Vasc Biol. 2023 May 11. doi: 10.1161/ATVBAHA.122.317262.
Abstract

CHEN Z, Tian J, Ouyang R
Clinical characteristics and risk factors for primary Sjogren's syndrome complicated with pulmonary arterial hypertension.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48:339-346.
Abstract

KIELT M, Beer L, Rivera B, Jama W, et al
Association of the Respiratory Severity Score with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Infants Born Extremely Preterm.
Res Sq. 2023 Apr 27:rs.3.rs-2852392. doi: 10.21203/rs.3.rs-2852392.
Abstract

YOGESWARAN A, Mamazhakypov A, Schermuly RT, Weiss A, et al
Erratum to: Right ventricular failure in pulmonary hypertension: recent insights from experimental models.
Herz. 2023 May 9. doi: 10.1007/s00059-023-05190.
Abstract

ANTOUNIANS L, Zani A
Beyond the diaphragm and the lung: a multisystem approach to understanding congenital diaphragmatic hernia.
Pediatr Surg Int. 2023;39:194.
Abstract

MAYER M, Badesch DB, Nielsen KH, Kawut S, et al
Impact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Association Registry.
Pulm Circ. 2023;13:e12233.
Abstract

JAIN S, Yingchoncharoen P, Nugent K
Effect of Continuous Positive Airway Pressure Therapy in Patient with Obstructive Sleep Apnea and Pulmonary Hypertension: A literature review.
Cardiol Rev. 2023 May 5. doi: 10.1097/CRD.0000000000000564.
Abstract

COMPAGNONE M, Demola P, Serino F, Masiero G, et al
[Right heart catheterization in Italian catheterization laboratories: results of the SICI-GISE national survey promoted by the GISE Young Committee].
G Ital Cardiol (Rome). 2023;24:30-38.
Abstract

KIANI A, Rahimi F, Afaghi S, Paat M, et al
Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis.
Can Respir J. 2023;2023:8678702.
Abstract

ZHANG MQ, Wang CC, Pang XB, Shi JZ, et al
Role of macrophages in pulmonary arterial hypertension.
Front Immunol. 2023;14:1152881.
Abstract

LIANG YR, Yang YC, Yang BL, Zeng QX, et al
[Evaluation effect of COMPERA 2.0 risk assessment model on prognosis of Chinese patients with pulmonary arterial hypertension].
Zhonghua Yi Xue Za Zhi. 2023;103:1410-1416.
Abstract

BARATTO C, Caravita S, Dewachter C, Faini A, et al
RIGHT HEART ADAPTATION TO EXERCISE IN PULMONARY HYPERTENSION: AN INVASIVE HEMODYNAMIC STUDY.
J Card Fail. 2023 May 5:S1071-9164(23)00151.
Abstract

AIMAIER S, Tao Y, Lei F, Yupeng Z, et al
Protective effects of the Terminalia bellirica tannin-induced Nrf2/HO-1 signaling pathway in rats with high-altitude pulmonary hypertension.
BMC Complement Med Ther. 2023;23:150.
Abstract

LI F, Wan J, Zhai ZG, Xie WM, et al
[Clinical features and CT findings of fibrosing mediastinitis associated pulmonary hypertension].
Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:460-465.
Abstract

TURNER V, Maret E, Kim JB, Codari M, et al
Reduced Pulmonary Artery Distensibility Predicts Persistent Pulmonary Hypertension and 2-Year Mortality in Patients with Severe Aortic Stenosis Undergoing TAVR.
Acad Radiol. 2023 May 3:S1076-6332(23)00126-5. doi: 10.1016/j.acra.2023.
Abstract

ABDULKAREEM AO, Tiwari P, Lone ZR, Iqbal H, et al
Corrigendum to "Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension" [Eur. J. Pharmacol. 943 (2023) 175558].
Eur J Pharmacol. 2023 May 3:175750. doi: 10.1016/j.ejphar.2023.175750.
Abstract

PAPADEMETRIOU E, Liu X, Beaudet A, Tsang Y, et al
Comparative evaluation of costs and healthcare resource utilization of oral selexipag versus inhaled treprostinil or oral treprostinil in patients with pulmonary arterial hypertension.
J Med Econ. 2023;26:644-655.
Abstract

LIU P, Gao S, Li Z, Pan S, et al
Endothelial progenitor cell-derived exosomes inhibit pulmonary artery smooth muscle cell in vitro proliferation and resistance to apoptosis by modulating the Mitofusin-2 and Ras-Raf-ERK1/2 signaling pathway.
Eur J Pharmacol. 2023;949:175725.
Abstract

HYE T, Hossain MR, Saha D, Foyez T, et al
Emerging biologics for the treatment of pulmonary arterial hypertension.
J Drug Target. 2023;31:471-485.
Abstract

MA B, Cao Y, Qin J, Chen Z, et al
Pulmonary artery smooth muscle cell phenotypic switching: A key event in the early stage of pulmonary artery hypertension.
Drug Discov Today. 2023;28:103559.
Abstract

GHARAHI H, Filonova V, Mullagura HN, Nama N, et al
A multiscale framework for defining homeostasis in distal vascular trees: applications to the pulmonary circulation.
Biomech Model Mechanobiol. 2023;22:971-986.
Abstract

PAYNE C, Jacobs S, Shaboodien S, Jumaar C, et al
A pulmonary arterial hypertension diagnostic algorithm for a third-world context: SYMQUICK.
J Investig Med. 2023;71:542-544.
Abstract

FRANCESCATO G, Capolupo I, Cerbo RM, Doni D, et al
Reply to the comment on "Fluid restriction in management of patent ductus arteriosus in Italy: a nationwide survey".
Eur J Pediatr. 2023;182:1931-1932.
Abstract

HE Z
Comment on "1,8-Cineole ameliorates right ventricle dysfunction associated with pulmonary arterial hypertension by restoring connexin43 and mitochondrial homeostasis".
Pharmacol Res. 2023;191:106622.
Abstract

ALVES-SILVA JM, Zuzarte M, Marques C, Viana S, et al
Reply to the Comment on "1,8-Cineole ameliorates right ventricle dysfunction associated with pulmonary arterial hypertension by restoring connexin43 and mitochondrial homeostasis".
Pharmacol Res. 2023;191:106623.
Abstract

PARIKH R, Farber HW
Response to "Noninvasive determinants of pulmonary hypertension (PH) in interstitial lung disease (ILD)" by Joseph et al.
Pulm Circ. 2023;13:e12239.
Abstract

XU W, Deng M, Zhang L, Zhang P, et al
Qualification of Ventricular Flow in Patients With Precapillary Pulmonary Hypertension With 4-dimensional Flow Magnetic Resonance Imaging.
J Thorac Imaging. 2023 May 15. doi: 10.1097/RTI.0000000000000715.
Abstract

LIN S, He L, Ji L, Peng Y, et al
[Analysis on missed diagnosis or misdiagnosis of anomalous origin of left coronary artery from pulmonary artery by echocardiography from one single medical center].
Zhonghua Xin Xue Guan Bing Za Zhi. 2023;51:481-489.
Abstract

LIU H, Wang S, Chen Q, Ge X, et al
Natural Targeting Potent ROS-eliminating Tungsten-based Polyoxometalate Nanodots for Efficient Treatment of Pulmonary Hypertension.
Adv Healthc Mater. 2023 May 17:e2300252. doi: 10.1002/adhm.202300252.
Abstract

PICHON J, Roche A, Fauvel C, Boucly A, et al
Clinical relevance and prognostic value of renal Doppler in acute decompensated precapillary pulmonary hypertension.
Eur Heart J Cardiovasc Imaging. 2023 May 17:jead104. doi: 10.1093.
Abstract

RAMADHIANI R, Ikeda K, Miyagawa K, Ryanto GRT, et al
Endothelial cell senescence exacerbates pulmonary hypertension by inducing juxtacrine Notch signaling in smooth muscle cells.
iScience. 2023;26:106662.
Abstract

KRZYZEWSKA A, Baranowska-Kuczko M, Kasacka I, Kozlowska H, et al
Cannabidiol alleviates right ventricular fibrosis by inhibiting the transforming growth factor beta pathway in monocrotaline-induced pulmonary hypertension in rats.
Biochim Biophys Acta Mol Basis Dis. 2023;1869:166753.
Abstract

WIEDENROTH CB, Pruefer D, Adameit MSD, Mayer E, et al
Chronic thromboembolic pulmonary hypertension-medical, interventional, and surgical therapy.
Herz. 2023 Apr 25. doi: 10.1007/s00059-023-05172.
Abstract

NIELSEN R, Christensen KH, Gopalasingam N, Berg-Hansen K, et al
Hemodynamic Effects of Ketone Bodies in Patients With Pulmonary Hypertension.
J Am Heart Assoc. 2023;12:e028232.
Abstract

LI Y, Zhang R, Shan H, Shi W, et al
FVC/D(LCO) identifies pulmonary hypertension and predicts 5-year all-cause mortality in patients with COPD.
Eur J Med Res. 2023;28:174.
Abstract

JOSEPH P, Savarimuthu S, Oakland HT, Cullinan M, et al
Response to letter to the editor "noninvasive determinants of pulmonary hypertension in interstitial lung disease".
Pulm Circ. 2023;13:e12238.
Abstract

KURAMOTO K, Ogawa A, Kiyama K, Matsubara H, et al
Antiproliferative effect of selexipag active metabolite MRE-269 on pulmonary arterial smooth muscle cells from patients with chronic thromboembolic pulmonary hypertension.
Pulm Circ. 2023;13:e12231.
Abstract

KIM BJ, Kim SJ, Im SI, Kim H, et al
Pulmonary Hypertension With Unilateral Pulmonary Vein Atresia.
Int J Heart Fail. 2023;5:102-105.
Abstract

CHARIFA A, Olivier B, Steeve P, Sebastien B, et al
The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets.
Vascul Pharmacol. 2023 May 11:107180. doi: 10.1016/j.vph.2023.107180.
Abstract

ANDERSEN S, Reese-Petersen AL, Braams N, Andersen MJ, et al
Biomarkers of collagen turnover and wound healing in chronic thromboembolic pulmonary hypertension patients before and after pulmonary endarterectomy.
Int J Cardiol. 2023 May 11:S0167-5273(23)00706.
Abstract

HAVRANEK S, Fingrova Z, Skala T, Reichenbach A, et al
Catheter ablation of atrial fibrillation and atrial tachycardia in patients with pulmonary hypertension: a randomized study.
Europace. 2023 May 13:euad131. doi: 10.1093.
Abstract

HU H, Cai J, Qi D, Li B, et al
Identification of Potential Biomarkers for Group I Pulmonary Hypertension Based on Machine Learning and Bioinformatics Analysis.
Int J Mol Sci. 2023;24:8050.
Abstract

VALENTINI A, Franchi P, Cicchetti G, Messana G, et al
Pulmonary Hypertension in Chronic Lung Diseases: What Role Do Radiologists Play?
Diagnostics (Basel). 2023;13:1607.
Abstract

GREDIC M, Karnati S, Ruppert C, Guenther A, et al
Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally.
Cells. 2023;12:1278.
Abstract

FAIRLEY JL, Hansen D, Ross L, Proudman S, et al
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.
Arthritis Res Ther. 2023;25:77.
Abstract

BOBHATE P, Gupta RK, Karande T, Kulkarni S, et al
Inhaled iloprost as an add-on therapy for advanced pulmonary arterial hypertension: An Indian perspective.
Natl Med J India. 2023;35:338-343.
Abstract

MOHANKUMAR N, Namboodiri N, Nair KKM, Raghuram K, et al
Study of atrial arrhythmias after surgical or device closure of atrial septal defect.
Natl Med J India. 2023;35:271-275.
Abstract

CHEN A, Gao G, Lian G, Gong J, et al
Zinc promotes cell proliferation via regulating metal-regulatory transcription factor 1 expression and transcriptional activity in pulmonary arterial hypertension.
Cell Cycle. 2023;22:1284-1301.
Abstract

LIANG WL, Liang B
Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure.
Curr Cardiol Rep. 2023;25:607-613.
Abstract

ZHANG C, Tsang Y, He J, Panjabi S, et al
Predicting Risk of 1-Year Hospitalization Among Patients with Pulmonary Arterial Hypertension.
Adv Ther. 2023;40:2481-2492.
Abstract

BO B, Pugnaloni F, Licari A, Patel N, et al
Ductus arteriosus flow predicts outcome in neonates with congecsion.
Pediatr Pulmonol. 2023 Mar 15. doi: 10.1002/ppul.26385.
Abstract

MATSUSHITA FY, Krebs VLJ, de Carvalho WB
Identifying two distinct subphenotypes of patent ductus arteriosus in preterm infants using machine learning.
Eur J Pediatr. 2023 Feb 28. doi: 10.1007/s00431-023-04882.
Abstract

BEGHETTI M, Ivy D, Scott N, Machlitt-Northen S, et al
Letter to the Editor, regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17.
Eur J Pediatr. 2023;182:2453-2454.
Abstract

LI L, Ning J, Ma S
Correspondence, letter to the editor regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17.
Eur J Pediatr. 2023;182:2455.
Abstract

ARWAS N, Goldbart A, Aviram M, Dizitzer Y, et al
Flexible bronchoscopy in pediatric patients with Down syndrome: A case-control study of the indications, findings, and complications.
Pediatr Pulmonol. 2023;58:1658-1664.
Abstract

LENARDUZZI S, Spedicati B, Alessandrini B, Tesolin P, et al
Whole-exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases.
Mol Genet Genomic Med. 2023;11:e2143.
Abstract

LI L, Zhu X, Chen X, Gao J, et al
Advances in targeted therapy for pulmonary arterial hypertension in children.
Eur J Pediatr. 2023;182:2067-2076.
Abstract

YOGESWARAN A, Richter MJ, Husain-Syed F, Rako Z, et al
Estimated plasma volume status: association with congestion, cardiorenal syndrome and prognosis in precapillary pulmonary hypertension.
Front Cardiovasc Med. 2023;10:1161041.
Abstract

TING YH, Yu MW, Wu YJ, Wu SH, et al
Long-Term Experience and Safety of Transitioning from Subcutaneous Treprostinil to Oral Selexipag in the High-Risk Pulmonary Hypertension Patient: A Case Report.
Acta Cardiol Sin. 2023;39:492-496.
Abstract

KHAN A, Ubaid A, Hanif M, Jaiswal V, et al
An interesting case of pulmonary hypertension in nephrotic syndrome due to amphetamine use for attention-deficit hyperactivity disorder.
Ann Med Surg (Lond). 2023;85:1874-1877.
Abstract

SCHROEDER L, Monno P, Strizek B, Dresbach T, et al
Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants.
Sci Rep. 2023;13:8405.
Abstract

XIONG C, Yang B
Revising the hemodynamic criteria for pulmonary hypertension: A perspective from China.
J Transl Int Med. 2023;11:1-3.
Abstract

SERATI A, Keshmiri MS, Shafaghi S, Mohammad MM, et al
The Outcome of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the COVID-19 Pandemic.
Crit Pathw Cardiol. 2023;22:60-64.
Abstract

ZHANG M, Xie W, Xiao Y, Guo W, et al
Current status of diagnosis and treatment of pulmonary hypertension in Chinese tertiary hospitals: A nationwide survey.
Pulm Circ. 2023;13:e12241.
Abstract

YE Y, Xu Q, Wuren T
Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension.
Front Immunol. 2023;14:1162556.
Abstract

JANDL K, Radic N, Zeder K, Kovacs G, et al
Pulmonary vascular fibrosis in pulmonary hypertension - The role of the extracellular matrix as a therapeutic target.
Pharmacol Ther. 2023 May 18:108438. doi: 10.1016/j.pharmthera.2023.108438.
Abstract

THAPA KB, Paudel A, Dhital S, Shrestha A, et al
Polycythemia among Patients with Chronic Obstructive Pulmonary Disease Admitted to the Department of Medicine in a Tertiary Care Center: A Descriptive Cross-sectional Study.
JNMA J Nepal Med Assoc. 2023;61:343-346.
Abstract

LI H, Yu Y, Wang Y, Zhang Q, et al
Prognostic Risk Factors of 30-Day Death in Traumatic Lower Limb Fracture Patients with Acute Pulmonary Embolism: A Single-Center Retrospective Study.
Can Respir J. 2023;2023:8246730.
Abstract

MA H, Yu Y, Mo L, Chen Q, et al
Exosomal miR-663b from "M1" macrophages promotes pulmonary artery vascular smooth muscle cell dysfunction through inhibiting the AMPK/Sirt1 axis.
Aging (Albany NY). 2023;15:3549-3571.
Abstract

MA Q, Wang M, Li L, Zhang X, et al
Jiedu Quyu Decoction mitigates monocrotaline-induced right-sided heart failure associated with pulmonary artery hypertension by inhibiting NLRP3 inflammasome in rats.
J Ethnopharmacol. 2023;313:116556.
Abstract

YOSHIDA S, Kreger AM, Shaik IH, West RE 3rd, et al
Intra-amniotic sildenafil administration in rabbits: Safety, pharmacokinetics, organ distribution and histologic evaluation.
Toxicol Appl Pharmacol. 2023;469:116527.
Abstract

ALAMRI AK, Ma CL, Ryan JJ
Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?
Drugs. 2023;83:577-585.
Abstract

NAKAMURA Y, Hoashi T, Imai K, Okuda N, et al
Patient-prosthesis mismatch associated with somatic growth after mechanical mitral valve replacement in small children: metrics for reoperation and outcomes.
Semin Thorac Cardiovasc Surg. 2022 Apr 14. pii: S1043-0679(22)00076.
Abstract

SULLERE V, Sullere S, Khan IA, Goyal RG, et al
Pulmonary Hypertension, an Echo Assessment: Is it Arterial or Venous?
Int J Appl Basic Med Res. 2023;13:29-39.
Abstract

WIETESKA-MILEK M, Kusmierczyk-Droszcz B, Betkier-Lipinska K, Szmit S, et al
Long COVID syndrome after SARS-CoV-2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Pulm Circ. 2023;13:e12244.
Abstract

OTERO R, Lobo JL, Lopez R, Fernandez C, et al
Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study.
Thromb Res. 2023;228:1-9.
Abstract

KLOUDA T, Tsikis ST, Kim H, Liu T, et al
Pericytes Contribute to Flow-induced Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2023;68:705-708.
Abstract

BRANESCU I, Shetty S, Richards J, Vladareanu S, et al
Pulmonary Hypertension in Preterm Infants with Moderate to Severe Bronchopulmonary Dysplasia (BPD).
Acta Paediatr. 2023 Jun 1. doi: 10.1111/apa.16863.
Abstract

GURDOGAN M, Demir M, Yalta K, Gulertop Y, et al
Cancer Therapy-Related Pulmonary Hypertension: A Review of Mechanisms and Implications for Clinical Practice.
Anatol J Cardiol. 2023;27:299-307.
Abstract

TANYERI S, Tokgoz HC, Karagoz A, Akbal OY, et al
Reappraisal of the Transthoracic Echocardiographic Algorithm in Predicting Pulmonary Hypertension Redefined by Updated Pulmonary Artery Mean Pressure Threshold.
Anatol J Cardiol. 2023;27:348-359.
Abstract

SCHULZE KM, Musch TI
Skeletal muscle blood flow during exercise is reduced in a rat model of pulmonary hypertension.
Am J Physiol Regul Integr Comp Physiol. 2023;324:R772-R773.
Abstract

MORRIS HE, Neves KB, Nilsen M, Montezano AC, et al
Notch3/Hes5 Induces Vascular Dysfunction in Hypoxia-Induced Pulmonary Hypertension Through ER Stress and Redox-Sensitive Pathways.
Hypertension. 2023 May 31. doi: 10.1161/HYPERTENSIONAHA.122.20449.
Abstract

ADARE OE, Seife MA, Abate LG
Perioperative Anesthesia Management for Pregnant Mother with Multivalvular Heart Disease and Moderate Pulmonary Hypertension Who Underwent Caesarean Section, in Resource Limiting Area 2022: A Case Report.
Int Med Case Rep J. 2023;16:311-317.
Abstract

OLIYNYK OV, Rorat M, Strepetova OV, Dubrov SO, et al
Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension.
Viruses. 2023;15:1157.
Abstract

IZUMIDA T, Imamura T, Ushijima R, Kinugawa K, et al
Combination Treatment of Balloon Pulmonary Angioplasty and Direct Oral Anticoagulant in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated by Protein S Deficiency.
Medicina (Kaunas). 2023;59:909.
Abstract

KARYOFYLLIS P, Demerouti E, Habibis P, Apostolopoulou S, et al
Should We Change the Target of Therapy in Pulmonary Hypertension?
Life (Basel). 2023;13:1202.
Abstract

NOVOYATLEVA T
Pulmonary Hypertension: New Insights and Recent Advances from Basic Science to Translational Approaches.
Int J Mol Sci. 2023;24:8462.
Abstract

MAMAZHAKYPOV A, Maripov A, Sarybaev AS, Schermuly RT, et al
Osteopontin in Pulmonary Hypertension.
Biomedicines. 2023;11:1385.
Abstract

POYATOS P, Gratacos M, Samuel K, Orriols R, et al
Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension.
Antioxidants (Basel). 2023;12:1006.
Abstract

ZHANG J, Zhang S, Xu S, Zhang X, et al
Pulmonary Arterial Hypertension Induced by Immune Checkpoint Inhibitor Combined Therapy in a Patient with Intrahepatic Cholangiocarcinoma: A Case Report.
Iran J Immunol. 2023;20:240-246.
Abstract

KUMAR M, Zaman MK, Das S, Goyary D, et al
Transient Receptor Potential Vanilloid (TRPV4) channel inhibition: A novel promising approach for the treatment of lung diseases.
Biomed Pharmacother. 2023;163:114861.
Abstract

REICHMANN J, Verleden SE, Kuhnel M, Kamp JC, et al
Human lung virtual histology by multi-scale x-ray phase-contrast computed tomography.
Phys Med Biol. 2023;68.
Abstract

MIRHADI E, Kesharwani P, Johnston TP, Sahebkar A, et al
Nanomedicine-mediated therapeutic approaches for pulmonary arterial hypertension.
Drug Discov Today. 2023;28:103599.
Abstract

GALLOO X, Dietz MF, Fortuni F, Prihadi EA, et al
Prognostic implications of atrial vs. ventricular functional tricuspid regurgitation.
Eur Heart J Cardiovasc Imaging. 2023;24:733-741.
Abstract

CRUZ-UTRILLA A, Gallego-Zazo N, Perez-Olivares C, Hernandez-Gonzalez I, et al
Usefulness of genetics for clinical reclassification and refinement of prognostic stratification in pulmonary arterial hypertension.
Rev Esp Cardiol (Engl Ed). 2023;76:460-467.
Abstract

LU VM, Leuchter JD, Clarke JE, Luther EM, et al
The utility of congenital cardiac status to predict endoscopic third ventriculostomy and ventriculoperitoneal shunt failure in hydrocephalic infants.
J Neurosurg Pediatr. 2022 Mar 4:1-8. doi: 10.3171/2022.1.PEDS21567.
Abstract

GUO Q, Lu L, Jia B, Liu Y, et al
A Meta-analysis Assessing the Efficacy of Balloon Pulmonary Angioplasty in Resolving Chronic Thromboembolic Pulmonary Hypertension.
Altern Ther Health Med. 2023 Jun 9:AT8717.
Abstract

BORDAG N, Nagy BM, Zugner E, Ludwig H, et al
Lipidomics for diagnosis and prognosis of pulmonary hypertension.
medRxiv. 2023 May 24:2023.05.17.23289772. doi: 10.1101/2023.05.17.23289772.
Abstract

HE S, Qian H, Xu X
Editorial: Pulmonary hypertension associated with congenital heart disease.
Front Pediatr. 2023;11:1217010.
Abstract

HOSOKAWA K, Yamasaki Y, Abe K
Technical Considerations for Performing Safe and Effective Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension.
Interv Cardiol Clin. 2023;12:367-380.
Abstract

WISSMULLER M, Dohr J, Adler J, Ochs L, et al
Pulmonary hypertension associated with left heart disease.
Herz. 2023 Jun 8. doi: 10.1007/s00059-023-05189.
Abstract

ZHOU Q, Jiang J, Xu Y, Qiu H, et al
Congenital hepatic hemangioma: an unusual case report of pulmonary hypertension.
BMC Pediatr. 2023;23:284.
Abstract

GAYEN S, Ansari S, Lashari BH, Zhao H, et al
Pulmonary vasodilator therapy in sarcoidosis-associated pulmonary hypertension may decrease lung function decline and mortality.
Pulm Circ. 2023;13:e12245.
Abstract

ZHANG F, Huang X, Lin J, Yu R, et al
Identification of a novel diagnosis model based on 5 hub genes for chronic thromboembolic pulmonary hypertension.
Curr Med Chem. 2023 Jun 5. doi: 10.2174/0929867330666230605125512.
Abstract

HAGIWARA H, Akatsuka M, Takahashi K, Yoshinaka A, et al
A Patient with Class III Obesity and a Body Mass Index of 70.1 kg/m(2) Requiring Pulmonary Artery Catheterization to Confirm the Diagnosis of Pulmonary Hypertension.
Am J Case Rep. 2023;24:e939383.
Abstract

RATWATTE S, Strange G, Playford D, Stewart S, et al
Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomes.
Open Heart. 2023;10:e002268.
Abstract

LI YS, Zhang Z, Xie WM, Zhai ZG, et al
[Advances in the epidemiology of chronic thromboembolic pulmonary hypertension].
Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:603-609.
Abstract

LIN YK, Yang DH, Lei C, Luo H, et al
[Hereditary pulmonary hypertension family with BMPR2 gene variation: a case report and literature review].
Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:558-564.
Abstract

ZHAI ZG, Yang YH, Wang C
[Strengthening the construction of standardized system to enhance the standard diagnosis, treatment and comprehensive management of pulmonary hypertension in China].
Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:553-557.
Abstract

SURGIT O, Guner A, Turkmen I, Kahraman S, et al
Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism.
Ulus Travma Acil Cerrahi Derg. 2023;29:677-684.
Abstract

WANG L, Wang F, Tuo Y, Wan H, et al
Correction: Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes.
BMC Pulm Med. 2023;23:192.
Abstract

ORIEUX A, Samson C, Pieroni L, Drouin S, et al
Pulmonary hypertension without heart failure causes cardiorenal syndrome in a porcine model.
Sci Rep. 2023;13:9130.
Abstract

MORALES-LARA AC, Elkhatib W, Oluleye O, Alhusain R, et al
Impact of Pulmonary Hypertension Hemodynamic Phenotype on Incident Atrial Fibrillation.
Cardiology. 2023 Jun 5. doi: 10.1159/000531402.
Abstract

PROVOST M, Mornex JF, Nasser M, Zeghmar S, et al
Changes in the management of chronic thromboembolic pulmonary hypertension over a 10-year period, in a French expert regional competence centre.
Respir Med Res. 2023;84:101021.
Abstract

MAHMUD E, Ang L
Percutaneous Interventional Therapy for Chronic Thromboembolic Pulmonary Hypertension.
Struct Heart. 2022;7:100115.
Abstract

TSUCHIYA N, Xu YY, Ito J, Yamashiro T, et al
Chronic thromboembolic pulmonary hypertension is associated with a loss of total lung volume on computed tomography.
World J Radiol. 2023;15:146-156.
Abstract

ZHAO YN, Liu GH, Wang C, Zhang YX, et al
Pulmonary hypertension, nephrotic syndrome, and polymyositis due to hepatitis C virus infection: A case report.
World J Gastroenterol. 2023;29:3040-3047.
Abstract

XU Y, Yang B, Hui J, Zhang C, et al
The emerging role of sacubitril/valsartan in pulmonary hypertension with heart failure.
Front Cardiovasc Med. 2023;10:1125014.
Abstract

EROL N, Alpinar A, Kulcu NU
Infantile hemangiomatosis, a rare cause of high-output heart failure and pulmonary hypertension in the newborn baby: a case report.
Cardiol Young. 2023 Jun 5:1-3. doi: 10.1017/S1047951123001488.
Abstract

LIU Y, Deng J, Zhao Y, Liu K, et al
Outcomes of pregnancy in mice with pulmonary hypertension induced by Hypoxia/SU5416.
Biochem Biophys Res Commun. 2023;669:128-133.
Abstract

ALBINNI S, Heno J, Pavo I, Kitzmueller E, et al
Macitentan in the Young-Mid-term Outcomes of Patients with Pulmonary Hypertensive Vascular Disease treated in a Pediatric Tertiary Care Center.
Paediatr Drugs. 2023 Jun 3. doi: 10.1007/s40272-023-00573.
Abstract

ZHANG Q, Chen Y, Wang Q, Wang Y, et al
HMGB1-induced activation of ER stress contributes to pulmonary artery hypertension in vitro and in vivo.
Respir Res. 2023;24:149.
Abstract

HAJIAHMADI S, Tabesh F, Shayganfar A, Shirani F, et al
Pulmonary artery obstruction index, pulmonary artery diameter and right ventricle strain as prognostic CT findings in patient with acute pulmonary embolism.
Radiologia (Engl Ed). 2023;65:200-212.
Abstract

TOBITA K, Goda A, Teruya K, Nishida Y, et al
Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2023;12:e026890.
Abstract

FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
Abstract

XUE Z, Zhou M, Liu Y, Qin H, et al
A modified Fangji Huangqi decoction ameliorates pulmonary artery hypertension via phosphatidylinositide 3-kinases/protein kinase B-mediated regulation of proliferation and apoptosis of smooth muscle cells in vitro and in vivo.
J Ethnopharmacol. 2023;314:116544.
Abstract

COLLERAN JA, Daykin EC, Hernandez C, Ray J, et al
Novel mosaic TRAF7 likely pathogenic variant in an African American family.
Am J Med Genet A. 2023;191:1990-1993.
Abstract

RAMARAJ AB, Rice-Townsend SE, Foster CL, Yung D, et al
Association Between Early Prostacyclin Therapy and Extracorporeal Life Support Use in Patients With Congenital Diaphragmatic Hernia.
JAMA Pediatr. 2023;177:582-589.
Abstract

GUGLIANDOLO E, Macri F, Fusco R, Siracusa R, et al
Inhibiting IL-6 in medicine: a new twist to sustain inhibition of his cytokine tin the therapy of Pulmonary Arterial Hypertension.
Pharmacol Res. 2023;192:106750.
Abstract

DE JAGER P, Curley MAQ, Cheifetz IM, Kneyber MCJ, et al
Hemodynamic Effects of a High-Frequency Oscillatory Ventilation Open-Lung Strategy in Critically Ill Children With Acquired or Congenital Cardiac Disease.
Pediatr Crit Care Med. 2023;24:e272-e281.
Abstract

CHEN Y, Xu R, Xie X, Wang T, et al
Fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia: systematic review and meta-analysis.
Ultrasound Obstet Gynecol. 2023 Jan 27. doi: 10.1002/uog.26164.
Abstract

ISHII S, Hatano M, Maki H, Minatsuki S, et al
Prognostic value of follow-up vasoreactivity test in pulmonary arterial hypertension.
J Cardiol. 2023;82:69-75.
Abstract

DONNELLY RP, Smyth AE, Mullan C, Riley MS, et al
Responses to exercise in systemic sclerosis-associated interstitial lung disease.
Clin Physiol Funct Imaging. 2023;43:253-262.
Abstract

DIEZ M, Caneva J, Diez A, Perna ER, et al
Risk stratification, prognosis, and survival in a pulmonary arterial hypertension cohort in Latin America. A multicenter study.
Respir Med Res. 2023;83:100945.
Abstract

LIU W, LeBar K, Roth K, Pang J, et al
Alterations of biaxial viscoelastic properties of the right ventricle in pulmonary hypertension development in rest and acute stress conditions.
Front Bioeng Biotechnol. 2023;11:1182703.
Abstract

QU S, Shan L, Chen X, Zhang Z, et al
The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism.
BMC Pulm Med. 2023;23:209.
Abstract

ITURRIAGA R, Castillo-Galan S
The Beneficial Effect of the Blockade of Stim-Activated TRPC-ORAI Channels on Vascular Remodeling and Pulmonary Hypertension Induced by Intermittent Hypoxia Is Independent of Oxidative Stress.
Adv Exp Med Biol. 2023;1427:53-60.
Abstract

LANG IM, Delcroix M
Novel acquisitions in chronic thromboembolic pulmonary hypertension.
Eur Heart J. 2023 Jun 15:ehad314. doi: 10.1093.
Abstract

LAKSHMINRUSIMHA S, Fraga MV
Longitudinal Trajectory of Ventricular Function and Pulmonary Hypertension in Congenital Diaphragmatic Hernia.
J Pediatr. 2023 Jun 12:113550. doi: 10.1016/j.jpeds.2023.113550.
Abstract

SHI H, Chen L, Zhang S, Li R, et al
Dynamic association of ambient air pollution with incidence and mortality of pulmonary hypertension: A multistate trajectory analysis.
Ecotoxicol Environ Saf. 2023;262:115126.
Abstract

MINATSUKI S, Hatano M, Tanikawa I, Hirose K, et al
Verification of Optimal Balloon Size in Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
Cardiovasc Intervent Radiol. 2023 Jun 13. doi: 10.1007/s00270-023-03489.
Abstract

IGARASHI S, Ishida Y, Sekiguchi S, Fujita Y, et al
Evaluation of total intravenous anesthesia with remimazolam in general anesthesia for pulmonary endarterectomy of chronic thromboembolic pulmonary hypertension: a case report.
JA Clin Rep. 2023;9:34.
Abstract

AVITABILE CM, Hopper RK, Handler SS, Bates A, et al
Editorial: Advances in the care of the pediatric pulmonary hypertension patient: from the neonate to the adolescent-young adult patient.
Front Pediatr. 2023;11:1220070.
Abstract

NAKAYAMA H, Ishida M, Nakaoka H, Nishimura Y, et al
Pulmonary hypertension secondary to interstitial fibrosis with pulmonary venous lesions masquerading pulmonary veno-occlusive disease.
Respirol Case Rep. 2023;11:e01179.
Abstract

NAKAYAMA M, Konishi M, Sugano T, Okamura M, et al
Association between sarcopenia and exercise capacity in patients with pulmonary hypertension without left heart disease.
Int J Cardiol. 2023 Jun 9:S0167-5273(23)00883.
Abstract

MURNI IK, Kato T, Wirawan MT, Arafuri N, et al
An electrocardiographic score to predict pulmonary hypertension in children with atrial septal defect.
BMC Pediatr. 2023;23:288.
Abstract

KHEYFETS VO, Kumar S, Heerdt PM, Ichimura K, et al
Characterizing the Spatiotemporal Transcriptomic Response of the Right Ventricle to Acute Pressure Overload.
Int J Mol Sci. 2023;24:9746.
Abstract

WOLOWIEC L, Medlewska M, Osiak J, Wolowiec A, et al
MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment.
Int J Mol Sci. 2023;24:9735.
Abstract

LUO A, Jia Y, Hao R, Yu Y, et al
Quantitative Proteomic and Phosphoproteomic Profiling of Lung Tissues from Pulmonary Arterial Hypertension Rat Model.
Int J Mol Sci. 2023;24:9629.
Abstract

RIOU M, Enache I, Sauer F, Charles AL, et al
Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?
Int J Mol Sci. 2023;24:9572.
Abstract

KHALIL S
Is Expectant Management Noninferior to Early Ibuprofen for Patent Ductus Arteriosus?: Pediatrician's Viewpoint.
Indian Pediatr. 2023;60:490-491.
Abstract

GUPTA N
Is Expectant Management Noninferior to Early Ibuprofen for Patent Ductus Arteriosus?: Neonatologist's Viewpoint.
Indian Pediatr. 2023;60:489-490.
Abstract

KUMAR A, Dutta S
Is Expectant Management Noninferior to Early Ibuprofen for Patent Ductus Arteriosus?: Evidence-based Medicine Viewpoint.
Indian Pediatr. 2023;60:488-489.
Abstract

MA R, Gao H, Cui J, Shi H, et al
Pregnancy feasibility in women with mild pulmonary arterial hypertension: a systematic review and meta-analysis.
BMC Pregnancy Childbirth. 2023;23:427.
Abstract

SURESH MV, Aggarwal V, Raghavendran K
The Intersection of Pulmonary Vascular Disease and Hypoxia-Inducible Factors.
Interv Cardiol Clin. 2023;12:443-452.
Abstract

JAIN N, Perkins S, Maligireddy AR, Rosenfield K, et al
Evolving Role and Clinical Evidence in the Global Practice of Balloon Pulmonary Angioplasty.
Interv Cardiol Clin. 2023;12:417-427.
Abstract

VISOVATTI SH
Pulmonary Embolism Center of Excellence: Putting It All Together.
Interv Cardiol Clin. 2023;12:393-398.
Abstract

TANNU M, Krasuski RA
The Evolution of Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension.
Interv Cardiol Clin. 2023;12:381-391.
Abstract

HAFT JW, Yost G
Open Surgical Treatment of Acute and Chronic Pulmonary Embolism.
Interv Cardiol Clin. 2023;12:339-347.
Abstract

BAE JY, Murugiah K
Invasive Pulmonary Angiogram Performance and Interpretation in the Diagnosis of Pulmonary Thromboembolic Disease.
Interv Cardiol Clin. 2023;12:299-307.
Abstract

HAMEED A, Condliffe R, Swift AJ, Alabed S, et al
Assessment of Right Ventricular Function-a State of the Art.
Curr Heart Fail Rep. 2023;20:194-207.
Abstract

TIAN Z, Cen L
Interaction of Biochemical Processes between Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension (PAH), and Coronavirus Disease 2019 (COVID-19).
Pol J Microbiol. 2023;72:143-154.
Abstract

KRISHNATHASAN K, Constantine A, Rafiq I, Barradas Pires A, et al
Management of pulmonary arterial hypertension during pregnancy.
Expert Rev Respir Med. 2023;17:413-423.
Abstract

ASAKAGE A, Baekgaard J, Mebazaa A, Deniau B, et al
Management of Acute Right Ventricular Failure.
Curr Heart Fail Rep. 2023;20:218-229.
Abstract

RAKHA S, Hammad A, Elmarsafawy H, Korkor MS, et al
A deeper look into the functions of right ventricle using three-dimensional echocardiography: the forgotten ventricle in children with systemic lupus erythematosus.
Eur J Pediatr. 2023;182:2807-2819.
Abstract

MARTENS P, Yu S, Larive B, Borlaug BA, et al
Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications.
Eur Heart J. 2023;44:1979-1991.
Abstract

SHEIKH REZAEI S, Gatterer C, Sulzgruber P, Hofer F, et al
Risk stratification and long-term outcome of patients receiving in-hospital medical emergency team critical care: experience from Austria's largest medical center.
Minerva Med. 2023;114:307-315.
Abstract

LIU Z, Zhang C, Gong W, Xu J, et al
Biological functions of miR-124/notch in pulmonary arterial hypertension.
Minerva Med. 2023;114:404-405.
Abstract

ROUBENNE L, Laisne M, Benoist D, Campagnac M, et al
OP2113, a new drug for chronic hypoxia-induced pulmonary hypertension treatment in rat.
Br J Pharmacol. 2023 Jun 23. doi: 10.1111/bph.16174.
Abstract

ZHANG H, Li QW, Li YY, Tang X, et al
Myeloid-derived suppressor cells and pulmonary hypertension.
Front Immunol. 2023;14:1189195.
Abstract

BRALEY K, Richardson K, Whitley L, Werner K, et al
Patient perspectives on pulmonary hypertension in the United States: Burdens, expectations, and goals.
Pulm Circ. 2023;13:e12247.
Abstract

ARKANI M, Kianzad A, Jansen S, Smit J, et al
Discrimination Between Pre- and Postcapillary Pulmonary Hypertension Using Platelet RNA.
J Am Heart Assoc. 2023 Jun 22:e028447. doi: 10.1161/JAHA.122.028447.
Abstract

NI H, Wei Y, Yang L, Wang Q, et al
An increased risk of pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema: a meta-analysis.
BMC Pulm Med. 2023;23:221.
Abstract

SU H, Zhu H, Wang S, Li Y, et al
CircItgb5 promotes synthetic phenotype of pulmonary artery smooth muscle cells via interacting with miR-96-5p and Uba1 in monocrotaline-induced pulmonary arterial hypertension.
Respir Res. 2023;24:165.
Abstract

LI M, Plecita-Hlavata L, Dobrinskikh E, McKeon BA, et al
SIRT3 Is a Critical Regulator of Mitochondrial Function of Fibroblasts in Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2023 Jun 21. doi: 10.1165/rcmb.2022-0360.
Abstract

LEYENS J, Schroeder L, Geipel A, Berg C, et al
Dynamics of pulmonary hypertension severity in the first 48 h in neonates with prenatally diagnosed congenital diaphragmatic hernia.
Front Pediatr. 2023;11:1164473.
Abstract

EJIRI K, Akagi S, Ito H
Woman in Her 50s With Pulmonary Hypertension Associated With Takayasu Arteritis.
JAMA Cardiol. 2023 Jun 21. doi: 10.1001/jamacardio.2023.1650.
Abstract

TEIXEIRA-FONSECA JL, Joviano-Santos JV, Beserra SS, de Lima Conceicao MR, et al
Exploring the involvement of TASK-1 in the control of isolated rat right atrium function from healthy animals and an experimental model of monocrotaline-induced pulmonary hypertension.
Naunyn Schmiedebergs Arch Pharmacol. 2023.
Abstract

VAKHSHOORZADEH J, Lui JK, Sangani RA, Trojanowski MA, et al
Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension.
Respir Med. 2023;216:107333.
Abstract

ASCHNER J, Avachat C, Birnbaum A, Sherwin C, et al
Multi-dose enteral L-citrulline administration in premature infants at risk of developing pulmonary hypertension associated with bronchopulmonary dysplasia.
Res Sq. 2023 Jun 9:rs.3.rs-3006963. doi: 10.21203/rs.3.rs-3006963.
Abstract

AHMED A, Ahmed S, Radegran G
Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines.
Pulm Circ. 2023;13:e12253.
Abstract

BABU G, Annis JS, Garry JD, Freiberg MS, et al
Clinical features do not identify risk of progression from isolated postcapillary pulmonary hypertension to combined pre- and postcapillary pulmonary hypertension.
Pulm Circ. 2023;13:e12249.
Abstract

KATOTO PDMC, Mukasa SL, Sani MU, Karaye KM, et al
HIV status and survival of patients with pulmonary hypertension due to left heart disease: the Pan African Pulmonary Hypertension Cohort.
Sci Rep. 2023;13:9790.
Abstract

GU C, Yang Z, Su S, Ma K, et al
4-Terpineol attenuates pulmonary vascular remodeling via suppressing PI3K/Akt signaling pathway in hypoxia-induced pulmonary hypertension rats.
Toxicol Appl Pharmacol. 2023;473:116596.
Abstract

MORRISON AM, Huang S, Annis JS, Garry JD, et al
Cardiometabolic Risk Factors Associated With Right Ventricular Function and Compensation in Patients Referred for Echocardiography.
J Am Heart Assoc. 2023;12:e028936.
Abstract

SHAW DE, Smith N, Beerli R, Cotesta S, et al
Design and Synthesis of Inhibitors of the E3 Ligase SMAD Specific E3 Ubiquitin Protein Ligase 1 as a Treatment for Lung Remodeling in Pulmonary Arterial Hypertension.
J Med Chem. 2023;66:8130-8139.
Abstract

CHEN L, Li M, Shen M, Zhu Y, et al
Bioinformatics exploration of potential common therapeutic targets for systemic and pulmonary arterial hypertension-induced myocardial hypertrophy.
Acta Biochim Biophys Sin (Shanghai). 2023;55:831-841.
Abstract

YOSHIDA K, Axelsen JB, Saku K, Andersen A, et al
How to incorporate tricuspid regurgitation in right ventricular-pulmonary arterial coupling.
J Appl Physiol (1985). 2023;135:53-59.
Abstract

TANG BL, Liu Y, Zhang JL, Lu ML, et al
Ginsenoside Rg1 ameliorates hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and inflammation by regulating CCN1.
Biomed Pharmacother. 2023;164:114920.
Abstract

HUNSAKER AR
Editorial Comment: Pulmonary Arterial Thrombosis Due to Embolic Events-or In Situ Thrombosis?
AJR Am J Roentgenol. 2023;221:68.
Abstract

MA C, Wang X, Zhang L, Zhu X, et al
Super Enhancer-Associated Circular RNA-CircKrt4 Regulates Hypoxic Pulmonary Artery Endothelial Cell Dysfunction in Mice.
Arterioscler Thromb Vasc Biol. 2023;43:1179-1198.
Abstract

GUPTA D, Greenberg RG, Natarajan G, Jani S, et al
Association of patent ductus arteriosus with extubation failure among preterm infants.
Pediatr Pulmonol. 2023 Apr 21. doi: 10.1002/ppul.26420.
Abstract

BUENDIA JA, Lindarte EF, Guerrero Patino D
Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis.
Value Health Reg Issues. 2023;36:44-50.
Abstract

BARANGA L, Khanuja S, Scott JA, Provancha I, et al
In Situ Pulmonary Arterial Thrombosis-Literature Review and Clinical Significance of a Distinct Entity.
AJR Am J Roentgenol. 2023 Mar 1. doi: 10.2214/AJR.23.28996.
Abstract

IANNAZZO F, Pellicano C, Colalillo A, Ramaccini C, et al
Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement.
Clin Exp Med. 2023;23:897-903.
Abstract

SANDEEP B, Cheng H, Luo L, Li Y, et al
Assessing Right Ventricle Pulmonary Artery Coupling and Uncoupling Using Echocardiography and Cardiopulmonary Exercise Test in Post Operative TOF Patients.
Curr Probl Cardiol. 2023;48:101214.
Abstract

BAQIR M, Singam NS, DuBrock H
Pulmonary hypertension in ANCA-associated vasculitis: a retrospective analysis.
Sarcoidosis Vasc Diffuse Lung Dis. 2023;40:e2023020.
Abstract

WU XC, Liu Y, Bai ZP
[Compound Tinglizi Decoction intervenes COPD-associated pulmonary hypertension through regulation of HMGB1-mediated pyroptosis and immune imbalance].
Zhongguo Zhong Yao Za Zhi. 2023;48:3055-3065.
Abstract

ITO R, Yamashita J, Ikeda S, Nakajima Y, et al
Predictors of procedural complications in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
J Cardiol. 2023 Jun 26:S0914-5087(23)00156-9. doi: 10.1016/j.jjcc.2023.
Abstract

MORALES-CANO D, Izquierdo-Garcia JL, Barreira B, Esquivel-Ruiz S, et al
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model.
Front Pharmacol. 2023;14:1228923.
Abstract

DONG W, Ma L, Huang Q, Yang X, et al
Gut microbiome alterations in pulmonary hypertension in highlanders and lowlanders.
ERJ Open Res. 2023;9:00617-2022.
Abstract

FTIKOS P, Falara A, Rellia P, Leontiadis E, et al
Monitoring of Levosimendan Administration in Patients with Pulmonary Hypertension Undergoing Cardiac Surgery and Effect of Two Different Dosing Schemes on Hemodynamic and Echocardiographic Parameters.
Pharmaceuticals (Basel). 2023;16:815.
Abstract

NAKATA M, Yokota N, Uehara H, Tabata K, et al
Congenital Isolated Unilateral Agenesis of Pulmonary Arteries with 3-Year Follow-Up after Initiation of Treatment.
Medicina (Kaunas). 2023;59:1161.
Abstract

KEW EP, Caruso V, Grapsa J, Bosco P, et al
Predictors of Outcome in Patients with Pulmonary Hypertension Undergoing Mitral and Tricuspid Valve Surgery.
Medicina (Kaunas). 2023;59:1103.
Abstract

SKAFAR M, Ambrozic J, Toplisek J, Cvijic M, et al
Role of Exercise Stress Echocardiography in Pulmonary Hypertension.
Life (Basel). 2023;13:1385.
Abstract

TRUSHENKO NV, Suvorova OA, Nekludova GV, Levina IA, et al
Predictors of Pulmonary Hypertension and Right Ventricular Dysfunction in Patients with Hypersensitivity Pneumonitis.
Life (Basel). 2023;13:1348.
Abstract

JANSA P, Ambroz D, Aschermann M, Cerny V, et al
Correction: Jansa et al. Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension. J. Clin. Med. 2022, 11, 6189.
J Clin Med. 2023;12:3939.
Abstract

LIU R, Yuan T, Wang R, Gong D, et al
Insights into Endothelin Receptors in Pulmonary Hypertension.
Int J Mol Sci. 2023;24:10206.
Abstract

LTAIEF Z, Yerly P, Liaudet L
Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management.
Int J Mol Sci. 2023;24:9971.
Abstract

SAVALE L, Kularatne M, Roche A, Pichon J, et al
Management of Acutely Decompensated Pulmonary Hypertension.
Semin Respir Crit Care Med. 2023 Jun 27. doi: 10.1055/s-0043-1770119.
Abstract

MATHEW R, Iacobas S, Huang J, Iacobas DA, et al
Metabolic Deregulation in Pulmonary Hypertension.
Curr Issues Mol Biol. 2023;45:4850-4874.
Abstract

LAMMI MR, Kolstad KD, Saketkoo LA, Khatri A, et al
Endothelial biomarkers of systemic sclerosis-associated pulmonary hypertension.
Arthritis Care Res (Hoboken). 2023 Jun 26. doi: 10.1002/acr.25180.
Abstract

HANUNA M, Pattathu J, Buech J, Kamla C, et al
Case report: Central venous catheter thrombosis complicated by chronic thromboembolic disease/pulmonary hypertension in two children requiring parenteral nutrition.
Front Cardiovasc Med. 2023;10:1198204.
Abstract

GOYAL A, Avery R, Cuttica MJ, Flaherty JD, et al
Case report: Multimodality imaging of unusual coronary to pulmonary collaterals in chronic thromboembolic pulmonary hypertension.
Front Cardiovasc Med. 2023;10:1204736.
Abstract

FABYAN KD, Chandel A, King CS
Pulmonary Hypertension in Interstitial Lung Disease: Management Options to Move Beyond Supportive Care.
Curr Pulmonol Rep. 2023 May 22:1-8. doi: 10.1007/s13665-023-00311.
Abstract

KJELLSTROM B, Runheim H, Beaudet A, Husberg M, et al
Societal costs associated to chronic thromboembolic pulmonary hypertension: A study utilizing linked national registries.
Pulm Circ. 2023;13:e12254.
Abstract

MITTAL A, Hossain A, Wang D, Khrais A, et al
Role of Gastroesophageal Reflux Disease in Morbidity and Mortality for Patients Admitted With Pulmonary Hypertension.
Cureus. 2023;15:e39431.
Abstract

TCHUENTE FOGUEM G, Teguede Keleko A
Artificial intelligence applied in pulmonary hypertension: a bibliometric analysis.
AI Ethics. 2023 Mar 7:1-31. doi: 10.1007/s43681-023-00267.
Abstract

KASAHARA T, Ogata T, Nakanishi N, Tomita S, et al
Cavin-2 loss exacerbates hypoxia-induced pulmonary hypertension with excessive eNOS phosphorylation and protein nitration.
Heliyon. 2023;9:e17193.
Abstract

COOK CM, Craddock VD, Ram AK, Abraham AA, et al
HIV and Drug Use: A Tale of Synergy in Pulmonary Vascular Disease Development.
Compr Physiol. 2023;13:4659-4683.
Abstract

JONE PN, Ivy DD, Hauck A, Karamlou T, et al
Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association.
Circ Heart Fail. 2023 Jun 26:e000080. doi: 10.1161/HHF.0000000000000080.
Abstract

LIU Y, Luo Y, Shi X, Lu Y, et al
Role of KLF4/NDRG1/DRP1 axis in hypoxia-induced pulmonary hypertension.
Biochim Biophys Acta Mol Basis Dis. 2023 Jun 23:166794.
Abstract

WANG EL, Zhang JJ, Luo FM, Fu MY, et al
Cerebellin-2 promotes endothelial-mesenchymal transition in hypoxic pulmonary hypertension rats by activating NF-kappaB/HIF-1alpha/Twist1 pathway.
Life Sci. 2023;328:121879.
Abstract

WANG J, Ma YR, Chang YE, Duo DL, et al
Preventive effect of LCZ696 on hypoxic pulmonary hypertension in rats via regulating the PI3K/AKT signaling pathway.
Pulm Pharmacol Ther. 2023 Jun 22:102229. doi: 10.1016/j.pupt.2023.102229.
Abstract

ZHANG H, Kan J, Zhang J, Xie D, et al
3-Year Outcome in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension: Results From PADN-5 Trial.
JACC Heart Fail. 2023 Jun 12:S2213-1779(23)00252.
Abstract

ANDRASKA EA, Bonaroti J, Zhang Y, Rivera-Lebron B, et al
Predictors of Chronic Thromboembolic Pulmonary Hypertension in patients with Submassive Pulmonary Embolism treated with catheter directed thrombolysis versus anticoagulation alone: a secondary analysis of the SUNSET sPE trial.
J Vasc Surg Venous Lymphat Disord. 2023 Jun 21:S2213-333X(23)00235.
Abstract

ZHAO Q, Zhang R, Shi J, Xie H, et al
Imaging Features in BMPR2 Mutation-associated Pulmonary Arterial Hypertension.
Radiology. 2023 May 16:222488. doi: 10.1148/radiol.222488.
Abstract

WANG J, Zhang Y, Luo Y, Liu ML, et al
PDK1 upregulates PINK1-mediated pulmonary endothelial cell mitophagy during hypoxia-induced pulmonary vascular remodeling.
Mol Biol Rep. 2023;50:5585-5596.
Abstract

GUGLIN M, Kozaily E, Kittleson MM
Choosing wisely: incorporating appropriate donor-recipient size matching in heart transplantation.
Heart Fail Rev. 2023;28:967-975.
Abstract

PRICE KW, Nguyen K, Lin P
A 48-YEAR-OLD WOMAN WITH CHRONIC, PROGRESSIVE BILATERAL VISION LOSS AND DYSPNEA.
Retin Cases Brief Rep. 2023;17.
Abstract

DINI FL, Pugliese NR, Ameri P, Attanasio U, et al
Right ventricular failure in left heart disease: from pathophysiology to clinical manifestations and prognosis.
Heart Fail Rev. 2023;28:757-766.
Abstract

SHIMOKAWAHARA H, Inami T, Kubota K, Taniguchi Y, et al
Protocol for a multicentre, double-blind, randomised, placebo-controlled trial of riociguat on peak cardiac index during exercise in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty (THERAPY-HYBRID-BPA tr
BMJ Open. 2023;13:e072241.
Abstract

MORGAN RW, Reeder RW, Ahmed T, Bell MJ, et al
Outcomes and Characteristics of Cardiac Arrest in Children with Pulmonary Hypertension: A Secondary Analysis of the ICU-RESUS Clinical Trial.
Resuscitation. 2023 Jul 3:109897. doi: 10.1016/j.resuscitation.2023.109897.
Abstract

LANG IM
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Clinical Outcomes.
Eur Cardiol. 2023;18:e11.
Abstract

ZEIGER E, Jakob A, Dalla Pozza R, Fischer M, et al
Evaluation of the diagnostic and prognostic potential of optical coherence tomography (OCT) of the pulmonary arteries during standardised right heart catheterisation in patients with pulmonary hypertension: a cross-sectional single-centre experience.
Cardiovasc Diagn Ther. 2023;13:453-464.
Abstract

SIMPSON CE, Ambade AS, Harlan R, Roux A, et al
Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension.
Pulm Circ. 2023;13:e12260.
Abstract

CASTRO MF, Oliveira EC, Nunes MCP, Oliveira C, et al
Reverse Potts for the Treatment of Severe Idiopathic Pulmonary Hypertension in Children.
Braz J Cardiovasc Surg. 2023;38:e20220320.
Abstract

TA HT, Critser PJ, Schafer M, Ollberding NJ, et al
Ventricular global function index is associated with clinical outcomes in pediatric pulmonary hypertension.
J Cardiovasc Magn Reson. 2023;25:39.
Abstract

FENG X, Yang C, Sun Z, Kan W, et al
Risk factors for mortality in patients with acute exacerbation of cor pulmonale in plateau.
BMC Pulm Med. 2023;23:238.
Abstract

THOMAS S, Jain S, Murthy P, Joseph CJ, et al
Neurodevelopmental Outcomes of Preterm Infants Born <29 weeks with Bronchopulmonary Dysplasia Associated Pulmonary Hypertension: A Multicenter Study.
Am J Perinatol. 2023 Jul 3. doi: 10.1055/a-2121-8878.
Abstract

MAO M, Song S, Li X, Lu J, et al
Advances in epigenetic modifications of autophagic process in pulmonary hypertension.
Front Immunol. 2023;14:1206406.
Abstract

FAWZY A, Mafeld S, Oreopoulos G, de Perrot M, et al
Chronic thromboembolic pulmonary hypertension secondary to a vascular malformation: case report diagnosis by lung subtraction iodine mapping.
Front Med (Lausanne). 2023;10:1206116.
Abstract

ZHAO Y, Wu J, Guan S, Xue T, et al
PIF1 Promotes Autophagy to Inhibit Chronic Hypoxia Induced Apoptosis of Pulmonary Artery Endothelial Cells.
Int J Chron Obstruct Pulmon Dis. 2023;18:1319-1332.
Abstract

JUSTIN PAUL G, Anne Princy S, Anju S, Anita S, et al
Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India.
Eur Heart J. 2023;44:1530-1540.
Abstract

WANG D, Luo MY, Tian Y, Zhang J, et al
Critical miRNAs in regulating pulmonary hypertension: A focus on Signaling pathways and therapeutic Targets.
Anal Biochem. 2023 Jun 30:115228. doi: 10.1016/j.ab.2023.115228.
Abstract

POKHAREL MD, Marciano DP, Fu P, Franco MC, et al
Metabolic reprogramming, oxidative stress, and pulmonary hypertension.
Redox Biol. 2023;64:102797.
Abstract

WANG G, Qin J, Han D
Long-term safety of macitentan in patients with pulmonary hypertension: A meta-analysis of randomised controlled trials.
Eur J Clin Invest. 2023 Jul 1:e14059. doi: 10.1111/eci.14059.
Abstract

ESCARCEGA RO, Lopez-Mattei J
Editorial: The importance of RV-PA coupling assessment prior to TAVR in patients with RV dysfunction and pulmonary hypertension.
Cardiovasc Revasc Med. 2023 Jun 25:S1553-8389(23)00670.
Abstract

AHMAD M, Del Cid Fratti J, Henien M, Pant K, et al
Association Between Pulmonary Hypertension and Its Effect on 30-Day Mortality, Readmission, and Cost After Transcatheter Aortic Valve Replacement: A Multicenter Study.
Cureus. 2023;15:e40976.
Abstract

MAINI A, Cousins S, Holliday T, Memoli JW, et al
Hemoptysis: unilateral pulmonary artery atresia? a case report.
J Cardiothorac Surg. 2023;18:199.
Abstract

ANDERSEN MO, Diederichsen SZ, Svendsen JH, Carlsen J, et al
Continuous long-term heart rate variability and risk assessment in pulmonary hypertension.
Open Heart. 2023;10:e002302.
Abstract

HAN QJ, Forfia P, Vaidya A, Ramani G, et al
Effects of ranolazine on right ventricular function, fluid dynamics, and metabolism in patients with precapillary pulmonary hypertension: insights from a longitudinal, randomized, double-blinded, placebo controlled, multicenter study.
Front Cardiovasc Med. 2023;10:1118796.
Abstract

FORTMEIER V, Lachmann M, Rudolph V
Reply: Right Ventricular-Pulmonary Arterial Coupling: So You Think You Can Tell?
JACC Cardiovasc Interv. 2023;16:1550.
Abstract

FORTUNI F, Ciliberti G, Zilio F
Right Ventricular-Pulmonary Arterial Coupling: So You Think You Can Tell.
JACC Cardiovasc Interv. 2023;16:1549.
Abstract

AMANN U, Nadine Wentzell, Kollhorst B, Haug U, et al
Prescribing of endothelin receptor antagonists and riociguat in women of childbearing age in a large German claims database study.
Reprod Toxicol. 2023;119:108415.
Abstract

NOH CY, Chock VY, Bhombal S, Danzer E, et al
Early nitric oxide is not associated with improved outcomes in congenital diaphragmatic hernia.
Pediatr Res. 2023 Feb 1. doi: 10.1038/s41390-023-02491.
Abstract

NEKOOEIAN M, Ezzatzadegan Jahromi S, Masjedi F, Sohooli M, et al
The significance of volume overload in the development of pulmonary arterial hypertension in continuous ambulatory peritoneal dialysis patients.
Ther Apher Dial. 2023;27:760-770.
Abstract

WU X, Li J, Ma J, Liu Q, et al
Vaccination against coronavirus disease 2019 in patients with pulmonary hypertension: a national prospective cohort study.
Chin Med J (Engl). 2023 Jul 13. doi: 10.1097/CM9.0000000000002767.
Abstract

WANG Y, Zeng Z, Zeng Z, Chu G, et al
Elevated CHCHD4 orchestrates mitochondrial oxidative phosphorylation to disturb hypoxic pulmonary hypertension.
J Transl Med. 2023;21:464.
Abstract

WANG E, Zhou S, Zeng D, Wang R, et al
Molecular regulation and therapeutic implications of cell death in pulmonary hypertension.
Cell Death Discov. 2023;9:239.
Abstract

LE DUC K, Rakza T, Baudelet JB, Boukhris MR, et al
Diastolic ventricular function in persistent pulmonary hypertension of the newborn.
Front Pediatr. 2023;11:1175178.
Abstract

GAVOTTO A, Amedro P, Cambonie G
Think out of the box: association of left congenital diaphragmatic hernia and abnormal origin of the right pulmonary artery : A train can hide another.
BMC Pediatr. 2023;23:349.
Abstract

HEMMATI F, Barzegar H
Persistent pulmonary hypertension of the newborn due to methylmalonic acidemia: a case report and review of the literature.
J Med Case Rep. 2023;17:288.
Abstract

DONG TX, Zhu Q, Wang ST, Wang YH, et al
Diagnostic and prognostic value of echocardiography in pulmonary hypertension: an umbrella review of systematic reviews and meta-analyses.
BMC Pulm Med. 2023;23:253.
Abstract

DU D, Yuan YD
Efficacy and safety of macitentan for pulmonary hypertension: A meta-analysis.
Clin Respir J. 2023 Jul 10. doi: 10.1111/crj.13621.
Abstract

MILES KG, Critser PJ, Evers PD, Cash M, et al
Factors leading to supranormal cardiac index in pediatric pulmonary hypertension patients treated with parenteral prostanoid therapy.
Pulm Circ. 2023;13:e12264.
Abstract

VAN GENECHTEN S, Meyns B, Godinas L, Maleux G, et al
Anthracofibrosis mimicking chronic thromboembolic pulmonary hypertension.
Pulm Circ. 2023;13:e12263.
Abstract

PISTELLI L, Piccione MC, Parisi F, Di Bella G, et al
Rapid Onset Idiopathic Pulmonary Hypertension: A Case Report with a Review of Echocardiographic Parameters.
J Cardiovasc Echogr. 2023;33:43-48.
Abstract

ZHENG L, Tan J, Yan Y, Wang S, et al
Retrospective on global pulmonary hypertension clinical trials: 1999-2021.
J Thorac Dis. 2023;15:3372-3385.
Abstract

SINGH H, Agarwal L, Jani C, Bhatt P, et al
Pulmonary hypertension associated mortality in the United States from 2003 to 2020: an observational analysis of time trends and disparities.
J Thorac Dis. 2023;15:3256-3272.
Abstract

SCHUSSLER A, Lug Q, Kremer N, Harth S, et al
Evaluation of diagnostic accuracy of dual-energy computed tomography in patients with chronic thromboembolic pulmonary hypertension compared to V/Q-SPECT and pulmonary angiogram.
Front Med (Lausanne). 2023;10:1194272.
Abstract

LI B, Teng C, Yu H, Jiang X, et al
Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries.
Acta Pharm Sin B. 2023;13:2369-2382.
Abstract

RENAPURKAR RD, Bullen J, Rizk A, Abozeed M, et al
A Novel Dual Energy Computed Tomography Score Correlates With Postoperative Outcomes in Chronic Thromboembolic Pulmonary Hypertension.
J Thorac Imaging. 2023 Jul 7. doi: 10.1097/RTI.0000000000000724.
Abstract

CHO S, Oh SB, Kim HJ, Kim SJ, et al
T18/S19 diphosphorylation of myosin regulatory light chain impairs pulmonary artery relaxation in monocrotaline-induced pulmonary hypertensive rats.
Pflugers Arch. 2023 Jul 8. doi: 10.1007/s00424-023-02836.
Abstract

MAJEED H, Cannon B, Raj K, Nasrullah A, et al
COVID-19 Patients with Pulmonary Hypertension Hospitalized in the United States During the Early Pandemic: Analysis of In-Hospital Mortality, Clinical Outcomes, and Racial Disparities.
Curr Probl Cardiol. 2023 Jul 7:101933. doi: 10.1016/j.cpcardiol.2023.101933.
Abstract

ARONSON K, Jacobs SS, Repola D, Swigris JJ, et al
Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?
BMJ Open Respir Res. 2023;10:e001546.
Abstract

FOX TH, LaNasa M, Saketkoo LA, Saito S, et al
STOP-Bang for OSA screening in patients with pulmonary hypertension.
Respir Med. 2023;217:107339.
Abstract

OMER KA, Mlauzi R, Basera W, McGuire J, et al
Low incidence of pulmonary hypertension in children with suspected obstructive sleep apnea: A prospective observational study.
Int J Pediatr Otorhinolaryngol. 2023;171:111648.
Abstract

METHODS IN MEDICINE CAM
Retracted: The Levels of TNF-alpha, Tissue Factor, and Coagulation Function in Rats with Pulmonary Hypertension and the Intervention Effect of Sildenafil Encapsulated by Targeted Nanocarriers.
Comput Math Methods Med. 2023;2023:9805127.
Abstract

CARR H, Gunnerbeck A, Eisenlauer P, Johansson S, et al
Severity of preterm birth and the risk of pulmonary hypertension in childhood: A population-based cohort study in Sweden.
Paediatr Perinat Epidemiol. 2023 Jul 6. doi: 10.1111/ppe.12997.
Abstract

BERGMANN LL, Ackman JB, Starekova J, Moeller A, et al
MR Angiography of Pulmonary Vasculature.
Magn Reson Imaging Clin N Am. 2023;31:475-491.
Abstract

KAZMIRCZAK F, Prisco SZ, Knoper R, Huddleston S, et al
Effect of Combination of Balloon Pulmonary Angioplasty and Medical Therapy on Reverse Right Ventricular Remodeling and Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension.
J Invasive Cardiol. 2023;35:E312-E320.
Abstract

ATZENI IM, Al-Adwi Y, Doornbos-van der Meer B, Roozendaal C, et al
The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis.
Front Immunol. 2023;14:1189257.
Abstract

ZHENG R, Xu T, Lin Y, Huang X, et al
Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?
Cardiovasc Res. 2023;119:e140-e141.
Abstract

RODOR J, Chen SH, Baker AH
Response to: Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?
Cardiovasc Res. 2023;119:e142-e143.
Abstract

ISHIDA S, Nakanishi H, Kosaka Y, Yamaguchi A, et al
Evaluation of newborns with Down syndrome with weight less than 1500 g in the neonatal intensive care unit: A Japanese multicentre study.
J Paediatr Child Health. 2023 Apr 28. doi: 10.1111/jpc.16418.
Abstract

THOMPSON WS, Bendel-Stenzel EM, Lanpher BC, Arteaga GM, et al
Neonatal Diagnosis of Alveolar Capillary Dysplasia via Rapid Genomic Sequencing: A New Gold Standard?
Neonatology. 2023 Mar 21:1-5. doi: 10.1159/000529439.
Abstract

BODENBERGER AL, Konietzke P, Weinheimer O, Wagner WL, et al
Quantification of airway wall contrast enhancement on virtual monoenergetic images from spectral computed tomography.
Eur Radiol. 2023;33:5557-5567.
Abstract

MARQUEZ MF
Editorial commentary: The heart at high altitude.
Trends Cardiovasc Med. 2023;33:316-318.
Abstract

ARMAGAN B, Oksul M, Sener YZ, Sari A, et al
Pulmonary hypertension in Behcet's disease: echocardiographic screening and multidisciplinary approach.
Turk J Med Sci. 2023;53:563-571.
Abstract

AWAD AK, Gad ER, Abdelgalil MS, Elsaeidy AS, et al
Sildenafil for congenital heart diseases induced pulmonary hypertension, a meta-analysis of randomized controlled trials.
BMC Pediatr. 2023;23:372.
Abstract

YUCEL IK, Epcacan S, Bulut MO, Demir IH, et al
A Challenging Interventional Procedure: Transcatheter Closure of Tubular Patent Ductus Arteriosus in Patients with Pulmonary Hypertension.
Pediatr Cardiol. 2023 Jul 20. doi: 10.1007/s00246-023-03240.
Abstract

AYAN G, Sari A, Ardali Duzgun S, Kaya EB, et al
Could pulmonary arterial hypertension-specific agents be an option for Takayasu's arteritis related pulmonary hypertension?
Clin Exp Rheumatol. 2023 Jul 5. doi: 10.55563.
Abstract

LANG IM, Andreassen AK, Andersen A, Bouvaist H, et al
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function.
Eur Heart J. 2023 Jul 20:ehad413. doi: 10.1093.
Abstract

YILDIRIM S
Inhaled iloprost is an effective alternative therapy for persistent pulmonary hypertension in newborns.
Pulm Circ. 2023;13:e12268.
Abstract

GOTO S, Goto S
Long-term outcome of chronic thromboembolic pulmonary hypertension in the era where direct oral anticoagulants become available.
J Thromb Haemost. 2023;21:2058-2060.
Abstract

WEST N, Smoot K, Patzlaff N, Miceli M, et al
Plain language summary of the INCREASE study: inhaled treprostinil (Tyvaso) for the treatment of pulmonary hypertension due to interstitial lung disease.
Future Cardiol. 2023 Jul 19. doi: 10.2217/fca-2022-0108.
Abstract

YAGMUR B, Simsek E, Kayikcioglu M, Yuce EI, et al
Could Impedance Cardiography be a Non-Invasive Alternative Method of Measuring Cardiac Output in Patients with Pulmonary Hypertension?
Anatol J Cardiol. 2023 Jul 19. doi: 10.14744/AnatolJCardiol.2023.2820.
Abstract

DENIWAR A, Hernandez J, Aregullin EO, Khan SK, et al
Atrial septal defect-associated pulmonary hypertension with decompensated heart failure: outcomes after fenestrated device closure.
Cardiol Young. 2023 Jul 19:1-6. doi: 10.1017/S104795112300152.
Abstract

DAVE J, Jagana V, Janostiak R, Bisserier M, et al
Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development.
J Transl Med. 2023;21:477.
Abstract

KONDO T, Fujiwara K, Nakagawa M, Fujimoto K, et al
Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients.
Sci Rep. 2023;13:11524.
Abstract

SONG JR, Zhang JW, Li B, Deng MJ, et al
[Pulmonary arterial hypertension in a pedigree with bone morphogenetic protein receptor 2 c.282 mutation].
Zhonghua Xin Xue Guan Bing Za Zhi. 2023;51:769-772.
Abstract

CHIVERS S, Cleary A, Knowles R, Babu-Narayan SV, et al
COVID-19 in congenital heart disease (COaCHeD) study.
Open Heart. 2023;10:e002356.
Abstract

WANG Y, Tan YP, Zhang L, Zheng LN, et al
Application of lung ultrasound in monitoring bronchopulmonary dysplasia and pulmonary arterial pressure in preterm infants.
Eur Rev Med Pharmacol Sci. 2023;27:5964-5972.
Abstract

GOPALRATNAM K, Odeyemi Y, Del Valle KT, Frank RD, et al
Characteristics and Outcomes of Critically Ill Patients With Pulmonary Hypertension Who Undergo Endotracheal Intubation and Mechanical Ventilation.
J Intensive Care Med. 2023 Jul 16:8850666231186761.
Abstract

NEWMAN A, D'Souza SL
Patient-Friendly Summary of the ACR Appropriateness Criteria(R): Suspected Pulmonary Hypertension.
J Am Coll Radiol. 2023 Jul 4:S1546-1440(23)00417.
Abstract

BENZIDIA I, Robitaille C, Abualsaud A, McDonald L, et al
Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension.
Thromb Res. 2023;229:139-145.
Abstract

ZHANG ZJ, Wang HF, Lian TY, Zhou YP, et al
Human Plasma IgG N-Glycome Profiles Reveal a Proinflammatory Phenotype in Chronic Thromboembolic Pulmonary Hypertension.
Hypertension. 2023 Jul 14. doi: 10.1161/HYPERTENSIONAHA.123.21408.
Abstract

XU WJ, Wu Q, He WN, Wang S, et al
Interleukin-6 and pulmonary hypertension: from physiopathology to therapy.
Front Immunol. 2023;14:1181987.
Abstract

JIANG CY, Wu LW, Liu YW, Feng B, et al
Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension.
Front Immunol. 2023;14:1153573.
Abstract

LI Y, Chen Y, Yang L, Li Y, et al
Increased plasma expression of a disintegrin and metalloproteinase with thrombospondin motifs like 4 in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Pulm Circ. 2023;13:e12267.
Abstract

GRANOT Y, Ziv-Baran T, Berliner S, Topilsky Y, et al
Left atrium volume and ventricular volume ratio algorithm as indication of pulmonary hypertension etiology.
Acta Radiol. 2023 Jul 13:2841851231187065. doi: 10.1177/02841851231187065.
Abstract

LEY L, Wiedenroth CB, Ghofrani HA, Hoeltgen R, et al
Analysis of Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Balloon Pulmonary Angioplasty.
J Clin Med. 2023;12:4196.
Abstract

JONAS K, Kurzyna M, Mroczek E, Chrzanowski L, et al
Impact of diabetes mellitus on disease severity and patient survival in idiopathic pulmonary arterial hypertension: data from the Polish multicentre registry (BNP-PL).
Cardiovasc Diabetol. 2023;22:177.
Abstract

KASAVI C
Idiopathic Pulmonary Arterial Hypertension: Network-Based Integration of Multi-Omics Data Reveals New Molecular Signatures and Candidate Drugs.
OMICS. 2023;27:315-326.
Abstract

COCIANNI D, Stolfo D, Perotto M, Contessi S, et al
Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure.
Circ Cardiovasc Imaging. 2023 Jun 29:e014988.
Abstract

ZHANG R, Zhang J, Zhang YL, Gong SG, et al
Single-Cell Transcriptome Analysis of Peripheral Neutrophils From Patients With Idiopathic Pulmonary Arterial Hypertension.
Hypertension. 2023 Jun 14. doi: 10.1161/HYPERTENSIONAHA.123.21142.
Abstract

GARCIA MVF, Coz-Yataco A, Al-Jaghbeer MJ
Pulmonary arterial hypertension trials put to the test: Using the fragility index to assess trials robustness.
Heart Lung. 2023;61:147-152.
Abstract

DOGGRELL SA
Is sotatercept, which traps activins and growth differentiation factors, a new dawn in treating pulmonary arterial hypertension (PAH)?
Expert Opin Biol Ther. 2023;23:589-593.
Abstract

CHOMETTE L, Hupkens E, Romitti M, Dewachter L, et al
Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity.
Am J Med Genet A. 2023;191:2064-2073.
Abstract

DAY RW, Lai KV, Baisch HN, Lau IC, et al
Descriptive images and features of pulmonary vascular disease in a child with a FOXF1 variant.
Pediatr Pulmonol. 2023;58:2383-2385.
Abstract

FRITZ AS, Keller T, Kribs A, Hunseler C, et al
Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life.
Eur J Pediatr. 2023 Apr 18. doi: 10.1007/s00431-023-04973.
Abstract

IACONELLI A, Cuthbert J, Kazmi S, Maffia P, et al
Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity.
Clin Res Cardiol. 2023;112:1077-1086.
Abstract

METHODS IN MEDICINE CAM
Retracted: HMGB1 Upregulates RAGE to Trigger the Expression of Inflammatory Factors in the Lung Tissue in a Hypoxic Pulmonary Hypertension Rat Model.
Comput Math Methods Med. 2023;2023:9830545.
Abstract

FINSTERER J
Confusion in connection with pulmonary hypertension due to premature ventricular complexes requires diagnostic work-up.
Eur Heart J Case Rep. 2023;7:ytad281.
Abstract

LUANI B, Wiemer M, Braun-Dullaeus RC
Confusion in connection with pulmonary hypertension due to premature ventricular complexes requires diagnostic work-up.
Eur Heart J Case Rep. 2023;7:ytad321.
Abstract

BASHIR R, Noory A, Oliveros E, Romero C, et al
Refined Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: Initial Results of U.S. Regional Program.
JACC Adv. 2023;2:100291.
Abstract

ALERHAND S, Adrian RJ
What echocardiographic findings differentiate acute pulmonary embolism and chronic pulmonary hypertension?
Am J Emerg Med. 2023;72:72-84.
Abstract

SALINAS CE, Patey OV, Murillo C, Gonzales M, et al
Preeclampsia and risk of maternal pulmonary hypertension at high altitude in Bolivia.
J Dev Orig Health Dis. 2023 Jul 27:1-9. doi: 10.1017/S2040174423000193.
Abstract

PLECITA-HLAVATA L, Brazdova A, Krivonoskova M, Hu CJ, et al
Microenvironmental regulation of T-cells in pulmonary hypertension.
Front Immunol. 2023;14:1223122.
Abstract

KARMOUTY-QUINTANA H
Correction to "Inhibition of hyaluronan synthesis attenuates pulmonary hypertension associated with lung fibrosis".
Br J Pharmacol. 2023 Jul 25. doi: 10.1111/bph.16194.
Abstract

ALABDALJABAR MS, Naser JA, Kane CJ, Lara-Breitinger KM, et al
Tricuspid Regurgitation Impact on Outcomes (TRIO) score for risk stratification in patients with pulmonary hypertension.
J Am Soc Echocardiogr. 2023 Jul 23:S0894-7317(23)00364.
Abstract

WESSELS JN, Celant LR, de Man FS, Noordegraaf AV, et al
The Right Ventricle in Pulmonary Hypertension.
Semin Respir Crit Care Med. 2023 Jul 24. doi: 10.1055/s-0043-1770117.
Abstract

TORBICKI A, Kurzyna M
The Diagnostic Approach to Pulmonary Hypertension.
Semin Respir Crit Care Med. 2023 Jul 24. doi: 10.1055/s-0043-1770116.
Abstract

BLANCO I, Hernandez-Gonzalez F, Garcia A, Torres-Castro R, et al
Management of Pulmonary Hypertension Associated with Chronic Lung Disease.
Semin Respir Crit Care Med. 2023 Jul 24. doi: 10.1055/s-0043-1770121.
Abstract

YANG H, Cao J, Li JM, Li C, et al
Exploration of the molecular mechanism of tea polyphenols against pulmonary hypertension by integrative approach of network pharmacology, molecular docking, and experimental verification.
Mol Divers. 2023 Jul 24. doi: 10.1007/s11030-023-10700.
Abstract

OZTURK SAHIN B, Galata Z, Demir S, Yilmaz Demirci N, et al
Granulomatous Mediastinitis: A Rare Cause of Pulmonary Hypertension.
Thorac Res Pract. 2023;24:231-234.
Abstract

THENAPPAN T, Gomberg-Maitland M
Pulmonary Artery Denervation for Combined Pre- and Post-Capillary Pulmonary Hypertension: Hype or Hope?
JACC Heart Fail. 2023 Jul 8:S2213-1779(23)00331.
Abstract

KUCHERENKO MM, Sang P, Yao J, Gransar T, et al
Elastin stabilization prevents impaired biomechanics in human pulmonary arteries and pulmonary hypertension in rats with left heart disease.
Nat Commun. 2023;14:4416.
Abstract

SAVEETA F, Payal F, Bai Bansari R
Comment on "Riociguat and Balloon Pulmonary Angioplasty Improve Prognosis in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension".
Curr Probl Cardiol. 2023 Jul 19:101967. doi: 10.1016/j.cpcardiol.2023.101967.
Abstract

DYESS NF, Palmer C, Soll RF, Clark RH, et al
Practices and Outcomes from a Prospective, Multicenter Registry for Preterm Newborns with Pulmonary Hypertension.
J Pediatr. 2023 Jul 19:113614. doi: 10.1016/j.jpeds.2023.113614.
Abstract

LUO Y, Gordon J, Xu J, Kolstad KD, et al
Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry.
Rheumatology (Oxford). 2023 Jul 21:kead368. doi: 10.1093.
Abstract

ORIHARA Y, Asakura M, Min KD, Matsumoto Y, et al
Mean pulmonary artery pressure estimated by echocardiogram rapidly exceeds 20 mmHg from the normal range in patients with connective tissue disease.
Heart Vessels. 2023;38:1172-1180.
Abstract

MA J, Luo F, Yan L
Neonatal outcomes in pregnant women with pulmonary arterial hypertension associated with heart disease.
Pediatr Neonatol. 2023;64:450-454.
Abstract

WANG X, Liu M, Li J, Wang Z, et al
Relationship between quality of life, fear of disease progression, and coping styles in patients with pulmonary hypertension: A network analysis.
Res Nurs Health. 2023 Aug 3. doi: 10.1002/nur.22333.
Abstract

MENG XP, Sun XB, Xu WQ, Tao XC, et al
[Comparison of pulmonary vascular tortuosity and fractal dimension in patients with chronic thromboembolic pulmonary disease and chronic thromboembolic pulmonary hypertension].
Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:774-780.
Abstract

ENNIS S, Sandhu HK, Bruce J, Seers K, et al
Development of a complex exercise rehabilitation intervention for people with pulmonary hypertension: the supervised pulmonary hypertension exercise rehabilitation (SPHERe) trial.
BMJ Open. 2023;13:e066053.
Abstract

SONG R, Wang P, Yang L, Liu J, et al
Association of FOXO3A with right ventricular myocardial fibrosis and its detection by speckle-tracking echocardiography in pulmonary hypertension.
Echocardiography. 2023 Aug 3. doi: 10.1111/echo.15663.
Abstract

AKIYAMA T, Sadahiro T, Yamada Y, Fujita R, et al
Flk1 Deficiency and Hypoxia Synergistically Promote Endothelial Dysfunction, Vascular Remodeling, and Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2023 Aug 3. doi: 10.1161/ATVBAHA.123.319266.
Abstract

KIM J, Jeong J, Park K, Shin K, et al
Evaluation of improved transvenous heartworm extraction brush in dogs with caval syndrome.
J Vet Sci. 2023;24:e46.
Abstract

TITZ A, Mayer L, Appenzeller P, Muller J, et al
Long-term outcome of patients with combined post- and pre-capillary pulmonary hypertension.
Eur Heart J Open. 2023;3:oead069.
Abstract

SHI H, Zhao Y, Li S, Wu H, et al
TNF-alpha and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats.
Open Life Sci. 2023;18:20220650.
Abstract

BAUERSACHS J, Rosenkranz S
Pulmonary hypertension.
Herz. 2023;48:257-258.
Abstract

KHATTAR G, Mustafa A, Siddiqui FS, Gharib KE, et al
Pulmonary hypertension: An unexplored risk factor for stroke in patients with atrial fibrillation.
J Stroke Cerebrovasc Dis. 2023;32:107247.
Abstract

SUN ML, Zhu YJ, Zhou YP, Zhu XJ, et al
Percutaneous transluminal pulmonary angioplasty for Takayasu arteritis-associated pulmonary hypertension: A single-arm meta-analysis.
Catheter Cardiovasc Interv. 2023 Jul 31. doi: 10.1002/ccd.30773.
Abstract

BAGHERI M, Agrawal V, Annis J, Shi M, et al
Genetics of Pulmonary Pressure and Right Ventricle Stress Identify Diabetes as a Causal Risk Factor.
J Am Heart Assoc. 2023;12:e029190.
Abstract

KAZMIRCZAK F, Prins KW
Diabetes Enters Stage Right: Genetic Association Studies Suggest Diabetes Promotes Pulmonary Hypertension and Right Ventricular Dysfunction.
J Am Heart Assoc. 2023;12:e030954.
Abstract

KANEZAWA M, Naito T, Shimokawahara H, Ogawa A, et al
Rescue balloon pulmonary angioplasty for refractory heart failure in chronic thromboembolic pulmonary hypertension complicated with takotsubo cardiomyopathy.
J Cardiol Cases. 2023;28:79-82.
Abstract

MINKIN R, Hopson R, Ramasubbu K, Gharanei M, et al
Pulmonary hypertension predicts higher mortality in patients admitted with severe COVID-19 infection.
SAGE Open Med. 2023;11:20503121231187755.
Abstract

SULLIVAN RT, Raj JU, Austin ED
Recent Advances in Pediatric Pulmonary Hypertension: Implications for Diagnosis and Treatment.
Clin Ther. 2023 Jul 28:S0149-2918(23)00251.
Abstract

BERNARDO RJ, de Jesus Perez VA
Health Care Disparities in Pulmonary Arterial Hypertension.
Clin Chest Med. 2023;44:543-554.
Abstract

MUMBY S, Perros F, Grynblat J, Manaud G, et al
Differential responses of pulmonary vascular cells from PAH patients and controls to TNFalpha and the effect of the BET inhibitor JQ1.
Respir Res. 2023;24:193.
Abstract

PARK DY, Heo W, Kang M, Ahn T, et al
Role of TRPC3 in Right Ventricular Dilatation under Chronic Intermittent Hypoxia in 129/SvEv Mice.
Int J Mol Sci. 2023;24:11284.
Abstract

CINAR C, Yildizeli SO, Balcan B, Yildizeli B, et al
Determinants of Severe Nocturnal Hypoxemia in Adults with Chronic Thromboembolic Pulmonary Hypertension and Sleep-Related Breathing Disorders.
J Clin Med. 2023;12:4639.
Abstract

STARK P, Chang EY
Sleep Apnea Combined with Pulmonary Hypertension in a Veteran Patient Population.
J Clin Med. 2023;12:4634.
Abstract

KACPRZAK A, Tomkowski W, Szturmowicz M
Pulmonary Hypertension in the Course of Interstitial Lung Diseases-A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy.
Diagnostics (Basel). 2023;13:2354.
Abstract

ZHENG X, Diktonaite K, Qiu H
Epigenetic Reader Bromodomain-Containing Protein 4 in Aging-Related Vascular Pathologies and Diseases: Molecular Basis, Functional Relevance, and Clinical Potential.
Biomolecules. 2023;13:1135.
Abstract

MACE EH, Kimlinger MJ, Billings FT 4th, Lopez MG, et al
Targeting Soluble Guanylyl Cyclase during Ischemia and Reperfusion.
Cells. 2023;12:1903.
Abstract

COLPMAN P, Dasgupta A, Archer SL
The Role of Mitochondrial Dynamics and Mitotic Fission in Regulating the Cell Cycle in Cancer and Pulmonary Arterial Hypertension: Implications for Dynamin-Related Protein 1 and Mitofusin2 in Hyperproliferative Diseases.
Cells. 2023;12:1897.
Abstract

KARIKI O, Karyofyllis P, Mililis P, Saplaouras A, et al
Electrocardiographic changes after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: Data from the Hellenic Registry.
J Electrocardiol. 2023;81:26-31.
Abstract

LEVIN JC, Sheils CA, Hayden LP
Pre-Flight Hypoxemia Challenge Testing in Bronchopulmonary Dysplasia.
Pediatrics. 2023;152:e2022061001.
Abstract

PARATI G, Piepoli M
Issue 30.10 focus on arterial hypertension.
Eur J Prev Cardiol. 2023;30:913-915.
Abstract

ALEXANDRE A, Furtado I, Carvalho L, Goncalves F, et al
Transitioning intravenous epoprostenol to oral selexipag in idiopathic pulmonary arterial hypertension: a case report.
ESC Heart Fail. 2023;10:2722-2727.
Abstract

LI N, Wu Q, Meng J, Feng C, et al
Macitentan treatment of portopulmonary hypertension with hepatopulmonary syndrome: a case report and literature review.
ESC Heart Fail. 2023;10:2718-2721.
Abstract

YAYLALI YT, Yagmur B, Sinan UY, Meric M, et al
Risk Assessment Tool Implementation in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
Anatol J Cardiol. 2023;27:479-485.
Abstract

AYON RJ, Yuan JX
Revisiting the Role of KCNA5 in Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2023;69:123-125.
Abstract

FRUMP AL, Machado RF
Bound Together: RNA Binding Protein Quaking, STAT3, and Pulmonary Vascular Remodeling.
Am J Respir Cell Mol Biol. 2023;69:119-120.
Abstract

YIN Q, Wang S, Yang J, Fan C, et al
Nobiletin attenuates monocrotaline-induced pulmonary arterial hypertension through PI3K/Akt/STAT3 pathway.
J Pharm Pharmacol. 2023;75:1100-1110.
Abstract

JHA N, Divya MB, Jha AK
Management and outcomes of pulmonary artery hypertension and Eisenmenger syndrome during pregnancy: a prospective observational cohort study.
BJOG. 2023;130:1258-1268.
Abstract

VERA-ZAMBRANO A, Lago-Docampo M, Gallego N, Franco-Gonzalez JF, et al
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2023;69:147-158.
Abstract

MEMIC SANCAR K, Yildiz M, Kahraman S, Uygur B, et al
Early echocardiographic evaluation of right ventricular load adaptability after sequential combination treatment in pulmonary arterial hypertension.
Herz. 2023;48:316-324.
Abstract

NAKAGAWA A, Nakamura N, Torii S, Goto S, et al
Acute pulmonary hypertension due to microthrombus formation following COVID-19 vaccination: a case report.
Eur Heart J Case Rep. 2023;7:ytad353.
Abstract

XUE C, Gu X, Han J, Zhao Y, et al
Echocardiographic features and influencing factors of pulmonary hypertension of total anomalous pulmonary venous connection in adults.
J Thorac Dis. 2023;15:3791-3799.
Abstract

LIU Y, Li H, Li Y, Zhang J, et al
Outcomes of pregnancy in women with different types of pulmonary hypertension.
BMC Cardiovasc Disord. 2023;23:391.
Abstract

YOO HHB
Transthoracic Echocardiography in Pulmonary Hypertension: Easy Tool, but Caution is Needed!
Arq Bras Cardiol. 2023;120:e20230380.
Abstract

REZENDE CF, Mancuzo EV, Nunes MDCP, Correa RA, et al
Accuracy of Transthoracic Echocardiogram as a Screening Method in the Clinical Practice of Pulmonary Hypertension Investigation.
Arq Bras Cardiol. 2023;120:e20220461.
Abstract

DONAHOE LL, Snelgrove JW, de Perrot M, Sermer M, et al
Pregnancy and pulmonary hypertension in the pre-lung transplant patient: Successfully saving two lives with extracorporeal lung support.
JTCVS Tech. 2023;20:186-191.
Abstract

ZHENG X, Cao J, Zhang G
Stunning tornado: severe pulmonary hypertension due to cor triatriatum sinister.
Eur Heart J. 2023 Aug 9:ehad505. doi: 10.1093.
Abstract

LAKSHMINRUSIMHA S, Madappa R
Acute Pulmonary Hypertension of Early Infancy - Is Thiamine Deficiency the Only Cause?
Indian Pediatr. 2023 Jun 21:S097475591600557.
Abstract

MILLER M, Johnston N, Livengood I, Spinelli M, et al
A topological data analysis study on murine pulmonary arterial trees with pulmonary hypertension.
Math Biosci. 2023 Aug 5:109056. doi: 10.1016/j.mbs.2023.109056.
Abstract

YOGESWARAN A, Zedler D, Richter MJ, Steinke S, et al
Hepatorenal dysfunction in patients with chronic thromboembolic pulmonary hypertension.
Front Med (Lausanne). 2023;10:1207474.
Abstract

LIAO Z, Liu K, Ding S, Zhao Q, et al
Automatic echocardiographic evaluation of the probability of pulmonary hypertension using machine learning.
Pulm Circ. 2023;13:e12272.
Abstract

YOSHIDA S, Kreger AM, Gittes GK
Intra-amniotic sildenafil treatment improves lung blood flow and pulmonary hypertension in congenital diaphragmatic hernia rats.
Front Bioeng Biotechnol. 2023;11:1195623.
Abstract

D'ALTO M, Liccardo B, Di Maio M, Del Giudice C, et al
Lung Ultrasound, Echocardiography and Fluid Challenge for the Differential Diagnosis of Pulmonary Hypertension.
J Am Soc Echocardiogr. 2023 Aug 4:S0894-7317(23)00411.
Abstract

BACZYNSKI M, Jasani B, De Castro C, Dani C, et al
Association between immediate oxygenation response and survival in preterm infants receiving rescue inhaled nitric oxide therapy for hypoxemia from pulmonary hypertension: A systematic review and meta-analysis.
Early Hum Dev. 2023;184:105841.
Abstract

KUNDU P, Schafer M, Le L, Thomas T, et al
Three-Dimensional, Right Ventricular Surface Strain Computation From Three Dimensional Echocardiographic Images From Patients With Pediatric Pulmonary Hypertension.
J Biomech Eng. 2023 Aug 5:1-39. doi: 10.1115/1.4063121.
Abstract

ROSS CE
Pulmonary hypertension in pediatric cardiac arrest: A pressure point for a personalized approach.
Resuscitation. 2023 Aug 2:109918. doi: 10.1016/j.resuscitation.2023.109918.
Abstract

HUANG T, Zeng Y, Yang Y, Fan H, et al
Comprehensive analysis of m(6)A methylomes in idiopathic pulmonary arterial hypertension.
Epigenetics. 2023;18:2242225.
Abstract

LIU M, He H, Fan F, Qiu L, et al
Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR/HSP90alpha axis.
J Mol Cell Cardiol. 2023;181:15-30.
Abstract

JIANG J, Liu S, Yang H, Lv Y, et al
Application of transcriptomics and proteomics in pulmonary arterial hypertension.
Per Med. 2023;20:183-192.
Abstract

ERMERAK NO, Yildizeli SO, Kocakaya D, Mutlu B, et al
Surgical Treatment of Another Sequalae of COVID-19: Post-COVID CTEPH.
Thorac Cardiovasc Surg. 2023;71:413-417.
Abstract

YUCHI Y, Suzuki R, Saito T, Yasumura Y, et al
Echocardiographic characteristics of dogs with pulmonary hypertension secondary to respiratory diseases.
J Vet Intern Med. 2023 Aug 18. doi: 10.1111/jvim.16836.
Abstract

COSTA-RODRIGUEZ N, Garcia-Rodriguez SN, Matos JI, Falcon-Cordon Y, et al
Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?
Parasit Vectors. 2023;16:292.
Abstract

KUANG M, Chen Y, Xing Y, Du M, et al
Echocardiographic evaluation of right heart failure which might be associated with DNA damage response in SU5416-hypoxia induced pulmonary hypertension rat model.
Respir Res. 2023;24:202.
Abstract

OLSSON KM, Corte TJ, Kamp JC, Montani D, et al
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management.
Lancet Respir Med. 2023 Aug 14:S2213-2600(23)00259.
Abstract

DELCROIX M, de Perrot M, Jais X, Jenkins DP, et al
Chronic thromboembolic pulmonary hypertension: realising the potential of multimodal management.
Lancet Respir Med. 2023 Aug 14:S2213-2600(23)00292.
Abstract

NEWMAN J, Pepke-Zaba J
Illuminating the many faces of pulmonary hypertension.
Lancet Respir Med. 2023 Aug 14:S2213-2600(23)00291.
Abstract

LI Y, Fu Y, Liu Y, Zhao D, et al
An optimized machine learning method for predicting wogonin therapy for the treatment of pulmonary hypertension.
Comput Biol Med. 2023;164:107293.
Abstract

MAIMAITIAILI N, Zeng Y, Ju P, Zhakeer G, et al
NLRC3 deficiency promotes hypoxia-induced pulmonary hypertension development via IKK/NF-kappaB p65/HIF-1alpha pathway.
Exp Cell Res. 2023 Aug 14:113755. doi: 10.1016/j.yexcr.2023.113755.
Abstract

YUAN C, Zhang Q
Risk factors for microalbuminuria in adult Tibetan patients with high-altitude pulmonary hypertension: a cross-sectional study.
Cardiovasc Diagn Ther. 2023;13:336-344.
Abstract

JACOBS S, Payne C, Shaboodien S, Kgatla T, et al
Gut microbiota crosstalk mechanisms are key in pulmonary hypertension: The involvement of melatonin is instrumental too.
Pulm Circ. 2023;13:e12277.
Abstract

ZHANG S, Tian YN, Song ZY, Wang XT, et al
[Panax notoginseng saponins improve monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting ADAM10/Notch3 signaling pathway].
Sheng Li Xue Bao. 2023;75:503-511.
Abstract

LIU XX, Chen AD, Pan Y, Zhang F, et al
[Angiotensin-(1-7) improves endothelium-dependent vasodilation in rats with monocrotaline-induced pulmonary arterial hypertension].
Sheng Li Xue Bao. 2023;75:497-502.
Abstract

LIAN G, You J, Lin W, Gao G, et al
Bioinformatics analysis of the immune cell infiltration characteristics and correlation with crucial diagnostic markers in pulmonary arterial hypertension.
BMC Pulm Med. 2023;23:300.
Abstract

RAWLINGS GH, Novakova B, Armstrong I, Thompson AR, et al
A systematic review of psychological interventions in adults with pulmonary hypertension: Is the evidence-base disproportionate to the problem?
Clin Respir J. 2023 Aug 15. doi: 10.1111/crj.13685.
Abstract

JIN Y, Guo G, Wang C, Jiang B, et al
Association of red cell distribution width with pulmonary arterial hypertension in patients with mixed connective tissue disease.
BMC Pulm Med. 2023;23:299.
Abstract

KACHABI A, Colebank MJ, Chesler N
Subject-specific one-dimensional fluid dynamics model of chronic thromboembolic pulmonary hypertension.
Res Sq. 2023 Aug 3:rs.3.rs-3214385. doi: 10.21203/rs.3.rs-3214385.
Abstract

FERNANDEZ-GONZALEZ A, Mukhia A, Nadkarni J, Willis GR, et al
Immunoregulatory macrophages modify local pulmonary immunity and ameliorate hypoxic-pulmonary hypertension.
bioRxiv. 2023 Aug 2:2023.07.31.551394. doi: 10.1101/2023.07.31.551394.
Abstract

PUTRA SD, Prakoso R, Sembiring AA, Sakti DDA, et al
Palliative interatrial septum stenting with a vascular stent in a chronic thromboembolic pulmonary hypertension patient: Is it beneficial?
Egypt Heart J. 2023;75:70.
Abstract

DURMUS N, Chen WC, Park SH, Marsh LM, et al
Resistin-like Molecule alpha and Pulmonary Vascular Remodeling: A Multi-Strain Murine Model of Antigen and Urban Ambient Particulate Matter Co-Exposure.
Int J Mol Sci. 2023;24:11918.
Abstract

KATZ MG, Hadas Y, Vincek A, Freage-Kahn L, et al
Acid ceramidase gene therapy ameliorates pulmonary arterial hypertension with right heart dysfunction.
Respir Res. 2023;24:197.
Abstract

DELCROIX M, Belge C, Maleux G, Godinas L, et al
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension.
Semin Respir Crit Care Med. 2023 Aug 11. doi: 10.1055/s-0043-1770122.
Abstract

YUAN J, Li S, Han Y, Li F, et al
Restoration of miR-328a-5p function curtails hypoxic pulmonary hypertension through a mechanism involving PIN1/GSK3beta/beta-catenin axis.
Int Immunopharmacol. 2023;123:110599.
Abstract

AMPATZIDOU F, Drosos O, Madesis A, Drossos G, et al
Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH).
Kardiochir Torakochirurgia Pol. 2023;20:129-131.
Abstract

ROMERO-ZERTUCHE D, Santos-Martinez LE, Loaiza-Sanchez JF, Moreno-Ruiz LA, et al
Echocardiographic analysis of pulmonary arterial systolic pressure in pulmonary hypertension.
Arch Cardiol Mex. 2023;93:267-275.
Abstract

SAHAY S, Lane J, Sharpe MG, Toth D, et al
Impact on Pulmonary Hypertension Hemodynamic Classification Based on the Methodology Used to Measure Pulmonary Artery Wedge Pressure and Cardiac Output.
Ann Am Thorac Soc. 2023 Aug 10. doi: 10.1513/AnnalsATS.202303.
Abstract

JOSE A, Elwing JM, Kawut SM, Pauciulo MW, et al
Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertension.
Commun Biol. 2023;6:826.
Abstract

PAHAL P, Sharma S, Braga CL, Santos RT, et al
Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension.
Life Sci. 2023;329:121988.
Abstract

NANDULA PS, Shah SD, Caputo A, Papa S, et al
Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
Curr Heart Fail Rep. 2023;20:263-270.
Abstract

ZI-YANG Y, Nanshan X, Dongling L, Tao H, et al
ACE2 gene polymorphisms are associated with elevated pulmonary artery pressure in congenital heart diseases.
Gene. 2023;882:147642.
Abstract

ABU-HANNA J, Anastasakis E, Patel JA, Eddama MMR, et al
Prostacyclin mimetics inhibit DRP1-mediated pro-proliferative mitochondrial fragmentation in pulmonary arterial hypertension.
Vascul Pharmacol. 2023;151:107194.
Abstract

PALMIERO G, Monda E, Verrillo F, Dongiglio F, et al
Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis.
Int J Cardiol. 2023;388:131147.
Abstract

MARCUS B, Marynen F, Fieuws S, Van Beersel D, et al
The perioperative use of inhaled prostacyclins in cardiac surgery: a systematic review and meta-analysis.
Can J Anaesth. 2023 Jun 28. doi: 10.1007/s12630-023-02520.
Abstract

YU X, Wu M, Meng Q, Zhu W, et al
Ligustrazine alleviates pulmonary arterial hypertension in rats by promoting the formation of myocardin transcription complex in the nucleus of pulmonary artery smooth muscle cells.
Clin Transl Sci. 2023;16:1369-1380.
Abstract

CULLEY MK, Rao RJ, Mehta M, Zhao J, et al
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function.
Vascul Pharmacol. 2023;151:107181.
Abstract

SANZ J, Nelson KF
Towards Noninvasive Evaluation of the Right Heart-Pulmonary Circulation Unit.
JACC Cardiovasc Imaging. 2023;16:1035-1037.
Abstract

ZHONG L, Leng S, Alabed S, Chai P, et al
Pulmonary Artery Strain Predicts Prognosis in Pulmonary Arterial Hypertension.
JACC Cardiovasc Imaging. 2023;16:1022-1034.
Abstract

YAN J, Duan Y, Cheng M
Clinical Diagnostic Value of Serum GABA, NE, ET-1, and VEGF in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension.
Int J Chron Obstruct Pulmon Dis. 2023;18:1803-1813.
Abstract

KARIA N, Howard L, Johnson M, Kiely DG, et al
Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study.
Eur Heart J. 2023 Aug 24:ehad532. doi: 10.1093.
Abstract

NAKAMURA J, Tsujino I, Shima H, Nakaya T, et al
Impact of cancer on the prevalence, management, and outcome of patients with chronic thromboembolic pulmonary hypertension.
J Thromb Thrombolysis. 2023 Aug 24. doi: 10.1007/s11239-023-02868.
Abstract

MAHENDRA M, Chu P, Amin EK, Nawaytou H, et al
Associated radiation exposure from medical imaging and excess lifetime risk of developing cancer in pediatric patients with pulmonary hypertension.
Pulm Circ. 2023;13:e12282.
Abstract

DAI M, Zhang C, Li C, Wang Q, et al
Clinical characteristics and prognosis in systemic lupus erythematosus-associated pulmonary arterial hypertension based on consensus clustering and risk prediction model.
Arthritis Res Ther. 2023;25:155.
Abstract

LI M, Tang M, Zhao C, Dang P, et al
Prognostic Potential of Pulmonary Hypertension in Patients with Hematologic Malignancy.
Adv Ther. 2023 Aug 23. doi: 10.1007/s12325-023-02639.
Abstract

GUTENSCHWAGER DW, Patel A, Soyad AT, Patel S, et al
Provision of ambrisentan from a health-system specialty pharmacy affiliated with a pulmonary hypertension Center of Comprehensive Care.
Am J Health Syst Pharm. 2023 Aug 23:zxad191. doi: 10.1093.
Abstract

TEIXEIRA-FONSECA JL, Joviano-Santos JV, da Silva Alcantara F, de Lima Conceicao MR, et al
Evaluation of right atrium structure and function in a rat model of monocrotaline-induced pulmonary hypertension: Exploring the possible antiarrhythmic properties of amiodarone.
Clin Exp Pharmacol Physiol. 2023 Aug 23. doi: 10.1111/1440-1681.13813.
Abstract

NAUD R, Bermudez J, Resseguier N, Nieves A, et al
Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases.
ERJ Open Res. 2023;9:00027-2023.
Abstract

JANSA P, Kopec G, Torbicki A, Sadushi-Kolici R, et al
The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil.
Pulm Circ. 2023;13:e12274.
Abstract

FENG X, Wang K, Yang T, Dang B, et al
Overexpressed microRNA (miR)-382-3p promoted vascular remodeling via suppressing autophagy-related protein 7 (ATG7) in chronic thromboembolic pulmonary hypertension.
Curr Mol Med. 2023 Aug 22. doi: 10.2174/1566524023666230822120453.
Abstract

HANER WASSERSTEIN D, Frishman WH
Impact of Balloon Pulmonary Angioplasty on Right Ventricular Function in Patients With Chronic Thromboembolic Pulmonary Hypertension.
Cardiol Rev. 2023 Aug 22. doi: 10.1097/CRD.0000000000000571.
Abstract

HRDLICKA J, Jurka M, Bircakova B, Ambroz D, et al
Even non-expert radiologists report chronic thromboembolic pulmonary hypertension (CTEPH) on CT pulmonary angiography with high sensitivity and almost perfect agreement.
Eur Radiol. 2023 Aug 22. doi: 10.1007/s00330-023-10098.
Abstract

PUST F, Deis T, Larsson J, Hansen BL, et al
Importance of heart failure duration for development of pulmonary hypertension in advanced heart failure.
Int J Cardiol. 2023 Aug 19:131232. doi: 10.1016/j.ijcard.2023.131232.
Abstract

CHEN R, Wang H, Zheng C, Zhang X, et al
Polo-like kinase 1 promotes pulmonary hypertension.
Respir Res. 2023;24:204.
Abstract

FANG A, Mayorga-Carlin M, Han P, Cassady S, et al
Risk factors and treatment interventions associated with incomplete thrombus resolution and pulmonary hypertension after a pulmonary embolism.
J Vasc Surg Venous Lymphat Disord. 2023 Aug 16:S2213-333X(23)00317.
Abstract

SEITLER S, Dimopoulos K, Ernst S, Price LC, et al
Medical Emergencies in Pulmonary Hypertension.
Semin Respir Crit Care Med. 2023 Aug 18. doi: 10.1055/s-0043-1770120.
Abstract

LECHARTIER B, Kularatne M, Jais X, Humbert M, et al
Updated Hemodynamic Definition and Classification of Pulmonary Hypertension.
Semin Respir Crit Care Med. 2023 Aug 18. doi: 10.1055/s-0043-1770115.
Abstract

BREINIG S, Ehlinger V, Roze JC, Storme L, et al
Pulmonary hypertension among preterm infants born at 22 through 32 weeks gestation in France: Prevalence, survival, morbidity and management in the EPIPAGE-2 cohort study.
Early Hum Dev. 2023;184:105837.
Abstract

PAHAL P, Sharma S, Panchal J, Jaiswal S, et al
Development of novel bosentan analogues as endothelin receptor antagonists for pulmonary arterial hypertension.
Eur J Med Chem. 2023;259:115681.
Abstract

TELLO K, Naeije R, de Man F, Guazzi M, et al
Pathophysiology of the right ventricle in health and disease: an update.
Cardiovasc Res. 2023;119:1891-1904.
Abstract

MENG CY, Zou JZ, Wang Y, Wei YD, et al
Pathological findings in congenital diaphragmatic hernia on necropsy studies: A single-center case series.
Pediatr Pulmonol. 2023 Jun 28. doi: 10.1002/ppul.26565.
Abstract

KANE CJ, Lara-Breitinger KM, Alabdaljabar MS, Nkomo VT, et al
Pulmonary artery pulsatility index in patients with tricuspid valve regurgitation: a simple non-invasive tool for risk stratification.
Eur Heart J Cardiovasc Imaging. 2023;24:1210-1221.
Abstract

DENIWAR A, Hernandez J, Aregullin EO, Khan SK, et al
Atrial septal defect-associated pulmonary hypertension with decompensated heart failure: outcomes after fenestrated device closure - CORRIGENDUM.
Cardiol Young. 2023 Sep 1:1. doi: 10.1017/S1047951123003281.
Abstract

ZENG X, Wu Z, Cen C, Wen S, et al
Thrombosis is not the only determinant of chronic thromboembolic pulmonary hypertension.
Int J Cardiol. 2023 Aug 29:131304. doi: 10.1016/j.ijcard.2023.131304.
Abstract

PARGANA J, Cale R, Martinho M, Santos J, et al
Prevalence and predictors of chronic thromboembolic pulmonary hypertension following severe forms of acute pulmonary embolism.
Rev Port Cardiol. 2023 Aug 29:S0870-2551(23)00392.
Abstract

KURNICK A, Zaveri S, Tadayoni A, Chandrakumar HP, et al
Reversible severe pulmonary hypertension and right heart failure with cardiogenic shock due to scurvy: a case report.
Eur Heart J Case Rep. 2023;7:ytad404.
Abstract

NAFEES B, de Freitas HM, Beaudet A, Todd E, et al
A Health State Utility Study to Elicit Societal Values Associated with Pulmonary Hypertension.
Patient Prefer Adherence. 2023;17:2119-2130.
Abstract

DIMITRY MO, Soliman YMA, ElKorashy RI, Raslan HM, et al
Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension.
Egypt Heart J. 2023;75:76.
Abstract

TSIAMITA O, White K
Post-thrombotic syndrome and chronic thromboembolic pulmonary hypertension: diagnosis and management.
Br J Hosp Med (Lond). 2023;84:1-10.
Abstract

GENG Y, Hu Y, Zhang F, Tuo Y, et al
Mitochondria in hypoxic pulmonary hypertension, roles and the potential targets.
Front Physiol. 2023;14:1239643.
Abstract

WU Y, Tian P, Liang L, Chen Y, et al
Improved Prognostic Performance of Right Atrial Pressure-Corrected Cardiac Power Output in Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction.
J Cardiovasc Transl Res. 2023 Aug 29. doi: 10.1007/s12265-023-10429.
Abstract

ZHANG W, Liu Z, Lin W, Zhang F, et al
[Diagnosis and treatment of a child with alveolar capillary dysplasia with misalignment of pulmonary veins due to variant of FOXF1 gene].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2023;40:1171-1175.
Abstract

MIZUNO R, Uesugi A, Yamazaki M
Giant pulmonary artery aneurysm in long-standing chronic thromboembolic pulmonary hypertension.
Eur Heart J Cardiovasc Imaging. 2023 Aug 29:jead217. doi: 10.1093.
Abstract

DENG XX, Jin BW, Li SS, Zhou HM, et al
Pulmonary hypertension- a novel phenotypic hypothesis of Kabuki syndrome: a case report and literature review.
BMC Pediatr. 2023;23:429.
Abstract

ISHIDA M, Yamamura A, Fujiwara M, Amano T, et al
Pimaric acid reduces vasoconstriction via BK(Ca) channel activation and VDCC inhibition in rat pulmonary arterial smooth muscles.
J Pharmacol Sci. 2023;153:84-88.
Abstract

WU H, Huan C, Hu Y, Xiao S, et al
Development and validation of a nomogram for predicting all-cause mortality in patients with hemodialysis having pulmonary hypertension.
Cardiorenal Med. 2023 Aug 28. doi: 10.1159/000533674.
Abstract

WU XC, Ye FL, Zheng XZ
Fetal pulmonary artery stiffness is a strong predictor of persistent pulmonary hypertension of the newborn - An echocardiographic study.
Eur J Obstet Gynecol Reprod Biol. 2023;289:60-64.
Abstract

ESPARHAM A, Shoar S, Mehri A, Modukuru VR, et al
Bariatric Surgery and Cardiovascular Disease Risk in Patients with Pulmonary Hypertension: A Propensity Score Matched Analysis of US National Inpatient Sample.
Obes Surg. 2023 Aug 28. doi: 10.1007/s11695-023-06799.
Abstract

WANG H, Zhou X, Xiong C
A rare etiology of pulmonary hypertension-pulmonary tumor thrombotic microangiopathy.
Eur Heart J Cardiovasc Imaging. 2023 Aug 28:jead219. doi: 10.1093.
Abstract

OLIVEIRA AC, Karas MM, Alves M, He J, et al
ACE2 overexpression in corticotropin-releasing-hormone cells offers protection against pulmonary hypertension.
Front Neurosci. 2023;17:1223733.
Abstract

KERKUTLUOGLU M, Gunes H, Atilla N, Celik E, et al
Relationship Between Soluble ST2 Level and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in Acute Pulmonary Embolism (PE) Patients.
Cureus. 2023;15:e42449.
Abstract

WANG LJ, Feng F, Li JC, Chen TT, et al
Role of heparanase in pulmonary hypertension.
Front Pharmacol. 2023;14:1202676.
Abstract

DUAN A, Huang Z, Zhao Z, Zhao Q, et al
The potential of cystatin C as a predictive biomarker in pulmonary hypertension.
BMC Pulm Med. 2023;23:311.
Abstract

KAULINS R, Rudzitis A, Lejnieks A, Kigitovica D, et al
Baseline Clinical Characteristics and Incidence of Chronic Thromboembolic Pulmonary Hypertension Patients in Latvia, 2019-2020.
Medicina (Kaunas). 2023;59:1426.
Abstract

SANCHEZ-GLORIA JL, Martinez-Olivares CE, Del Valle-Mondragon L, Cortes-Camacho F, et al
Allicin, an Emerging Treatment for Pulmonary Arterial Hypertension: An Experimental Study.
Int J Mol Sci. 2023;24:12959.
Abstract

PULLAMSETTI SS, Sitapara R, Osterhout R, Weiss A, et al
Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension.
Int J Mol Sci. 2023;24:12653.
Abstract

DILLON K, Lamba V, Philip RR, Weems MF, et al
Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
Children (Basel). 2023;10:1397.
Abstract

MANDOLI GE, Landra F, Chiantini B, Sciaccaluga C, et al
Tricuspid Regurgitation Velocity and Mean Pressure Gradient for the Prediction of Pulmonary Hypertension According to the New Hemodynamic Definition.
Diagnostics (Basel). 2023;13:2619.
Abstract

CONTI M, Minniti M, Tine M, De Francesco M, et al
Extracellular Vesicles in Pulmonary Hypertension: A Dangerous Liaison?
Biology (Basel). 2023;12:1099.
Abstract

MARTIN G, Canuet M, Rahli M, Schuller A, et al
Severe pre-capillary pulmonary hypertension associated with kyphoscoliosis: Description of 4 cases.
Respir Med Res. 2023;84:101034.
Abstract

ISHIDA H, Maeda J, Uchida K, Yamagishi H, et al
Unique Pulmonary Hypertensive Vascular Diseases Associated with Heart and Lung Developmental Defects.
J Cardiovasc Dev Dis. 2023;10:333.
Abstract

STERINGER-MASCHERBAUER R, Huber C, Froschl U, Engleder D, et al
Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps-Single-Center Experience over More Than a Decade.
J Cardiovasc Dev Dis. 2023;10:318.
Abstract

CHAI L, Wang Q, Wang Y, Li D, et al
Downregulation of PDCD4 through STAT3/ATF6/autophagy mediates MIF-induced PASMCs proliferation/migration and vascular remodeling.
Eur J Pharmacol. 2023;956:175968.
Abstract

WOOD KP, Fleming GA, Chamberlain RC
Update on Transcatheter Device Closure of Congenital Septal Defects.
Curr Cardiol Rep. 2023;25:1083-1093.
Abstract

SFERRA SR, Guo M, Gonzalez Salazar AJ, Penikis AB, et al
Sex-specific Differences in Congenital Diaphragmatic Hernia Mortality.
J Pediatr. 2023 May 15:113481. doi: 10.1016/j.jpeds.2023.113481.
Abstract

WEI Q, Chen W, Liang Q, Song S, et al
Effect of Endotracheal Suctioning on Infants Born through Meconium-Stained Amniotic Fluid: A Meta-Analysis.
Am J Perinatol. 2022 Jan 11. doi: 10.1055/s-0041-1741034.
Abstract

HUANG H, Yang L
Research Progress of Inflammatory Factors in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension at High Altitude.
Altern Ther Health Med. 2023 Sep 8:AT9086.
Abstract

LOAR RW, Tsao C, Ogunyankin F, Wilkes JK, et al
Mid-Systolic Notching of the Pulmonary Valve Doppler Signal is Highly Associated with Pulmonary Hypertension.
Pediatr Cardiol. 2023 Sep 7. doi: 10.1007/s00246-023-03285.
Abstract

BRAAMS NJ, Kianzad A, van Wezenbeek J, Wessels JN, et al
Long-Term Effects of Pulmonary Endarterectomy on Right Ventricular Stiffness and Fibrosis in Chronic Thromboembolic Pulmonary Hypertension.
Circ Heart Fail. 2023 Sep 7:e010336. doi: 10.1161/CIRCHEARTFAILURE.122.010336.
Abstract

FAIRCLOTH JM, Bhatt ND, Chartan CA, Coleman RD, et al
Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration.
Front Pediatr. 2023;11:1275389.
Abstract

HONORE PM, Bousbiat I, Perriens E, Blackman S, et al
Chronic thromboembolic pulmonary hypertension: early recognition leads to optimal therapy and drastically decreases mortality!
Ann Transl Med. 2023;11:340.
Abstract

LICHTBLAU M, Titz A, Bahrampoori B, Schmiedeskamp M, et al
What changed after the 2022 guidelines for pulmonary hypertension?
Eur J Intern Med. 2023 Sep 4:S0953-6205(23)00305.
Abstract

TSUTSUI M
[Protective role of the nitric oxide synthases system in inter-organ communication].
Nihon Yakurigaku Zasshi. 2023;158:374-378.
Abstract

DARDI F, Rotunno M, Guarino D, Suarez SM, et al
Comparison of different treatment strategies in patients with chronic thromboembolic pulmonary hypertension: A single centre real-world experience.
Int J Cardiol. 2023 Sep 4:131333. doi: 10.1016/j.ijcard.2023.131333.
Abstract

YU X, Qin W, Lin X, Shan Z, et al
Synergizing the enhanced RIME with fuzzy K-nearest neighbor for diagnose of pulmonary hypertension.
Comput Biol Med. 2023;165:107408.
Abstract

HOU C, Wen DM, Wang J
[Advances in neuromodulation of pulmonary hypertension].
Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:936-940.
Abstract

GIRALDO-RAMIREZ S, Gandara-Ricardo JA, Velasquez-Penagos J, Florez-Munoz J, et al
[Once in a blue moon: coronavirus disease complicates pregnancy in a patient with unknown pulmonary hypertension and subsequent left ventricular dysfunction].
Arch Cardiol Mex. 2023 Sep 5. doi: 10.24875/ACM.22000089.
Abstract

GODA A, Takeuchi K, Kikuchi H, Inami T, et al
Pulmonary artery pressure-perfusion relation during exercise in patients with chronic thromboembolic pulmonary hypertension using pulmonary arteriography and right-heart catheterization.
Int J Cardiol Heart Vasc. 2023;48:101252.
Abstract

ZHAO F, Chen Y, Xie Y, Kong S, et al
Identification of Zip8-correlated hub genes in pulmonary hypertension by informatic analysis.
PeerJ. 2023;11:e15939.
Abstract

SHAN X, Wang J, Feng H, Zhang Z, et al
Aloperine Protects Pulmonary Hypertension via Triggering PPARgamma Signaling and Inhibiting Calcium Regulatory Pathway in Pulmonary Arterial Smooth Muscle Cells.
Am J Physiol Cell Physiol. 2023 Sep 4. doi: 10.1152/ajpcell.00286.2023.
Abstract

CERNY V, Pagac J, Novak M, Jansa P, et al
Semi-automatic quantification of mosaic perfusion of lung parenchyma and its correlation with haemodynamic parameters in patients with chronic thromboembolic pulmonary hypertension.
Clin Radiol. 2023 Aug 23:S0009-9260(23)00365-3. doi: 10.1016/j.crad.2023.
Abstract

CAMPOS-CARRARO C, Turck P, de Lima-Seolin BG, Teixeira RB, et al
Copaiba oil improves pulmonary nitric oxide bioavailability in monocrotaline-treated rats.
Can J Physiol Pharmacol. 2023;101:447-454.
Abstract

HARUTYUNOVA S, Benjamin N, Eichstaedt C, Marra AM, et al
Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension.
Respiration. 2023;102:579-590.
Abstract

SAINT-MARTIN WILLER A, Santos-Gomes J, Adao R, Bras-Silva C, et al
Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.
J Physiol. 2023;601:3717-3737.
Abstract

SUNGUR A, Sungur MA, Karagoz A, Sert Sekerci S, et al
Cardiohepatic syndrome and its prognostic predictive ability in patients with pulmonary arterial hypertension.
Scand J Clin Lab Invest. 2023;83:290-298.
Abstract

ROTONDO C, Sciacca S, Rella V, Busto G, et al
Subclinical coronary atherosclerosis, detected by computer tomography with coronary calcium score, and the occurrence of major cardiovascular events at 5 years of follow-up in a cohort of patients with systemic sclerosis.
Eur J Intern Med. 2023;115:62-69.
Abstract

WUNDER F, Stasch JP, Knorr A, Mondritzki T, et al
Identification and characterization of the new generation soluble guanylate cyclase stimulator BAY-747 designed for the treatment of resistant hypertension.
Br J Pharmacol. 2023;180:2500-2513.
Abstract

MA J, Li C, Zhai Z, Zhen Y, et al
Distribution of thrombus predicts severe reperfusion pulmonary edema after pulmonary endarterectomy.
Asian J Surg. 2023;46:3766-3772.
Abstract

HOEPER MM
Extracorporeal Life Support in Pulmonary Hypertension: Practical Aspects.
Semin Respir Crit Care Med. 2023 Sep 14. doi: 10.1055/s-0043-1772752.
Abstract

BARATTO C, Caravita S, Vachiery JL
Pulmonary Hypertension Associated with Left Heart Disease.
Semin Respir Crit Care Med. 2023 Sep 14. doi: 10.1055/s-0043-1772754.
Abstract

ALQARNI AA, Aldhahir AM, Bintalib HM, Alqahtani JS, et al
Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review.
Front Med (Lausanne). 2023;10:1217156.
Abstract

AKIN EJ, Aoun J, Jimenez C, Mayne K, et al
ANO1, CaV1.2, and IP3R form a localized unit of EC-coupling in mouse pulmonary arterial smooth muscle.
J Gen Physiol. 2023;155:e202213217.
Abstract

STEWART S, Chan YK, Playford D, Harris S, et al
Incident pulmonary hypertension in 13 488 cases investigated with repeat echocardiography: a clinical cohort study.
ERJ Open Res. 2023;9:00082-2023.
Abstract

KURIYAMA A, Kasai H, Sugiura T, Nagata J, et al
Clinical significance of lung cross-sectional area measured by computed tomography in chronic thromboembolic pulmonary hypertension: The correlation with pulmonary hemodynamics and the limitations.
Pulm Circ. 2023;13:e12287.
Abstract

ZHANG X, Guo X, Zhang B, Yang Q, et al
The Role of Strain by Cardiac Magnetic Resonance Imaging in Predicting the Prognosis of Patients with Chronic Thromboembolic Pulmonary Hypertension.
Clin Appl Thromb Hemost. 2023;29:10760296231176253.
Abstract

GARCIA RU, Beshish A, Butto A, Kanaan U, et al
Continuous Prostanoid Initiation in Severe Pulmonary Hypertension in the Pediatric Cardiac Intensive Care Unit.
Pediatr Cardiol. 2023 Sep 12. doi: 10.1007/s00246-023-03282.
Abstract

LUO F, Fu M, Wang T, Qi Y, et al
Down-regulation of the mitochondrial fusion protein Opa1/Mfn2 promotes cardiomyocyte hypertrophy in Su5416/hypoxia-induced pulmonary hypertension rats.
Arch Biochem Biophys. 2023;747:109743.
Abstract

BIRD E, Hasenstab K, Kim N, Madani M, et al
Mapping the Spatial Extent of Hypoperfusion in Chronic Thromboembolic Pulmonary Hypertension Using Multienergy CT.
Radiol Cardiothorac Imaging. 2023;5:e220221.
Abstract

RAMANAND P, Indic P, Gentle SJ, Ambalavanan N, et al
Information Based Similarity Analysis of Oxygen Saturation Recordings to Detect Pulmonary Hypertension in Preterm Infants.
Biomed Signal Process Control. 2023;86.
Abstract

QU J, Li M, Zhang X, Zhang M, et al
A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
Respir Res. 2023;24:220.
Abstract

YANG Y, Yang B, Liu B, Liang Y, et al
Circulating choline levels are associated with prognoses in patients with pulmonary hypertension: a cohort study.
BMC Pulm Med. 2023;23:313.
Abstract

GONZALEZ-HERMOSILLO LM, Cueto-Robledo G, Navarro-Vergara DI, Roldan-Valadez E, et al
Prevalence and prognosis of hypothyroidism in patients with chronic thromboembolic pulmonary hypertension: an updated review with description of case series.
Curr Probl Cardiol. 2023 Sep 7:102069. doi: 10.1016/j.cpcardiol.2023.102069.
Abstract

FAZELIFAR AF, Talebian F, Ghaffarinejad Z, Habibi MA, et al
Electrocardiographic manifestations of pulmonary stenosis versus pulmonary hypertension.
J Electrocardiol. 2023;81:117-122.
Abstract

GUERRA-OJEDA S, Suarez A, Valls A, Verdu D, et al
The Role of Aryl Hydrocarbon Receptor in the Endothelium: A Systematic Review.
Int J Mol Sci. 2023;24:13537.
Abstract

BASSAREO PP, D'Alto M
Metabolomics in Pulmonary Hypertension-A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology.
Int J Mol Sci. 2023;24:13227.
Abstract

PELAIA C, Armentaro G, Lupia C, Maiorano A, et al
Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension.
J Clin Med. 2023;12:5472.
Abstract

PEZZUTO B, Agostoni P
The Current Role of Cardiopulmonary Exercise Test in the Diagnosis and Management of Pulmonary Hypertension.
J Clin Med. 2023;12:5465.
Abstract

YANG J, Zhou F, Zhou X, Sun Y, et al
Survival and prognosis analysis of systemic lupus erythematosus patients with pulmonary hypertension: A systematic review and meta-analysis.
Medicine (Baltimore). 2023;102:e34947.
Abstract

OTA H, Higuchi S
Editorial for "Multicenter Standardization of Phase Resolved Functional Lung MRI in Patients With Suspected Chronic Thromboembolic Pulmonary Hypertension".
J Magn Reson Imaging. 2023 Sep 8. doi: 10.1002/jmri.28992.
Abstract

FUJIWARA T, Takeda N, Hara H, Ishii S, et al
PGC-1alpha-mediated angiogenesis prevents pulmonary hypertension in mice.
JCI Insight. 2023;8:e162632.
Abstract

LACHANT D, Minkin R, Swisher J, Mogri M, et al
Safety and efficacy of transitioning from selexipag to oral treprostinil in pulmonary arterial hypertension: Findings from the ADAPT registry.
Pulm Pharmacol Ther. 2023;82:102232.
Abstract

GOKCEN N
Serum markers in systemic sclerosis with cardiac involvement.
Clin Rheumatol. 2023;42:2577-2588.
Abstract

YI D, Liu B, Ding H, Li S, et al
E2F1 Mediates SOX17 Deficiency-Induced Pulmonary Hypertension.
Hypertension. 2023 Sep 22. doi: 10.1161/HYPERTENSIONAHA.123.21241.
Abstract

PAWAR SG, Khan N, Salam A, Joshi M, et al
The association of Pulmonary Hypertension and right ventricular systolic function -updates in diagnosis and treatment.
Dis Mon. 2023 Sep 19:101635. doi: 10.1016/j.disamonth.2023.101635.
Abstract

TURESH K, Tanisha, Soojal, Rajani D, et al
Comment on: Impact of Pulmonary Hypertension in Patients with Hypertrophic Cardiomyopathy Presented with Cardiogenic Shock / Acute Decompensated Heart Failure.
Curr Probl Cardiol. 2023 Sep 19:102091. doi: 10.1016/j.cpcardiol.2023.102091.
Abstract

MOHER ALSADY T, Voskrebenzev A, Behrendt L, Olsson K, et al
Multicenter Standardization of Phase-Resolved Functional Lung MRI in Patients With Suspected Chronic Thromboembolic Pulmonary Hypertension.
J Magn Reson Imaging. 2023 Sep 21. doi: 10.1002/jmri.28995.
Abstract

FUKUDA Y, Shimokawahara H, Chikama S, Watanabe A, et al
Combination of rescue balloon pulmonary angioplasty and riociguat therapy for chronic thromboembolic pulmonary hypertension with nonsustained polymorphic ventricular tachycardia: A case report.
Pulm Circ. 2023;13:e12290.
Abstract

COLGLAZIER E, Ng AJ, Parker C, Woolsey D, et al
Safety and tolerability of continuous inhaled iloprost in critically ill pediatric pulmonary hypertension patients: A retrospective case series.
Pulm Circ. 2023;13:e12289.
Abstract

ZHAO H, Wang L, Yan Y, Zhao QH, et al
Identification of the shared gene signatures between pulmonary fibrosis and pulmonary hypertension using bioinformatics analysis.
Front Immunol. 2023;14:1197752.
Abstract

LI M, Shi Y, Zhao J, Wang Q, et al
Identification of potential susceptibility genes in patients with primary Sjogren's syndrome-associated pulmonary arterial hypertension through whole exome sequencing.
Arthritis Res Ther. 2023;25:175.
Abstract

KLINGER JR, Wu B, Morland K, Classi P, et al
Burden of pulmonary hypertension due to chronic obstructive pulmonary disease: Analysis of exacerbations and healthcare resource utilization in the United States.
Respir Med. 2023 Sep 18:107412. doi: 10.1016/j.rmed.2023.107412.
Abstract

CONDLIFFE R, Newton R, Bauchmuller K, Bonnett T, et al
Surgery and Anesthesia in Patients with Pulmonary Hypertension.
Semin Respir Crit Care Med. 2023 Sep 20. doi: 10.1055/s-0043-1772753.
Abstract

IGNATIUK D, Miles K, Gurbani N, Hossain MM, et al
Occurrence of sleep-disordered breathing in children with pulmonary hypertension.
Pediatr Pulmonol. 2023 Sep 20. doi: 10.1002/ppul.26693.
Abstract

FRONRATH MJ, Hencken L, Martz CR, Kelly B, et al
Fluid Resuscitation and Relation to Respiratory Support Escalation in Patients with and without Pulmonary Hypertension with Sepsis.
Pharmacotherapy. 2023 Sep 20. doi: 10.1002/phar.2879.
Abstract

YOGESWARAN A, Rako ZA, Yildiz S, Ghofrani HA, et al
Echocardiographic evaluation of right ventricular diastolic function in pulmonary hypertension.
ERJ Open Res. 2023;9:00226-2023.
Abstract

SWINNEN K, Verstraete K, Baratto C, Hardy L, et al
Machine learning to differentiate pulmonary hypertension due to left heart disease from pulmonary arterial hypertension.
ERJ Open Res. 2023;9:00229-2023.
Abstract

MOORE SS, De Carvalho Nunes G, Dancea A, Wutthigate P, et al
Early cardiac function and death, severe bronchopulmonary dysplasia and pulmonary hypertension in extremely preterm infants.
Pediatr Res. 2023 Sep 19. doi: 10.1038/s41390-023-02817.
Abstract

BHATIA M, Scheiber CJ, Arora S, Gustafson C, et al
Should All Patients With Pulmonary Hypertension Undergoing Non-Cardiac Surgery Be Managed by Cardiothoracic Fellowship-Trained Anesthesiologists?
Semin Cardiothorac Vasc Anesth. 2023 Sep 19:10892532231203128.
Abstract

LIU JN, Zhao ZG, Luo FM
Pulmonary hypertension-related dynamic left ventricular outflow tract obstruction.
Eur Heart J. 2023 Sep 19:ehad605. doi: 10.1093.
Abstract

JOYA-SEIJO MD, Garrido-Lestache MEB, Rueda-Camino JA, Angelina-Garcia M, et al
External validation of the InShape II study algorithm for exclusion of chronic thromboembolic pulmonary hypertension in patients with pulmonary thromboembolism.
Rev Clin Esp (Barc). 2023 Sep 16:S2254-8874(23)00105.
Abstract

KAZMIRCZAK F, Thenappan T, Prins KW, Prisco SZ, et al
Sex differences in right ventricular function between Groups 1 and 3 pulmonary hypertension.
Pulm Circ. 2023;13:e12288.
Abstract

ZHAO F, Pan C, Zhang Y, Yang J, et al
Polyphyllin VII alleviates pulmonary hypertension by inducing miR-205-5p to target the beta-catenin pathway.
Biomed Pharmacother. 2023;167:115516.
Abstract

GARCIA AR, Blanco I, Ramon L, Perez-Sagredo J, et al
Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry.
Respir Res. 2023;24:223.
Abstract

WAWRZYNIAK R, Biesemans M, Kugacka-Dabrowska A, Lewicka E, et al
Plasma untargeted metabolomics with proteinase K discloses phospholipid signature associated with pulmonary arterial hypertension.
Sci Rep. 2023;13:15280.
Abstract

VORA K, Dharmakumar R
Editorial Commentary for State-of-the-Art Cardiac Magnetic Resonance in Pulmonary Hypertension - An Update on Diagnosis, Risk Stratification and Treatment.
Trends Cardiovasc Med. 2023 Sep 13:S1050-1738(23)00076.
Abstract

ZHAO Q, Liu Z, Song P, Yuan Z, et al
Mitochondria Derived Vesicle Packaging as a Novel Therapeutic Mechanism in Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2023 Sep 15. doi: 10.1165/rcmb.2023-0010.
Abstract

MATSUGI E, Takashima S, Doteguchi S, Kobayashi T, et al
Real-world safety and effectiveness of inhaled nitric oxide therapy for pulmonary hypertension during the perioperative period of cardiac surgery: a post-marketing study of 2817 patients in Japan.
Gen Thorac Cardiovasc Surg. 2023 Sep 15. doi: 10.1007/s11748-023-01971.
Abstract

GHAREPAPAGH E, Rahimi F, Koohi A, Bakhshandeh H, et al
Clot Burden As a Predictor of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism: A Cohort Study.
Thorac Res Pract. 2023;24:276-281.
Abstract

HUANG Z, Cheng X, Lin B, Zhao J, et al
Diameter of ductus arteriosus on postnatal Day 7 is associated with late pulmonary hypertension in extremely preterm infants.
Pediatr Pulmonol. 2023 Sep 15. doi: 10.1002/ppul.26686.
Abstract

KRISHNAN M, Desjardin JT, Vaidya A, DE Marco T, et al
Reproductive Care in Pulmonary Arterial Hypertension.
J Card Fail. 2023;29:1314-1318.
Abstract

HUMBERT M, Sitbon O, Guignabert C, Savale L, et al
Treatment of pulmonary arterial hypertension: recent progress and a look to the future.
Lancet Respir Med. 2023;11:804-819.
Abstract

KITTIPIBUL V, Agarwal R
The Many Sides of Right Heart Dysfunction: Exploring Exercise Markers in Heart Failure with Preserved Ejection Fraction versus Pulmonary Arterial Hypertension.
J Card Fail. 2023 Jun 22:S1071-9164(23)00225.
Abstract

WU Y, Tian P, Liang L, Chen Y, et al
Combined use of right ventricular coupling and pulmonary arterial elastance as a comprehensive stratification approach for right ventricular function.
Clin Transl Sci. 2023;16:1582-1593.
Abstract

AROOR S, Handattu K, Mundkur SC, Verma A, et al
Severe Pulmonary Arterial Hypertension in Healthy Young Infants: Single Center Experience.
Indian Pediatr. 2023;60:748-751.
Abstract

ISHISAKA Y, Watanabe A, Takagi H, Takayama H, et al
Use of Perioperative Extracorporeal Membranous Oxygenation in Pulmonary Endarterectomy Cases: A Systematic Review and Meta-Analysis.
J Intensive Care Med. 2023;38:785-796.
Abstract

OKA H, Sumitomo S, Shimizu H, Kanamori M, et al
Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy.
Intern Med. 2023;62:2747-2751.
Abstract

BEHROOZ L, Barillas-Lara M, Fattouh M, Loubeau B, et al
The role of invasive cardiopulmonary exercise testing in patients with unexplained dyspnea: a systemic review.
Acta Cardiol. 2023;78:754-760.
Abstract

NAKAZATO K, Sugimoto K, Oikawa M, Takeishi Y, et al
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension:its history and development, and regional medical cooperation in Fukushima.
Fukushima J Med Sci. 2023 Sep 28. doi: 10.5387/fms.2023.
Abstract

VELIDAKIS N, Khattab E, Gkougkoudi E, Kadoglou NPE, et al
Pulmonary Hypertension in Left Ventricular Valvular Diseases: A Comprehensive Review on Pathophysiology and Prognostic Value.
Life (Basel). 2023;13:1793.
Abstract

GOSS KN
Preterm birth: An important risk factor for pulmonary hypertension.
Paediatr Perinat Epidemiol. 2023;37:641-642.
Abstract

ZHENG R, Xu T, Wang X, Yang L, et al
Stem cell therapy in pulmonary hypertension: current practice and future opportunities.
Eur Respir Rev. 2023;32:230112.
Abstract

KAW RK
Unrecognized Pulmonary Hypertension in Non-Cardiac Surgical Patients: At-Risk Populations, Preoperative Evaluation, Intraoperative Management and Postoperative Complications.
J Cardiovasc Dev Dis. 2023;10:403.
Abstract

TOPYLA-PUTOWSKA W, Tomaszewski M, Wojtkowska A, Styczen A, et al
Tricuspid Regurgitation Velocity/Tricuspid Annular Plane Systolic Excursion (TRV/TAPSE) Ratio as a Novel Indicator of Disease Severity and Prognosis in Patients with Precapillary Pulmonary Hypertension.
Diseases. 2023;11:117.
Abstract

SULLIVAN RD, Shults NV, Suzuki YJ
Case Report: Two Case Reports of Pulmonary Hypertension after mRNA COVID-19 Vaccination.
Diseases. 2023;11:114.
Abstract

MULLER J, Mayer L, Schneider SR, Titz A, et al
Pulmonary arterial wedge pressure increase during exercise in patients diagnosed with pulmonary arterial or chronic thromboembolic pulmonary hypertension.
ERJ Open Res. 2023;9:00379-2023.
Abstract

JIANG Y, Song S, Liu J, Zhang L, et al
Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension.
Front Immunol. 2023;14:1206452.
Abstract

GUIMARAES-ERVILHA LO, Soares LL, Bento IDSP, Carvalho RPR, et al
Effect of Induced Pulmonary Arterial Hypertension on Testicular Parameters of Wistar Rats Subjected to Resistance Exercise Training.
Microsc Microanal. 2023;29:635-648.
Abstract

XU Y, Zhang Y, Zhang J, Liang W, et al
High driving pressure ventilation induces pulmonary hypertension in a rabbit model of acute lung injury.
J Intensive Care. 2023;11:42.
Abstract

BILLINGS C, Reinero C, Masseau I, Bryant J, et al
Hyperthyroid cats have altered pulmonary arterial hemodynamics but rarely have intermediate or high probability of pulmonary hypertension.
Am J Vet Res. 2023 Sep 26:1-7. doi: 10.2460/ajvr.23.07.0172.
Abstract

FARINA S, Pezzuto B, Vignati C, Laveneziana P, et al
Intrapulmonary distribution of blood flow during exercise in pulmonary hypertension assessed by a new combination technique.
Front Cardiovasc Med. 2023;10:1241379.
Abstract

LEMMERS JM, van Caam AP, Kersten B, van den Ende CH, et al
Nailfold capillaroscopy and candidate-biomarker levels in systemic sclerosis-associated pulmonary hypertension: A cross-sectional study.
J Scleroderma Relat Disord. 2023;8:221-230.
Abstract

BRITO J
New insights into chronic thromboembolic pulmonary hypertension.
Rev Port Cardiol. 2023 Sep 22:S0870-2551(23)00424.
Abstract

D'ADDARIO CA, Matsumura S, Kitagawa A, Lainer GM, et al
Global and endothelial G-protein coupled receptor 75 (GPR75) knockout relaxes pulmonary artery and mitigates hypoxia-induced pulmonary hypertension.
Vascul Pharmacol. 2023;153:107235.
Abstract

XIA Y, Zhang Y, Huang J, Chen B, et al
N6-Methyladenosine Modifications in Pulmonary Hypertension.
Pharmacology. 2023 Sep 22:1-7. doi: 10.1159/000533588.
Abstract

JIANG T, Wang Q, Zhang Z, Qi J, et al
Value of the neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease complicated with pulmonary hypertension.
J Int Med Res. 2023;51:3000605231200266.
Abstract

WANG S, Yan Y, Zhang J, Yuan P, et al
Comparing the efficacy and safety of low, medium, and high dosages of selexipag for treating pulmonary hypertension: A systematic review and meta-analysis.
Animal Model Exp Med. 2023 Sep 23. doi: 10.1002/ame2.12347.
Abstract

VARDHAN A, Singh D, Tripathi S, Kumar M, et al
Congenital myopathy presenting as recurrent pneumonia with lung collapse and pulmonary artery hypertension.
BMJ Case Rep. 2023;16:e255502.
Abstract

FURUKAWA Y, Cao Y, Ikarashi J, Tachibana T, et al
[Left Main Trunk Orifice Reconstruction Using Aortic flap and Autologous Pulmonary Arterial Patch for Severe Left Main Trunk Stenosis After Arterial Switch Operation].
Kyobu Geka. 2023;76:681-684.
Abstract

YM SC, Choo KS, Nam KJ, Lee K, et al
Clinical characteristics of tetralogy of Fallot with left pulmonary artery acute angulation on computed tomography.
Heart Vessels. 2023;38:1380-1385.
Abstract

VITARELLI A, Miraldi F, Capotosto L, Galea N, et al
Comprehensive echocardiographic assessment of right ventricular function, pulmonary arterial elastic properties and ventricular-vascular coupling in adult patients with repaired tetralogy of fallot: clinical significance of 3D derived indices.
Int J Cardiovasc Imaging. 2023;39:1631-1641.
Abstract

KIDO K, Fang W, Broscious R, Colvin BM, et al
Evaluation of a pharmacist-provider collaborative clinic for treatment of iron deficiency in patients with heart failure.
Am J Health Syst Pharm. 2023;80:1326-1335.
Abstract

AVITABILE CM, Flohr S, Mathew L, Wang Y, et al
Quantitative Measures of Right Ventricular Size and Function by Echocardiogram Correlate with Cardiac Catheterization Hemodynamics in Congenital Diaphragmatic Hernia.
J Pediatr. 2023 Jun 15:113564. doi: 10.1016/j.jpeds.2023.113564.
Abstract

SUGIYAMA K, Matsuyama K, Ogino H
Redo mitral valve replacement in an adult with severe pulmonary hypertension resulting from structural valve deterioration and left ventricular outflow tract obstruction and a history of atrioventricular septal defect repair: a case report.
J Cardiothorac Surg. 2023;18:270.
Abstract

SUGINOBE H, Ishida H, Ishii Y, Ueda K, et al
Isogenic pairs of induced-pluripotent stem-derived endothelial cells identify DYRK1A/PPARG/EGR1 pathway is responsible for Down syndrome-associated pulmonary hypertension.
Hum Mol Genet. 2023 Oct 4:ddad162. doi: 10.1093.
Abstract

KUDRYASHOVA TV, Zaitsev S, Jiang L, Buckley BJ, et al
PAI-1 Deficiency Drives Pulmonary Vascular Smooth Muscle Remodeling and Pulmonary Hypertension.
bioRxiv. 2023 Sep 22:2023.09.21.558893. doi: 10.1101/2023.09.21.558893.
Abstract

AHMAD A, Zhang P, Li L, Wang X, et al
Editorial: Advances in understanding the mechanisms of pulmonary hypertension.
Front Cardiovasc Med. 2023;10:1249889.
Abstract

MENDOZA ZAMBRANO EM, Gomez Rodriguez B, Garcia Lunar I, Pereda Arnau D, et al
Microvesicles and inflammatory markers in an animal model of chronic postcapillary pulmonary hypertension.
Int J Med Sci. 2023;20:1336-1338.
Abstract

EL-SAIE A, Varghese NP, Webb MK, Villafranco N, et al
Bronchopulmonary dysplasia - Associated pulmonary hypertension: An updated review.
Semin Perinatol. 2023 Sep 9:151817. doi: 10.1016/j.semperi.2023.151817.
Abstract

CHHABRIA MS, Boppana LKT, Manek G, Tonelli AR, et al
Portopulmonary hypertension: A focused review for the internist.
Cleve Clin J Med. 2023;90:632-639.
Abstract

TANGMAHAKUL N, Orton EC, Surachetpong SD
Investigation of red blood cell and platelet indices in adult dogs suffered from myxomatous mitral valve disease with and without pulmonary hypertension.
Front Vet Sci. 2023;10:1234768.
Abstract

LIU Q, Hu Y, Chen W, Yao T, et al
Evaluation of right ventricular longitudinal strain in pediatric patients with pulmonary hypertension by two-dimensional speckle-tracking echocardiography.
Front Pediatr. 2023;11:1189373.
Abstract

LU W, Xu J, Chen Y, Huang J, et al
Identication and validation of cell senescence biomarkers in idiopathic pulmonary hypertension via integrated transcriptome analyses and machine learning.
Exp Gerontol. 2023;182:112303.
Abstract

SATOH T, Yaoita N, Nochioka K, Tatebe S, et al
Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left-sided heart diseases.
ESC Heart Fail. 2023 Sep 29. doi: 10.1002/ehf2.14515.
Abstract

GOHIR Q, Ghosh S, Bosher O, Crawford E, et al
Pleural-based giant solitary fibrous tumour with associated hypoglycaemia: unusual presentation with pulmonary hypertension in a patient with Doege-Potter syndrome.
Clin Med (Lond). 2023;23:518-520.
Abstract

VIRSINSKAITE R, Karia N, Kotecha T, Schreiber BE, et al
Pulmonary hypertension - the latest updates for physicians.
Clin Med (Lond). 2023;23:449-454.
Abstract

ENGEL SALLBERG A, Helleberg S, Ahmed S, Ahmed A, et al
Plasma tumour necrosis factor-alpha-related proteins in prognosis of heart failure with pulmonary hypertension.
ESC Heart Fail. 2023 Sep 29. doi: 10.1002/ehf2.14507.
Abstract

WANG MT, Chi PL, Cheng CC, Huang WC, et al
Application of homocysteine as a non-invasive and effort-free measurements for risk assessment of patients with pulmonary hypertension.
Cardiol J. 2023 Sep 29. doi: 10.5603/cj.92813.
Abstract

KUNDAVARAM R, Kumar P, Malik S, Bhatt G, et al
Impact of Asthma Phenotypes on Myocardial Performance and Pulmonary Hypertension in Children and Adolescents With Moderate to Severe Persistent Asthma.
Cureus. 2023;15:e44252.
Abstract

RAHMIANTI ND, Dinarti LK, Mumpuni H, Triastuti F, et al
Global Longitudinal Strain Right Ventricle (GLS RV) as a Predictor for Mean Pulmonary Artery Pressure (MPAP) on Secundum Atrial Septal Defect (ASD) with Pulmonary Hypertension.
J Cardiovasc Echogr. 2023;33:83-87.
Abstract

PUSIANAWATI D, Suryawan AZ, Tjandraprawira KD, Cool CJ, et al
Dilemmas in pregnancies with pulmonary hypertension: Case report from a low-resource setting.
SAGE Open Med Case Rep. 2023;11:2050313X231201737.
Abstract

CHINAWA JM, Arodiwe I, Onyia JT, Chinawa AT, et al
Eisenmenger Syndrome: A Revisit of a Hidden but Catastrophic Disease.
West Afr J Med. 2023;40:973-981.
Abstract

WEI Y, Zhao H, Kalionis B, Huai X, et al
The Impact of Abnormal Lipid Metabolism on the Occurrence Risk of Idiopathic Pulmonary Arterial Hypertension.
Int J Mol Sci. 2023;24:14280.
Abstract

FRAGA MV, Dysart KC, Stoller JZ, Huber M, et al
Echocardiographic Assessment of Pulmonary Arterial Hypertension Following Inhaled Nitric Oxide in Infants with Severe Bronchopulmonary Dysplasia.
Neonatology. 2023 Aug 11:1-9. doi: 10.1159/000531586.
Abstract

YANG F, Chen R, Yang Z, Yang Y, et al
Predictive value of reduced pulmonary arterial elasticity in acute pulmonary embolism for right ventricular dysfunction.
J Thromb Thrombolysis. 2023;56:529-537.
Abstract

ZHAO HL, Tang ZW, Zheng SQ, Chen JQ, et al
Prognostic Implication of Pulmonary Arterial Pressure in Surgical Repair of Predominantly Congenital Mitral Valve Regurgitation-Based Intracardiac Abnormalities.
Cardiology. 2023;148:448-456.
Abstract

DEL POZO R, Cruz-Utrilla A, Escribano-Subias P
Prognostic Stratification and Treatment for Pulmonary Arterial Hypertension. Gaps and Promising Remedies.
Arch Bronconeumol. 2023;59:617-618.
Abstract

HINOJOSA W, Cruz-Utrilla A, Jimenez Lopez-Guarch C, Velazquez-Martin M, et al
Outcome of moderate-severe tricuspid regurgitation after pulmonary endarterectomy or balloon pulmonary angioplasty.
Rev Esp Cardiol (Engl Ed). 2023;76:774-782.
Abstract

CHAIGNE B, Chevalier K, Boucly A, Agard C, et al
In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre study.
Rheumatology (Oxford). 2023;62:3261-3267.
Abstract

HAYNES ZA, Chandel A, King CS
Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics.
Cells. 2023;12:2394.
Abstract

TSIKIS ST, Klouda T, Hirsch TI, Fligor SC, et al
A pneumonectomy model to study flow-induced pulmonary hypertension and compensatory lung growth.
Cell Rep Methods. 2023 Oct 4:100613. doi: 10.1016/j.crmeth.2023.100613.
Abstract

LACHARIE M, Villa A, Milidonis X, Hasaneen H, et al
Role of pulmonary perfusion magnetic resonance imaging for the diagnosis of pulmonary hypertension: A review.
World J Radiol. 2023;15:256-273.
Abstract

LIN J, Lin S, Zhang Y, Liu W, et al
Identification of Ferroptosis-related potential biomarkers and immunocyte characteristics in Chronic Thromboembolic Pulmonary Hypertension via bioinformatics analysis.
BMC Cardiovasc Disord. 2023;23:504.
Abstract

KONG S, Yu J, Li HF, Xie YL, et al
A ring N(CH(3))(2)-based derivative of resveratrol inhibits pulmonary vascular remodeling in hypoxia pulmonary hypertension.
Eur J Pharmacol. 2023 Oct 9:176077. doi: 10.1016/j.ejphar.2023.176077.
Abstract

MOSEICHUK KA, Filippov EV
Features of the Diagnosis of Pulmonary Hypertension in Outpatient Practice.
Kardiologiia. 2023;63:63-71.
Abstract

SALLMON H, Urlesberger B, Koestenberger M
Echocardiographic Mid-systolic Pulmonary Valve Notching in Extremely Low Gestational Age Neonates (ELGANs) with Severe Pulmonary Hypertension.
Pediatr Cardiol. 2023 Oct 9. doi: 10.1007/s00246-023-03317.
Abstract

DARIE AM
Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension - Holy Grail or Holy Trinity?
Int J Cardiol. 2023 Oct 7:131423. doi: 10.1016/j.ijcard.2023.131423.
Abstract

LI M
The role of vitamin D in chronic obstructive pulmonary disease with pulmonary hypertension.
Pulm Circ. 2023;13:e12294.
Abstract

CHEN G, Orozco L, Parmisano S, Jahng JWS, et al
Generation of two induced pluripotent stem cell lines from patients suffering from pulmonary hypertension.
Stem Cell Res. 2023;72:103218.
Abstract

HARADA M, Yamada A, Nagasawa S, Yamashita N, et al
BMPR2 variant may be related to pulmonary hypertension after lung irradiation.
Pediatr Int. 2023;65:e15652.
Abstract

DAI SZ, Li SS, Zhou MY, Xu Y, et al
[Assessment of risk factors for bronchopulmonary dysplasia with pulmonary hypertension and construction of a prediction nomogram model].
Zhonghua Er Ke Za Zhi. 2023;61:902-909.
Abstract

COOL CJ, Kamarullah W, Pranata R, Putra ICS, et al
A meta-analysis of atrial septal defect closure in patients with severe pulmonary hypertension: is there a room for poking holes amidst debate?
Curr Probl Cardiol. 2023 Oct 4:102121. doi: 10.1016/j.cpcardiol.2023.102121.
Abstract

MURRAY-TORRES RM, Chilson K, Sharma A
Anesthetic management of children with medically refractory pulmonary hypertension undergoing surgical Potts shunt.
Paediatr Anaesth. 2023 Oct 6. doi: 10.1111/pan.14764.
Abstract

LIU Y, Cheng Z, Zha B, Chen X, et al
Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis.
Lupus. 2023;32:1310-1319.
Abstract

MUSAYEV O, Kayikcioglu M, Shahbazova S, Nalbantgil S, et al
Could Heart Rate Variability Serve as a Prognostic Factor in Patients with Pulmonary Hypertension? A Single-center Pilot Study.
Turk Kardiyol Dern Ars. 2023;51:454-463.
Abstract

SINAN UY, Engin K, Kucukoglu MS
The Impact of the New Hemodynamic Definition on the Prevalence of Pre-Capillary Pulmonary Hypertension.
Turk Kardiyol Dern Ars. 2023;51:486-487.
Abstract

MERIC M, Cagliyan CE, Eker Akilli R, Kilickiran Avci B, et al
Six-Minute Walk Test: How to do Guide for Performing a Reliable Test, Interpretation, and Prognostication in Pulmonary Hypertension.
Turk Kardiyol Dern Ars. 2023;51:516-520.
Abstract

COLAK A, Kumral Z, Kis M, Senturk B, et al
The Usefulness of the TAPSE/sPAP Ratio for Predicting Survival in Medically Treated Chronic Thromboembolic Pulmonary Hypertension.
Turk Kardiyol Dern Ars. 2023;51:470-477.
Abstract

BASARICI I, Onac M
Unusual Case of Pulmonary Hypertension due to Acquired Arteriovenous Fistula.
Turk Kardiyol Dern Ars. 2023;51:512-515.
Abstract

ASLANGER E, Akaslan D, Kaya H, Nizam AC, et al
Evaluation of Pulmonary Hypertension with Exercise Right Heart Catheterization in an Adult Patient with Cor Triatriatum Sinister.
Turk Kardiyol Dern Ars. 2023;51:502-506.
Abstract

TOKGOZ HC, Tanyeri S, Sekban A, Hakgor A, et al
Hoarseness as a Predictor for Pulmonary Arterial Aneurysm and Extrinsic Left Main Coronary Artery Compression in Patients with Severe Pulmonary Hypertension.
Turk Kardiyol Dern Ars. 2023;51:447-453.
Abstract

ARABACI HO, Tasdelen AG, Bugday I, Ulkucu A, et al
A Breathtaking Case of Pulmonary Hypertension with Frightening Complications and Intertwining Different Etiologies.
Turk Kardiyol Dern Ars. 2023;51:488-492.
Abstract

KILICKIRAN AVCI B, Soysal AU, Cerme E, Kargin OA, et al
Pulmonary Hypertension Due to High-Output Heart Failure: Hereditary Hemorrhagic Telangiectasia.
Turk Kardiyol Dern Ars. 2023;51:493-497.
Abstract

AKASLAN D, Aslanger E, Basa CI, Ozturk RK, et al
Bendopnea Predicts Right Ventricular Energy Failure in Patients with Pulmonary Hypertension.
Turk Kardiyol Dern Ars. 2023;51:440-446.
Abstract

BORHANI A, Porter KK, Umair M, Chu LC, et al
Quantifying 4D flow cardiovascular magnetic resonance vortices in patients with pulmonary hypertension: A pilot study.
Pulm Circ. 2023;13:e12298.
Abstract

ZHANG Z, Wang D, Zuo W, Wang X, et al
COVID-19 vaccination for children with pulmonary hypertension: efficacy, safety and reasons for opting against vaccination.
Front Pediatr. 2023;11:1259753.
Abstract

CUETO-ROBLEDO G, Gonzalez-Hermosillo LM, Porres-Aguilar M, Navarro-Vergara DI, et al
Complications of right heart catheterization in patients >/= 70 years of age with suspected pulmonary hypertension: Experience from a tertiary care center.
Curr Probl Cardiol. 2023 Oct 17:102136. doi: 10.1016/j.cpcardiol.2023.102136.
Abstract

ROSENZWEIG E, Villeda GAV, Crook S, Koli F, et al
Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study.
Tex Heart Inst J. 2023;50:e227866.
Abstract

KARPOV AA, Mihailova AM, Cherepanov DE, Chefu SG, et al
The Use of Microencapsulated Autologous Thrombi for Modelling Chronic Thromboembolic Pulmonary Hypertension in Rats.
Bull Exp Biol Med. 2023 Oct 19. doi: 10.1007/s10517-023-05912.
Abstract

PAKHOMOV NV, Kostyunina DS, Macori G, Dillon E, et al
High-Soluble-Fiber Diet Attenuates Hypoxia-Induced Vascular Remodeling and the Development of Hypoxic Pulmonary Hypertension.
Hypertension. 2023;80:2372-2385.
Abstract

AEBERHARD J, Lichtblau M, Arenja N
An unexpected cause of pulmonary hypertension in a young woman: a case report.
Eur Heart J Case Rep. 2023;7:ytad474.
Abstract

KOHANZADEH A, Wajsberg B, Yakubova E, Kravitz MB, et al
Association and risk factors of pediatric pulmonary hypertension with obstructive sleep apnea: A national study utilizing the Kids' Inpatient Database (KID).
Int J Pediatr Otorhinolaryngol. 2023;175:111750.
Abstract

TASKAR V
Chronic thromboembolic pulmonary hypertension - Time is of the essence.
J Postgrad Med. 2023 Oct 16. doi: 10.4103.
Abstract

TOKGOZ HC, Ocal BE, Erkus YC, Tanyeri S, et al
Remembering the Occam's Razor: Could Simple Electrocardiographic Findings Provide Relevant Predictions for Current Hemodynamic Criteria of Pulmonary Hypertension?
Anatol J Cardiol. 2023 Oct 16. doi: 10.14744/AnatolJCardiol.2023.3181.
Abstract

GAYEN SK, Baughman RP, Nathan SD, Wells AU, et al
Pulmonary hemodynamics and transplant-free survival in sarcoidosis-associated pulmonary hypertension: Results from an international registry.
Pulm Circ. 2023;13:e12297.
Abstract

ISHISAKA Y, Watanabe A, Takagi H, Steiger D, et al
Anticoagulation in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
Thromb Res. 2023;231:91-98.
Abstract

KACPRZAK A, Tomkowski W, Szturmowicz M
Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension-A Challenging Mystery.
Diagnostics (Basel). 2023;13:3132.
Abstract

AETOU M, Wahab L, Dreher M, Daher A, et al
Significance of Hypocapnia in the Risk Assessment of Patients with Pulmonary Hypertension.
J Clin Med. 2023;12:6307.
Abstract

FERRARO A, Hartnack S, Schwarzwald CC
Diagnostic value of two-dimensional echocardiographic measurements of the pulmonary artery diameter and the pulmonary artery distensibility index to detect pulmonary hypertension in horses.
J Vet Cardiol. 2023;49:52-66.
Abstract

KALAMARA TV, Dodos K, Vlachaki E
Splenectomy is significantly associated with thrombosis but not with pulmonary hypertension in patients with transfusion-dependent thalassemia: a meta-analysis of observational studies.
Front Med (Lausanne). 2023;10:1259785.
Abstract

LI C, Lv J, Wumaier G, Zhao Y, et al
NDRG1 promotes endothelial dysfunction and hypoxia-induced pulmonary hypertension by targeting TAF15.
Precis Clin Med. 2023;6:pbad024.
Abstract

WANG ZF, Su LL, Li S, Li HZ, et al
Evaluation of right heart function changes in patients with pulmonary hypertension via two-dimensional speckle tracking imaging: a retrospective study.
Ann Med. 2023;55:2272711.
Abstract

LEY L, Grimminger F, Richter M, Tello K, et al
The Early Detection of Pulmonary Hypertension.
Dtsch Arztebl Int. 2023;.
Abstract

ALQARNI AA, Aldhahir AM, Alghamdi SA, Alqahtani JS, et al
Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD.
Front Med (Lausanne). 2023;10:1275684.
Abstract

LU G, Du R, Liu Y, Zhang S, et al
RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension.
Vasc Health Risk Manag. 2023;19:673-688.
Abstract

RADCHENKO G, Sirenko Y
When Pulmonary Arterial Hypertension may be Associated with Portal Hypertension: A Case Report of Two Different Hepatic Disorders in One Patient with Pulmonary Hypertension.
Curr Cardiol Rev. 2023 Oct 20. doi: 10.2174/011573403X267162231011154808.
Abstract

HU S, Zhang Y, Qiu C, Li Y, et al
RGS10 inhibits proliferation and migration of pulmonary arterial smooth muscle cell in pulmonary hypertension via AKT/mTORC1 signaling.
Clin Exp Hypertens. 2023;45:2271186.
Abstract

TEIXEIRA-FONSECA JL, Joviano-Santos JV, Machado FS, Silva PLD, et al
Isolated Left Atrium Morphofunctional Study of an Experimental Pulmonary Hypertension Model in Rats.
Arq Bras Cardiol. 2023;120:e20230188.
Abstract

ISEPPI M, Savonitto G, Tommasini A, Pin A, et al
A very rare cause of pre-capillary pulmonary hypertension: The PAMI syndrome.
Pulm Circ. 2023;13:e12300.
Abstract

PARK JM, Seo YS, Kim SH, Kim HY, et al
Impact of inhalation exposure to cigarette smoke on the pathogenesis of pulmonary hypertension primed by monocrotaline in rats.
J Appl Toxicol. 2023 Oct 24. doi: 10.1002/jat.4555.
Abstract

MAHFOUD F, Gotzinger F
Pulmonary artery denervation - the suspense continues?
EuroIntervention. 2023;19:623-624.
Abstract

LIU A, Xu W, Xi L, Deng M, et al
Cardiovascular metrics on CT pulmonary angiography in patients with pulmonary hypertension - re-evaluation under the updated guidelines of pulmonary hypertension.
Insights Imaging. 2023;14:179.
Abstract

LONGEVITY OMAC
Retracted: S-Nitroso-L-Cysteine Ameliorated Pulmonary Hypertension in the MCT-Induced Rats through Anti-ROS and Anti-Inflammatory Pathways.
Oxid Med Cell Longev. 2023;2023:9781259.
Abstract

MATHAVAN A, Mathavan A, Reddy R, Jones K, et al
Pulmonary hypertension in hereditary hemorrhagic telangiectasia: A clinical review.
Pulm Circ. 2023;13:e12301.
Abstract

SHEHZAD I, Banker A, Das B, Humayun A, et al
Successful Weaning From Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) After Initiation of Inhaled Epoprostenol in a Neonate With Refractory Persistent Pulmonary Hypertension of the Newborn (PPHN).
Cureus. 2023;15:e45595.
Abstract

GALLO A, Agnese V, Sciacca S, Scardulla C, et al
MicroRNA-30d and -483-3p for bi-ventricular remodelling and miR-126-3p for pulmonary hypertension in advanced heart failure.
ESC Heart Fail. 2023 Oct 21. doi: 10.1002/ehf2.14546.
Abstract

FANG H, Wang J, Shi R, Li Y, et al
Biventricular Dysfunction and Ventricular Interdependence in Patients With Pulmonary Hypertension: A 3.0-T Cardiac MRI Feature Tracking Study.
J Magn Reson Imaging. 2023 Oct 21. doi: 10.1002/jmri.29044.
Abstract

YAGMUR B, Kayikcioglu M, Simsek E, Nalbantgil S, et al
Long-Term Natural Course of Patients with Pulmonary Artery Pressures in the Range of 21-24 mmHg: Insights from a Single-Center Study.
Turk Kardiyol Dern Ars. 2023;51:478-485.
Abstract

CENGIZ ELCIOGLU B, Gursoy E, Helvaci F, Tefik N, et al
The Relationship of Systolic Pulmonary Artery Pressure with Perioperative Mortality and Morbidity in Patients Undergoing Non-Cardiac Surgery: A Single-Center Experience.
Turk Kardiyol Dern Ars. 2023;51:464-469.
Abstract

COLAK A, Kumral Z, Ozpelit E, Akdeniz B, et al
Heritable Pulmonary Arterial Hypertension Diagnosed during the Postpartum Period: A Case Report and Literature Review.
Turk Kardiyol Dern Ars. 2023;51:498-501.
Abstract

SERENY D, Ulrich S, Berlier C
[Vaskulare Dyspnoe: Pulmonale Hypertonie].
Ther Umsch. 2023;80:272-278.
Abstract

KRAMER T, Hoenemann JN, Weis H, Hoffmann F, et al
Electrocardiographic changes during sustained normobaric hypoxia in patients after myocardial infarction.
Sci Rep. 2023;13:17452.
Abstract

KAKALETSIS S, Malinowski M, Snider JC, Mathur M, et al
Untangling the mechanisms of pulmonary arterial hypertension-induced right ventricular stiffening in a large animal model.
Acta Biomater. 2023;171:155-165.
Abstract

TOMASZEWSKI M, Mertowska P, Janczewska M, Styczen A, et al
In the Search for Biomarkers of Pulmonary Arterial Hypertension, Are Cytokines IL-2, IL-4, IL-6, IL-10, and IFN-Gamma the Right Indicators to Use?
Int J Mol Sci. 2023;24:13694.
Abstract

HESAR ME, Seyedsadrkhani NS, Khan D, Naghashian A, et al
AI-enabled epidermal electronic system to automatically monitor a prognostic parameter for hypertension with a smartphone.
Biosens Bioelectron. 2023;241:115693.
Abstract

ZHONG Y, Yu PB
Angiogenesis Redux: An Overall Protective Role of VEGF/KDR Signaling in the Microvasculature in Pulmonary Arterial Hypertension.
Arterioscler Thromb Vasc Biol. 2023;43:1784-1787.
Abstract

RISCHARD FP, Bernardo RJ, Vanderpool RR, Kwon DH, et al
Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension.
Circ Heart Fail. 2023 Sep 4:e010555. doi: 10.1161/CIRCHEARTFAILURE.123.010555.
Abstract

WITS M, Becher C, de Man F, Sanchez-Duffhues G, et al
Sex-biased TGFbeta signalling in pulmonary arterial hypertension.
Cardiovasc Res. 2023;119:2262-2277.
Abstract

GOTO K
Vascular smooth muscle TRPV4 channel: a promising therapeutic target for salt-induced hypertension?
Hypertens Res. 2023;46:2409-2411.
Abstract

HELLER S, See C, Singh I, Fredericks CA, et al
Cognitive impairment in pulmonary arterial hypertension.
Ann Clin Transl Neurol. 2023;10:1899-1903.
Abstract

GALAMBOS C, Logan JW, Stankiewicz P, Szafranski P, et al
Histologic features and decreased lung FOXF1 gene expression in severe bronchopulmonary dysplasia without a genetic diagnosis of alveolar capillary dysplasia.
Pediatr Pulmonol. 2023;58:2746-2749.
Abstract

HOEPER MM
Surrogate endpoints in pulmonary arterial hypertension trials.
Lancet Respir Med. 2023;11:852-853.
Abstract

PAMMI M, Kelagere Y, Koh S, Sisson A, et al
Prognostic value of echocardiographic parameters in congenital diaphragmatic hernia: a systematic review and meta-analysis.
Arch Dis Child Fetal Neonatal Ed. 2023;108:631-637.
Abstract

O'CALLAGHAN B, Zablah JE, Weinman JP, Englund EK, et al
Computed tomographic parenchymal lung findings in premature infants with pulmonary vein stenosis.
Pediatr Radiol. 2023 Apr 28. doi: 10.1007/s00247-023-05673.
Abstract

LANGE TJ
Refined risk stratification, current treatment, and new therapeutic approaches in pulmonary arterial hypertension.
Herz. 2023;48:259-265.
Abstract

ZHANG N, Liu S, Zhang Z, Liu Y, et al
Lung Transplantation: A Viable Option for Connective Tissue Disease?
Arthritis Care Res (Hoboken). 2023;75:2389-2398.
Abstract

LUIJTEN D, de Jong CMM, Ninaber MK, Spruit MA, et al
Post-Pulmonary Embolism Syndrome and Functional Outcomes after Acute Pulmonary Embolism.
Semin Thromb Hemost. 2023;49:848-860.
Abstract

SEGOVIA F, Garcia H, Alkhateeb H, Mukherjee D, et al
Updates in the Pharmacotherapy of Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction.
Cardiovasc Hematol Disord Drug Targets. 2023.
Abstract

GUARINO D, Ballerini A, Manes A
What changed after the 2022 guidelines for pulmonary hypertension?
Eur J Intern Med. 2023 Oct 31:S0953-6205(23)00384.
Abstract

CHEN S, Lin S, Liu W, Lin Q, et al
Serum Metabolomic Profile in Hypoxia-Induced Pulmonary Hypertension Mice after C75 Treatment.
Front Biosci (Landmark Ed). 2023;28:251.
Abstract

HELD M, Wilkens H
[Pulmonary hypertension - The new ESC guideline].
Dtsch Med Wochenschr. 2023;148:1448-1455.
Abstract

CHEN YX, Deng ZH, Xue-Gao, Qiang-Du, et al
Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway.
Biomed Pharmacother. 2023;168:115816.
Abstract

ROTHMAN A, Restrepo H, Evans WN, Sarukhanov V, et al
CAR Selectively Enhances the Pulmonary Vasodilatory Effect of Fasudil in a Microsphere Model of Pulmonary Hypertension.
Open Respir Med J. 2023;17:e187430642303160.
Abstract

COLLACO JM, Abman SH, Austin ED, Avitabile CM, et al
Kids Mod PAH trial: A multicenter trial comparing mono- versus duo-therapy for initial treatment of pediatric pulmonary hypertension.
Pulm Circ. 2023;13:e12305.
Abstract

ZENG C, Liu J, Zheng X, Hu X, et al
Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.
Respir Res. 2023;24:263.
Abstract

MARCHIORI E, Hochhegger B, Zanetti G
Pulmonary hypertension.
J Bras Pneumol. 2023;49:e20230275.
Abstract

EROL C
Machine Learning, Pulmonary Hypertension....
Anatol J Cardiol. 2023;27:615.
Abstract

RAJARATNAM A, El-Swais A, McTiernan C, Thoma FW, et al
Persistence of pulmonary hypertension in patients undergoing ventricular assist devices and orthotopic heart transplantation.
Pulm Circ. 2023;13:e12296.
Abstract

MARINHO Y, Villarreal ES, Aboagye SY, Williams DL, et al
Schistosomiasis-associated pulmonary hypertension unveils disrupted murine gut-lung microbiome and reduced endoprotective Caveolin-1/BMPR2 expression.
Front Immunol. 2023;14:1254762.
Abstract

JOHNG S, Fraga MV, Patel N, Kipfmueller F, et al
Unique Cardiopulmonary Interactions in Congenital Diaphragmatic Hernia: Physiology and Therapeutic Implications.
Neoreviews. 2023;24:e720-e732.
Abstract

TOJAGA N, Egholm G, Lund Hansen D
Clinical challenges in the treatment of a patient with decompensated heart failure and glucose-6-phosphate dehydrogenase deficiency (G6PDd).
BMJ Case Rep. 2023;16:e255722.
Abstract

SANDEEP B, Li H, Huang X, Xiao Z, et al
An editorial regarding the article 'A meta-analysis of atrial septal defect closure in patients with severe pulmonary hypertension: is there a room for poking holes amidst debate?'.
Curr Probl Cardiol. 2023 Oct 29:102172. doi: 10.1016/j.cpcardiol.2023.102172.
Abstract

CADOUR F, Sourdon J, Rapacchi S
Editorial for "Biventricular Dysfunction and Ventricular Interdependence in Patients With Pulmonary Hypertension: A 3.0-T Cardiac MRI Feature Tracking Study".
J Magn Reson Imaging. 2023 Oct 31. doi: 10.1002/jmri.29092.
Abstract

LANG IM, Delcroix M
Preexisting Chronic Thromboembolic Pulmonary Hypertension in Acute Pulmonary Embolism? A Case Report and Discussion.
Hamostaseologie. 2023 Oct 30. doi: 10.1055/a-2173-7712.
Abstract

BARBERA JA, Humbert M
Monographic Issue on Pulmonary Hypertension.
Semin Respir Crit Care Med. 2023;44:719-720.
Abstract

QIN J, Wang G, Han D
Benefits of Macitentan in Patients with Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Glob Heart. 2023;18:58.
Abstract

TOMASINO M, Soriano Colome T, Sambola Ayala A, Gordon Ramirez B, et al
Acute pulmonary artery dissection in an adult with chronic pulmonary hypertension secondary to congenital heart disease: a case report.
Eur Heart J Case Rep. 2023;7:ytad508.
Abstract

LIU X, Zhou H, Zhang H, Jin H, et al
Advances in the research of sulfur dioxide and pulmonary hypertension.
Front Pharmacol. 2023;14:1282403.
Abstract

YU W, Zhang Q, Qiu Y, Chen H, et al
CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cells.
Clin Exp Hypertens. 2023;45:2272062.
Abstract

ROSE SW, Highland KB, Kelkar AA
Clinical Utility of Patient-Reported Outcome Instruments in the Management of Pulmonary Hypertension: A Systematic Review.
JACC Heart Fail. 2023 Oct 25:S2213-1779(23)00616.
Abstract

ISHIYAMA M, Fujimoto N, Fukuoka S, Omori T, et al
Effects of a Rho-Kinase Inhibitor in Patients With Pulmonary Hypertension Due to Left Heart Disease.
JACC Heart Fail. 2023 Oct 11:S2213-1779(23)00611.
Abstract

GALLEGO-ZAZO N, Miranda-Alcaraz L, Cruz-Utrilla A, Del Cerro Marin MJ, et al
Seven Additional Patients with SOX17 Related Pulmonary Arterial Hypertension and Review of the Literature.
Genes (Basel). 2023;14:1965.
Abstract

GUNAYDIN FE, Belen E, Altin S, Demir AU, et al
Assessment of Knowledge, Attitude, and Practice Patterns in Pulmonary Arterial Hypertension among Cardiologists and Pulmonologists: Evidence from Turkey.
Medicina (Kaunas). 2023;59:1869.
Abstract

GOPALAN D, Riley JYJ, Leong K, Alsanjari S, et al
Computed Tomography Pulmonary Angiography Prediction of Adverse Long-Term Outcomes in Chronic Thromboembolic Pulmonary Hypertension: Correlation with Hemodynamic Measurements Pre- and Post-Pulmonary Endarterectomy.
Tomography. 2023;9:1787-1798.
Abstract

GREDIC M, Hadzic S
Pulmonary Hypertension: Unveiling Molecular Mechanisms, Diagnosis, and Therapeutic Targets.
J Pers Med. 2023;13:1446.
Abstract

REDDY R, Kalra SS, Alzghoul B, Khan A, et al
Effect of Obesity on Mortality in Pulmonary Hypertension-A Systematic Review and Meta-Analysis.
J Cardiovasc Dev Dis. 2023;10:419.
Abstract

KIM JS, Jang JH, Jo DY, Ahn SY, et al
Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea.
J Korean Med Sci. 2023;38:e328.
Abstract

AHMED A, Ahmed S, Radegran G
[Risk stratification in pulmonary arterial hypertension - implementation of an internet-based risk calculator to guide treatment].
Lakartidningen. 2023;120:23075.
Abstract

SZAFRANSKI P, Garimella RP, Mani H, Hartman R, et al
Further refinement of the differentially methylated distant lung-specific FOXF1 enhancer in a neonate with alveolar capillary dysplasia.
Clin Epigenetics. 2023;15:169.
Abstract

XI J, Ma Y, Liu D, Li R, et al
Astragaloside IV restrains pyroptosis and fibrotic development of pulmonary artery smooth muscle cells to ameliorate pulmonary artery hypertension through the PHD2/HIF1alpha signaling pathway.
BMC Pulm Med. 2023;23:386.
Abstract

KAMINSKY DA, Hibbert KA, Luks AM
Review of Pulmonary Physiology.
Semin Respir Crit Care Med. 2023;44:509-510.
Abstract

RAZA F, Chesler NC
Distensibility, an Early Disease Marker of Pulmonary Vascular Health: Ready for Clinical Application.
J Am Heart Assoc. 2023;12:e031605.
Abstract

ELLIOTT J, Menakuru N, Martin KJ, Rahaghi FN, et al
iCPET Calculator: A Web-Based Application to Standardize the Calculation of Alpha Distensibility in Patients With Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2023;12:e029667.
Abstract

ZHANG N, Qiu Q, Chen Y, Sun Z, et al
[Quercetin improves pulmonary arterial hypertension in rats by regulating the HMGB1/RAGE/NF-kappaB pathway].
Nan Fang Yi Ke Da Xue Xue Bao. 2023;43:1606-1612.
Abstract

KOBAK L, Abrahamovych O, Abrahamovych U, Maksymuk A, et al
DIAGNOSTIC VALUE OF LABORATORY MARKERS OF SYNTROPIC LESIONS OF THE CIRCULATORY SYSTEM ORGANS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
Georgian Med News. 2023;.
Abstract

QIAN AM, Cheng R, Gu XY, Yin R, et al
[Treatment of patent ductus arteriosus in very preterm infants in China].
Zhonghua Er Ke Za Zhi. 2023;61:896-901.
Abstract

VALLE LRD, Martins CN, Lopes RM, Fantini FA, et al
Reversed Potts Shunt as a Palliative Option for EndStage Idiopathic Pulmonary Arterial Hypertension in Childhood.
Braz J Cardiovasc Surg. 2023;38:e20220034.
Abstract

MCCONNELL J, Bilir SP, Xu Y, Tsang Y, et al
Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension.
J Med Econ. 2023;26:1349-1355.
Abstract

MUTGAN AC, Jandl K, Radic N, Valzano F, et al
Pentastatin, a matrikine of the collagen IValpha5, is a novel endogenous mediator of pulmonary endothelial dysfunction.
Am J Physiol Cell Physiol. 2023;325:C1294-C1312.
Abstract

PEPLINSKI BS, Buber J, Gharib SA, Pi H, et al
Associations of Histamine Metabolites with Disease Severity and Mortality in Pulmonary Arterial Hypertension.
Ann Am Thorac Soc. 2023;20:1676-1679.
Abstract

SZAFRON JM, Yang W, Feinstein JA, Rabinovitch M, et al
A computational growth and remodeling framework for adaptive and maladaptive pulmonary arterial hemodynamics.
Biomech Model Mechanobiol. 2023;22:1935-1951.
Abstract

LJUBOJEVIC-HOLZER S, Crnkovic S
Boosting the Exhausted Vasculature-SIRT3 (to the) Rescue.
Am J Respir Cell Mol Biol. 2023;69:497-499.
Abstract

MILLER CE, Franco V, Smith JS, Balasubramanian V, et al
Parenteral treprostinil induction for rapid attainment of therapeutic doses of oral treprostinil.
Respir Med. 2023;218:107374.
Abstract

JENKINS DP, Martinez G, Salaunkey K, Reddy SA, et al
Perioperative Management in Pulmonary Endarterectomy.
Semin Respir Crit Care Med. 2023;44:851-865.
Abstract

ALI HJ, Sahay S
End-of-Life and Palliative Care Issues for Patients Living with Pulmonary Arterial Hypertension: Barriers and Opportunities.
Semin Respir Crit Care Med. 2023;44:866-876.
Abstract

BAO ZY, Li HM, Zhang SB, Fei YQ, et al
Administration of A. muciniphila ameliorates pulmonary arterial hypertension by targeting miR-208a-3p/NOVA1 axis.
Acta Pharmacol Sin. 2023;44:2201-2215.
Abstract

GARNET B, Diaz-Lankenau R, Jean E, Campos M, et al
Accuracy of Pulse Oximetry for Long-Term Oxygen Therapy Assessment in Chronic Obstructive Pulmonary Disease.
Ann Am Thorac Soc. 2023;20:1587-1594.
Abstract

WEATHERALD J, Varughese RA, Liu J, Humbert M, et al
Management of Pulmonary Arterial Hypertension.
Semin Respir Crit Care Med. 2023;44:746-761.
Abstract

SPEROTTO F, Gearhart A, Hoskote A, Alexander PMA, et al
Cardiac arrest and cardiopulmonary resuscitation in pediatric patients with cardiac disease: a narrative review.
Eur J Pediatr. 2023;182:4289-4308.
Abstract

BLETTE BS, Moutchia J, Al-Naamani N, Ventetuolo CE, et al
Is low-risk status a surrogate outcome in pulmonary arterial hypertension? An analysis of three randomised trials.
Lancet Respir Med. 2023;11:873-882.
Abstract

XU Z, Dou R, Zhou Z, Zhang H, et al
Differential biventricular adaption to pulmonary vascular disease in patients with idiopathic/heritable and congenital heart disease: a prospective cardiac magnetic resonance and invasive study.
Eur Heart J Cardiovasc Imaging. 2023;24:1528-1535.
Abstract

TAKATSUKI S, Shimokawahara H, Shimizu Y, Kawai R, et al
Clinical differences between children and adults with idiopathic and heritable pulmonary arterial hypertension.
Cardiol Young. 2023;33:1909-1912.
Abstract

CHOUBEY M, Kothari SS, Gupta SK, Ramakrishnan S, et al
Pulmonary arterial compliance in patients of CHD with increased pulmonary blood flow.
Cardiol Young. 2023;33:1889-1895.
Abstract

GE T, Yang Y, Zhao Y
A study of the efficacy of sacubitril/valsartan plus dapagliflozin combination treatment in pulmonary arterial hypertension due to left heart disease.
Perfusion. 2023;38:1697-1704.
Abstract

LI M, Liu L, Liu C, Chen Z, et al
Selexipag for the Treatment of Pediatric Pulmonary Hypertension: A Systematic Review.
Clin Ther. 2023 Nov 7:S0149-2918(23)00391.
Abstract

GALIE N, Palazzini M, Manes A
Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds.
Eur Heart J. 2023 Nov 7:ehad672. doi: 10.1093.
Abstract

PHAM AT, Oliveira AC, Albanna M, Alvarez-Castanon J, et al
Non-Interferon-Dependent Role of STING Signaling in Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2023 Nov 9. doi: 10.1161/ATVBAHA.123.320121.
Abstract

CAIN MT, Schafer M, Ross LK, Ivy DD, et al
4D-Flow MRI intracardiac flow analysis considering different subtypes of pulmonary hypertension.
Pulm Circ. 2023;13:e12307.
Abstract

QAISER KN, Almoushref A, Mehta AK, Alkhayyat M, et al
Fluid loading during the hemodynamic evaluation of pulmonary hypertension: a cross-sectional study.
Cardiovasc Diagn Ther. 2023;13:833-842.
Abstract

CANGIALOSI P, Wojtaszek E, Omar A, Gopalan R, et al
Riociguat for the treatment of pulmonary hypertension in patients with end stage renal disease.
Respir Med. 2023 Nov 6:107454. doi: 10.1016/j.rmed.2023.107454.
Abstract

XIN L, Zhang Y, Luo Q, Zhao Q, et al
Development and validation of a nomogram for predicting hemodynamic response to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
Respir Med. 2023 Nov 6:107440. doi: 10.1016/j.rmed.2023.107440.
Abstract

ALI HR, Thomas J, Sahay S, Guha A, et al
Management of pulmonary hypertension associated with valvular heart disease with angiotensin-receptor neprilysin inhibitor.
Pulm Circ. 2023;13:e12303.
Abstract

SATISH T, Chin K, Patel N
Outcomes After Supraventricular Tachycardia Ablation in Patients With Group 1 Pulmonary Hypertension.
Cardiol Res. 2023;14:403-408.
Abstract

MISMETTI V, Delavenne X, Montani D, Bezzeghoud S, et al
Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.
Respir Res. 2023;24:273.
Abstract

HOPKINS CD, Wessel C, Chen O, El-Kersh K, et al
Potential Roles of Metals in the Pathogenesis of Pulmonary and Systemic Hypertension.
Int J Biol Sci. 2023;19:5036-5054.
Abstract

TYAGI S, Batra V, Gautam A
Review of Advances on Management of Chronic Thromboembolic Pulmonary Hypertension.
Int J Angiol. 2023;32:207-214.
Abstract

ORJI R, Markson F, Ilelaboye A, Okoronkwo E, et al
Pulmonary Hypertension Is Associated with Worse Outcomes in Patients Hospitalized for Sick Sinus Syndrome.
J Innov Card Rhythm Manag. 2023;14:5622-5628.
Abstract

ZHANG W, Hua Y, Zheng D, Chen Q, et al
Expression and Clinical Significance of miR-8078 in Patients with Congenital Heart Disease-Associated Pulmonary Hypertension.
Gene. 2023 Nov 3:147964. doi: 10.1016/j.gene.2023.147964.
Abstract

YAN Q, Liu S, Sun Y, Chen C, et al
Pyroptosis, apoptosis, necroptosis and endoplasmic reticulum stress in pulmonary hypertension.
J Adv Res. 2023 Nov 3:S2090-1232(23)00321-1. doi: 10.1016/j.jare.2023.
Abstract

RIBAS SOLA J, Sanchez-Corral Mena MA, Riera-Mestre A
Update in the management of chronic thrombo-embolic pulmonary hypertension.
Med Clin (Barc). 2023 Nov 2:S0025-7753(23)00545.
Abstract

SANGES S, Sobanski V, Lamblin N, Hachulla E, et al
Pulmonary hypertension in connective tissue diseases: What every CTD specialist should know - but is afraid to ask!
Rev Med Interne. 2023 Nov 2:S0248-8663(23)01212.
Abstract

GERTZ RJ, Gerhardt F, Pienn M, Lennartz S, et al
Dual-layer dual-energy CT-derived pulmonary perfusion for the differentiation of acute pulmonary embolism and chronic thromboembolic pulmonary hypertension.
Eur Radiol. 2023 Nov 3. doi: 10.1007/s00330-023-10337.
Abstract

HAN Y, Guo Y, Duan L, Li T, et al
Modified Transannular Patching Palliation versus Modified Blalock-Taussig-Thomas Shunt in Infants with Severe Tetralogy of Fallot with Diminutive Pulmonary Arteries.
Heart Surg Forum. 2023;26:E512-E518.
Abstract

EVRARD B, Woillard JB, Legras A, Bouaoud M, et al
Diagnostic, prognostic and clinical value of left ventricular radial strain to identify paradoxical septal motion in ventilated patients with the acute respiratory distress syndrome: an observational prospective multicenter study.
Crit Care. 2023;27:424.
Abstract

WEI S, Lin L, Jiang W, Chen J, et al
Naked cuticle homolog 1 prevents mouse pulmonary arterial hypertension via inhibition of Wnt/beta-catenin and oxidative stress.
Aging (Albany NY). 2023;15:11114-11130.
Abstract

WELCH CL, Aldred MA, Balachandar S, Dooijes D, et al
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.
Genet Med. 2023;25:100925.
Abstract

ZHONG B, Tan K, Razak A, Sackett V, et al
Early neurodevelopmental outcomes of extreme preterm infants exposed to paracetamol: a retrospective cohort study.
Pediatr Res. 2023 May 17:1-6. doi: 10.1038/s41390-023-02649.
Abstract

CHEN X, Quan R, Qian Y, Yang Z, et al
10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry.
Rheumatology (Oxford). 2023;62:3555-3564.
Abstract

ALLWOOD BW, Joubert L, Janson J
Chronic thromboembolic pulmonary hypertension: More options, more awareness.
Afr J Thorac Crit Care Med. 2023;29.
Abstract

DAVIES-VAN ES SA, Pennel TC, Brink J, Symons GJ, et al
Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in Cape Town, South Africa.
Afr J Thorac Crit Care Med. 2023;29.
Abstract

ALLWOOD BW, Manie S, Stolbrink M, Hunter L, et al
Pulmonary hypertension in adults completing tuberculosis treatment.
Afr J Thorac Crit Care Med. 2023;29.
Abstract

WU C, Liu H, Ba M, Zha J, et al
Angiotensin-converting enzyme - human amniotic mesenchymal stem cells improve pulmonary vascular remodeling in rats with pulmonary hypertension by promoting angiogenesis and counteracting inflammation.
Int J Clin Exp Pathol. 2023;16:282-293.
Abstract

SUMITOMO NF, Yamanoi K, Akiyama S, Kimura N, et al
Successful Treatment of Pulmonary Artery Aneurysm With Atrioventricular Septal Defect and Pulmonary Hypertension: Clinical and Pathologic Features.
CJC Pediatr Congenit Heart Dis. 2023;2:143-145.
Abstract

ZHONG Z, Li K, Shen C, Ma Y, et al
Erythropoietin improves pulmonary hypertension by promoting the homing and differentiation of bone marrow mesenchymal stem cells in lung tissue.
Hum Cell. 2023 Nov 15. doi: 10.1007/s13577-023-01009.
Abstract

YOUNIS M, Al-Antary N, Dalbah R, Qarajeh A, et al
Echocardiography and Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease Undergoing Lung Transplantation Evaluation.
Am J Med Sci. 2023 Nov 13:S0002-9629(23)01405.
Abstract

KAHF SA, Roche A, Baron A, Chantalat-Auger C, et al
Pulmonary Hypertension in Sickle Cell Disease.
Presse Med. 2023 Nov 13:104209. doi: 10.1016/j.lpm.2023.104209.
Abstract

POCHEPNIA S, Lang IM, Milos RI, Rohrich S, et al
Hughes-Stovin syndrome-An important differential diagnosis in patients with suspected chronic thromboembolic pulmonary hypertension : A case report.
Wien Klin Wochenschr. 2023 Nov 15. doi: 10.1007/s00508-023-02299.
Abstract

BRUGGER B, Aouad S, Geenens A, Kharat AM, et al
[Home oxygen therapy].
Rev Med Suisse. 2023;19:2153-2158.
Abstract

GENECAND L, Firmann M, Gijs PJ, Lechartier B, et al
[Pulmonary hypertension: how to differentiate rare from frequent etiologies?].
Rev Med Suisse. 2023;19:2138-2145.
Abstract

TYE SK, Razali NS, Ahmad Shauqi SA, Azeman NA, et al
Perception towards palliative care among patients with pulmonary hypertension in malaysia: a correlation with disease status.
Cardiol Young. 2023 Nov 15:1-6. doi: 10.1017/S1047951123003773.
Abstract

MONTANI D, Antigny F, Jutant EM, Chaumais MC, et al
Pulmonary hypertension associated with diazoxide: the SUR1 paradox.
ERJ Open Res. 2023;9:00350-2023.
Abstract

WANG L, Huang J, Zhang R, Zhang M, et al
Culin5 aggravates hypoxic pulmonary hypertension by activating TRAF6/NF-kappaB/HIF-1alpha/VEGF.
iScience. 2023;26:108199.
Abstract

FENG XL, Lu YB, Yang D, Xue Q, et al
[Classification, diagnosis and treatment status of pulmonary hypertension from 2012 to 2019: a single center study in Yunnan province].
Zhonghua Xin Xue Guan Bing Za Zhi. 2023;51:1188-1193.
Abstract

CAIN MA, Lee J, Kuper S, Sinkey R, et al
Two pregnancies in a patient following pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
BMJ Case Rep. 2023;16:e256158.
Abstract

KAEMMERER H, Diller GP, Dahnert I, Eichstaedt CA, et al
[Pulmonary arterial hypertension in congenital heart disease - Part I].
Pneumologie. 2023;77:956-961.
Abstract

APITZ C, Kozlik-Feldmann R, Eichstaedt CA, Gorenflo M, et al
[New aspects in pediatric pulmonary hypertension - Commented 2022ERS/ESC-PH guidelines].
Pneumologie. 2023;77:947-955.
Abstract

GUTH S, Wilkens H, Halank M, Held M, et al
[Chronic thromboembolic pulmonary hypertension].
Pneumologie. 2023;77:937-946.
Abstract

SCHMIDT KH, Bikou O, Blindt R, Bruch L, et al
[Pulmonary hypertension associated with left heart disease (group 2)].
Pneumologie. 2023;77:926-936.
Abstract

HALANK M, Zeder KE, Sommer N, Ulrich S, et al
[Pulmonary hypertension associated with lung disease].
Pneumologie. 2023;77:916-925.
Abstract

LICHTBLAU M, Harutyunova S, Nechwatal R, Mayer L, et al
[General measures and management of pulmonary arterial hypertension].
Pneumologie. 2023;77:907-915.
Abstract

GRUNIG E, Halank M, Neurohr C, Behr J, et al
[Medication treatment in pulmonary arterial hypertension with comorbidities - Which phenotypes and points to consider].
Pneumologie. 2023;77:901-906.
Abstract

KLOSE H, Harbaum L, Richter MJ, Lichtblau M, et al
[Targeted therapy for pulmonary arterial hypertension in patients without comorbidities].
Pneumologie. 2023;77:890-900.
Abstract

TELLO K, Richter MJ, Kremer N, Gall H, et al
[Diagnostic Algorithm and Screening of Pulmonary Hypertension].
Pneumologie. 2023;77:871-889.
Abstract

EICHSTAEDT CA, Bikou O, Sommer N, Schermuly RT, et al
[Genetic diagnostics and molecular approaches in pulmonary arterial hypertension].
Pneumologie. 2023;77:862-870.
Abstract

DOUSCHAN P, Egenlauf B, Gall H, Grunig E, et al
[New definition and classification of pulmonary hypertension].
Pneumologie. 2023;77:854-861.
Abstract

GRUNIG E, Benjamin N, Behr J, Skowasch D, et al
[The new European Guidelines for Pulmonary Hypertension with Updated Commentary of the PH-DACH Conference - A position paper of the German Society for Pneumology and Respiratory Medicine (DGP)].
Pneumologie. 2023;77:852-853.
Abstract

STEPPAN J, Wang H, Nandakumar K, Poe A, et al
LOXL2 inhibition ameliorates pulmonary artery remodeling in pulmonary hypertension.
bioRxiv. 2023 Oct 28:2023.10.24.563874. doi: 10.1101/2023.10.24.563874.
Abstract

HOUSMAN B, Laskey D, Dawodu G, Scheinin S, et al
Single Lung Transplant for Secondary Pulmonary Hypertension: The Right Option for the Right Patient.
J Clin Med. 2023;12:6789.
Abstract

BALSA A, Adao R, Bras-Silva C
Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function-Preclinical Studies.
Int J Mol Sci. 2023;24:15539.
Abstract

LUI JK, Gillmeyer KR, Sangani RA, Smyth RJ, et al
A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension.
Lung. 2023 Nov 13. doi: 10.1007/s00408-023-00646.
Abstract

YU J, Huang S, Shen W, Zhang Z, et al
Expression Profiles of circRNAs and Identification of hsa_circ_0007608 and hsa_circ_0064656 as Potential Biomarkers for COPD-PH Patients.
Int J Chron Obstruct Pulmon Dis. 2023;18:2457-2471.
Abstract

LV Z, Liang G, Cheng M
Predictive Value of GDF-15 and sST2 for Pulmonary Hypertension in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2023;18:2431-2438.
Abstract

GRAFHAM GK, Bambrick M, Houbois C, Mafeld S, et al
Enhancing preoperative assessment in chronic thromboembolic pulmonary hypertension: A comprehensive analysis of interobserver agreement and proximity-based CT pulmonary angiography scoring.
Heliyon. 2023;9:e20899.
Abstract

TAKAGI K, Kasai H, Tani H, Sakao S, et al
Macitentan Administration for Pulmonary Hypertension Due to beta-thalassemia with Multiple Organ Failure: A Case Report.
Intern Med. 2023 Nov 13. doi: 10.2169/internalmedicine.2307.
Abstract

LIU Y, Wang H, Lan L, Shao J, et al
A commentary regarding the article 'A meta-analysis of atrial septal defect closure in patients with severe pulmonary hypertension: is there a room for poking holes amidst debate?'.
Curr Probl Cardiol. 2023 Nov 10:102188. doi: 10.1016/j.cpcardiol.2023.102188.
Abstract

HIROSE K, Minatsuki S, Saito A, Yagi H, et al
Impact of psychiatric disorders on the hemodynamic and quality of life outcome of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a retrospective study.
Respir Res. 2023;24:274.
Abstract

KITAHARA K, Omura J, Wada S, Kim SW, et al
Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database.
Pulm Ther. 2023 Nov 11. doi: 10.1007/s41030-023-00243.
Abstract

ADAMEIT MSD, Wiedenroth CB, Omlor A, Schafers HJ, et al
[Chronic thromboembolic pulmonary hypertension].
Dtsch Med Wochenschr. 2023;148:1514-1523.
Abstract

DAHER A, Klose H
[Pathophysiology, diagnosis, prognosis and treatment of pulmonary hypertension associated with chronic lung disease].
Dtsch Med Wochenschr. 2023;148:1507-1513.
Abstract

WISSMULLER M, Tichelbacker T, Finke K, Dohr J, et al
[Pulmonary hypertension associated with left heart disease (group 2)].
Dtsch Med Wochenschr. 2023;148:1498-1506.
Abstract

PIZARRO C, Nickenig G, Skowasch D
[Diagnosis and therapy of pulmonary arterial hypertension].
Dtsch Med Wochenschr. 2023;148:1491-1497.
Abstract

EMON IM, Al-Qazazi R, Rauh MJ, Archer SL, et al
The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases.
Cells. 2023;12:2528.
Abstract

LIU H, Wang Y, Zhang Q, Liu C, et al
Macrophage-derived inflammation promotes pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension mice.
Immunol Lett. 2023;263:113-122.
Abstract

REN H, Dai R, Nik Nabil WN, Xi Z, et al
Unveiling the dual role of autophagy in vascular remodelling and its related diseases.
Biomed Pharmacother. 2023;168:115643.
Abstract

PIZZUTO MF, Laughon MM, Jackson WM
Current and emerging pharmacotherapies for the treatment of pulmonary arterial hypertension in infants.
Expert Opin Pharmacother. 2023;24:1875-1886.
Abstract

AHMED MS, Ghallab M, Ostrow T, Nashawi M, et al
Pharmacotherapy of refractory pulmonary arterial hypertension.
Expert Opin Pharmacother. 2023;24:1861-1874.
Abstract

ABDELHAFIZ A, Benscoter AL, Batlivala SP
Spontaneous neonatal pulmonary arterial thrombosis - cases, mechanisms, and literature review.
Cardiol Young. 2023;33:2452-2460.
Abstract

AVITABILE CM, Yung D, Handler S, Hopper RK, et al
Measurement of Physical Activity by Actigraphy in Infants and Young Children with Pulmonary Arterial Hypertension.
J Pediatr. 2023 Jul 28:113639. doi: 10.1016/j.jpeds.2023.113639.
Abstract

JEON K, Yoo SB, Lee Y, Lee EB, et al
Safety and effectiveness of ambrisentan in real clinical practice in pulmonary arterial hypertension: Results from the Korean post-marketing surveillance.
Pharmacoepidemiol Drug Saf. 2023;32:1387-1394.
Abstract

HASSAN AB, Hozayen RF, Mustafa ZS, Lundberg IE, et al
The prevalence of pulmonary arterial hypertension in patients with mixed connective tissue disease: a systematic review and meta-analysis.
Clin Exp Rheumatol. 2023;41:2301-2311.
Abstract

RADEL LJ, Iqbal M, Griffiths M
Intravenous prostacyclins for right ventricular failure following left ventricular assist device in paediatric heart failure.
Cardiol Young. 2023;33:2422-2424.
Abstract

ZHANG YW, Wu D, Zhu ZZ, Ou JC, et al
Analysis of the Imaging Features and Prognosis of Pulmonary Tuberculosis Complicated with Pulmonary Embolism.
Curr Med Imaging. 2024;20:e310323215270.
Abstract

YASUHARA J, Watanabe K, Watanabe A, Shirasu T, et al
Pulmonary vasodilator therapies in pulmonary arterial hypertension associated with CHD: a systematic review and network meta-analysis.
Cardiol Young. 2023;33:2297-2311.
Abstract

NIZHNIKAVA V, Reiter U, Kovacs G, Reiter C, et al
Myocardial strain parameters in pulmonary hypertension are determined by changes in volumetric function rather than by hemodynamic alterations.
Eur J Radiol. 2023;170:111187.
Abstract

STEINBERG ZL, Rayner SG, Leary PJ
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension due to septic emboli.
Catheter Cardiovasc Interv. 2023 Nov 22. doi: 10.1002/ccd.30919.
Abstract

HUANG Y, Luo Y, Hou H, Gao J, et al
Pulmonary manifestations of POEM syndrome: a retrospective analysis of 282 cases.
BMC Pulm Med. 2023;23:465.
Abstract

OLIVEIRA APS, Campoy AT, Oliveira RKF, Ota-Arakaki JS, et al
Pulmonary hypertension outcomes during the COVID-19 pandemic in Brazil.
J Bras Pneumol. 2023;49:e20230020.
Abstract

WEISS T, Near AM, Zhao X, Ramey DR, et al
Healthcare resource utilization in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD): a real-world data analysis.
BMC Pulm Med. 2023;23:455.
Abstract

AKDOGAN A, Sari A, Sade LE
Primary Systemic Vasculitides as a Cause of Group IV Pulmonary Hypertension.
Anatol J Cardiol. 2023 Nov 21. doi: 10.14744/AnatolJCardiol.2023.3650.
Abstract

WANG Z, Li X, Li M, Peng J, et al
The efficacy of the treat-repair-treat strategy for severe pulmonary arterial hypertension associated with congenital heart disease: a meta-analysis.
BMC Cardiovasc Disord. 2023;23:569.
Abstract

WANG C, Yang H, Li T, Wen Y, et al
Analysis of characteristics related to interstitial lung disease or pulmonary hypertension in patients with dermatomyositis.
Clin Respir J. 2023 Nov 20. doi: 10.1111/crj.13720.
Abstract

LI N, Su S, Xie X, Yang Z, et al
Tsantan Sumtang, a traditional Tibetan medicine, protects pulmonary vascular endothelial function of hypoxia-induced pulmonary hypertension rats through AKT/eNOS signaling pathway.
J Ethnopharmacol. 2023;320:117436.
Abstract

LIU Y, Zhu L, Ming Y, Wu Z, et al
A role of TRIM59 in pulmonary hypertension: modulating the protein ubiquitylation modification.
J Transl Med. 2023;21:821.
Abstract

DHONT S, Stassen J, Herbots L, Hoedemakers S, et al
Exercise Pulmonary Hypertension by the mPAP/CO slope in Primary Mitral Regurgitation.
Eur Heart J Cardiovasc Imaging. 2023 Nov 17:jead313. doi: 10.1093.
Abstract

CSOSZA G, Szucs G, Rozgonyi Z, Csoma B, et al
Circulating apelin, IL22RA2 and VEGF in pre-capillary pulmonary hypertension.
Physiol Int. 2023 Nov 17. doi: 10.1556/2060.2023.00264.
Abstract

THOMAS C, Tobes D, Trela K, Montes M, et al
A Case Report of Percutaneous Right Ventricular Assist Device Utilization After Cesarean Delivery in a Patient With Severe Pulmonary Arterial Hypertension.
A A Pract. 2023;17:e01728.
Abstract

TSOI SM, Nawaytou H, Almeneisi H, Steurer M, et al
Prostaglandin-E1 infusion in persistent pulmonary hypertension of the newborn.
Pediatr Pulmonol. 2023 Nov 17. doi: 10.1002/ppul.26759.
Abstract

VAIDY A, O'Corragain O, Vaidya A
Diagnosis and Management of Pulmonary Hypertension and Right Ventricular Failure in the Cardiovascular Intensive Care Unit.
Crit Care Clin. 2024;40:121-135.
Abstract

TANG L, Cai Q, Wang X, Li X, et al
Canagliflozin ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting pulmonary arterial smooth muscle cell proliferation.
Clin Exp Hypertens. 2023;45:2278205.
Abstract

MILARA J, Roger I, Montero P, Artigues E, et al
Targeting IL-11 system as a treatment of pulmonary arterial hypertension.
Pharmacol Res. 2023;197:106985.
Abstract

YI Y, Tianxin Y, Zhangchi L, Cui Z, et al
Pinocembrin attenuates susceptibility to atrial fibrillation in rats with pulmonary arterial hypertension.
Eur J Pharmacol. 2023;960:176169.
Abstract

GERZEN OP, Lisin RV, Balakin AA, Mukhlynina EA, et al
Characteristics of the right atrial and right ventricular contractility in a model of monocrotaline-induced pulmonary arterial hypertension.
J Muscle Res Cell Motil. 2023;44:299-309.
Abstract

ALWAN L, Tomii D, Heg D, Okuno T, et al
Impact of right ventricular-pulmonary arterial coupling on clinical outcomes in patients undergoing transcatheter aortic valve implantation.
Cardiovasc Revasc Med. 2023;56:27-34.
Abstract

KUMARI J, Advani M, Purohit G
Prevalence of pulmonary hypertension in chronic simple silicosis patients and its correlation with smoking history, occupation type, age and duration of silica exposure.
Monaldi Arch Chest Dis. 2023 Nov 30. doi: 10.4081/monaldi.2023.2719.
Abstract

ZHANG J, Hu X, Wang T, Xiao R, et al
Extracellular vesicles in venous thromboembolism and pulmonary hypertension.
J Nanobiotechnology. 2023;21:461.
Abstract

GOKTEKIN MC, Aksu F, Perilioglu AZ, Akkoc RF, et al
Relationship of Main Pulmonary Artery (Truncus Pulmonalis) Diameter With Hospital Stay and Mortality in Pulmonary Hypertension Patients Admitted to the Emergency Department.
Cureus. 2023;15:e47918.
Abstract

KUBOTA K, Imai Y, Okuyama T, Ishiyama Y, et al
Response to the Letter by Frumkin Regarding the Article, "Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis".
Int Heart J. 2023;64:1167.
Abstract

PRINS KW, Durbin J, Archer SL
Complete revascularization of the pulmonary circulation in chronic thromboembolic pulmonary hypertension: value of addressing chronic total occlusions.
Can J Cardiol. 2023 Nov 27:S0828-282X(23)01955.
Abstract

TRUONG LN, Santos EW, Zheng YM, Wang YX, et al
Rieske Iron-Sulfur Protein Mediates Pulmonary Hypertension Following Nicotine/Hypoxia Co-Exposure.
Am J Respir Cell Mol Biol. 2023 Nov 29. doi: 10.1165/rcmb.2023-0181.
Abstract

WEI E, Chen XH, Zhou SJ
Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study.
Front Pediatr. 2023;11:1270712.
Abstract

ZHANG H, Song H
A 1-month-old infant with pulmonary hypertensive crisis after cardiac surgery was successfully rescued with connection of left atrial and right ventricular pressure measurement tubes: a case report.
Eur Heart J Case Rep. 2023;7:ytad527.
Abstract

YAMAZAKI Y, Numasawa Y, Mase T, Arai M, et al
A case of atrial septal defect with right-to-left shunting without pulmonary hypertension.
J Cardiol Cases. 2023;28:224-227.
Abstract

HADI DD, Marsool MDM, Marsool ADM, Vora N, et al
Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension.
Immun Inflamm Dis. 2023;11:e1079.
Abstract

KACHABI A, Colebank MJ, Chesler NC
Subject-specific one-dimensional fluid dynamics model of chronic thromboembolic pulmonary hypertension.
Biomech Model Mechanobiol. 2023 Nov 29. doi: 10.1007/s10237-023-01786.
Abstract

PATEL B, D'Souza S, Sahni T, Yehya A, et al
Pulmonary hypertension secondary to valvular heart disease: a state-of-the-art review.
Heart Fail Rev. 2023 Nov 29. doi: 10.1007/s10741-023-10372.
Abstract

LUO A, Jia Y, Hao R, Zhou X, et al
Proteomic and Phosphoproteomic Analysis of Right Ventricular Hypertrophy in the Pulmonary Hypertension Rat Model.
J Proteome Res. 2023 Nov 28. doi: 10.1021/acs.jproteome.3c00546.
Abstract

PIPER B, Bogamuwa S, Hossain T, Farkas D, et al
RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension.
J Clin Invest. 2023 Nov 28:e169441. doi: 10.1172/JCI169441.
Abstract

VILLAMOR E, van Westering-Kroon E, Gonzalez-Luis GE, Bartos F, et al
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
JAMA Netw Open. 2023;6:e2345299.
Abstract

KELLY NJ, Newhouse D, Chapagain H, Patel A, et al
Omics and Extreme Phenotyping Reveal Longitudinal Association Between Left Atrial Size and Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension.
J Am Heart Assoc. 2023 Nov 28:e031746. doi: 10.1161/JAHA.123.031746.
Abstract

WANG Q, Su W, Liu J, Zhao D, et al
Advances in the investigation of the role of autophagy in the etiology of chronic obstructive pulmonary disease: A review.
Medicine (Baltimore). 2023;102:e36390.
Abstract

PAPADOPOULOS GE, Arvanitaki A, Markidis E, Mouratoglou SA, et al
Temporal Trends in Diagnostic Hemodynamics and Survival of Patients with Pulmonary Hypertension: A Single-Center Study.
Life (Basel). 2023;13:2225.
Abstract

LABRADA L, Romero C, Sadek A, Belardo D, et al
Intravenous Diuresis in Severe Precapillary Pulmonary-Hypertension-Related Right Heart Failure: Effects on Renal Function and Blood Pressure.
J Clin Med. 2023;12:7149.
Abstract

ARCHAMBAULT JL, Delaney CA
A Review of Serotonin in the Developing Lung and Neonatal Pulmonary Hypertension.
Biomedicines. 2023;11:3049.
Abstract

ALRUWAILI N, Kandhi S, Froogh G, Kelly MR, et al
Superoxide-Mediated Upregulation of MMP9 Participates in BMPR2 Destabilization and Pulmonary Hypertension Development.
Antioxidants (Basel). 2023;12:1961.
Abstract

SIAMWALA JH, Pagano FS, Dubielecka PM, Ivey MJ, et al
IL-1beta-mediated adaptive reprogramming of endogenous human cardiac fibroblasts to cells with immune features during fibrotic remodeling.
Commun Biol. 2023;6:1200.
Abstract

MATSUSHITA FY, Krebs VLJ, de Campos CV, de Vincenzi Gaiolla PV, et al
Reassessing the role of milrinone in the treatment of heart failure and pulmonary hypertension in neonates and children: a systematic review and meta-analysis.
Eur J Pediatr. 2023 Nov 24. doi: 10.1007/s00431-023-05342.
Abstract

YE L, Wang B, Xu H, Zhang X, et al
The Emerging Therapeutic Role of Prostaglandin E2 Signaling in Pulmonary Hypertension.
Metabolites. 2023;13:1152.
Abstract

REIMANN L, Mayer L, Schneider SR, Schwarz EI, et al
Change in Right-to-Left Shunt Fraction in Patients with Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Endarterectomy.
J Cardiovasc Dev Dis. 2023;10:442.
Abstract

ZHOU Y, Chen M, Zheng J, Shui X, et al
Insights into the relationship between serum uric acid and pulmonary hypertension (Review).
Mol Med Rep. 2024;29:10.
Abstract

HAN SK, Baik SK, Kim MY
[Pulmonary Complications in Patients with Liver Cirrhosis].
Korean J Gastroenterol. 2023;82:213-223.
Abstract

YANG SS, Huang WC, Wang P, Gong FQ, et al
Echocardiographic measurements of left ventricular dimensions and function in newborns with omphalocele and pulmonary.
BMC Pediatr. 2023;23:585.
Abstract

ISOBE S, Nair RV, Kang HY, Wang L, et al
Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension.
Nat Commun. 2023;14:7578.
Abstract

ZHAO C, Le X, Li M, Hu Y, et al
Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model.
Respir Res. 2023;24:289.
Abstract

FRUMKIN LR
Letter by Frumkin Regarding Article, "Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis.".
Int Heart J. 2023;64:1166.
Abstract

ROOKE DA, Kertai MD, Abrams B
Advancing the Role of the Anesthesiologist in Perioperative Medicine.
Semin Cardiothorac Vasc Anesth. 2023;27:249-251.
Abstract

AUTH R, Klinger JR
Emerging pharmacotherapies for the treatment of pulmonary arterial hypertension.
Expert Opin Investig Drugs. 2023;32:1025-1042.
Abstract

FIKRI YA, Mulia EPB, Nugroho FW
Preoperative Sildenafil in Pediatric Patients Undergoing Congenital Heart Surgeries: A Systematic Review and Meta-Analysis.
Semin Cardiothorac Vasc Anesth. 2023;27:252-259.
Abstract

RYAN RM, Mukherjee D, Ford S, Lingappan K, et al
Pharmacotherapy of BPD: Current status & future perspectives.
Semin Perinatol. 2023;47:151819.
Abstract

WAN M, Lu C, Liu Y, Luo F, et al
Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism.
Respir Res. 2023;24:233.
Abstract

SARGENT T, Tsang Y, Panjabi S, Funtanilla V, et al
Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis.
Adv Ther. 2023;40:5037-5054.
Abstract

NIEMCZYK A, Waskiel-Burnat A, Zaremba M, Czuwara J, et al
The profile of adipokines associated with fibrosis and impaired microcirculation in systemic sclerosis.
Adv Med Sci. 2023;68:298-305.
Abstract

GHASOUB R, Benkhadra M, Kassem N, Alshurafa A, et al
Carfilzomib-induced life-threatening lung injury in refractory multiple myeloma.
J Oncol Pharm Pract. 2023;29:2041-2044.
Abstract

TAN K, Liu C, Zhao Z, Wang S, et al
Effectiveness of Halo-Pelvic Traction and Thoracoplasty for Pulmonary Artery Pressure and Cardiopulmonary Function in Patients With Severe Spinal Deformity.
Clin Spine Surg. 2023;36:E464-E470.
Abstract

QIAN J, Chen Y, Yang X, Wang Q, et al
Association Study Identified HLA-DQA1 as a Novel Genetic Risk of Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
Arthritis Rheumatol. 2023;75:2207-2215.
Abstract

SIMPSON CE, Hemnes AR, Griffiths M, Grunig G, et al
Metabolomic Differences in Connective Tissue Disease-Associated Versus Idiopathic Pulmonary Arterial Hypertension in the PVDOMICS Cohort.
Arthritis Rheumatol. 2023;75:2240-2251.
Abstract

GALLO FERNANDEZ I, Rodriguez Nieto J, Perea Armijo J, Pastor Wulf D, et al
Middle-aged woman with congestive symptoms: more than just pulmonary arterial hypertension.
Rev Esp Cardiol (Engl Ed). 2023;76:1063-1065.
Abstract

ZHANG X, Xiao K, Li L, Wang N, et al
Hemodynamic factors affecting pulmonary hypertension in hemodialysis patients.
Kidney Res Clin Pract. 2023 Dec 5. doi: 10.23876.
Abstract

DAI Q, Shang M, Zhou Y, Wei Q, et al
Evaluation of maternal-fetal outcomes in pregnancy complicated with severe pulmonary hypertension and its influencing factors: a single-center retrospective study in China.
J Matern Fetal Neonatal Med. 2023;36:2290923.
Abstract

YOSHIMURA N
[Postoperative Management for Severe Pulmonary Hypertension Associated with Congenital Heart Disease].
Kyobu Geka. 2023;76:809-813.
Abstract

SHARMA S, Rizwi K, Prasad SN, Meena A, et al
Systemic arterial to pulmonary arterial shunt masquerading as acute pulmonary embolism.
BMJ Case Rep. 2023;16:e256008.
Abstract

HOU P, Chen HM, Lin SY, Guo WL, et al
Preliminary study on the short-term changes of pulmonary perfusion after a single balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
Ther Adv Respir Dis. 2023;17:17534666231212307.
Abstract

ZHANG J, Li Y, Zhang J, Liu L, et al
ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through N1-methyladenosine modification of circCDK17.
Acta Pharm Sin B. 2023;13:4840-4855.
Abstract

LIU H, Wang S, Chen Q, Ge X, et al
Natural Targeting Potent ROS-Eliminating Tungsten-Based Polyoxometalate Nanodots for Efficient Treatment of Pulmonary Hypertension.
Adv Healthc Mater. 2023;12:e2303784.
Abstract

MADONNA R, Alberti M, Biondi F, Morganti R, et al
Chronic thromboembolic pulmonary disease: Association with exercise-induced pulmonary hypertension and right ventricle adaptation over time: Chronic thromboembolic pulmonary disease and exercise pulmonary hypertension.
Eur J Intern Med. 2023 Dec 1:S0953-6205(23)00417.
Abstract

DAYIOGLU M, Gursel G, Ozercan S, Aydin EM, et al
Performance of handheld ultrasound devices in diagnosis of pulmonary hypertension and right heart dysfunction in ICU patients.
Echocardiography. 2023 Dec 1. doi: 10.1111/echo.15721.
Abstract

NAKAMURA N, Murakami T, Ishiodori T, Nozaki Y, et al
Acute exacerbation of pulmonary arterial hypertension after COVID-19 vaccination.
Pediatr Int. 2023;65:e15711.
Abstract

CHANG WT, Lee WC, Lin YW, Shih JY, et al
Transpulmonary Expression of Exosomal microRNAs in Idiopathic and Congenital Heart Disease-Related Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2023;12:e031435.
Abstract

HOLDEN KI, Martino AM, Guner YS, Harting MT, et al
Extracorporeal life support in congenital diaphragmatic hernia.
Semin Pediatr Surg. 2023;32:151328.
Abstract

XU C, Wang B, Li M, Dong Z, et al
FUNDC1/USP15/Drp1 ameliorated TNF-alpha-induced pulmonary artery endothelial cell proliferation by regulating mitochondrial dynamics.
Cell Signal. 2024;113:110939.
Abstract

LI Q, Zhang M
Echocardiography assessment of right ventricular-pulmonary artery coupling: Validation of surrogates and clinical utilities.
Int J Cardiol. 2024;394:131358.
Abstract

FLING C, De Marco T, Kime NA, Lammi MR, et al
Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry.
Ann Am Thorac Soc. 2023;20:1718-1725.
Abstract

LUO J, Sun J, Xu L, Chen J, et al
Analysis of relationship between P wave dispersion and diagnosis of pulmonary arterial hypertension and risk stratification.
J Electrocardiol. 2023;81:94-100.
Abstract

GARCIA MVF, Souza R, Caruso P
Reply to: "Mortality and prognostic factors in connective tissue disease-associated pulmonary arterial hypertension patients complicated with right heart failure".
Int J Rheum Dis. 2023;26:2612-2614.
Abstract

CAJIGAS HR, Lavon B, Harmsen W, Muchmore P, et al
Quantitative CT measures of pulmonary vascular volume distribution in pulmonary hypertension associated with COPD: Association with clinical characteristics and outcomes.
Pulm Circ. 2023;13:e12321.
Abstract

TOSUN SONER H, Bulut E, Uzundere O, Soner S, et al
Management of anesthesia in pregnant women with pulmonary hypertension.
Eur Rev Med Pharmacol Sci. 2023;27:11315-11322.
Abstract

HANNEMANN J, Freytag J, Schiefer LM, Macholz F, et al
Asymmetric and symmetric dimethylarginine in high altitude pulmonary hypertension (HAPH) and high altitude pulmonary edema (HAPE).
Front Physiol. 2023;14:1297636.
Abstract

MA L, Wang Y, Li X, Wang Z, et al
Tom70-regulated mitochondrial biogenesis via TFAM improves hypoxia-induced dysfunction of pulmonary vascular endothelial cells and alleviates hypoxic pulmonary hypertension.
Respir Res. 2023;24:310.
Abstract

ZHAO W, Guo J, Dong N, Hei H, et al
Diagnostic value of 3D volume measurement of central pulmonary artery based on CTPA images in the pulmonary hypertension.
BMC Med Imaging. 2023;23:211.
Abstract

ZHENG Y, Yuan P, Zhang Z, Fu Y, et al
Fatty Oil of Descurainia Sophia Nanoparticles Improve Monocrotaline-Induced Pulmonary Hypertension in Rats Through PLC/IP3R/Ca(2+) Signaling Pathway.
Int J Nanomedicine. 2023;18:7483-7503.
Abstract

KHANGOORA V, Bernstein EJ, King CS, Shlobin OA, et al
Connective tissue disease-associated pulmonary hypertension: A comprehensive review.
Pulm Circ. 2023;13:e12276.
Abstract

GASHLER K, Li T, Gonzalez J, Hasoon J, et al
Anaesthetic considerations: management of pulmonary hypertension and difficult airway in a patient undergoing radical nephrectomy for renal cell carcinoma.
Anaesthesiol Intensive Ther. 2023;55:307-309.
Abstract

WADILE S, Banpurkar A, Kulkarni S
Trans-catheter closure of an unusual type of Abernethy malformation in a child presenting with severe pulmonary hypertension.
Cardiol Young. 2023 Dec 12:1-3. doi: 10.1017/S1047951123004006.
Abstract

EBRAHIMI BS, Khwaounjoo P, Argus F, Chan HF, et al
Predicting Patient Status in Chronic Thromboembolic Pulmonary Hypertension Using a Biophysical Model.
Annu Int Conf IEEE Eng Med Biol Soc. 2023;2023:1-4.
Abstract

SCHNEIDER SR, Muller J, Bauer M, Mayer L, et al
Overnight exposure to high altitude in pulmonary hypertension: adverse events and effect of oxygen therapy.
Eur Heart J. 2023 Dec 11:ehad789. doi: 10.1093.
Abstract

BOCTOR D, Bakke B, Chorba JS
The Silent Threat: Bartonella quintana Endocarditis Unveiling Heart Failure and Severe Pulmonary Hypertension.
Am J Case Rep. 2023;24:e942160.
Abstract

MILLIGAN I, Shaw AK, Leu R, Kanaan U, et al
Prevalence of pulmonary hypertension in obstructive sleep apnea and relation to disease severity.
J Clin Sleep Med. 2023 Dec 11. doi: 10.5664/jcsm.10952.
Abstract

AUBERT JD, Ulrich S
Editorial: Challenges in chronic thrombo-embolic pulmonary hypertension (CTEPH).
Front Med (Lausanne). 2023;10:1326429.
Abstract

XI Q, Liu Z, Xiong C, Luo Q, et al
Pulmonary artery dilatation in different causes of pulmonary hypertension.
Pulm Circ. 2023;13:e12313.
Abstract

JIA Q, Ouyang Y, Yang Y, Yao S, et al
Adipokines in pulmonary hypertension: angels or demons?
Heliyon. 2023;9:e22482.
Abstract

YANG W, Shen J, Shi G, Zhang T, et al
Bibliometric and visual analysis of hypoxic pulmonary hypertension from 2013 to 2022.
Heliyon. 2023;9:e22044.
Abstract

GLEESON M, Murray J, Gaine S
An acute presentation of Chronic Thromboembolic Pulmonary Hypertension complicated by cerebellar infarction.
Respir Med Case Rep. 2023;46:101931.
Abstract

MOHANTY S, Della Rocca DG, Torlapati PG, Chierchia GB, et al
Pulsed-Field Ablation Does Not Worsen Baseline Pulmonary Hypertension Following Prior Radiofrequency Ablations.
JACC Clin Electrophysiol. 2023 Nov 22:S2405-500X(23)00832.
Abstract

ANAND S, Sadek A, Vaidya A, Oliveros E, et al
Diagnostic Evaluation of Pulmonary Hypertension: A Comprehensive Approach for Primary Care Physicians.
J Clin Med. 2023;12:7309.
Abstract

JUDINA A, Niglas M, Leonov V, Kirkby NS, et al
Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function.
Cells. 2023;12:2764.
Abstract

MATOS JI, Garcia-Rodriguez SN, Costa-Rodriguez N, Caro-Vadillo A, et al
Usefulness of Tissue Doppler Imaging for the Evaluation of Pulmonary Hypertension in Canine Heartworm Disease.
Animals (Basel). 2023;13:3647.
Abstract

TAKALDANI AHS, Javanshir N, Honardoost H, Negaresh M, et al
Extramedullary hematopoiesis in ribs and severe pulmonary hypertension disease following intermediate beta-thalassemia: a case report.
J Med Case Rep. 2023;17:503.
Abstract

WU YC, Wang WT, Yang MC, Su YT, et al
The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension.
Biol Res. 2023;56:66.
Abstract

HE M, Jiang R, Fei-Sun, Cao JX, et al
Cardiac magnetic resonance imaging-derived septum swing index detects pulmonary hypertension: A diagnostic study.
J Transl Int Med. 2023;11:459-467.
Abstract

TONG CX, Meng T
Twin pregnancy with sudden heart failure and pulmonary hypertension after atrial septal defect repair: A case report.
World J Clin Cases. 2023;11:8350-8356.
Abstract

SATO K, Shimokawahara H, Matsubara H
Balloon Pulmonary Angioplasty for a Patient With Central-Type Chronic Thromboembolic Pulmonary Hypertension With Lung Cavitation.
JACC Cardiovasc Interv. 2023 Dec 8:S1936-8798(23)01548.
Abstract

CHEN S, Zhong J, Hu B, Shao N, et al
Whole-genome microRNA sequencing analysis in patients with pulmonary hypertension.
Front Genet. 2023;14:1250629.
Abstract

KITAHARA K, Omura J, Wada S, Kim SW, et al
Correction: Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database.
Pulm Ther. 2023 Dec 20. doi: 10.1007/s41030-023-00247.
Abstract

CONDLIFFE R, Dorfmuller P, Gopalan D, Sitbon O, et al
From the microscopic to the macroscopic: clinical-radiological-pathological correlation in pulmonary hypertension.
Eur Respir Rev. 2023;32:230237.
Abstract

VERBELEN T, Godinas L, Dorfmuller P, Gopalan D, et al
Clinical-radiological-pathological correlation in chronic thromboembolic pulmonary hypertension.
Eur Respir Rev. 2023;32:230149.
Abstract

LICHTBLAU M, Mayer L, Gopalan D, Dorfmuller P, et al
Clinical-radiological-pathological correlation in pulmonary hypertension with unclear and/or multifactorial mechanisms.
Eur Respir Rev. 2023;32:230119.
Abstract

CONDLIFFE R, Durrington C, Hameed A, Lewis RA, et al
Clinical-radiological-pathological correlation in pulmonary arterial hypertension.
Eur Respir Rev. 2023;32:230138.
Abstract

LIU C, Zhou YP, Lian TY, Li RN, et al
Clonal Hematopoiesis of Indeterminate Potential in Chronic Thromboembolic Pulmonary Hypertension: A Multicenter Study.
Hypertension. 2023 Dec 20. doi: 10.1161/HYPERTENSIONAHA.123.22274.
Abstract

BERARDI E, Antonica G, Procaccio A, Marziliano D, et al
Cutaneous polyarteritis nodosa and pulmonary arterial hypertension: An unexpected liaison. A case report.
Medicine (Baltimore). 2023;102:e36563.
Abstract

BAEK SH, Shin JE, Han J, Song IG, et al
Factors associated with the response to postnatal dexamethasone use in very low birthweight infants: a nationwide cohort study.
BMJ Paediatr Open. 2023;7:e002302.
Abstract

QIN Y, Yan G, Qiao Y, Wang D, et al
Identification of hub genes based on integrated analysis of single-cell and microarray transcriptome in patients with pulmonary arterial hypertension.
BMC Genomics. 2023;24:788.
Abstract

SINGH N, Eickhoff C, Garcia-Agundez A, Bertone P, et al
Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension.
Sci Rep. 2023;13:22534.
Abstract

DAVIS S, Edwards T, Norcross L, Fehnel S, et al
Use of the National Cancer Institute Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to assess treatment tolerability in pulmonary arterial hypertension: qualitative patient research findings in current and form
J Patient Rep Outcomes. 2023;7:134.
Abstract

SATO S, Ito T, Tabata T, Ogawa A, et al
Effect of balloon pulmonary angioplasty on cardio-ankle vascular index and biventricular remodeling in patients with chronic thromboembolic pulmonary hypertension.
Front Cardiovasc Med. 2023;10:1325846.
Abstract

XU W, Deng M, Xi L, Liu A, et al
Comparison of cardiovascular metrics on computed tomography pulmonary angiography of the updated and old diagnostic criteria for pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension.
Quant Imaging Med Surg. 2023;13:7910-7923.
Abstract

MCNEIL AL, Al-Shibli NK, Fuller ME, Goldstein SA, et al
Pregnancy-related outcomes in obstetric patients with pulmonary hypertension: a single-center retrospective cohort study.
Int J Obstet Anesth. 2023 Dec 1:103964. doi: 10.1016/j.ijoa.2023.103964.
Abstract

HE H, Tong X, Ning Z, Zhou J, et al
Diffusing capacity of lungs for carbon monoxide associated with subclinical myocardial impairment in systemic sclerosis: A cardiac MR study.
RMD Open. 2023;9:e003391.
Abstract

ALLAN L, Shanks AM, Polkey M
Lung infarction secondary to infected pulmonary arterial thrombosis in a patient with Eisenmenger's syndrome.
BMJ Case Rep. 2023;16:e257803.
Abstract

CHAROENPONG P, Dhillon N, Murnane K, Goeders N, et al
Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).
BMJ Open Respir Res. 2023;10:e001917.
Abstract

YEGAMBARAM M, Sun X, Lu Q, Jin Y, et al
Mitochondrial hyperfusion induces metabolic remodeling in lung endothelial cells by modifying the activities of electron transport chain complexes I and III.
Free Radic Biol Med. 2024;210:183-194.
Abstract

CASTILLO-LARIOS R, Pollak PM, Chaudhary S, Case JB, et al
Percutaneous Transseptal Extracorporeal Membrane Oxygenation to Rescue a Failing Right Ventricle in an Animal Model.
Innovations (Phila). 2023;18:583-588.
Abstract

MCEVOY C, Argula R, Sahay S, Shapiro S, et al
Tyvaso DPI: Drug-device characteristics and patient clinical considerations.
Pulm Pharmacol Ther. 2023;83:102266.
Abstract

COLAK A, Erdemir AG, Hazirolan T, Pirat B, et al
Multiparametric assessment of right ventricular function in heart transplant recipients by echocardiography and relations with pulmonary hemodynamics.
Echocardiography. 2023;40:1350-1355.
Abstract

HUANG J, Xie Y, Chen B, Xia Y, et al
GPR146 regulates pulmonary vascular remodeling by promoting pulmonary artery smooth muscle cell proliferation through 5-lipoxygenase.
Eur J Pharmacol. 2023;961:176123.
Abstract

XING YY, Ruan Y, Qin H, Zhao L, et al
Effects of maternal pulmonary arterial hypertension on fetal hemodynamics and maternal-fetal outcome in late pregnancy.
Echocardiography. 2023;40:1339-1349.
Abstract

LI D, Chen Y, Wang Y, Liu J, et al
NAMPT mediates PDGF-induced pulmonary arterial smooth muscle cell proliferation by TLR4/NF-kappaB/PLK4 signaling pathway.
Eur J Pharmacol. 2023;961:176151.
Abstract

ZHANG Y, Lin Z, Chen Y, Hong L, et al
Factors related to pre-operative cough strength in cardiac surgical patients: a cross-sectional study.
Heart Lung. 2024;63:128-135.
Abstract

MUHLFELD C, Bienas LM, Bornemann M, Schipke J, et al
Chronic hypoxia-induced alterations of the right ventricular myocardium are not aggravated by alimentary obesity in the mouse.
Microvasc Res. 2024;151:104618.
Abstract

ABEL P, Bulow R, Stubbe B, Heine A, et al
[Fatal course of pulmonary embolism after successful pulmonary endarterectomy: a rare case].
Pneumologie. 2023;77:1009-1012.
Abstract

SUGITANI Y, Muneuchi J, Watanabe M
Home-inhaled nitric oxide in a child with pulmonary arterial hypertension associated with post-operative pulmonary venous obstruction.
Cardiol Young. 2023;33:2673-2675.
Abstract

ABAGNALE L, Candia C, Motta A, Galloway B, et al
Flow-mediated dilation as a marker of endothelial dysfunction in pulmonary diseases: A narrative review.
Respir Med Res. 2023;84:101049.
Abstract

TSANG Y, Stokes M, Kim YJ, Tilney R, et al
Impact of selexipag use within 12 months of pulmonary arterial hypertension diagnosis on hospitalizations and medical costs: A retrospective cohort study.
Clin Respir J. 2023;17:1209-1222.
Abstract

PURMESSUR R, Spencer H, Onwuka NB, Muthialu N, et al
From 6-wk Lungs to 6 y: Increasing the Donor Pool for Pediatric Lung Transplantation.
Transplantation. 2023 Oct 4. doi: 10.1097/TP.0000000000004815.
Abstract

HE X, Fang J, Gong M, Zhang J, et al
Identification of immune-associated signatures and potential therapeutic targets for pulmonary arterial hypertension.
J Cell Mol Med. 2023;27:3864-3877.
Abstract

LIU C, Wan N, Wei L, Rong W, et al
Therapeutic potential and protective role of GRK6 overexpression in pulmonary arterial hypertension.
Vascul Pharmacol. 2023;153:107233.
Abstract

LI HR, Chen GL, Fang XL, Cai XJ, et al
Circ_0068481 Affects the Human Pulmonary Artery Smooth Muscle Cells' Progression by miR-361-3p/KLF5 Axis.
Am J Hypertens. 2024;37:33-45.
Abstract

HE YZ, Wang YX, Ma JS, Li RN, et al
MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension.
Vascul Pharmacol. 2023;153:107216.
Abstract

KOPEC G
Sotatercept as a next-generation therapy for pulmonary arterial hypertension: insights from the STELLAR trial.
Cardiovasc Res. 2023;119:e155-e157.
Abstract

ZHANG J, Meng H, Yin Y, Zhang Y, et al
Prevalence and Determinants of Delay in Time-to-Diagnosis for Pulmonary Arterial Hypertension Patients in Gansu China: A Observational Cohort Study.
Curr Probl Cardiol. 2023;48:102026.
Abstract

NISAR S, Kareem O, Muzaffer U, Tanvir M, et al
Descriptive spectrum of thiamine deficiency in pregnancy: A potentially preventable condition.
Int J Gynaecol Obstet. 2023 Jul 17. doi: 10.1002/ijgo.14989.
Abstract

LONGINOW J, Buggey J, Jacob M, Martens P, et al
Significance of Pulmonary Hypertension in Cardiac Amyloidosis.
Am J Cardiol. 2023;192:147-154.
Abstract

ASLANGER E, Akaslan D, Atas H, Kocakaya D, et al
Right Ventricular Energy Failure Predicts Mortality in Patients With Pulmonary Hypertension.
Am J Cardiol. 2023;193:19-27.
Abstract

MUKHERJEE M, Ogunmoroti O, Jani V, Kapoor K, et al
Characteristics of Right Ventricular to Pulmonary Arterial Coupling and Association With Functional Status Among Older Aged Adults from the Multi-Ethnic Study of Atherosclerosis.
Am J Cardiol. 2023;196:41-51.
Abstract

BONNESEN K, Klok FA, Andersen MJ, Andersen A, et al
Long-Term Prognostic Impact of Pulmonary Hypertension After Venous Thromboembolism.
Am J Cardiol. 2023 May 16:S0002-9149(23)00236.
Abstract

FORTUNI F, Delgado V
Gender and Age Differences in Right Ventricular to Pulmonary Arterial Coupling in Healthy Subjects - Knowing the Norm to Spot the Disease.
Am J Cardiol. 2023;197:84-86.
Abstract

ARRIGO M, Huber LC
Pulmonary Hypertension in Pulmonary Embolism.
Am J Cardiol. 2023 Jun 13:S0002-9149(23)00335.
Abstract

HARINSTEIN ME, Rajaratnam A
Enhancing Detection of Pulmonary Hypertension: A Screening Tool to Quickly Identify and Refer Patients.
Am J Cardiol. 2023 Jul 25:S0002-9149(23)00565.
Abstract

ONI OO, Odeyemi AO, Olasinde YT, Odeyemi AO, et al
Pulmonary Hypertension and Left Ventricular Geometric Types in Sickle Cell Anemia.
Am J Cardiol. 2023;203:175-183.
Abstract

GOTSMAN I, Abu Ghosh Z, Zwas DR, Amir O, et al
Pulmonary Hypertension Severity in Heart Failure: Clinical Characteristics and Impact on Outcome.
Am J Cardiol. 2023;204:29-31.
Abstract

OZCAN KAHRAMAN B, Tanriverdi A, Savci S, Odaman H, et al
Effects of Inspiratory Muscle Training in Patients With Pulmonary Hypertension.
Am J Cardiol. 2023;203:406-413.
Abstract

VEDAGE NA, Forfia PR, Grafstrom A, Vaidya A, et al
Virtual Echocardiography Screening Tool Identifies Pulmonary Arterial Hypertension Significantly Earlier Than High-Risk Clinical Diagnosis.
Am J Cardiol. 2023;201:328-334.
Abstract

SHAH AH, Oechslin E, Benson L, Crean AM, et al
Long-Term Outcomes of Unrepaired Isolated Partial Anomalous Pulmonary Venous Connection With an Intact Atrial Septum.
Am J Cardiol. 2023;201:232-238.
Abstract

GOMEZ-RODRIGUEZ C, Tadeo-Espinoza H, Solis-Huerta F, Leal-Villarreal MAJ, et al
Hemodynamic Evaluation of Right-Sided Congestion With Doppler Ultrasonography in Pulmonary Hypertension.
Am J Cardiol. 2023;203:459-462.
Abstract

RZECHORZEK W, Dey S, Shah A, Michaud L, et al
High-Risk Pulmonary Hypertension Does Not Worsen Outcomes in Heart Transplantation.
Am J Cardiol. 2023;205:290-297.
Abstract

ALPERT MA
Beneficial Effects of Inspiratory Muscle Training in Patients With Pulmonary Arterial Hypertension.
Am J Cardiol. 2023 Aug 7:S0002-9149(23)00689.
Abstract

SHEN CP, Bagsic SRS, Pandey AC
Strain and Exercise-Induced Pulmonary Hypertension.
Am J Cardiol. 2023;205:442-444.
Abstract

ATHANASSOPOULOS GD, Armenis I
A Glimpse for Venous Congestion Management in Pulmonary Hypertension by POCUS of Portal Vein Flow.
Am J Cardiol. 2023 Sep 1:S0002-9149(23)00783.
Abstract

LU D, Cheng CY, Zhu XJ, Li JY, et al
Heart Rate Response Predicts 6-Minutes Walking Distance in Pulmonary Arterial Hypertension.
Am J Cardiol. 2023;204:207-214.
Abstract

AGOSTONI P, Mattavelli I
The Pulmonary Hypertension Treatment: Dogmas and Ghosts.
Am J Cardiol. 2023 Sep 19:S0002-9149(23)00963.
Abstract

CASCINO TM, Schopfer DW, Meyer CS, Zhang N, et al
Exercise Rehabilitation is Underutilized Among Veterans With Pulmonary Hypertension.
Am J Cardiol. 2023;207:4-6.
Abstract

KRISHTOPAYTIS E, Ampnti SA, Obeidat M, Ramahi N, et al
Can Inhaled Nitric Oxide Response Predict Tolerance to Therapies and Survival in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension?
Am J Cardiol. 2023;207:363-369.
Abstract

CHOPRA L, Ueyama H, Dalsania A, Prandi FR, et al
Prognostic Implication of Pulmonary Hypertension in Low-Flow Low-Gradient Aortic Stenosis After Transcatheter Aortic Valve Replacement.
Am J Cardiol. 2023;208:6-12.
Abstract

KIDO K, Shimizu M, Shiga T, Hashiguchi M, et al
Meta-analysis Comparing Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Chronic Thromboembolic Pulmonary Hypertension.
Am J Cardiol. 2023 Oct 14:S0002-9149(23)01151.
Abstract

VASQUEZ MA, Iskander M, Mustafa M, Quintero-Martinez JA, et al
Pericardiocentesis Outcomes in Patients with Pulmonary Hypertension: A Nationwide Analysis from the United States.
Am J Cardiol. 2023 Oct 22:S0002-9149(23)01199.
Abstract

SKOWRONSKI J, Keen S, Harinstein ME
Advancing the Understanding of the Utility of Inhaled Nitric Oxide to Guide Treatment in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension.
Am J Cardiol. 2023 Oct 25:S0002-9149(23)01138.
Abstract

ROSSI R, Coppi F, Sgura FA, Monopoli DE, et al
Effects of Ivabradine on Right Ventricular Systolic Function in Patients With Chronic Obstructive Pulmonary Disease and Cor Pulmonale.
Am J Cardiol. 2023;207:179-183.
Abstract

TADURU SS, Roy SD
Pericardiocentesis in Pulmonary Hypertension: Unveiling Risks and Outcomes in a National Cohort.
Am J Cardiol. 2023 Nov 9:S0002-9149(23)01305.
Abstract

KAILAS M, Layton AM, Pesce M, Liberman L, et al
Exercise-Induced Electrocardiography Changes in Pulmonary Arterial Hypertension.
Am J Cardiol. 2023;208:60-64.
Abstract

ASLANGER E, Akaslan D, Atas H, Yildirimturk O, et al
Is Pulmonary Capillary Wedge Pressure a Reliable Indicator of Postcapillary Pulmonary Hypertension?
Am J Cardiol. 2023 Nov 18:S0002-9149(23)01324.
Abstract

TOBITA K, Sakamoto H, Inami T, Fujisawa D, et al
Understanding Patient Perspectives Toward Shared Decision Making in Patients with Pulmonary Hypertension.
Am J Cardiol. 2023 Nov 18:S0002-9149(23)01336.
Abstract

RUBENS M, Ramamoorthy V, Saxena A, Jimenez J, et al
Hospital Outcomes Among Pulmonary Hypertension Patients with Atrial Fibrillation in the United States.
Am J Cardiol. 2023 Nov 29:S0002-9149(23)01347.
Abstract

KIKUCHI H, Goda A, Takeuchi K, Inami T, et al
Transition from Intravenous Epoprostenol to Treprostinil Due to Intolerable Side Effects in Patients With Pulmonary Arterial Hypertension.
Am J Cardiol. 2023;206:31-34.
Abstract

BROWN RD, Hunter KS, Li M, Frid MG, et al
Functional and Molecular Determinants of Right Ventricular Response to Severe Pulmonary Hypertension in a Large Animal Model.
Am J Physiol Heart Circ Physiol. 2023 Mar 24. doi: 10.1152/ajpheart.00614.2022.
Abstract

MCNAIR BD, Polson SM, Shorthill SK, Yusifov A, et al
Metformin protects against pulmonary hypertension-induced right ventricular dysfunction in an age- and sex-specific manner independent of cardiac AMPK.
Am J Physiol Heart Circ Physiol. 2023 Jun 30. doi: 10.1152/ajpheart.00124.2023.
Abstract

GILBERT RM, Gleghorn JP
Connecting clinical, environmental, and genetic factors point to an essential role for vitamin A signaling in the pathogenesis of congenital diaphragmatic hernia.
Am J Physiol Lung Cell Mol Physiol. 2023;324:L456-L467.
Abstract

BIGNARD J, Atassi F, Claude O, Ghigna MR, et al
T-cell dysregulation and inflammatory process in Gcn2 (Eif2ak4(-/-))-deficient rats in basal and stress conditions.
Am J Physiol Lung Cell Mol Physiol. 2023;324:L609-L624.
Abstract

DOUGHERTY EJ, Chen LY, Awad KS, Ferreyra GA, et al
Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 loss.
Am J Physiol Lung Cell Mol Physiol. 2023;324:L783-L798.
Abstract

SIMPSON CE, Coursen J, Hsu S, Gough EK, et al
Metabolic profiling of in vivo right ventricular function and exercise performance in pulmonary arterial hypertension.
Am J Physiol Lung Cell Mol Physiol. 2023;324:L836-L848.
Abstract

MASSON B, Saint-Martin Willer A, Dutheil M, Penalva L, et al
Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension.
Am J Physiol Lung Cell Mol Physiol. 2023;325:L246-L261.
Abstract

PANKOKE S, Schweitzer T, Bikker R, Pich A, et al
Obesity impacts hypoxia adaptation of the lung.
Am J Physiol Lung Cell Mol Physiol. 2023;325:L352-L359.
Abstract

ALMAZROUE H, Jin Y, Nelin LD, Barba JC 2nd, et al
Human pulmonary microvascular endothelial cell DDAH1-mediated nitric oxide production promotes pulmonary smooth muscle cell apoptosis in co-culture.
Am J Physiol Lung Cell Mol Physiol. 2023;325:L360-L367.
Abstract

LINGAPPAN K, Olutoye OO 2nd, Cantu A, Cantu Gutierrez ME, et al
Molecular insights using spatial transcriptomics of the distal lung in congenital diaphragmatic hernia.
Am J Physiol Lung Cell Mol Physiol. 2023;325:L477-L486.
Abstract

BARNES EA, Ito R, Che X, Alvira CM, et al
Loss of Prolyl Hydroxylase 1 and 2 in SM22alpha-Expressing Cells Prevents Hypoxia-Induced Pulmonary Hypertension.
Am J Physiol Lung Cell Mol Physiol. 2023 Oct 17. doi: 10.1152/ajplung.00428.2022
Abstract

SIMPSON CE, Ambade AS, Harlan R, Roux A, et al
Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension.
Am J Physiol Lung Cell Mol Physiol. 2023;325:L617-L627.
Abstract

WANG ZH, Zhou Q
Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising NKT Cell-based Therapy.
Am J Respir Crit Care Med. 2023 Jan 13. doi: 10.1164/rccm.202211-2134.
Abstract

JANDL K, Marsh LM, Mutgan AC, Crnkovic S, et al
Reply to: Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising NKT Cell-based Therapy.
Am J Respir Crit Care Med. 2023 Jan 13. doi: 10.1164/rccm.202212-2214.
Abstract

RAFFAY TM, Jensen EA
Can Intermittent Hypoxemia Help Detect Pulmonary Hypertension in High-Risk Preemies?
Am J Respir Crit Care Med. 2023 Jan 11. doi: 10.1164/rccm.202212-2290.
Abstract

XANTHOULI P
Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: For Real?
Am J Respir Crit Care Med. 2023;207:238-240.
Abstract

GOLDBERG HJ
Comparing the Incomparable: Identifying Common Themes Across a Diverse Landscape to Address Equity in Lung Allocation.
Am J Respir Crit Care Med. 2023;207:236-238.
Abstract

HASSAN HJ, Naranjo M, Ayoub N, Housten T, et al
Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: The Johns Hopkins Registry.
Am J Respir Crit Care Med. 2023;207:312-322.
Abstract

KOLAITIS NA, Chen H, Calabrese DR, Kumar K, et al
The Lung Allocation Score Remains Inequitable for Patients with Pulmonary Arterial Hypertension, Even after the 2015 Revision.
Am J Respir Crit Care Med. 2023;207:300-311.
Abstract

VISWANATHAN G, Kirshner HF, Nazo N, Ali S, et al
Single-Cell Analysis Reveals Distinct Immune and Smooth Muscle Cell Populations that Contribute to Chronic Thromboembolic Pulmonary Hypertension.
Am J Respir Crit Care Med. 2023 Feb 21. doi: 10.1164/rccm.202203-0441.
Abstract

Erratum: Prognostic Value of Exercise as Compared to Resting Pulmonary Hypertension in Patients with Normal or Mildly Elevated Pulmonary Arterial Pressure.
Am J Respir Crit Care Med. 2023;207:636.
Abstract

LIN S, Frank DB
SOX17 at the Intersection of Sex, Transcription, and Metabolism in Pulmonary Hypertension.
Am J Respir Crit Care Med. 2023 Mar 16. doi: 10.1164/rccm.202302-0284.
Abstract

SANGAM S, Sun X, Schwantes-An TH, Yegambaram M, et al
SOX17 Deficiency Mediates Pulmonary Hypertension: At the Crossroads of Sex, Metabolism, and Genetics.
Am J Respir Crit Care Med. 2023 Mar 13. doi: 10.1164/rccm.202203-0450.
Abstract

OLIVEIRA SD
Cardiopulmonary Pathogenic Networks: Unveiling the Gut-Lung Microbiome Axis in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2023;207:655-657.
Abstract

MOUTSOGLOU DM, Tatah J, Prisco SZ, Prins KW, et al
Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites.
Am J Respir Crit Care Med. 2023;207:740-756.
Abstract

MCNAMARA PJ, Lakshminrusimha S
Maldevelopment of the Immature Pulmonary Vasculature and Prolonged Patency of the Ductus Arteriosus: Association or Cause?
Am J Respir Crit Care Med. 2023;207:814-816.
Abstract

ULRICH S
A Further Step Toward Meaningful Trial Outcomes for Patients with Pulmonary Arterial Hypertension: Minimal Important Difference in 6-minute-walk Distance.
Am J Respir Crit Care Med. 2023;207:972-974.
Abstract

VANDERPOOL RR, Insel M, Kubba S, Rischard FP, et al
The Acute Effects of Prostacyclin on Right Ventricular Contractility and Pulmonary Artery Coupling.
Am J Respir Crit Care Med. 2023;207:1100-1102.
Abstract

MOUTCHIA J, McClelland RL, Al-Naamani N, Appleby DH, et al
Minimal Clinically Important Difference in the 6-minute-walk Distance for Patients with Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2023;207:1070-1079.
Abstract

CORNFIELD DN, Nogee LM
Rare to "Ubiquitinous": Alveolar Capillary Dysplasia, FOXF1, and a Sly Approach to Angiogenesis.
Am J Respir Crit Care Med. 2023;207:969-971.
Abstract

PRADHAN A, Che L, Ustiyan V, Reza AA, et al
Novel FOXF1-Stabilizing Compound TanFe Stimulates Lung Angiogenesis in Alveolar Capillary Dysplasia.
Am J Respir Crit Care Med. 2023;207:1042-1054.
Abstract

BRUSATORI S, Zinnato C, Busana M, Romitti F, et al
High- versus Low-Flow Extracorporeal Respiratory Support in Experimental Hypoxemic Acute Lung Injury.
Am J Respir Crit Care Med. 2023;207:1183-1193.
Abstract

NATHAN SD
Progress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease.
Am J Respir Crit Care Med. 2023 May 9. doi: 10.1164/rccm.202212-2342.
Abstract

QUARCK R, Bogaard HJ, Delcroix M
The Cellular Landscape of Chronic Thromboembolic Pulmonary Hypertension Revealed by Single-Cell Sequencing: Therapeutic Implications?
Am J Respir Crit Care Med. 2023;207:1266-1268.
Abstract

WANG RS, Huang S, Waldo SW, Hess E, et al
Elevated Pulmonary Arterial Compliance Is Associated with Survival in Pulmonary Hypertension: Results from a Novel Network Medicine Analysis.
Am J Respir Crit Care Med. 2023 Jun 5. doi: 10.1164/rccm.202211-2097.
Abstract

YANAGIHARA T, Tsubouchi K, Zhou Q, Chong M, et al
Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.
Am J Respir Crit Care Med. 2023;207:1498-1514.
Abstract

SONNTAG E, Akgun KM, Bag R, Rosensweig EB, et al
Access to Medically Necessary Reproductive Care for Individuals with Pulmonary Hypertension.
Am J Respir Crit Care Med. 2023 Jun 13. doi: 10.1164/rccm.202302-0230.
Abstract

MONTANI D, Thore P, Mignard X, Jais X, et al
Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study.
Am J Respir Crit Care Med. 2023 Jun 13. doi: 10.1164/rccm.202210-1941.
Abstract

WEATHERALD J, Zanini U, Humbert M
Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension.
Am J Respir Crit Care Med. 2023 Jun 22. doi: 10.1164/rccm.202306-0990.
Abstract

MARON BA
Introducing the Pulmonary Hypertension Thematic Series.
Am J Respir Crit Care Med. 2023 Jun 21. doi: 10.1164/rccm.202306-1005.
Abstract

LEIVA O, Garcia BD, Hobbs G
Pulmonary Hypertension in Myeloproliferative Neoplasms: New Insights and Unexplored Horizons.
Am J Respir Crit Care Med. 2023 Jul 10. doi: 10.1164/rccm.202306-1001.
Abstract

JOHNSON S, Sommer N, Cox-Flaherty K, Weissmann N, et al
Pulmonary Hypertension: A Contemporary Review.
Am J Respir Crit Care Med. 2023 Jul 14. doi: 10.1164/rccm.202302-0327.
Abstract

FORBES LM, Bull TM, Lahm T, Lawley JS, et al
Right Ventricular Response to Acute Hypoxia among Healthy Humans.
Am J Respir Crit Care Med. 2023;208:333-336.
Abstract

ROCHESTER CL, Alison JA, Carlin B, Jenkins AR, et al
Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline.
Am J Respir Crit Care Med. 2023;208:e7-e26.
Abstract

BRITTAIN EL, Tedford RJ, Maron BA
Reply to: Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
Am J Respir Crit Care Med. 2023 Aug 10. doi: 10.1164/rccm.202307-1180.
Abstract

WU Y, Su X, Wang J, Zhang H, et al
Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
Am J Respir Crit Care Med. 2023 Aug 10. doi: 10.1164/rccm.202306-1076.
Abstract

HAN MK
From Conundrum to Cures, Pioneering Breakthroughs in Chronic Obstructive Pulmonary Disease Research: Introduction to an AJRCCM Special Issue.
Am J Respir Crit Care Med. 2023;208:339-340.
Abstract

FARHA S, Aldred MA
Regulating the Regulators: Epigenetic Modulation of Regulatory T-Cells in Pulmonary Hypertension.
Am J Respir Crit Care Med. 2023 Sep 8. doi: 10.1164/rccm.202308-1456.
Abstract

GUO M, Wikenheiser-Brokamp KA, Kitzmiller JA, Jiang C, et al
Single Cell Multiomics Identifies Cells and Genetic Networks Underlying Alveolar Capillary Dysplasia.
Am J Respir Crit Care Med. 2023;208:709-725.
Abstract

NORLANDER AE, Abney M, Cephus JY, Roe CE, et al
Prostaglandin I(2) Therapy Promotes Regulatory T Cell Generation in Patients with Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2023;208:737-739.
Abstract

YASUMA T, Fujimoto H, D'Alessandro-Gabazza CN, Gabazza EC, et al
Epoprostenol and Treprostinil: Differential Effects on Regulatory T-Cell Generation in Patients with Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2023;208:1248.
Abstract

WEATHERALD J, Moutchia J, Al-Naamani N, McClelland RL, et al
Win Statistics in Pulmonary Arterial Hypertension Clinical Trials.
Am J Respir Crit Care Med. 2023;208:1231-1234.
Abstract

ELMI-SARABI M, Jarry S, Couture EJ, Haddad F, et al
Pulmonary Vasodilator Response of Combined Inhaled Epoprostenol and Inhaled Milrinone in Cardiac Surgical Patients.
Anesth Analg. 2023;136:282-294.
Abstract

MENG ML, Fuller M, Federspiel JJ, Engelhard M, et al
Maternal Morbidity According to Mode of Delivery Among Pregnant Patients With Pulmonary Hypertension.
Anesth Analg. 2023 May 16. doi: 10.1213/ANE.0000000000006523.
Abstract

YAMAGUCHI CT, Moody AE, Beutler BD, Lee JP, et al
Severe Pulmonary Hypertension and Septum Left Shift.
Anesthesiology. 2023 Jul 12. doi: 10.1097/ALN.0000000000004638.
Abstract

ESTRADA RA
In symptomatic PAH, adding sotatercept to stable background therapy improved 6-min walk distance at 24 wk.
Ann Intern Med. 2023;176:JC69.
Abstract

SANGES S, Rice L, Tu L, Valenzi E, et al
Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis.
Ann Rheum Dis. 2023;82:365-373.
Abstract

IUDICI M, Allali D, Porcher R
Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'.
Ann Rheum Dis. 2023;82:e65.
Abstract

GRUNIG E, Benjamin N, Xanthouli P, Jordan S, et al
Response to: ' Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'' by Iudici et al.
Ann Rheum Dis. 2023;82:e66.
Abstract

KABADI AA, Fernandes TM, Papamatheakis DG, Poch DS, et al
Airway Hemorrhage Complicating Pulmonary Thromboendarterectomy: Risk Factors and Outcomes.
Ann Thorac Surg. 2023;116:121-128.
Abstract

BARCO S, Mavromanoli AC, Kreitner KF, Bunck AC, et al
Pre-existing chronic thromboembolic pulmonary hypertension in acute pulmonary embolism.
Chest. 2023 Jan 5:S0012-3692(23)00013-2. doi: 10.1016/j.chest.2022.
Abstract

ALOTAIBI M, Shao J, Pauciulo MW, Nichols WC, et al
Metabolomic Profiles Differentiate Scleroderma-PAH From Idiopathic PAH and Correspond With Worsened Functional Capacity.
Chest. 2023;163:204-215.
Abstract

HOWARD LS, Rosenkranz S, Frantz RP, Hemnes AR, et al
Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE).
Chest. 2023;163:407-418.
Abstract

KITHAS AC, Ramani GV, Cassady SJ
A Rapidly Evacuated Pericardial Effusion in the Setting of Chronic Pulmonary Hypertension.
Chest. 2023;163:e137-e139.
Abstract

YANG J, Madani MM, Mahmud E, Kim NH, et al
" Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension".
Chest. 2023 Mar 27:S0012-3692(23)00457-9. doi: 10.1016/j.chest.2023.
Abstract

AL-QADI MO, Holbrook J, Ford HJ, Ceppe A, et al
Prognostic Value of Respiratory Variation in Right Atrial Pressure in Patients with Precapillary Pulmonary Hypertension.
Chest. 2023 Mar 27:S0012-3692(23)00458-0. doi: 10.1016/j.chest.2023.
Abstract

MORRIS TA, Fernandes TM, Channick R
How we do it: evaluation of dyspnea and exercise intolerance after acute pulmonary embolism.
Chest. 2022 Jul 2. pii: S0012-3692(22)01215-6. doi: 10.1016/j.chest.2022.
Abstract

FORBES LM, Bull TM, Lahm T, Make BJ, et al
Exercise Testing in the Risk Assessment of Pulmonary Hypertension.
Chest. 2023 Apr 13:S0012-3692(23)00509-3. doi: 10.1016/j.chest.2023.
Abstract

SCARPATO BM, McDonald J, Bayrak-Toydemir P, Elliott CG, et al
The Shunt of It.
Chest. 2023;163:e201-e205.
Abstract

THENAPPAN T, Brittain EL
Right Ventricular Imaging for Predicting Risk in Pulmonary Arterial Hypertension: The Elephant in the Room.
Chest. 2023;163:1013-1015.
Abstract

EL-KERSH K, Zhao C, Elliott G, Farber HW, et al
Derivation of a Risk Score (REVEAL-ECHO) Based on Echocardiographic Parameters of Patients With Pulmonary Arterial Hypertension.
Chest. 2023;163:1232-1244.
Abstract

SULLIVAN RT, Austin ED
Developing a Broader Understanding of Pediatric PAH Worldwide.
Chest. 2023;163:1353-1355.
Abstract

QIAN Y, Quan R, Chen X, Gu Q, et al
Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
Chest. 2023;163:1531-1542.
Abstract

CARBONE RG, Monselise A, Puppo F
Treprostinil and Clinical Outcome in Pulmonary Hypertension and Interstitial Lung Disease: Is All Clear?
Chest. 2023;164:e21.
Abstract

DUBROCK HM
Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.
Chest. 2023;164:206-214.
Abstract

MOINZADEH P, Bonella F, Oberste M, Weliwitage J, et al
Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival - a large cohort study of the German network for systemic sclerosis.
Chest. 2023 Aug 13:S0012-3692(23)05274-1. doi: 10.1016/j.chest.2023.
Abstract

KULARATNE M, Eyries M, Savale L, Humbert M, et al
Isolated Pulmonary Arteriovenous Malformations Associated With BMPR2 Pathogenic Variants.
Chest. 2023;164:e23-e26.
Abstract

KOLAITIS NA
Lung Transplantation for Pulmonary Arterial Hypertension.
Chest. 2023 May 5:S0012-3692(23)00649-9. doi: 10.1016/j.chest.2023.
Abstract

SELF A, Afshar K, Kafi A, Yung G, et al
An Unexpected Cause of Lung Disease Identified After Lung Transplantation.
Chest. 2023;164:e111-e115.
Abstract

LUI JK, Cozzolino M, Winburn M, Trojanowski MA, et al
Role of Left Ventricular Dysfunction in Systemic Sclerosis-related Pulmonary Hypertension.
Chest. 2023 Dec 19:S0012-3692(23)05932-9. doi: 10.1016/j.chest.2023.
Abstract

FAUVEL C, Liu Y, Correa-Jaque P, Kanwar MK, et al
Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial.
Chest. 2023;164:1518-1530.
Abstract

CUTHBERTSON I, Morrell NW, Caruso P
BMPR2 Mutation and Metabolic Reprogramming in Pulmonary Arterial Hypertension.
Circ Res. 2023;132:109-126.
Abstract

WANG L, Moonen JR, Cao A, Isobe S, et al
Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
Circ Res. 2023 Feb 6. doi: 10.1161/CIRCRESAHA.121.320541.
Abstract

PI H, Xia L, Ralph DD, Rayner SG, et al
Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes.
Circ Res. 2023;132:254-266.
Abstract

GONCHAROVA EA, Kudryashova TV, de Jesus Perez VA, Rafikova O, et al
UnWNTing the Heart: Targeting WNT Signaling in Pulmonary Arterial Hypertension.
Circ Res. 2023;132:1486-1488.
Abstract

NAYAKANTI SR, Friedrich A, Sarode P, Jafari L, et al
Targeting Wnt-ss-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling.
Circ Res. 2023;132:1468-1485.
Abstract

ZHOU X, Jiang Y, Wang Y, Fan L, et al
Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension.
Circ Res. 2023 Aug 17. doi: 10.1161/CIRCRESAHA.122.321200.
Abstract

RANASINGHE ADCU, Holohan M, Borger KM, Donahue DL, et al
Altered Smooth Muscle Cell Histone Acetylome by the SPHK2/S1P Axis Promotes Pulmonary Hypertension.
Circ Res. 2023 Sep 12. doi: 10.1161/CIRCRESAHA.123.322740.
Abstract

DAI Z, Thorp EB
New Way to Study Pulmonary Hypertension in HFpEF.
Circ Res. 2023;133:899-901.
Abstract

AGRAWAL V, Kropski JA, Gokey JJ, Kobeck E, et al
Myeloid Cell Derived IL1beta Contributes to Pulmonary Hypertension in HFpEF.
Circ Res. 2023;133:885-898.
Abstract

KNIGHT H, Abis G, Kaur M, Green HLH, et al
Cyclin D-CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation.
Circ Res. 2023;133:966-988.
Abstract

CHIN KM, Santiago-Munoz P
Pregnancy and Congenital Heart Disease-Associated Pulmonary Hypertension: Are Outcomes Improving?
Circulation. 2023;147:562-564.
Abstract

ZHANG Q, Zhu F, Shi G, Hu C, et al
Maternal Outcomes Among Pregnant Women With Congenital Heart Disease-Associated Pulmonary Hypertension.
Circulation. 2023;147:549-561.
Abstract

RAJAGOPAL S, Ruetzler K, Ghadimi K, Horn EM, et al
Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association.
Circulation. 2023 Mar 16. doi: 10.1161/CIR.0000000000001136.
Abstract

WALTERS R, Vasilaki E, Aman J, Chen CN, et al
SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension.
Circulation. 2023 Apr 17. doi: 10.1161/CIRCULATIONAHA.122.061940.
Abstract

JANI V, Aslam MI, Fenwick AJ, Ma W, et al
Right Ventricular Sarcomere Contractile Depression and the Role of Thick Filament Activation in Human Heart Failure With Pulmonary Hypertension.
Circulation. 2023 May 17. doi: 10.1161/CIRCULATIONAHA.123.064717.
Abstract

Correction to: Gremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension.
Circulation. 2023;147:e718.
Abstract

GUIGNABERT C, Savale L, Boucly A, Thuillet R, et al
Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension.
Circulation. 2023 Apr 25. doi: 10.1161/CIRCULATIONAHA.122.061501.
Abstract

Correction to: Heteroplasmy of Wild-Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty.
Circulation. 2023;148:e2.
Abstract

KUEHN BM
Experimental Drug, Combination Pill Show Promise for Treating Pulmonary Hypertension.
Circulation. 2023;148:852-854.
Abstract

HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
Abstract

WALTERS R, Vasilaki E, Wilkins MR, Zhao L, et al
Response by Walters et al to Letter Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
Circulation. 2023;148:1825-1826.
Abstract

LI G, Chen H, Ren C
Letter by Li et al Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
Circulation. 2023;148:1823-1824.
Abstract

PICCARI L, Aguilar-Colindres R, Rodriguez-Chiaradia DA
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?
Curr Opin Pulm Med. 2023 Jul 3. doi: 10.1097/MCP.0000000000000984.
Abstract

BAIR ND, Heresi GA
Lessons learned in developing a chronic thromboembolic pulmonary hypertension program.
Curr Opin Pulm Med. 2023 Jun 29. doi: 10.1097/MCP.0000000000000983.
Abstract

COTTIN V, Diesler R, Turquier S, Valenzuela C, et al
Interstitial lung disease-associated pulmonary hypertension - what the future holds.
Curr Opin Pulm Med. 2023 Jul 10. doi: 10.1097/MCP.0000000000000992.
Abstract

LABRADA L, Vaidy A, Vaidya A
Right ventricular assessment in pulmonary hypertension.
Curr Opin Pulm Med. 2023 Jul 7. doi: 10.1097/MCP.0000000000000980.
Abstract

FRANTZ RP
Group 2 pulmonary hypertension: from diagnosis to treatment.
Curr Opin Pulm Med. 2023 Jul 18. doi: 10.1097/MCP.0000000000001002.
Abstract

KHAN SL, Mathai SC
Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?
Curr Opin Pulm Med. 2023;29:380-390.
Abstract

KABADI A, Kerr K, Fernandes TM
Updates in the diagnosis and management of chronic thromboembolic disease.
Curr Opin Pulm Med. 2023;29:340-347.
Abstract

DESHWAL H, Sulica R
Approach to the hospitalized patient with pulmonary arterial hypertension.
Curr Opin Pulm Med. 2023;29:329-339.
Abstract

ATCHLEY WT, Kakkera TK
Pulmonary hypertension in chronic obstructive pulmonary disease: current understanding, knowledge gaps and future directions.
Curr Opin Pulm Med. 2023 Dec 14. doi: 10.1097/MCP.0000000000001041.
Abstract

KAYAWAKE H, Tanaka S, Yamada Y, Baba S, et al
Comparison of living-donor lobar lung transplantation and cadaveric lung transplantation for pulmonary hypertension.
Eur J Cardiothorac Surg. 2023 Feb 1:ezad024. doi: 10.1093.
Abstract

VAN RAEMDONCK D, Vos R, Verleden GM, Ceulemans LJ, et al
Living-donor lobar lung transplantation for pulmonary hypertension: living on the edge?
Eur J Cardiothorac Surg. 2023 Mar 23:ezad097. doi: 10.1093.
Abstract

KAYAWAKE H, Date H
Living-donor lobar lung transplantation: a viable option for recipients with pulmonary hypertension.
Eur J Cardiothorac Surg. 2023 Apr 4:ezad132. doi: 10.1093.
Abstract

ZENGIN A, Kalkan R, Yildiz Aydin K, Olgun Yildizeli S, et al
Extracellular matrix collagen biomarker levels in patients who underwent pulmonary endarterectomy.
Eur J Cardiothorac Surg. 2023;63:ezad106.
Abstract

MORENO P, Alvarez A
Living-Donor Lobar Lung Transplantation: A Powerful BUT Still Undervalued Resource To Overcome Donor Shortage.
Eur J Cardiothorac Surg. 2023 Mar 16:ezad081. doi: 10.1093.
Abstract

WATANABE T, Matsuo S, Watanabe Y, Hirama T, et al
Bilateral Lung Transplant with Pulmonary Artery Reconstruction using Donor Aorta for Pulmonary Hypertension with a Giant Pulmonary Arterial Aneurysm.
Eur J Cardiothorac Surg. 2023 Jun 19:ezad234. doi: 10.1093.
Abstract

ORMISTON ML, Jankov RP, Stewart DJ
Oh NO! Loss of PHD2 leads to "radical" changes in the lung vasculature.
Eur Respir J. 2022;60:2201776.
Abstract

RUBIN LJ, Naeije R
Sotatercept for pulmonary arterial hypertension: something old and something new.
Eur Respir J. 2023;61:2201972.
Abstract

PRICE LC, Weatherald J
The new 2022 pulmonary hypertension guidelines: some small steps and some giant leaps forward for evidence-based care.
Eur Respir J. 2023;61:2202150.
Abstract

HUMBERT M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, et al
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension.
Eur Respir J. 2023;61:2201347.
Abstract

EICHSTAEDT CA, Belge C, Chung WK, Graf S, et al
Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH.
Eur Respir J. 2023;61:2201471.
Abstract

KOUDSTAAL T, Boomars KA
Inflammatory biomarkers in pulmonary arterial hypertension: ready for clinical implementation?
Eur Respir J. 2023;61:2300018.
Abstract

BOUCLY A, Tu L, Guignabert C, Rhodes C, et al
Cytokines as prognostic biomarkers in pulmonary arterial hypertension.
Eur Respir J. 2023;61:2201232.
Abstract

DE JONG CMM, Visser C, Bemelmans RHH, Boersma WG, et al
Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism.
Eur Respir J. 2023;61:2300171.
Abstract

SCHMIDT KH, Milger K, Pausch C, Huscher D, et al
Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis.
Eur Respir J. 2023;61:2202440.
Abstract

DE MAN FS, Vonk Noordegraaf A
The right ventricle tamed.
Eur Respir J. 2023;61:2300509.
Abstract

SAMARANAYAKE CB, Kempny A, Naeije R, Gatzoulis M, et al
Beta-blockade improves right ventricular diastolic function in exercising pulmonary arterial hypertension.
Eur Respir J. 2023;61:2300144.
Abstract

LUIJTEN D, Talerico R, Barco S, Cannegieter SC, et al
Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: an updated systematic review and meta-analysis.
Eur Respir J. 2023 Jun 15:2300449. doi: 10.1183/13993003.00449-2023.
Abstract

GONCHAROVA EA, Kudryashova TV, Pullamsetti SS
Too hot? Too cold? Wnt signalling in pulmonary arterial hypertension: can we treat it "just right"?
Eur Respir J. 2023;61:2300504.
Abstract

CHAKRABORTY A, Nathan A, Orcholski M, Agarwal S, et al
Wnt7a deficit is associated with dysfunctional angiogenesis in pulmonary arterial hypertension.
Eur Respir J. 2023;61:2201625.
Abstract

COTTIN V, Valenzuela C, Humbert M
Inhaled treprostinil for interstitial lung disease-associated pulmonary hypertension: a silver lining on a very dark cloud.
Eur Respir J. 2023;61:2300944.
Abstract

WAXMAN A, Restrepo-Jaramillo R, Thenappan T, Engel P, et al
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study.
Eur Respir J. 2023;61:2202414.
Abstract

PICCARI L, Blanco I, Torralba Y, Arismendi E, et al
Mechanisms of hypoxaemia in severe pulmonary hypertension associated with COPD.
Eur Respir J. 2023 Jul 6:2300463. doi: 10.1183/13993003.00463-2023.
Abstract

YEH FC, Chen CN, Xie CY, Baxan N, et al
TLR7/8 activation induces autoimmune vasculopathy and causes severe pulmonary arterial hypertension.
Eur Respir J. 2023;62:2300204.
Abstract

PAN HM, McClelland RL, Moutchia J, Appleby DH, et al
Heterogeneity of treatment effects by risk in pulmonary arterial hypertension.
Eur Respir J. 2023;62:2300190.
Abstract

OLSSON KM, Fuge J, Park DH, Kamp JC, et al
Effects of sotatercept on lung diffusion capacity and blood gases in patients with pulmonary arterial hypertension.
Eur Respir J. 2023;62:2301070.
Abstract

ALABED S, Garg P, Alandejani F, Dwivedi K, et al
Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension.
Eur Respir J. 2023;62:2202225.
Abstract

PRICE LC, McCabe C, Weatherald J
Reducing the pressure in pulmonary arterial hypertension: sotatercept, haemodynamics and the right ventricle.
Eur Respir J. 2023;62:2301513.
Abstract

SOUZA R, Badesch DB, Ghofrani HA, Gibbs JSR, et al
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial.
Eur Respir J. 2023;62:2301107.
Abstract

WISSMULLER M, Wartner V, Hohmann C, Adler J, et al
Impact of Face Masks on the Six Minute Walking Distance in Pulmonary Hypertension Patients During the COVID-19 Pandemic: A Prospective, Randomised Cross-over Study.
Eur Respir J. 2023 Oct 12:2201454. doi: 10.1183/13993003.01454-2022.
Abstract

JEVNIKAR M, Solinas S, Brenot P, Lechartier B, et al
Sequential multimodal therapy in chronic thromboembolic pulmonary hypertension (CTEPH) with mixed anatomical lesions: a proof of concept.
Eur Respir J. 2023 Oct 6:2300517. doi: 10.1183/13993003.00517-2023.
Abstract

MCNEILL JN, Roshandelpoor A, Alotaibi M, Choudhary A, et al
The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension.
Eur Respir J. 2023;62:2300561.
Abstract

HADZIC S, Wu CY, Gredic M, Pak O, et al
Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice.
Eur Respir J. 2023 Oct 26:2201606. doi: 10.1183/13993003.01606-2022.
Abstract

ANDRUSKA AM, Zamanian RT
Sorting the wheat from the chaff: the innovative case of precision transpulmonary metabolomics.
Eur Respir J. 2023;62:2301547.
Abstract

HUMBERT M
Viewpoint: activin signalling inhibitors for the treatment of pulmonary arterial hypertension.
Eur Respir J. 2023;62:2301726.
Abstract

NEPTUNE ER, Cardoso WV
Unravelling the expanding role of FGF10 signalling in lung homeostasis and maintenance.
Eur Respir J. 2023;62:2301691.
Abstract

PAUSCH C, Pittrow D, Hoeper MM, Huscher D, et al
Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables.
Eur Respir J. 2023;62:2301023.
Abstract

MCCORMICK A, Krishnan A, Badesch D, Benza RL, et al
Pulmonary artery compliance in different forms of pulmonary hypertension.
Heart. 2023 Feb 14:heartjnl-2022-321760. doi: 10.1136/heartjnl-2022-321760.
Abstract

EDWARD J, Banchs J, Parker H, Cornwell W, et al
Right ventricular function across the spectrum of health and disease.
Heart. 2023;109:349-355.
Abstract

RATWATTE S, Playford D, Stewart S, Strange G, et al
Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes.
Heart. 2023 Apr 3:heartjnl-2022-322187. doi: 10.1136/heartjnl-2022-322187.
Abstract

RATWATTE S, Stewart S, Strange G, Playford D, et al
Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes.
Heart. 2023 Apr 3:heartjnl-2022-322184. doi: 10.1136/heartjnl-2022-322184.
Abstract

CRAMARIUC D, Urheim S
Pulmonary hypertension in significant aortic valve disease: a dive into real-world data.
Heart. 2023 Apr 24:heartjnl-2023-322495. doi: 10.1136/heartjnl-2023-322495.
Abstract

KEARNEY K, Lau EM
Pulmonary arterial compliance: a physiological variable still searching for clinical relevance?
Heart. 2023;109:1052-1053.
Abstract

CARDAIOLI F, Nai Fovino L, Fabris T, Masiero G, et al
Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation.
Heart. 2023 Jul 6:heartjnl-2023-322881. doi: 10.1136/heartjnl-2023-322881.
Abstract

MICHELENA HI, Anand V, Enriquez-Sarano M, Pellikka PA, et al
Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Ratwatte et al.
Heart. 2023 Sep 1:heartjnl-2023-323347. doi: 10.1136/heartjnl-2023-323347.
Abstract

RATWATTE S, Celermajer DS
Response to: Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Michelena et al.
Heart. 2023 Sep 1:heartjnl-2023-323348. doi: 10.1136/heartjnl-2023-323348.
Abstract

CELANT LR, Wessels JN, Kianzad A, Marcus JT, et al
Restoration of right ventricular function in the treatment of pulmonary arterial hypertension.
Heart. 2023;109:1844-1850.
Abstract

SAHIN C, Pamukcu O
Serum Cystatin C: A Potential Biomarker in Pulmonary Hypertension in Children.
Indian J Pediatr. 2023 Feb 2. doi: 10.1007/s12098-023-04487.
Abstract

FORFIA PR
Association of Left Ventricular Filling Pressure With Chronic Thromboembolic Pulmonary Hypertension: A Matter of Perspective.
J Am Coll Cardiol. 2023;81:665-667.
Abstract

GERGES C, Pistritto AM, Gerges M, Friewald R, et al
Left Ventricular Filling Pressure in Chronic Thromboembolic Pulmonary Hypertension.
J Am Coll Cardiol. 2023;81:653-664.
Abstract

COSTANZO MR, Marwick TH
Right Atrium as Barometer of Right Ventricular Stiffness and Treatment Responsiveness in Precapillary Pulmonary Hypertension.
J Am Coll Cardiol. 2023;82:718-720.
Abstract

WESSELS JN, van Wezenbeek J, de Rover J, Smal R, et al
Right Atrial Adaptation to Precapillary Pulmonary Hypertension: Pressure-Volume, Cardiomyocyte, and Histological Analysis.
J Am Coll Cardiol. 2023;82:704-717.
Abstract

JAVAHERI S, Somers VK
Sleep, Hypoxia, and Survival in Group 1 Pulmonary Arterial Hypertension: What to Do?
J Am Coll Cardiol. 2023;82:2006-2008.
Abstract

MATHIAS W JR, Le Bihan DCS, Hajjar LA
Stress Echocardiography: Another Hilltop, and It Is Better Than Ever.
J Am Coll Cardiol. 2023;82:1986-1988.
Abstract

GARGANI L, Pugliese NR, De Biase N, Mazzola M, et al
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation.
J Am Coll Cardiol. 2023;82:1973-1985.
Abstract

NAG P, Chowdhury SR, Behera SK, Das M, et al
Levosimendan or Milrinone for Ventricular Septal Defect Repair With Pulmonary Arterial Hypertension.
J Cardiothorac Vasc Anesth. 2023;37:972-979.
Abstract

LOOSEN G, Taboada D, Ortmann E, Martinez G, et al
How Would I Treat My Own Chronic Thromboembolic Pulmonary Hypertension in the Perioperative Period?
J Cardiothorac Vasc Anesth. 2023 Jul 21:S1053-0770(23)00504.
Abstract

CHOI C, Banks D
Chronic Thromboembolic Pulmonary Hypertension Due to a Rare Anterior Mediastinal Venous Malformation.
J Cardiothorac Vasc Anesth. 2023 Aug 1:S1053-0770(23)00507.
Abstract

MOHANANEY D, Martin AK, Mandawat H, Hauser JM, et al
Analysis of the 2022 European Society of Cardiology/European Respiratory Society Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.
J Cardiothorac Vasc Anesth. 2023 Nov 3:S1053-0770(23)00906.
Abstract

LI SS, Liang S, Li L, Yang H, et al
circNFXL1 Modulates the Kv2.1 Channel Function in Hypoxic Human Pulmonary Artery Smooth Muscle Cells via Sponging miR-29b-2-5p as a Competitive Endogenous RNA.
J Cardiovasc Pharmacol. 2023;81:292-299.
Abstract

BROCKMOLLER J, Ivanoski S, Hundack L, Blohm JH, et al
Clinical and hemodynamic improvement in pulmonary hypertension after switching to sacubitril/valsartan in heart failure patients with preserved ejection fraction.
J Cardiovasc Pharmacol. 2023 Sep 1. doi: 10.1097/FJC.0000000000001477.
Abstract

ROSENKRANZ S, Pausch C, Coghlan JG, Huscher D, et al
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.
J Heart Lung Transplant. 2023;42:102-114.
Abstract

URIEL MH, Clerkin KJ, Takeda K, Naka Y, et al
Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach.
J Heart Lung Transplant. 2023;42:124-133.
Abstract

GALLARDO-VARA E, Ntokou A, Dave JM, Jovin DG, et al
Vascular pathobiology of pulmonary hypertension.
J Heart Lung Transplant. 2022 Dec 21:S1053-2498(22)02256.
Abstract

RICHTER MJ, Fortuni F, Alenezi F, D'Alto M, et al
Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis.
J Heart Lung Transplant. 2022 Dec 9:S1053-2498(22)02243.
Abstract

HIRSCH K, Nolley S, Ralph DD, Zheng Y, et al
Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
J Heart Lung Transplant. 2022;42:173-82.
Abstract

DAHIYA G, Kyvernitakis A, Elhamdani A, Begg A, et al
Prognostic role of pulmonary hemodynamics before transcatheter aortic valve replacement among patients with severe aortic stenosis.
J Heart Lung Transplant. 2022 Oct 9:S1053-2498(22)02167.
Abstract

NISHIHARA T, Shimokawahara H, Ogawa A, Naito T, et al
Comparison of the safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension patients with surgically accessible and inaccessible lesions.
J Heart Lung Transplant. 2023 Jan 19:S1053-2498(23)00007.
Abstract

HADINNAPOLA CM, Southwood M, Hernandez-Sanchez J, Bunclark K, et al
Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH-Results from a prospective discovery and validation biomarker study.
J Heart Lung Transplant. 2023;42:398-405.
Abstract

FROST AE, Zhao C, Farber HW, Benza R, et al
Smoking history and pulmonary arterial hypertension: Demographics, onset, and outcomes.
J Heart Lung Transplant. 2023;42:377-389.
Abstract

HUANG Y, Zhang QZ, Lv SJ
Comments and opinions regarding "Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension".
J Heart Lung Transplant. 2023 Mar 20:S1053-2498(23)01788.
Abstract

STRUEBER M
TREATMENT STRATEGIES FOR END-STAGE PULMONARY HYPERTENSION.
J Heart Lung Transplant. 2023 Apr 4:S1053-2498(23)01814.
Abstract

ASHWIN REDDY S, Swietlik EM, Robertson L, Michael A, et al
Natural History of Chronic Thromboembolic Pulmonary Disease with no or mild Pulmonary Hypertension.
J Heart Lung Transplant. 2023 May 16:S1053-2498(23)01848.
Abstract

WIEDENROTH CB, Guth S
Response to Huang et al. regarding "Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension".
J Heart Lung Transplant. 2023 Jun 20:S1053-2498(23)01908.
Abstract

XIE F, Quan R, Zhang G, Tian H, et al
Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry.
J Heart Lung Transplant. 2023;42:974-984.
Abstract

CHAN JCY, Man HSJ, Asghar UM, McRae K, et al
Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
J Heart Lung Transplant. 2023 Jul 6:S1053-2498(23)01897.
Abstract

RAKO ZA, Yogeswaran A, Lakatos BK, Fabian A, et al
Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension.
J Heart Lung Transplant. 2023 Jul 12:S1053-2498(23)01935.
Abstract

FERNANDES TM, Kim NH, Kerr KM, Auger WR, et al
Distal vessel pulmonary thromboendarterectomy: Results from a single institution.
J Heart Lung Transplant. 2023;42:1112-1119.
Abstract

STOLFO D, Barbisan D, Ameri P, Lombardi CM, et al
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension.
J Heart Lung Transplant. 2023;42:1082-1092.
Abstract

ZHANG J, Kan J, Wei Y, Zhang C, et al
Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial.
J Heart Lung Transplant. 2023;42:1140-1151.
Abstract

PIENN M, Gertz RJ, Gerhardt F, Kroger JR, et al
CT-derived Lung Vessel Morphology Correlates with Prognostic Markers in Pre-capillary Pulmonary Hypertension.
J Heart Lung Transplant. 2023 Aug 22:S1053-2498(23)01973.
Abstract

YE JR, Hu SY, Lin YH, Huang CH, et al
Surgery for fibrosing mediastinitis with severe pulmonary hypertension due to pulmonary venous stenosis.
J Heart Lung Transplant. 2023 Aug 25:S1053-2498(23)02002.
Abstract

UKITA R, Patel YJ, Kelly Wu W, Francois SA, et al
Ambulatory Seven-Day Mechanical Circulatory Support in Sheep Model of Pulmonary Hypertension and Right Heart Failure.
J Heart Lung Transplant. 2023 Oct 29:S1053-2498(23)02081.
Abstract

NATHAN SD, Chandel A, Wang Y, Xu J, et al
Derivation and validation of a non-invasive prediction tool to identify pulmonary hypertension in patients with IPF: evolution of the model FORD.
J Heart Lung Transplant. 2023 Nov 16:S1053-2498(23)02123.
Abstract

KIANZAD A, Baccelli A, Braams NJ, Andersen S, et al
Long-term effects of pulmonary endarterectomy on pulmonary hemodynamics, cardiac function and exercise capacity in chronic thromboembolic pulmonary hypertension.
J Heart Lung Transplant. 2023 Nov 22:S1053-2498(23)02130.
Abstract

TAKANO R, Aoki T, Asano R, Ueda J, et al
Recurrent Pulmonary Hypertension After Balloon Pulmonary Angioplasty for Inoperable Chronic Thromboembolic Pulmonary Hypertension.
J Heart Lung Transplant. 2023 Dec 19:S1053-2498(23)02174.
Abstract

JUTANT EM, Chelgham MK, Ottaviani M, Thuillet R, et al
Central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension.
J Heart Lung Transplant. 2024;43:120-133.
Abstract

SHARMA P, Beam K, Levy P, Beam AL, et al
PD(AI): the role of artificial intelligence in the management of patent ductus arteriosus.
J Perinatol. 2023;43:257-258.
Abstract

YURTTUTAN S, Gullu UU
Neonatal AKI in late preterm infants with patent ductus arteriosus.
J Perinatol. 2021;41:2383-2384.
Abstract

ZHU F, Ibarra Rios D, Joye S, Baczynski M, et al
Cardiopulmonary physiological effects of diuretic therapy in preterm infants with chronic pulmonary hypertension.
J Perinatol. 2023 Aug 7. doi: 10.1038/s41372-023-01742.
Abstract

STEFLIK HJ, Wessler LA, Shugart WW, Wagner CL, et al
Indomethacin patent ductus arteriosus prophylaxis in the modern era: renal implications.
J Perinatol. 2023;43:1045-1046.
Abstract

TIMBERLINE S, Bhatt A, Sunderji S, Tancredi DJ, et al
Novel scoring tool of hypoxemic respiratory failure and pulmonary hypertension for defining severity of persistent pulmonary hypertension of newborn.
J Perinatol. 2023 Aug 25. doi: 10.1038/s41372-023-01762.
Abstract

OSMAN A, Halling C, Crume M, Al Tabosh H, et al
Meconium aspiration syndrome: a comprehensive review.
J Perinatol. 2023 Aug 5. doi: 10.1038/s41372-023-01708.
Abstract

BEER L, Rivera BK, Jama W, Slaughter JL, et al
Association of the respiratory severity score with bronchopulmonary dysplasia-associated pulmonary hypertension in infants born extremely preterm.
J Perinatol. 2023 Oct 18. doi: 10.1038/s41372-023-01798.
Abstract

KILMARTIN KC, Al Balushi A, Altit G, Lapointe A, et al
Impact of persistent pulmonary hypertension and oxygenation on brain injury in neonates with neonatal encephalopathy treated with therapeutic hypothermia.
J Perinatol. 2023 Oct 23. doi: 10.1038/s41372-023-01805.
Abstract

FIKE CD, Aschner JL, Avachat C, Birnbaum AK, et al
Multi-dose enteral L-citrulline administration in premature infants at risk of developing pulmonary hypertension associated with bronchopulmonary dysplasia.
J Perinatol. 2023 Oct 31. doi: 10.1038/s41372-023-01809.
Abstract

LIU X, Ohlrich K, McGrath DP, Cobey F, et al
Intraoperative changes and prognostic implications of pulmonary hypertension in patients with hypertrophic obstructive cardiomyopathy undergoing surgical septal myectomy.
J Thorac Cardiovasc Surg. 2022 Oct 6:S0022-5223(22)01045.
Abstract

AWAD MA, Cires-Drouet R, Ramani G, Leibowitz JL, et al
Pulmonary Thromboendarterectomy in Hospitalized versus Elective Patients with Chronic Thromboembolic Pulmonary Hypertension.
J Thorac Cardiovasc Surg. 2023 Aug 21:S0022-5223(23)00728.
Abstract

AGGARWAL R, Potel KN, Jackson S, Lemke NT, et al
Impact of Lung Transplantation on Diastolic Dysfunction in Recipients with Pre-Transplant Pulmonary Hypertension.
J Thorac Cardiovasc Surg. 2023 Sep 21:S0022-5223(23)00855.
Abstract

ASTASHCHANKA A, Kerr KM, Yang JZ, Bautista A, et al
Repeat pulmonary thromboendarterectomy outcomes: A 15-year single-center retrospective review.
J Thorac Cardiovasc Surg. 2023;166:1512-1519.
Abstract

VALDEOLMILLOS E, Le Pavec J, Audie M, Savale L, et al
Thirty years of surgical management of pediatric pulmonary hypertension :mid-term outcomes following reverse Potts shunt and transplantation.
J Thorac Cardiovasc Surg. 2023 Dec 3:S0022-5223(23)01121.
Abstract

KROWKA MJ, Kamath PS
Portopulmonary hypertension: May we agree to disagree?
Liver Transpl. 2023;29:349-350.
Abstract

JOSE A, Kopras EJ, Shah SA, Elwing JM, et al
Portopulmonary hypertension practice patterns after liver transplantation.
Liver Transpl. 2023;29:365-376.
Abstract

HOEPER MM, Badesch DB, Ghofrani HA, Gibbs JSR, et al
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
N Engl J Med. 2023 Mar 6. doi: 10.1056/NEJMoa2213558.
Abstract

TAICHMAN DB, Leopold JA, Elliott G
Continued Progress in Therapy for Pulmonary Arterial Hypertension.
N Engl J Med. 2023 Mar 6. doi: 10.1056/NEJMe2300324.
Abstract

LE PAVEC J, Savale L, Prevot G, Montani D, et al
[Lung transplantation for severe pulmonary hypertension].
Rev Mal Respir. 2023 Jan 30:S0761-8425(22)00467.
Abstract

MONTANI D, Eichstaedt CA, Belge C, Chung WK, et al
[Genetic counselling and testing in pulmonary arterial hypertension - A consensus statement on behalf of the International Consortium for Genetic Studies in PAH - French version].
Rev Mal Respir. 2023;40.
Abstract

KING JA, Desai A, Semple T, Nicholson AG, et al
Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension-management challenges.
Thorax. 2023;78:107-109.
Abstract

MAI V, Gosselin C, Tremblay E, Rompre G, et al
Patients' perceptions on clinical trials outcomes in pulmonary arterial hypertension therapy.
Thorax. 2023;78:721-725.
Abstract

MARIN-ROMERO S, Ballaz-Quincoces A, Gomez-Cuervo C, Marchena-Yglesias PJ, et al
Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE study.
Thorax. 2023 Nov 30:thorax-2023-220580. doi: 10.1136/thorax-2023-220580.
Abstract

BARTNIK A, Pepke-Zaba J, Bunclark K, Ruggiero A, et al
Cardiac MRI in the assessment of chronic thromboembolic pulmonary hypertension and response to treatment.
Thorax. 2023 Nov 22:thorax-2022-219716. doi: 10.1136/thorax-2022-219716.
Abstract

NARULA T, Martin AK, Asif AA, Fritz AV, et al
Outcomes of Lung Transplantation in Patients With Combined Pulmonary Fibrosis and Emphysema: A Single-Center Experience.
Transplant Proc. 2023 Feb 25:S0041-1345(23)00003.
Abstract

SHARMA S, Ruiz J, Paghdar S, Desai S, et al
Revisiting Pulmonary Hypertension in the Era of Temporary Mechanical Circulatory Support - Literature Review and Case-Based Discussion.
Transplant Proc. 2023 Nov 16:S0041-1345(23)00650.
Abstract

MCCORMACK C, Kehoe B, Cullivan S, McCaffrey N, et al
Exploration of physical activity knowledge, preferences and support needs among pulmonary hypertension patients.
PLoS One. 2023;18:e0277696.
Abstract

TAKIGAMI M, Nakanishi N, Tsubata H, Fukai K, et al
Efficacy and safety of guide extension catheter in balloon pulmonary angioplasty for treatment of complex lesions in chronic thromboembolic pulmonary hypertension.
PLoS One. 2023;18:e0280683.
Abstract

MURNI IK, Patmasari L, Wirawan MT, Arafuri N, et al
Outcome and factors associated with undernutrition among children with congenital heart disease.
PLoS One. 2023;18:e0281753.
Abstract

KRONBERGER C, Mousavi RA, Ozturk B, Willixhofer R, et al
Functional capacity testing in patients with pulmonary hypertension (PH) using the one-minute sit-to-stand test (1-min STST).
PLoS One. 2023;18:e0282697.
Abstract

YANG Q, Fan W, Lai B, Liao B, et al
lncRNA-TCONS_00008552 expression in patients with pulmonary arterial hypertension due to congenital heart disease.
PLoS One. 2023;18:e0281061.
Abstract

TUKPAH AC, Rose JA, Seger DL, Dellaripa PF, et al
Development and validation of algorithms to build an electronic health record based cohort of patients with systemic sclerosis.
PLoS One. 2023;18:e0283775.
Abstract

GODA A, Yanagisawa Y, Takeuchi S, Takeuchi K, et al
Characteristics of cardiopulmonary exercise testing in patients with combined post- and pre-capillary pulmonary hypertension due to left heart disease.
PLoS One. 2023;18:e0286057.
Abstract

KITANO T, Nabeshima Y, Nagata Y, Takeuchi M, et al
Prognostic value of the right ventricular ejection fraction using three-dimensional echocardiography: Systematic review and meta-analysis.
PLoS One. 2023;18:e0287924.
Abstract

TSEGA W, Awoke W, Sendekie AK, Dagnew EM, et al
Electrocardiogram and echocardiography findings and the outcomes of patients with myocardial infarction: Retrospective study in tertiary care hospitals in Northwest Ethiopia.
PLoS One. 2023;18:e0288698.
Abstract

RAMBARAT P, Zern EK, Wang D, Roshandelpoor A, et al
Identifying high risk clinical phenogroups of pulmonary hypertension through a clustering analysis.
PLoS One. 2023;18:e0290553.
Abstract

HENRY DS, Pellegrino RG
A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer's disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial.
PLoS One. 2023;18:e0292863.
Abstract

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.

;